model;pk;GeneName;GeneID;EntryName;ProteinName
drug.Protein;P00734;F2;ENSG00000180210;P00734;"Prothrombin (EC 3.4.21.5) (Coagulation factor II) [Cleaved into: Activation peptide fragment 1; Activation peptide fragment 2; Thrombin light chain; Thrombin heavy chain]"
drug.Protein;P00533;EGFR;ENSG00000146648;P00533;Epidermal growth factor receptor (EC 2.7.10.1) (Proto-oncogene c-ErbB-1) (Receptor tyrosine-protein kinase erbB-1)
drug.Protein;O75015;FCGR3B;ENSG00000162747;O75015;Low affinity immunoglobulin gamma Fc region receptor III-B (Fc-gamma RIII-beta) (CD16-I) (Fc-gamma RIII) (Fc-gamma RIIIb) (FcRIII) (FcRIIIb) (FcR-10) (IgG Fc receptor III-1) (CD antigen CD16b)
drug.Protein;P02745;C1QA;ENSG00000173372;P02745;Complement C1q subcomponent subunit A
drug.Protein;P02746;C1QB;ENSG00000173369;P02746;Complement C1q subcomponent subunit B
drug.Protein;P02747;C1QC;ENSG00000159189;P02747;Complement C1q subcomponent subunit C
drug.Protein;P08637;FCGR3A;ENSG00000203747;P08637;Low affinity immunoglobulin gamma Fc region receptor III-A (IgG Fc receptor III-A) (CD16-II) (CD16a antigen) (Fc-gamma RIII-alpha) (Fc-gamma RIII) (Fc-gamma RIIIa) (FcRIII) (FcRIIIa) (FcgammaRIIIA) (FcR-10) (IgG Fc receptor III-2) (CD antigen CD16a)
drug.Protein;P12314;FCGR1A;ENSG00000150337;P12314;High affinity immunoglobulin gamma Fc receptor I (IgG Fc receptor I) (Fc-gamma RI) (FcRI) (Fc-gamma RIA) (FcgammaRIa) (CD antigen CD64)
drug.Protein;P12318;FCGR2A;ENSG00000143226;P12318;Low affinity immunoglobulin gamma Fc region receptor II-a (IgG Fc receptor II-a) (CDw32) (Fc-gamma RII-a) (Fc-gamma-RIIa) (FcRII-a) (CD antigen CD32)
drug.Protein;P01589;IL2RA;ENSG00000134460;P01589;Interleukin-2 receptor subunit alpha (IL-2 receptor subunit alpha) (IL-2-RA) (IL-2R subunit alpha) (IL2-RA) (TAC antigen) (p55) (CD antigen CD25)
drug.Protein;P14784;IL2RB;ENSG00000100385;P14784;Interleukin-2 receptor subunit beta (IL-2 receptor subunit beta) (IL-2R subunit beta) (IL-2RB) (High affinity IL-2 receptor subunit beta) (Interleukin-15 receptor subunit beta) (p70-75) (p75) (CD antigen CD122)
drug.Protein;P31785;IL2RG;ENSG00000147168;P31785;Cytokine receptor common subunit gamma (Interleukin-2 receptor subunit gamma) (IL-2 receptor subunit gamma) (IL-2R subunit gamma) (IL-2RG) (gammaC) (p64) (CD antigen CD132)
drug.Protein;P01375;TNF;ENSG00000232810;P01375;"Tumor necrosis factor (Cachectin) (TNF-alpha) (Tumor necrosis factor ligand superfamily member 2) (TNF-a) [Cleaved into: Tumor necrosis factor, membrane form (N-terminal fragment) (NTF); Intracellular domain 1 (ICD1); Intracellular domain 2 (ICD2); C-domain 1; C-domain 2; Tumor necrosis factor, soluble form]"
drug.Protein;P31994;FCGR2B;ENSG00000072694;P31994;Low affinity immunoglobulin gamma Fc region receptor II-b (IgG Fc receptor II-b) (CDw32) (Fc-gamma RII-b) (Fc-gamma-RIIb) (FcRII-b) (CD antigen CD32)
drug.Protein;P31995;FCGR2C;ENSG00000244682;P31995;Low affinity immunoglobulin gamma Fc region receptor II-c (IgG Fc receptor II-c) (CDw32) (Fc-gamma RII-c) (Fc-gamma-RIIc) (FcRII-c) (CD antigen CD32)
drug.Protein;P01374;LTA;ENSG00000226979;P01374;Lymphotoxin-alpha (LT-alpha) (TNF-beta) (Tumor necrosis factor ligand superfamily member 1)
drug.Protein;P05164;MPO;ENSG00000005381;P05164;"Myeloperoxidase (MPO) (EC 1.11.2.2) [Cleaved into: Myeloperoxidase; 89 kDa myeloperoxidase; 84 kDa myeloperoxidase; Myeloperoxidase light chain; Myeloperoxidase heavy chain]"
drug.Protein;P30968;GNRHR;ENSG00000109163;P30968;Gonadotropin-releasing hormone receptor (GnRH receptor) (GnRH-R)
drug.Protein;P48551;IFNAR2;ENSG00000159110;P48551;Interferon alpha/beta receptor 2 (IFN-R-2) (IFN-alpha binding protein) (IFN-alpha/beta receptor 2) (Interferon alpha binding protein) (Type I interferon receptor 2)
drug.Protein;P17181;IFNAR1;ENSG00000142166;P17181;Interferon alpha/beta receptor 1 (IFN-R-1) (IFN-alpha/beta receptor 1) (Cytokine receptor class-II member 1) (Cytokine receptor family 2 member 1) (CRF2-1) (Type I interferon receptor 1)
drug.Protein;P05177;CYP1A2;ENSG00000140505;P05177;Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)
drug.Protein;P00747;PLG;ENSG00000122194;P00747;"Plasminogen (EC 3.4.21.7) [Cleaved into: Plasmin heavy chain A; Activation peptide; Angiostatin; Plasmin heavy chain A, short form; Plasmin light chain B]"
drug.Protein;P02671;FGA;ENSG00000171560;P02671;"Fibrinogen alpha chain [Cleaved into: Fibrinopeptide A; Fibrinogen alpha chain]"
drug.Protein;Q03405;PLAUR;ENSG00000011422;Q03405;Urokinase plasminogen activator surface receptor (U-PAR) (uPAR) (Monocyte activation antigen Mo3) (CD antigen CD87)
drug.Protein;P05121;SERPINE1;ENSG00000106366;P05121;Plasminogen activator inhibitor 1 (PAI) (PAI-1) (Endothelial plasminogen activator inhibitor) (Serpin E1)
drug.Protein;Q02643;GHRHR;ENSG00000106128;Q02643;Growth hormone-releasing hormone receptor (GHRH receptor) (Growth hormone-releasing factor receptor) (GRF receptor) (GRFR)
drug.Protein;P19235;EPOR;ENSG00000187266;P19235;Erythropoietin receptor (EPO-R)
drug.Protein;P05120;SERPINB2;ENSG00000197632;P05120;Plasminogen activator inhibitor 2 (PAI-2) (Monocyte Arg-serpin) (Placental plasminogen activator inhibitor) (Serpin B2) (Urokinase inhibitor)
drug.Protein;P05154;SERPINA5;ENSG00000188488;P05154;Plasma serine protease inhibitor (Acrosomal serine protease inhibitor) (Plasminogen activator inhibitor 3) (PAI-3) (PAI3) (Protein C inhibitor) (PCI) (Serpin A5)
drug.Protein;P98164;LRP2;ENSG00000081479;P98164;Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin)
drug.Protein;Q9Y5Y6;ST14;ENSG00000149418;Q9Y5Y6;Suppressor of tumorigenicity 14 protein (EC 3.4.21.109) (Matriptase) (Membrane-type serine protease 1) (MT-SP1) (Prostamin) (Serine protease 14) (Serine protease TADG-15) (Tumor-associated differentially-expressed gene 15 protein)
drug.Protein;P14543;NID1;ENSG00000116962;P14543;Nidogen-1 (NID-1) (Entactin)
drug.Protein;P39900;MMP12;ENSG00000262406;P39900;Macrophage metalloelastase (MME) (EC 3.4.24.65) (Macrophage elastase) (ME) (hME) (Matrix metalloproteinase-12) (MMP-12)
drug.Protein;P22888;LHCGR;ENSG00000138039;P22888;Lutropin-choriogonadotropic hormone receptor (LH/CG-R) (Luteinizing hormone receptor) (LHR) (LSH-R)
drug.Protein;P30988;CALCR;ENSG00000004948;P30988;Calcitonin receptor (CT-R)
drug.Protein;Q99062;CSF3R;ENSG00000119535;Q99062;Granulocyte colony-stimulating factor receptor (G-CSF receptor) (G-CSF-R) (CD antigen CD114)
drug.Protein;P08246;ELANE;ENSG00000197561;P08246;Neutrophil elastase (EC 3.4.21.37) (Bone marrow serine protease) (Elastase-2) (Human leukocyte elastase) (HLE) (Medullasin) (PMN elastase)
drug.Protein;P15509;CSF2RA;ENSG00000198223;P15509;Granulocyte-macrophage colony-stimulating factor receptor subunit alpha (GM-CSF-R-alpha) (GMCSFR-alpha) (GMR-alpha) (CDw116) (CD antigen CD116)
drug.Protein;P26951;IL3RA;ENSG00000185291;P26951;Interleukin-3 receptor subunit alpha (IL-3 receptor subunit alpha) (IL-3R subunit alpha) (IL-3R-alpha) (IL-3RA) (CD antigen CD123)
drug.Protein;P32927;CSF2RB;ENSG00000100368;P32927;Cytokine receptor common subunit beta (CDw131) (GM-CSF/IL-3/IL-5 receptor common beta subunit) (CD antigen CD131)
drug.Protein;P34741;SDC2;ENSG00000169439;P34741;Syndecan-2 (SYND2) (Fibroglycan) (Heparan sulfate proteoglycan core protein) (HSPG) (CD antigen CD362)
drug.Protein;P13727;PRG2;ENSG00000186652;P13727;Bone marrow proteoglycan (BMPG) (Proteoglycan 2) [Cleaved into: Eosinophil granule major basic protein (EMBP) (MBP) (Pregnancy-associated major basic protein)]
drug.Protein;P10635;CYP2D6;ENSG00000100197;P10635;Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)
drug.Protein;P11712;CYP2C9;ENSG00000138109;P11712;Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)
drug.Protein;P05543;SERPINA7;ENSG00000123561;P05543;Thyroxine-binding globulin (Serpin A7) (T4-binding globulin)
drug.Protein;P16473;TSHR;ENSG00000165409;P16473;Thyrotropin receptor (Thyroid-stimulating hormone receptor) (TSH-R)
drug.Protein;P00742;F10;ENSG00000126218;P00742;"Coagulation factor X (EC 3.4.21.6) (Stuart factor) (Stuart-Prower factor) [Cleaved into: Factor X light chain; Factor X heavy chain; Activated factor Xa heavy chain]"
drug.Protein;P00740;F9;ENSG00000101981;P00740;"Coagulation factor IX (EC 3.4.21.22) (Christmas factor) (Plasma thromboplastin component) (PTC) [Cleaved into: Coagulation factor IXa light chain; Coagulation factor IXa heavy chain]"
drug.Protein;P04275;VWF;ENSG00000110799;P04275;von Willebrand factor (vWF) [Cleaved into: von Willebrand antigen 2 (von Willebrand antigen II)]
drug.Protein;O14832;PHYH;ENSG00000107537;O14832;Phytanoyl-CoA dioxygenase, peroxisomal (EC 1.14.11.18) (Phytanic acid oxidase) (Phytanoyl-CoA alpha-hydroxylase) (PhyH)
drug.Protein;P07307;ASGR2;ENSG00000161944;P07307;Asialoglycoprotein receptor 2 (ASGP-R 2) (ASGPR 2) (C-type lectin domain family 4 member H2) (Hepatic lectin H2) (HL-2)
drug.Protein;P11021;HSPA5;ENSG00000044574;P11021;Endoplasmic reticulum chaperone BiP (EC 3.6.4.10) (78 kDa glucose-regulated protein) (GRP-78) (Binding-immunoglobulin protein) (BiP) (Heat shock protein 70 family protein 5) (HSP70 family protein 5) (Heat shock protein family A member 5) (Immunoglobulin heavy chain-binding protein)
drug.Protein;P27797;CALR;ENSG00000179218;P27797;Calreticulin (CRP55) (Calregulin) (Endoplasmic reticulum resident protein 60) (ERp60) (HACBP) (grp60)
drug.Protein;P27824;CANX;ENSG00000127022;P27824;Calnexin (IP90) (Major histocompatibility complex class I antigen-binding protein p88) (p90)
drug.Protein;P49257;LMAN1;ENSG00000074695;P49257;Protein ERGIC-53 (ER-Golgi intermediate compartment 53 kDa protein) (Gp58) (Intracellular mannose-specific lectin MR60) (Lectin mannose-binding 1)
drug.Protein;Q07954;LRP1;ENSG00000123384;Q07954;"Prolow-density lipoprotein receptor-related protein 1 (LRP-1) (Alpha-2-macroglobulin receptor) (A2MR) (Apolipoprotein E receptor) (APOER) (CD antigen CD91) [Cleaved into: Low-density lipoprotein receptor-related protein 1 85 kDa subunit (LRP-85); Low-density lipoprotein receptor-related protein 1 515 kDa subunit (LRP-515); Low-density lipoprotein receptor-related protein 1 intracellular domain (LRPICD)]"
drug.Protein;Q8NI22;MCFD2;ENSG00000180398;Q8NI22;Multiple coagulation factor deficiency protein 2 (Neural stem cell-derived neuronal survival protein)
drug.Protein;P04070;PROC;ENSG00000115718;P04070;"Vitamin K-dependent protein C (EC 3.4.21.69) (Anticoagulant protein C) (Autoprothrombin IIA) (Blood coagulation factor XIV) [Cleaved into: Vitamin K-dependent protein C light chain; Vitamin K-dependent protein C heavy chain; Activation peptide]"
drug.Protein;P14778;IL1R1;ENSG00000115594;P14778;"Interleukin-1 receptor type 1 (IL-1R-1) (IL-1RT-1) (IL-1RT1) (EC 3.2.2.6) (CD121 antigen-like family member A) (Interleukin-1 receptor alpha) (IL-1R-alpha) (Interleukin-1 receptor type I) (p80) (CD antigen CD121a) [Cleaved into: Interleukin-1 receptor type 1, membrane form (mIL-1R1) (mIL-1RI); Interleukin-1 receptor type 1, soluble form (sIL-1R1) (sIL-1RI)]"
drug.Protein;P08183;ABCB1;ENSG00000085563;P08183;ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)
drug.Protein;Q92637;FCGR1BP;ENSG00000198019;Q92637;Putative high affinity immunoglobulin gamma Fc receptor IB (IgG Fc receptor IB) (Fc gamma receptor IB pseudogene) (Fc-gamma RIB) (FcRIB) (hFcgammaRIB)
drug.Protein;P01024;C3;ENSG00000125730;P01024;"Complement C3 (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 1) [Cleaved into: Complement C3 beta chain; C3-beta-c (C3bc); Complement C3 alpha chain; C3a anaphylatoxin; Acylation stimulating protein (ASP) (C3adesArg); Complement C3b alpha' chain; Complement C3c alpha' chain fragment 1; Complement C3dg fragment; Complement C3g fragment; Complement C3d fragment; Complement C3f fragment; Complement C3c alpha' chain fragment 2]"
drug.Protein;P0C0L4;C4A;ENSG00000244731;P0C0L4;"Complement C4-A (Acidic complement C4) (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 2) [Cleaved into: Complement C4 beta chain; Complement C4-A alpha chain; C4a anaphylatoxin; C4b-A; C4d-A; Complement C4 gamma chain]"
drug.Protein;P0C0L5;"C4B; C4B_2";ENSG00000224389;P0C0L5;"Complement C4-B (Basic complement C4) (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 3) [Cleaved into: Complement C4 beta chain; Complement C4-B alpha chain; C4a anaphylatoxin; C4b-B; C4d-B; Complement C4 gamma chain]"
drug.Protein;P01031;C5;ENSG00000106804;P01031;"Complement C5 (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 4) [Cleaved into: Complement C5 beta chain; Complement C5 alpha chain; C5a anaphylatoxin; Complement C5 alpha' chain]"
drug.Protein;P06213;INSR;ENSG00000171105;P06213;"Insulin receptor (IR) (EC 2.7.10.1) (CD antigen CD220) [Cleaved into: Insulin receptor subunit alpha; Insulin receptor subunit beta]"
drug.Protein;P08069;IGF1R;ENSG00000140443;P08069;"Insulin-like growth factor 1 receptor (EC 2.7.10.1) (Insulin-like growth factor I receptor) (IGF-I receptor) (CD antigen CD221) [Cleaved into: Insulin-like growth factor 1 receptor alpha chain; Insulin-like growth factor 1 receptor beta chain]"
drug.Protein;P16870;CPE;ENSG00000109472;P16870;Carboxypeptidase E (CPE) (EC 3.4.17.10) (Carboxypeptidase H) (CPH) (Enkephalin convertase) (Prohormone-processing carboxypeptidase)
drug.Protein;P48745;CCN3;ENSG00000136999;P48745;CCN family member 3 (Cellular communication network factor 3) (Insulin-like growth factor-binding protein 9) (IBP-9) (IGF-binding protein 9) (IGFBP-9) (Nephro blastoma-overexpressed gene protein homolog) (Protein NOV homolog) (NovH)
drug.Protein;Q16270;IGFBP7;ENSG00000163453;Q16270;Insulin-like growth factor-binding protein 7 (IBP-7) (IGF-binding protein 7) (IGFBP-7) (IGFBP-rP1) (MAC25 protein) (PGI2-stimulating factor) (Prostacyclin-stimulating factor) (Tumor-derived adhesion factor) (TAF)
drug.Protein;P14735;IDE;ENSG00000119912;P14735;Insulin-degrading enzyme (EC 3.4.24.56) (Abeta-degrading protease) (Insulin protease) (Insulinase) (Insulysin)
drug.Protein;P16519;PCSK2;ENSG00000125851;P16519;Neuroendocrine convertase 2 (NEC 2) (EC 3.4.21.94) (KEX2-like endoprotease 2) (Prohormone convertase 2) (Proprotein convertase 2) (PC2)
drug.Protein;P29120;PCSK1;ENSG00000175426;P29120;Neuroendocrine convertase 1 (NEC 1) (EC 3.4.21.93) (Prohormone convertase 1) (Proprotein convertase 1) (PC1)
drug.Protein;P05452;CLEC3B;ENSG00000163815;P05452;Tetranectin (TN) (C-type lectin domain family 3 member B) (Plasminogen kringle 4-binding protein)
drug.Protein;P05787;KRT8;ENSG00000170421;P05787;Keratin, type II cytoskeletal 8 (Cytokeratin-8) (CK-8) (Keratin-8) (K8) (Type-II keratin Kb8)
drug.Protein;P07355;ANXA2;ENSG00000182718;P07355;Annexin A2 (Annexin II) (Annexin-2) (Calpactin I heavy chain) (Calpactin-1 heavy chain) (Chromobindin-8) (Lipocortin II) (Placental anticoagulant protein IV) (PAP-IV) (Protein I) (p36)
drug.Protein;P23945;FSHR;ENSG00000170820;P23945;Follicle-stimulating hormone receptor (FSH-R) (Follitropin receptor)
drug.Protein;P15260;IFNGR1;ENSG00000027697;P15260;Interferon gamma receptor 1 (IFN-gamma receptor 1) (IFN-gamma-R1) (CDw119) (Interferon gamma receptor alpha-chain) (IFN-gamma-R-alpha) (CD antigen CD119)
drug.Protein;P38484;IFNGR2;ENSG00000159128;P38484;Interferon gamma receptor 2 (IFN-gamma receptor 2) (IFN-gamma-R2) (Interferon gamma receptor accessory factor 1) (AF-1) (Interferon gamma receptor beta-chain) (IFN-gamma-R-beta) (Interferon gamma transducer 1)
drug.Protein;P30518;AVPR2;ENSG00000126895;P30518;Vasopressin V2 receptor (V2R) (AVPR V2) (Antidiuretic hormone receptor) (Renal-type arginine vasopressin receptor)
drug.Protein;P37288;AVPR1A;ENSG00000166148;P37288;Vasopressin V1a receptor (V1aR) (AVPR V1a) (Antidiuretic hormone receptor 1a) (Vascular/hepatic-type arginine vasopressin receptor)
drug.Protein;P47901;AVPR1B;ENSG00000198049;P47901;Vasopressin V1b receptor (V1bR) (AVPR V1b) (AVPR V3) (Antidiuretic hormone receptor 1b) (Vasopressin V3 receptor)
drug.Protein;P23219;PTGS1;ENSG00000095303;P23219;Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)
drug.Protein;P35354;PTGS2;ENSG00000073756;P35354;Prostaglandin G/H synthase 2 (EC 1.14.99.1) (Cyclooxygenase-2) (COX-2) (PHS II) (Prostaglandin H2 synthase 2) (PGH synthase 2) (PGHS-2) (Prostaglandin-endoperoxide synthase 2)
drug.Protein;P10646;TFPI;ENSG00000003436;P10646;Tissue factor pathway inhibitor (TFPI) (Extrinsic pathway inhibitor) (EPI) (Lipoprotein-associated coagulation inhibitor) (LACI)
drug.Protein;P38435;GGCX;ENSG00000115486;P38435;Vitamin K-dependent gamma-carboxylase (EC 4.1.1.90) (Gamma-glutamyl carboxylase) (Peptidyl-glutamate 4-carboxylase) (Vitamin K gamma glutamyl carboxylase)
drug.Protein;P08709;F7;ENSG00000057593;P08709;"Coagulation factor VII (EC 3.4.21.21) (Proconvertin) (Serum prothrombin conversion accelerator) (SPCA) (Eptacog alfa) [Cleaved into: Factor VII light chain; Factor VII heavy chain]"
drug.Protein;P13726;F3;ENSG00000117525;P13726;Tissue factor (TF) (Coagulation factor III) (Thromboplastin) (CD antigen CD142)
drug.Protein;Q14626;IL11RA;ENSG00000137070;Q14626;Interleukin-11 receptor subunit alpha (IL-11 receptor subunit alpha) (IL-11R subunit alpha) (IL-11R-alpha) (IL-11RA) [Cleaved into: Soluble interleukin-11 receptor subunit alpha (sIL-11R) (sIL-11RA) (sIL11RA)]
drug.Protein;P21802;FGFR2;ENSG00000066468;P21802;Fibroblast growth factor receptor 2 (FGFR-2) (EC 2.7.10.1) (K-sam) (KGFR) (Keratinocyte growth factor receptor) (CD antigen CD332)
drug.Protein;P11362;FGFR1;ENSG00000077782;P11362;Fibroblast growth factor receptor 1 (FGFR-1) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1) (BFGFR) (bFGF-R-1) (Fms-like tyrosine kinase 2) (FLT-2) (N-sam) (Proto-oncogene c-Fgr) (CD antigen CD331)
drug.Protein;P98160;HSPG2;ENSG00000142798;P98160;"Basement membrane-specific heparan sulfate proteoglycan core protein (HSPG) (Perlecan) (PLC) [Cleaved into: Endorepellin; LG3 peptide]"
drug.Protein;P47871;GCGR;ENSG00000215644;P47871;Glucagon receptor (GL-R)
drug.Protein;O95838;GLP2R;ENSG00000065325;O95838;Glucagon-like peptide 2 receptor (GLP-2 receptor) (GLP-2-R) (GLP-2R)
drug.Protein;P43220;GLP1R;ENSG00000112164;P43220;Glucagon-like peptide 1 receptor (GLP-1 receptor) (GLP-1-R) (GLP-1R)
drug.Protein;P47712;PLA2G4A;ENSG00000116711;P47712;"Cytosolic phospholipase A2 (cPLA2) (Phospholipase A2 group IVA) [Includes: Phospholipase A2 (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase); Lysophospholipase (EC 3.1.1.5)]"
drug.Protein;P08684;CYP3A4;ENSG00000160868;P08684;Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)
drug.Protein;P47989;XDH;ENSG00000158125;P47989;"Xanthine dehydrogenase/oxidase [Includes: Xanthine dehydrogenase (XD) (EC 1.17.1.4); Xanthine oxidase (XO) (EC 1.17.3.2) (Xanthine oxidoreductase) (XOR)]"
drug.Protein;P05181;CYP2E1;ENSG00000130649;P05181;Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)
drug.Protein;P63027;VAMP2;ENSG00000220205;P63027;Vesicle-associated membrane protein 2 (VAMP-2) (Synaptobrevin-2)
drug.Protein;P23763;VAMP1;ENSG00000139190;P23763;Vesicle-associated membrane protein 1 (VAMP-1) (Synaptobrevin-1)
drug.Protein;Q8N9I0;SYT2;ENSG00000143858;Q8N9I0;Synaptotagmin-2 (Synaptotagmin II) (SytII)
drug.Protein;P12319;FCER1A;ENSG00000179639;P12319;High affinity immunoglobulin epsilon receptor subunit alpha (Fc-epsilon RI-alpha) (FcERI) (IgE Fc receptor subunit alpha)
drug.Protein;Q01362;MS4A2;ENSG00000149534;Q01362;High affinity immunoglobulin epsilon receptor subunit beta (FcERI) (Fc epsilon receptor I beta-chain) (IgE Fc receptor subunit beta) (Membrane-spanning 4-domains subfamily A member 2)
drug.Protein;O60603;TLR2;ENSG00000137462;O60603;Toll-like receptor 2 (Toll/interleukin-1 receptor-like protein 4) (CD antigen CD282)
drug.Protein;P02452;COL1A1;ENSG00000108821;P02452;Collagen alpha-1(I) chain (Alpha-1 type I collagen)
drug.Protein;P02458;COL2A1;ENSG00000139219;P02458;"Collagen alpha-1(II) chain (Alpha-1 type II collagen) [Cleaved into: Collagen alpha-1(II) chain; Chondrocalcin]"
drug.Protein;P02461;COL3A1;ENSG00000168542;P02461;Collagen alpha-1(III) chain
drug.Protein;P10912;GHR;ENSG00000112964;P10912;Growth hormone receptor (GH receptor) (Somatotropin receptor) [Cleaved into: Growth hormone-binding protein (GH-binding protein) (GHBP) (Serum-binding protein)]
drug.Protein;P16471;PRLR;ENSG00000113494;P16471;Prolactin receptor (PRL-R)
drug.Protein;P33261;CYP2C19;ENSG00000165841;P33261;Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase)
drug.Protein;P05106;ITGB3;ENSG00000259207;P05106;Integrin beta-3 (Platelet membrane glycoprotein IIIa) (GPIIIa) (CD antigen CD61)
drug.Protein;P08514;ITGA2B;ENSG00000005961;P08514;"Integrin alpha-IIb (GPalpha IIb) (GPIIb) (Platelet membrane glycoprotein IIb) (CD antigen CD41) [Cleaved into: Integrin alpha-IIb heavy chain; Integrin alpha-IIb light chain, form 1; Integrin alpha-IIb light chain, form 2]"
drug.Protein;P04004;VTN;ENSG00000109072;P04004;"Vitronectin (VN) (S-protein) (Serum-spreading factor) (V75) [Cleaved into: Vitronectin V65 subunit; Vitronectin V10 subunit; Somatomedin-B]"
drug.Protein;P00451;F8;ENSG00000185010;P00451;"Coagulation factor VIII (Antihemophilic factor) (AHF) (Procoagulant component) [Cleaved into: Factor VIIIa heavy chain, 200 kDa isoform; Factor VIIIa heavy chain, 92 kDa isoform; Factor VIII B chain; Factor VIIIa light chain]"
drug.Protein;P12259;F5;ENSG00000198734;P12259;"Coagulation factor V (Activated protein C cofactor) (Proaccelerin, labile factor) [Cleaved into: Coagulation factor V heavy chain; Coagulation factor V light chain]"
drug.Protein;P07204;THBD;ENSG00000178726;P07204;Thrombomodulin (TM) (Fetomodulin) (CD antigen CD141)
drug.Protein;P07225;PROS1;ENSG00000184500;P07225;Vitamin K-dependent protein S
drug.Protein;P02776;PF4;ENSG00000163737;P02776;Platelet factor 4 (PF-4) (C-X-C motif chemokine 4) (Iroplact) (Oncostatin-A) [Cleaved into: Platelet factor 4, short form (Endothelial cell growth inhibitor)]
drug.Protein;P35237;SERPINB6;ENSG00000124570;P35237;Serpin B6 (Cytoplasmic antiproteinase) (CAP) (Peptidase inhibitor 6) (PI-6) (Placental thrombin inhibitor)
drug.Protein;Q9UNN8;PROCR;ENSG00000101000;Q9UNN8;Endothelial protein C receptor (Activated protein C receptor) (APC receptor) (Endothelial cell protein C receptor) (CD antigen CD201)
drug.Protein;P20138;CD33;ENSG00000105383;P20138;Myeloid cell surface antigen CD33 (Sialic acid-binding Ig-like lectin 3) (Siglec-3) (gp67) (CD antigen CD33)
drug.Protein;P62993;GRB2;ENSG00000177885;P62993;Growth factor receptor-bound protein 2 (Adapter protein GRB2) (Protein Ash) (SH2/SH3 adapter GRB2)
drug.Protein;P30559;OXTR;ENSG00000180914;P30559;Oxytocin receptor (OT-R)
drug.Protein;Q92887;ABCC2;ENSG00000023839;Q92887;ATP-binding cassette sub-family C member 2 (EC 7.6.2.-) (EC 7.6.2.2) (EC 7.6.2.3) (Canalicular multidrug resistance protein) (Canalicular multispecific organic anion transporter 1) (Multidrug resistance-associated protein 2)
drug.Protein;P01137;TGFB1;ENSG00000105329;P01137;"Transforming growth factor beta-1 proprotein [Cleaved into: Latency-associated peptide (LAP); Transforming growth factor beta-1 (TGF-beta-1)]"
drug.Protein;P02768;ALB;ENSG00000163631;P02768;Albumin
drug.Protein;P04626;ERBB2;ENSG00000141736;P04626;Receptor tyrosine-protein kinase erbB-2 (EC 2.7.10.1) (Metastatic lymph node gene 19 protein) (MLN 19) (Proto-oncogene Neu) (Proto-oncogene c-ErbB-2) (Tyrosine kinase-type cell surface receptor HER2) (p185erbB2) (CD antigen CD340)
drug.Protein;P11836;MS4A1;ENSG00000156738;P11836;B-lymphocyte antigen CD20 (B-lymphocyte surface antigen B1) (Bp35) (Leukocyte surface antigen Leu-16) (Membrane-spanning 4-domains subfamily A member 1) (CD antigen CD20)
drug.Protein;P04234;CD3D;ENSG00000167286;P04234;T-cell surface glycoprotein CD3 delta chain (T-cell receptor T3 delta chain) (CD antigen CD3d)
drug.Protein;P07766;CD3E;ENSG00000198851;P07766;T-cell surface glycoprotein CD3 epsilon chain (T-cell surface antigen T3/Leu-4 epsilon chain) (CD antigen CD3e)
drug.Protein;P09693;CD3G;ENSG00000160654;P09693;T-cell surface glycoprotein CD3 gamma chain (T-cell receptor T3 gamma chain) (CD antigen CD3g)
drug.Protein;P20963;CD247;ENSG00000198821;P20963;T-cell surface glycoprotein CD3 zeta chain (T-cell receptor T3 zeta chain) (CD antigen CD247)
drug.Protein;P02763;ORM1;ENSG00000229314;P02763;Alpha-1-acid glycoprotein 1 (AGP 1) (Orosomucoid-1) (OMD 1)
drug.Protein;P01009;SERPINA1;ENSG00000197249;P01009;Alpha-1-antitrypsin (Alpha-1 protease inhibitor) (Alpha-1-antiproteinase) (Serpin A1) [Cleaved into: Short peptide from AAT (SPAAT)]
drug.Protein;P01130;LDLR;ENSG00000130164;P01130;Low-density lipoprotein receptor (LDL receptor)
drug.Protein;P04278;SHBG;ENSG00000129214;P04278;Sex hormone-binding globulin (SHBG) (Sex steroid-binding protein) (SBP) (Testis-specific androgen-binding protein) (ABP) (Testosterone-estradiol-binding globulin) (TeBG) (Testosterone-estrogen-binding globulin)
drug.Protein;P02790;HPX;ENSG00000110169;P02790;Hemopexin (Beta-1B-glycoprotein)
drug.Protein;Q02318;CYP27A1;ENSG00000135929;Q02318;Sterol 26-hydroxylase, mitochondrial (EC 1.14.15.15) (5-beta-cholestane-3-alpha,7-alpha,12-alpha-triol 26-hydroxylase) (Cytochrome P-450C27/25) (Cytochrome P450 27) (Sterol 27-hydroxylase) (Vitamin D(3) 25-hydroxylase)
drug.Protein;P15104;GLUL;ENSG00000135821;P15104;Glutamine synthetase (GS) (EC 6.3.1.2) (Glutamate--ammonia ligase) (Palmitoyltransferase GLUL) (EC 2.3.1.225)
drug.Protein;P06276;BCHE;ENSG00000114200;P06276;Cholinesterase (EC 3.1.1.8) (Acylcholine acylhydrolase) (Butyrylcholine esterase) (Choline esterase II) (Pseudocholinesterase)
drug.Protein;Q02928;CYP4A11;ENSG00000187048;Q02928;Cytochrome P450 4A11 (EC 1.14.14.1) (20-hydroxyeicosatetraenoic acid synthase) (20-HETE synthase) (CYP4AII) (CYPIVA11) (Cytochrome P-450HK-omega) (Cytochrome P450HL-omega) (Fatty acid omega-hydroxylase) (Lauric acid omega-hydroxylase) (Long-chain fatty acid omega-monooxygenase) (EC 1.14.14.80)
drug.Protein;P60880;SNAP25;ENSG00000132639;P60880;Synaptosomal-associated protein 25 (SNAP-25) (Super protein) (SUP) (Synaptosomal-associated 25 kDa protein)
drug.Protein;P62745;RHOB;ENSG00000143878;P62745;Rho-related GTP-binding protein RhoB (Rho cDNA clone 6) (h6)
drug.Protein;P25116;F2R;ENSG00000181104;P25116;Proteinase-activated receptor 1 (PAR-1) (Coagulation factor II receptor) (Thrombin receptor)
drug.Protein;P31358;CD52;ENSG00000169442;P31358;CAMPATH-1 antigen (CDw52) (Cambridge pathology 1 antigen) (Epididymal secretory protein E5) (Human epididymis-specific protein 5) (He5) (CD antigen CD52)
drug.Protein;Q04609;FOLH1;ENSG00000086205;Q04609;Glutamate carboxypeptidase 2 (EC 3.4.17.21) (Cell growth-inhibiting gene 27 protein) (Folate hydrolase 1) (Folylpoly-gamma-glutamate carboxypeptidase) (FGCP) (Glutamate carboxypeptidase II) (GCPII) (Membrane glutamate carboxypeptidase) (mGCP) (N-acetylated-alpha-linked acidic dipeptidase I) (NAALADase I) (Prostate-specific membrane antigen) (PSM) (PSMA) (Pteroylpoly-gamma-glutamate carboxypeptidase)
drug.Protein;P49069;CAMLG;ENSG00000164615;P49069;Guided entry of tail-anchored proteins factor CAMLG (Calcium signal-modulating cyclophilin ligand)
drug.Protein;Q96LZ3;PPP3R2;ENSG00000188386;Q96LZ3;Calcineurin subunit B type 2 (Calcineurin B-like protein) (CBLP) (Calcineurin BII) (CNBII) (PPP3R1-like) (Protein phosphatase 2B regulatory subunit 2) (Protein phosphatase 3 regulatory subunit B beta isoform)
drug.Protein;P62937;PPIA;ENSG00000196262;P62937;Peptidyl-prolyl cis-trans isomerase A (PPIase A) (EC 5.2.1.8) (Cyclophilin A) (Cyclosporin A-binding protein) (Rotamase A) [Cleaved into: Peptidyl-prolyl cis-trans isomerase A, N-terminally processed]
drug.Protein;P30405;PPIF;ENSG00000108179;P30405;Peptidyl-prolyl cis-trans isomerase F, mitochondrial (PPIase F) (EC 5.2.1.8) (Cyclophilin D) (CyP-D) (CypD) (Cyclophilin F) (Mitochondrial cyclophilin) (CyP-M) (Rotamase F)
drug.Protein;P20815;CYP3A5;ENSG00000106258;P20815;Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3)
drug.Protein;O95342;ABCB11;ENSG00000073734;O95342;Bile salt export pump (EC 7.6.2.-) (ATP-binding cassette sub-family B member 11)
drug.Protein;Q12908;SLC10A2;ENSG00000125255;Q12908;Ileal sodium/bile acid cotransporter (Apical sodium-dependent bile acid transporter) (ASBT) (Ileal Na(+)/bile acid cotransporter) (Ileal sodium-dependent bile acid transporter) (IBAT) (ISBT) (Na(+)-dependent ileal bile acid transporter) (Sodium/taurocholate cotransporting polypeptide, ileal) (Solute carrier family 10 member 2)
drug.Protein;Q14973;SLC10A1;ENSG00000100652;Q14973;Sodium/bile acid cotransporter (Cell growth-inhibiting gene 29 protein) (Na(+)/bile acid cotransporter) (Na(+)/taurocholate transport protein) (Sodium/taurocholate cotransporting polypeptide) (Solute carrier family 10 member 1)
drug.Protein;Q4U2R8;SLC22A6;ENSG00000197901;Q4U2R8;Solute carrier family 22 member 6 (Organic anion transporter 1) (hOAT1) (PAH transporter) (hPAHT) (Renal organic anion transporter 1) (hROAT1)
drug.Protein;Q5T3U5;ABCC10;ENSG00000124574;Q5T3U5;ATP-binding cassette sub-family C member 10 (EC 7.6.2.2) (EC 7.6.2.3) (Multidrug resistance-associated protein 7)
drug.Protein;Q9UNQ0;ABCG2;ENSG00000118777;Q9UNQ0;Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)
drug.Protein;Q9Y6L6;SLCO1B1;ENSG00000134538;Q9Y6L6;Solute carrier organic anion transporter family member 1B1 (Liver-specific organic anion transporter 1) (LST-1) (OATP-C) (Sodium-independent organic anion-transporting polypeptide 2) (OATP-2) (Solute carrier family 21 member 6)
drug.Protein;Q9NPD5;SLCO1B3;ENSG00000111700;Q9NPD5;Solute carrier organic anion transporter family member 1B3 (Liver-specific organic anion transporter 2) (LST-2) (Organic anion transporter 8) (Organic anion-transporting polypeptide 8) (OATP-8) (Solute carrier family 21 member 8)
drug.Protein;P06729;CD2;ENSG00000116824;P06729;T-cell surface antigen CD2 (Erythrocyte receptor) (LFA-2) (LFA-3 receptor) (Rosette receptor) (T-cell surface antigen T11/Leu-5) (CD antigen CD2)
drug.Protein;P20701;ITGAL;ENSG00000005844;P20701;Integrin alpha-L (CD11 antigen-like family member A) (Leukocyte adhesion glycoprotein LFA-1 alpha chain) (LFA-1A) (Leukocyte function-associated molecule 1 alpha chain) (CD antigen CD11a)
drug.Protein;P20702;ITGAX;ENSG00000140678;P20702;Integrin alpha-X (CD11 antigen-like family member C) (Leu M5) (Leukocyte adhesion glycoprotein p150,95 alpha chain) (Leukocyte adhesion receptor p150,95) (CD antigen CD11c)
drug.Protein;P06126;CD1A;ENSG00000158477;P06126;T-cell surface glycoprotein CD1a (T-cell surface antigen T6/Leu-6) (hTa1 thymocyte antigen) (CD antigen CD1a)
drug.Protein;Q95460;MR1;ENSG00000153029;Q95460;Major histocompatibility complex class I-related gene protein (MHC class I-related gene protein) (Class I histocompatibility antigen-like protein)
drug.Protein;P42081;CD86;ENSG00000114013;P42081;T-lymphocyte activation antigen CD86 (Activation B7-2 antigen) (B70) (BU63) (CTLA-4 counter-receptor B7.2) (FUN-1) (CD antigen CD86)
drug.Protein;P01730;CD4;ENSG00000010610;P01730;T-cell surface glycoprotein CD4 (T-cell surface antigen T4/Leu-3) (CD antigen CD4)
drug.Protein;P05556;ITGB1;ENSG00000150093;P05556;Integrin beta-1 (Fibronectin receptor subunit beta) (Glycoprotein IIa) (GPIIA) (VLA-4 subunit beta) (CD antigen CD29)
drug.Protein;P06756;ITGAV;ENSG00000138448;P06756;"Integrin alpha-V (Vitronectin receptor) (Vitronectin receptor subunit alpha) (CD antigen CD51) [Cleaved into: Integrin alpha-V heavy chain; Integrin alpha-V light chain]"
drug.Protein;P03951;F11;ENSG00000088926;P03951;"Coagulation factor XI (FXI) (EC 3.4.21.27) (Plasma thromboplastin antecedent) (PTA) [Cleaved into: Coagulation factor XIa heavy chain; Coagulation factor XIa light chain]"
drug.Protein;P09619;PDGFRB;ENSG00000113721;P09619;Platelet-derived growth factor receptor beta (PDGF-R-beta) (PDGFR-beta) (EC 2.7.10.1) (Beta platelet-derived growth factor receptor) (Beta-type platelet-derived growth factor receptor) (CD140 antigen-like family member B) (Platelet-derived growth factor receptor 1) (PDGFR-1) (CD antigen CD140b)
drug.Protein;P16234;PDGFRA;ENSG00000134853;P16234;Platelet-derived growth factor receptor alpha (PDGF-R-alpha) (PDGFR-alpha) (EC 2.7.10.1) (Alpha platelet-derived growth factor receptor) (Alpha-type platelet-derived growth factor receptor) (CD140 antigen-like family member A) (CD140a antigen) (Platelet-derived growth factor alpha receptor) (Platelet-derived growth factor receptor 2) (PDGFR-2) (CD antigen CD140a)
drug.Protein;P01023;A2M;ENSG00000175899;P01023;Alpha-2-macroglobulin (Alpha-2-M) (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 5)
drug.Protein;P20645;M6PR;ENSG00000003056;P20645;Cation-dependent mannose-6-phosphate receptor (CD Man-6-P receptor) (CD-MPR) (46 kDa mannose 6-phosphate receptor) (MPR 46)
drug.Protein;P01178;OXT;ENSG00000101405;P01178;"Oxytocin-neurophysin 1 (OT-NPI) [Cleaved into: Oxytocin (Ocytocin); Neurophysin 1]"
drug.Protein;P48147;PREP;ENSG00000085377;P48147;Prolyl endopeptidase (PE) (EC 3.4.21.26) (Post-proline cleaving enzyme)
drug.Protein;Q9UIQ6;LNPEP;ENSG00000113441;Q9UIQ6;Leucyl-cystinyl aminopeptidase (Cystinyl aminopeptidase) (EC 3.4.11.3) (Insulin-regulated membrane aminopeptidase) (Insulin-responsive aminopeptidase) (IRAP) (Oxytocinase) (OTase) (Placental leucine aminopeptidase) (P-LAP) [Cleaved into: Leucyl-cystinyl aminopeptidase, pregnancy serum form]
drug.Protein;Q15109;AGER;ENSG00000204305;Q15109;Advanced glycosylation end product-specific receptor (Receptor for advanced glycosylation end products)
drug.Protein;P13612;ITGA4;ENSG00000115232;P13612;Integrin alpha-4 (CD49 antigen-like family member D) (Integrin alpha-IV) (VLA-4 subunit alpha) (CD antigen CD49d)
drug.Protein;P05362;ICAM1;ENSG00000090339;P05362;Intercellular adhesion molecule 1 (ICAM-1) (Major group rhinovirus receptor) (CD antigen CD54)
drug.Protein;P00736;C1R;ENSG00000159403;P00736;"Complement C1r subcomponent (EC 3.4.21.41) (Complement component 1 subcomponent r) [Cleaved into: Complement C1r subcomponent heavy chain; Complement C1r subcomponent light chain]"
drug.Protein;P15692;VEGFA;ENSG00000112715;P15692;Vascular endothelial growth factor A (VEGF-A) (Vascular permeability factor) (VPF)
drug.Protein;P13688;CEACAM1;ENSG00000079385;P13688;Carcinoembryonic antigen-related cell adhesion molecule 1 (Biliary glycoprotein 1) (BGP-1) (CD antigen CD66a)
drug.Protein;Q9BYV1;AGXT2;ENSG00000113492;Q9BYV1;Alanine--glyoxylate aminotransferase 2, mitochondrial (AGT 2) (EC 2.6.1.44) ((R)-3-amino-2-methylpropionate--pyruvate transaminase) (EC 2.6.1.40) (Beta-ALAAT II) (Beta-alanine-pyruvate aminotransferase) (D-AIBAT)
drug.Protein;Q99259;GAD1;ENSG00000128683;Q99259;Glutamate decarboxylase 1 (EC 4.1.1.15) (67 kDa glutamic acid decarboxylase) (GAD-67) (Glutamate decarboxylase 67 kDa isoform)
drug.Protein;P35520;CBS;ENSG00000160200;P35520;Cystathionine beta-synthase (EC 4.2.1.22) (Beta-thionase) (Serine sulfhydrase)
drug.Protein;Q16719;KYNU;ENSG00000115919;Q16719;Kynureninase (EC 3.7.1.3) (L-kynurenine hydrolase)
drug.Protein;P34896;SHMT1;ENSG00000176974;P34896;Serine hydroxymethyltransferase, cytosolic (SHMT) (EC 2.1.2.1) (Glycine hydroxymethyltransferase) (Serine methylase)
drug.Protein;Q9Y697;NFS1;ENSG00000244005;Q9Y697;Cysteine desulfurase, mitochondrial (EC 2.8.1.7)
drug.Protein;P17174;GOT1;ENSG00000120053;P17174;Aspartate aminotransferase, cytoplasmic (cAspAT) (EC 2.6.1.1) (EC 2.6.1.3) (Cysteine aminotransferase, cytoplasmic) (Cysteine transaminase, cytoplasmic) (cCAT) (Glutamate oxaloacetate transaminase 1) (Transaminase A)
drug.Protein;P04181;OAT;ENSG00000065154;P04181;"Ornithine aminotransferase, mitochondrial (EC 2.6.1.13) (Ornithine delta-aminotransferase) (Ornithine--oxo-acid aminotransferase) [Cleaved into: Ornithine aminotransferase, hepatic form; Ornithine aminotransferase, renal form]"
drug.Protein;P11926;ODC1;ENSG00000115758;P11926;Ornithine decarboxylase (ODC) (EC 4.1.1.17)
drug.Protein;Q8N5Z0;AADAT;ENSG00000109576;Q8N5Z0;Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial (KAT/AadAT) (2-aminoadipate aminotransferase) (2-aminoadipate transaminase) (EC 2.6.1.39) (Alpha-aminoadipate aminotransferase) (AadAT) (Glycine transaminase AADAT) (EC 2.6.1.4) (Kynurenine aminotransferase II) (Kynurenine--glyoxylate transaminase AADAT) (EC 2.6.1.63) (Kynurenine--oxoglutarate aminotransferase II) (Kynurenine--oxoglutarate transaminase 2) (EC 2.6.1.7) (Kynurenine--oxoglutarate transaminase II) (Methionine--glyoxylate transaminase AADAT) (EC 2.6.1.73)
drug.Protein;P80404;ABAT;ENSG00000183044;P80404;4-aminobutyrate aminotransferase, mitochondrial (EC 2.6.1.19) ((S)-3-amino-2-methylpropionate transaminase) (EC 2.6.1.22) (GABA aminotransferase) (GABA-AT) (Gamma-amino-N-butyrate transaminase) (GABA transaminase) (GABA-T) (L-AIBAT)
drug.Protein;Q9NVS9;PNPO;ENSG00000108439;Q9NVS9;Pyridoxine-5'-phosphate oxidase (EC 1.4.3.5) (Pyridoxamine-phosphate oxidase)
drug.Protein;O95470;SGPL1;ENSG00000166224;O95470;Sphingosine-1-phosphate lyase 1 (S1PL) (SP-lyase 1) (SPL 1) (hSPL) (EC 4.1.2.27) (Sphingosine-1-phosphate aldolase)
drug.Protein;P17735;TAT;ENSG00000198650;P17735;Tyrosine aminotransferase (TAT) (EC 2.6.1.5) (L-tyrosine:2-oxoglutarate aminotransferase)
drug.Protein;Q16773;KYAT1;ENSG00000171097;Q16773;Kynurenine--oxoglutarate transaminase 1 (EC 2.6.1.7) (Cysteine-S-conjugate beta-lyase) (EC 4.4.1.13) (Glutamine transaminase K) (GTK) (Glutamine--phenylpyruvate transaminase) (EC 2.6.1.64) (Kynurenine aminotransferase 1) (Kynurenine aminotransferase I) (KATI) (Kynurenine--oxoglutarate transaminase I)
drug.Protein;O15270;SPTLC2;ENSG00000100596;O15270;Serine palmitoyltransferase 2 (EC 2.3.1.50) (Long chain base biosynthesis protein 2) (LCB 2) (Long chain base biosynthesis protein 2a) (LCB2a) (Serine-palmitoyl-CoA transferase 2) (SPT 2)
drug.Protein;Q9Y600;CSAD;ENSG00000139631;Q9Y600;Cysteine sulfinic acid decarboxylase (EC 4.1.1.29) (Aspartate 1-decarboxylase) (EC 4.1.1.11) (Cysteine-sulfinate decarboxylase) (Sulfinoalanine decarboxylase)
drug.Protein;P19113;HDC;ENSG00000140287;P19113;Histidine decarboxylase (HDC) (EC 4.1.1.22)
drug.Protein;Q96A70;AZIN2;ENSG00000142920;Q96A70;Antizyme inhibitor 2 (AzI2) (Arginine decarboxylase) (ADC) (ARGDC) (Ornithine decarboxylase-like protein) (ODC-like protein) (ornithine decarboxylase paralog) (ODC-p)
drug.Protein;P20132;SDS;ENSG00000135094;P20132;L-serine dehydratase/L-threonine deaminase (SDH) (EC 4.3.1.17) (L-serine deaminase) (L-threonine dehydratase) (TDH) (EC 4.3.1.19)
drug.Protein;O75600;GCAT;ENSG00000100116;O75600;2-amino-3-ketobutyrate coenzyme A ligase, mitochondrial (AKB ligase) (EC 2.3.1.29) (Aminoacetone synthase) (Glycine acetyltransferase)
drug.Protein;P23378;GLDC;ENSG00000178445;P23378;Glycine dehydrogenase (decarboxylating), mitochondrial (EC 1.4.4.2) (Glycine cleavage system P protein) (Glycine decarboxylase) (Glycine dehydrogenase (aminomethyl-transferring))
drug.Protein;P24298;GPT;ENSG00000167701;P24298;Alanine aminotransferase 1 (ALT1) (EC 2.6.1.2) (Glutamate pyruvate transaminase 1) (GPT 1) (Glutamic--alanine transaminase 1) (Glutamic--pyruvic transaminase 1)
drug.Protein;Q9Y617;PSAT1;ENSG00000135069;Q9Y617;Phosphoserine aminotransferase (EC 2.6.1.52) (Phosphohydroxythreonine aminotransferase) (PSAT)
drug.Protein;P13196;ALAS1;ENSG00000023330;P13196;5-aminolevulinate synthase, non-specific, mitochondrial (ALAS-H) (EC 2.3.1.37) (5-aminolevulinic acid synthase 1) (Delta-ALA synthase 1) (Delta-aminolevulinate synthase 1)
drug.Protein;P21549;AGXT;ENSG00000172482;P21549;Alanine--glyoxylate aminotransferase (AGT) (EC 2.6.1.44) (Serine--pyruvate aminotransferase) (SPT) (EC 2.6.1.51)
drug.Protein;Q96GD0;PDXP;ENSG00000241360;Q96GD0;Chronophin (EC 3.1.3.16) (EC 3.1.3.74) (Pyridoxal phosphate phosphatase) (PLP phosphatase)
drug.Protein;O15269;SPTLC1;ENSG00000090054;O15269;Serine palmitoyltransferase 1 (EC 2.3.1.50) (Long chain base biosynthesis protein 1) (LCB 1) (Serine-palmitoyl-CoA transferase 1) (SPT 1) (SPT1)
drug.Protein;P32929;CTH;ENSG00000116761;P32929;Cystathionine gamma-lyase (CGL) (CSE) (EC 4.4.1.1) (Cysteine desulfhydrase) (Cysteine-protein sulfhydrase) (Gamma-cystathionase) (Homocysteine desulfhydrase) (EC 4.4.1.2)
drug.Protein;P54687;BCAT1;ENSG00000060982;P54687;Branched-chain-amino-acid aminotransferase, cytosolic (BCAT(c)) (EC 2.6.1.42) (Protein ECA39)
drug.Protein;O15382;BCAT2;ENSG00000105552;O15382;Branched-chain-amino-acid aminotransferase, mitochondrial (BCAT(m)) (EC 2.6.1.42) (Placental protein 18) (PP18)
drug.Protein;O94903;PLPBP;ENSG00000147471;O94903;Pyridoxal phosphate homeostasis protein (PLP homeostasis protein) (Proline synthase co-transcribed bacterial homolog protein) (Pyridoxal phosphate-binding protein)
drug.Protein;P00505;GOT2;ENSG00000125166;P00505;Aspartate aminotransferase, mitochondrial (mAspAT) (EC 2.6.1.1) (EC 2.6.1.7) (Fatty acid-binding protein) (FABP-1) (Glutamate oxaloacetate transaminase 2) (Kynurenine aminotransferase 4) (Kynurenine aminotransferase IV) (Kynurenine--oxoglutarate transaminase 4) (Kynurenine--oxoglutarate transaminase IV) (Plasma membrane-associated fatty acid-binding protein) (FABPpm) (Transaminase A)
drug.Protein;P11216;PYGB;ENSG00000100994;P11216;Glycogen phosphorylase, brain form (EC 2.4.1.1)
drug.Protein;P11217;PYGM;ENSG00000068976;P11217;Glycogen phosphorylase, muscle form (EC 2.4.1.1) (Myophosphorylase)
drug.Protein;P20711;DDC;ENSG00000132437;P20711;Aromatic-L-amino-acid decarboxylase (AADC) (EC 4.1.1.28) (DOPA decarboxylase) (DDC)
drug.Protein;Q2TU84;;;;
drug.Protein;Q53ET4;;;;
drug.Protein;Q59FK2;;;;
drug.Protein;Q59GM9;;;;
drug.Protein;Q5JAM2;;;;
drug.Protein;Q5VZ30;;;;
drug.Protein;Q6IBS8;;;;
drug.Protein;Q6YP21;KYAT3;ENSG00000137944;Q6YP21;Kynurenine--oxoglutarate transaminase 3 (EC 2.6.1.7) (Cysteine-S-conjugate beta-lyase 2) (EC 4.4.1.13) (Kynurenine aminotransferase 3) (Kynurenine aminotransferase III) (KATIII) (Kynurenine--glyoxylate transaminase) (EC 2.6.1.63) (Kynurenine--oxoglutarate transaminase III)
drug.Protein;Q6ZQY3;GADL1;ENSG00000144644;Q6ZQY3;Acidic amino acid decarboxylase GADL1 (Aspartate 1-decarboxylase) (ADC) (HuADC) (EC 4.1.1.11) (Cysteine sulfinic acid decarboxylase) (CSADC) (HuCSADC) (EC 4.1.1.29) (Glutamate decarboxylase-like protein 1)
drug.Protein;Q96I15;SCLY;ENSG00000132330;Q96I15;Selenocysteine lyase (hSCL) (EC 4.4.1.16)
drug.Protein;Q6WRI0;IGSF10;ENSG00000152580;Q6WRI0;Immunoglobulin superfamily member 10 (IgSF10) (Calvaria mechanical force protein 608) (CMF608)
drug.Protein;Q8IUZ5;PHYKPL;ENSG00000175309;Q8IUZ5;5-phosphohydroxy-L-lysine phospho-lyase (EC 4.2.3.134) (Alanine--glyoxylate aminotransferase 2-like 2)
drug.Protein;Q8IVA8;;;;
drug.Protein;P34897;SHMT2;ENSG00000182199;P34897;Serine hydroxymethyltransferase, mitochondrial (SHMT) (EC 2.1.2.1) (Glycine hydroxymethyltransferase) (Serine methylase)
drug.Protein;P22557;ALAS2;ENSG00000158578;P22557;5-aminolevulinate synthase, erythroid-specific, mitochondrial (ALAS-E) (EC 2.3.1.37) (5-aminolevulinic acid synthase 2) (Delta-ALA synthase 2) (Delta-aminolevulinate synthase 2)
drug.Protein;Q8TD30;GPT2;ENSG00000166123;Q8TD30;Alanine aminotransferase 2 (ALT2) (EC 2.6.1.2) (Glutamate pyruvate transaminase 2) (GPT 2) (Glutamic--alanine transaminase 2) (Glutamic--pyruvic transaminase 2)
drug.Protein;Q96EN8;MOCOS;ENSG00000075643;Q96EN8;Molybdenum cofactor sulfurase (MCS) (MOS) (MoCo sulfurase) (hMCS) (EC 2.8.1.9) (Molybdenum cofactor sulfurtransferase)
drug.Protein;Q96GA7;SDSL;ENSG00000139410;Q96GA7;Serine dehydratase-like (L-serine deaminase) (L-serine dehydratase/L-threonine deaminase) (L-threonine dehydratase) (TDH) (EC 4.3.1.19) (Serine dehydratase 2) (SDH 2) (EC 4.3.1.17)
drug.Protein;Q9BXA1;;;;
drug.Protein;Q9GZT4;SRR;ENSG00000167720;Q9GZT4;Serine racemase (EC 5.1.1.18) (D-serine ammonia-lyase) (D-serine dehydratase) (EC 4.3.1.18) (L-serine ammonia-lyase) (L-serine dehydratase) (EC 4.3.1.17)
drug.Protein;Q9HD40;SEPSECS;ENSG00000109618;Q9HD40;O-phosphoseryl-tRNA(Sec) selenium transferase (EC 2.9.1.2) (Liver-pancreas antigen) (LP) (SLA-p35) (SLA/LP autoantigen) (Selenocysteine synthase) (Sec synthase) (Selenocysteinyl-tRNA(Sec) synthase) (Sep-tRNA:Sec-tRNA synthase) (SepSecS) (Soluble liver antigen) (SLA) (UGA suppressor tRNA-associated protein) (tRNA(Ser/Sec)-associated antigenic protein)
drug.Protein;Q9NUV7;SPTLC3;ENSG00000172296;Q9NUV7;Serine palmitoyltransferase 3 (EC 2.3.1.50) (Long chain base biosynthesis protein 2b) (LCB2b) (Long chain base biosynthesis protein 3) (LCB 3) (Serine-palmitoyl-CoA transferase 3) (SPT 3)
drug.Protein;Q9UGI5;;;;
drug.Protein;Q9UJX1;;;;
drug.Protein;Q99707;MTR;ENSG00000116984;Q99707;Methionine synthase (MS) (EC 2.1.1.13) (5-methyltetrahydrofolate--homocysteine methyltransferase) (Cobalamin-dependent methionine synthase) (Vitamin-B12 dependent methionine synthase)
drug.Protein;P22033;MMUT;ENSG00000146085;P22033;Methylmalonyl-CoA mutase, mitochondrial (MCM) (EC 5.4.99.2) (Methylmalonyl-CoA isomerase)
drug.Protein;Q9UBK8;MTRR;ENSG00000124275;Q9UBK8;Methionine synthase reductase (MSR) (EC 1.16.1.8) (Aquacobalamin reductase) (AqCbl reductase)
drug.Protein;Q8IVH4;MMAA;ENSG00000151611;Q8IVH4;Methylmalonic aciduria type A protein, mitochondrial (EC 3.6.-.-)
drug.Protein;Q9Y4U1;MMACHC;ENSG00000132763;Q9Y4U1;Cyanocobalamin reductase / alkylcobalamin dealkylase (Alkylcobalamin:glutathione S-alkyltransferase) (EC 2.5.1.151) (CblC) (Cyanocobalamin reductase (cyanide-eliminating)) (EC 1.16.1.6) (Methylmalonic aciduria and homocystinuria type C protein) (MMACHC)
drug.Protein;P42898;MTHFR;ENSG00000177000;P42898;Methylenetetrahydrofolate reductase (EC 1.5.1.20)
drug.Protein;Q96EY8;MMAB;ENSG00000139428;Q96EY8;Corrinoid adenosyltransferase MMAB (EC 2.5.1.-) (ATP:co(I)rrinoid adenosyltransferase MMAB) (Methylmalonic aciduria type B protein)
drug.Protein;Q9BXJ7;AMN;ENSG00000166126;Q9BXJ7;Protein amnionless [Cleaved into: Soluble protein amnionless]
drug.Protein;P20061;TCN1;ENSG00000134827;P20061;Transcobalamin-1 (TC-1) (Haptocorrin) (HC) (Protein R) (Transcobalamin I) (TC I) (TCI)
drug.Protein;P20062;TCN2;ENSG00000185339;P20062;Transcobalamin-2 (TC-2) (Transcobalamin II) (TC II) (TCII)
drug.Protein;P27352;CBLIF;ENSG00000134812;P27352;Cobalamin binding intrinsic factor (Gastric intrinsic factor) (Intrinsic factor) (IF) (INF)
drug.Protein;O60494;CUBN;ENSG00000107611;O60494;Cubilin (460 kDa receptor) (Intestinal intrinsic factor receptor) (Intrinsic factor-cobalamin receptor) (Intrinsic factor-vitamin B12 receptor)
drug.Protein;P33527;ABCC1;ENSG00000103222;P33527;Multidrug resistance-associated protein 1 (EC 7.6.2.2) (ATP-binding cassette sub-family C member 1) (Glutathione-S-conjugate-translocating ATPase ABCC1) (EC 7.6.2.3) (Leukotriene C(4) transporter) (LTC4 transporter)
drug.Protein;P11586;MTHFD1;ENSG00000100714;P11586;"C-1-tetrahydrofolate synthase, cytoplasmic (C1-THF synthase) (Epididymis secretory sperm binding protein) [Cleaved into: C-1-tetrahydrofolate synthase, cytoplasmic, N-terminally processed] [Includes: Methylenetetrahydrofolate dehydrogenase (EC 1.5.1.5); Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9); Formyltetrahydrofolate synthetase (EC 6.3.4.3)]"
drug.Protein;P13995;MTHFD2;ENSG00000065911;P13995;"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial [Includes: NAD-dependent methylenetetrahydrofolate dehydrogenase (EC 1.5.1.15); Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9)]"
drug.Protein;P48728;AMT;ENSG00000145020;P48728;Aminomethyltransferase, mitochondrial (EC 2.1.2.10) (Glycine cleavage system T protein) (GCVT)
drug.Protein;O75891;ALDH1L1;ENSG00000144908;O75891;Cytosolic 10-formyltetrahydrofolate dehydrogenase (10-FTHFDH) (FDH) (EC 1.5.1.6) (Aldehyde dehydrogenase family 1 member L1)
drug.Protein;O95954;FTCD;ENSG00000160282;O95954;"Formimidoyltransferase-cyclodeaminase (Formiminotransferase-cyclodeaminase) (FTCD) (LCHC1) [Includes: Glutamate formimidoyltransferase (EC 2.1.2.5) (Glutamate formiminotransferase) (Glutamate formyltransferase); Formimidoyltetrahydrofolate cyclodeaminase (EC 4.3.1.4) (Formiminotetrahydrofolate cyclodeaminase)]"
drug.Protein;P31939;ATIC;ENSG00000138363;P31939;"Bifunctional purine biosynthesis protein ATIC (AICAR transformylase/inosine monophosphate cyclohydrolase) (ATIC) [Cleaved into: Bifunctional purine biosynthesis protein ATIC, N-terminally processed] [Includes: Phosphoribosylaminoimidazolecarboxamide formyltransferase (EC 2.1.2.3) (5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase) (AICAR formyltransferase) (AICAR transformylase); Inosine 5'-monophosphate cyclohydrolase (IMP cyclohydrolase) (EC 3.5.4.10) (IMP synthase) (Inosinicase)]"
drug.Protein;Q96DP5;MTFMT;ENSG00000103707;Q96DP5;Methionyl-tRNA formyltransferase, mitochondrial (MtFMT) (EC 2.1.2.9)
drug.Protein;P12081;HARS1;ENSG00000170445;P12081;Histidine--tRNA ligase, cytoplasmic (EC 6.1.1.21) (Histidyl-tRNA synthetase) (HisRS)
drug.Protein;Q99624;SLC38A3;ENSG00000188338;Q99624;Sodium-coupled neutral amino acid transporter 3 (N-system amino acid transporter 1) (Na(+)-coupled neutral amino acid transporter 3) (Solute carrier family 38 member 3) (System N amino acid transporter 1)
drug.Protein;P42357;HAL;ENSG00000084110;P42357;Histidine ammonia-lyase (Histidase) (EC 4.3.1.3)
drug.Protein;Q8TF71;SLC16A10;ENSG00000112394;Q8TF71;Monocarboxylate transporter 10 (MCT 10) (Aromatic amino acid transporter 1) (Solute carrier family 16 member 10) (T-type amino acid transporter 1)
drug.Protein;Q14749;GNMT;ENSG00000124713;Q14749;Glycine N-methyltransferase (EC 2.1.1.20)
drug.Protein;P17707;AMD1;ENSG00000123505;P17707;"S-adenosylmethionine decarboxylase proenzyme (AdoMetDC) (SAMDC) (EC 4.1.1.50) [Cleaved into: S-adenosylmethionine decarboxylase alpha chain; S-adenosylmethionine decarboxylase beta chain]"
drug.Protein;P31153;MAT2A;ENSG00000168906;P31153;S-adenosylmethionine synthase isoform type-2 (AdoMet synthase 2) (EC 2.5.1.6) (Methionine adenosyltransferase 2) (MAT 2) (Methionine adenosyltransferase II) (MAT-II)
drug.Protein;Q00266;MAT1A;ENSG00000151224;Q00266;S-adenosylmethionine synthase isoform type-1 (AdoMet synthase 1) (EC 2.5.1.6) (Methionine adenosyltransferase 1) (MAT 1) (Methionine adenosyltransferase I/III) (MAT-I/III)
drug.Protein;P21964;COMT;ENSG00000093010;P21964;Catechol O-methyltransferase (EC 2.1.1.6)
drug.Protein;Q8N1G2;CMTR1;ENSG00000137200;Q8N1G2;Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 1 (EC 2.1.1.57) (Cap methyltransferase 1) (Cap1 2'O-ribose methyltransferase 1) (MTr1) (hMTr1) (FtsJ methyltransferase domain-containing protein 2) (Interferon-stimulated gene 95 kDa protein) (ISG95)
drug.Protein;Q9HBK9;AS3MT;ENSG00000214435;Q9HBK9;Arsenite methyltransferase (EC 2.1.1.137) (Methylarsonite methyltransferase) (S-adenosyl-L-methionine:arsenic(III) methyltransferase)
drug.Protein;P19623;SRM;ENSG00000116649;P19623;Spermidine synthase (SPDSY) (EC 2.5.1.16) (Putrescine aminopropyltransferase)
drug.Protein;O15427;SLC16A3;ENSG00000141526;O15427;Monocarboxylate transporter 4 (MCT 4) (Solute carrier family 16 member 3)
drug.Protein;P36021;SLC16A2;ENSG00000147100;P36021;Monocarboxylate transporter 8 (MCT 8) (Monocarboxylate transporter 7) (MCT 7) (Solute carrier family 16 member 2) (X-linked PEST-containing transporter)
drug.Protein;O15375;SLC16A5;ENSG00000170190;O15375;Monocarboxylate transporter 6 (MCT 6) (Monocarboxylate transporter 5) (MCT 5) (Solute carrier family 16 member 5)
drug.Protein;P30613;PKLR;ENSG00000143627;P30613;Pyruvate kinase PKLR (EC 2.7.1.40) (Pyruvate kinase 1) (Pyruvate kinase isozymes L/R) (R-type/L-type pyruvate kinase) (Red cell/liver pyruvate kinase)
drug.Protein;O15403;SLC16A6;ENSG00000108932;O15403;Monocarboxylate transporter 7 (MCT 7) (Monocarboxylate transporter 6) (MCT 6) (Solute carrier family 16 member 6)
drug.Protein;O60669;SLC16A7;ENSG00000118596;O60669;Monocarboxylate transporter 2 (MCT 2) (Solute carrier family 16 member 7)
drug.Protein;P11177;PDHB;ENSG00000168291;P11177;Pyruvate dehydrogenase E1 component subunit beta, mitochondrial (PDHE1-B) (EC 1.2.4.1)
drug.Protein;P14618;PKM;ENSG00000067225;P14618;Pyruvate kinase PKM (EC 2.7.1.40) (Cytosolic thyroid hormone-binding protein) (CTHBP) (Opa-interacting protein 3) (OIP-3) (Pyruvate kinase 2/3) (Pyruvate kinase muscle isozyme) (Threonine-protein kinase PKM2) (EC 2.7.11.1) (Thyroid hormone-binding protein 1) (THBP1) (Tumor M2-PK) (Tyrosine-protein kinase PKM2) (EC 2.7.10.2) (p58)
drug.Protein;O15374;SLC16A4;ENSG00000168679;O15374;Monocarboxylate transporter 5 (MCT 5) (Monocarboxylate transporter 4) (MCT 4) (Solute carrier family 16 member 4)
drug.Protein;O95907;SLC16A8;ENSG00000100156;O95907;Monocarboxylate transporter 3 (MCT 3) (Solute carrier family 16 member 8)
drug.Protein;P53985;SLC16A1;ENSG00000155380;P53985;Monocarboxylate transporter 1 (MCT 1) (Solute carrier family 16 member 1)
drug.Protein;P11498;PC;ENSG00000173599;P11498;Pyruvate carboxylase, mitochondrial (EC 6.4.1.1) (Pyruvic carboxylase) (PCB)
drug.Protein;Q92959;SLCO2A1;ENSG00000174640;Q92959;Solute carrier organic anion transporter family member 2A1 (Prostaglandin transporter) (PGT) (Solute carrier family 21 member 2)
drug.Protein;Q9UHI5;SLC7A8;ENSG00000092068;Q9UHI5;Large neutral amino acids transporter small subunit 2 (L-type amino acid transporter 2) (hLAT2) (Solute carrier family 7 member 8)
drug.Protein;Q9Y285;FARSA;ENSG00000179115;Q9Y285;Phenylalanine--tRNA ligase alpha subunit (EC 6.1.1.20) (CML33) (Phenylalanyl-tRNA synthetase alpha subunit) (PheRS)
drug.Protein;P00439;PAH;ENSG00000171759;P00439;Phenylalanine-4-hydroxylase (PAH) (EC 1.14.16.1) (Phe-4-monooxygenase)
drug.Protein;O95363;FARS2;ENSG00000145982;O95363;Phenylalanine--tRNA ligase, mitochondrial (EC 6.1.1.20) (Phenylalanyl-tRNA synthetase) (PheRS)
drug.Protein;Q9NSD9;FARSB;ENSG00000116120;Q9NSD9;Phenylalanine--tRNA ligase beta subunit (EC 6.1.1.20) (Phenylalanyl-tRNA synthetase beta subunit) (PheRS)
drug.Protein;P07101;TH;ENSG00000180176;P07101;Tyrosine 3-monooxygenase (EC 1.14.16.2) (Tyrosine 3-hydroxylase) (TH)
drug.Protein;P05166;PCCB;ENSG00000114054;P05166;Propionyl-CoA carboxylase beta chain, mitochondrial (PCCase subunit beta) (EC 6.4.1.3) (Propanoyl-CoA:carbon dioxide ligase subunit beta)
drug.Protein;P50747;HLCS;ENSG00000159267;P50747;"Biotin--protein ligase (EC 6.3.4.-) (Biotin apo-protein ligase) [Includes: Biotin--[methylmalonyl-CoA-carboxytransferase] ligase (EC 6.3.4.9); Biotin--[propionyl-CoA-carboxylase [ATP-hydrolyzing]] ligase (EC 6.3.4.10) (Holocarboxylase synthetase) (HCS); Biotin--[methylcrotonoyl-CoA-carboxylase] ligase (EC 6.3.4.11); Biotin--[acetyl-CoA-carboxylase] ligase (EC 6.3.4.15)]"
drug.Protein;Q9HCC0;MCCC2;ENSG00000131844;Q9HCC0;Methylcrotonoyl-CoA carboxylase beta chain, mitochondrial (MCCase subunit beta) (EC 6.4.1.4) (3-methylcrotonyl-CoA carboxylase 2) (3-methylcrotonyl-CoA carboxylase non-biotin-containing subunit) (3-methylcrotonyl-CoA:carbon dioxide ligase subunit beta)
drug.Protein;O00763;ACACB;ENSG00000076555;O00763;Acetyl-CoA carboxylase 2 (EC 6.4.1.2) (ACC-beta)
drug.Protein;Q96RQ3;MCCC1;ENSG00000078070;Q96RQ3;Methylcrotonoyl-CoA carboxylase subunit alpha, mitochondrial (MCCase subunit alpha) (EC 6.4.1.4) (3-methylcrotonyl-CoA carboxylase 1) (3-methylcrotonyl-CoA carboxylase biotin-containing subunit) (3-methylcrotonyl-CoA:carbon dioxide ligase subunit alpha)
drug.Protein;P05165;PCCA;ENSG00000175198;P05165;Propionyl-CoA carboxylase alpha chain, mitochondrial (PCCase subunit alpha) (EC 6.4.1.3) (Propanoyl-CoA:carbon dioxide ligase subunit alpha)
drug.Protein;Q13085;ACACA;ENSG00000278540;Q13085;Acetyl-CoA carboxylase 1 (ACC1) (EC 6.4.1.2) (Acetyl-Coenzyme A carboxylase alpha) (ACC-alpha)
drug.Protein;Q16678;CYP1B1;ENSG00000138061;Q16678;Cytochrome P450 1B1 (EC 1.14.14.1) (CYPIB1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)
drug.Protein;Q9Y289;SLC5A6;ENSG00000138074;Q9Y289;Sodium-dependent multivitamin transporter (Na(+)-dependent multivitamin transporter) (Solute carrier family 5 member 6)
drug.Protein;Q8N695;SLC5A8;ENSG00000256870;Q8N695;Sodium-coupled monocarboxylate transporter 1 (Apical iodide transporter) (Electrogenic sodium monocarboxylate cotransporter) (Sodium iodide-related cotransporter) (Solute carrier family 5 member 8)
drug.Protein;Q9Y5K3;PCYT1B;ENSG00000102230;Q9Y5K3;Choline-phosphate cytidylyltransferase B (EC 2.7.7.15) (CCT-beta) (CTP:phosphocholine cytidylyltransferase B) (CCT B) (CT B) (Phosphorylcholine transferase B)
drug.Protein;P22303;ACHE;ENSG00000087085;P22303;Acetylcholinesterase (AChE) (EC 3.1.1.7)
drug.Protein;P49585;PCYT1A;ENSG00000161217;P49585;Choline-phosphate cytidylyltransferase A (EC 2.7.7.15) (CCT-alpha) (CTP:phosphocholine cytidylyltransferase A) (CCT A) (CT A) (Phosphorylcholine transferase A)
drug.Protein;O14939;PLD2;ENSG00000129219;O14939;Phospholipase D2 (PLD 2) (hPLD2) (EC 3.1.4.4) (Choline phosphatase 2) (PLD1C) (Phosphatidylcholine-hydrolyzing phospholipase D2)
drug.Protein;Q13393;PLD1;ENSG00000075651;Q13393;Phospholipase D1 (PLD 1) (hPLD1) (EC 3.1.4.4) (Choline phosphatase 1) (Phosphatidylcholine-hydrolyzing phospholipase D1)
drug.Protein;Q8TCT1;PHOSPHO1;ENSG00000173868;Q8TCT1;Phosphoethanolamine/phosphocholine phosphatase (EC 3.1.3.75)
drug.Protein;P36544;CHRNA7;ENSG00000175344;P36544;Neuronal acetylcholine receptor subunit alpha-7
drug.Protein;Q9Y6K0;CEPT1;ENSG00000134255;Q9Y6K0;Choline/ethanolaminephosphotransferase 1 (hCEPT1) (EC 2.7.8.1) (EC 2.7.8.2) (1-alkenyl-2-acylglycerol choline phosphotransferase) (EC 2.7.8.22)
drug.Protein;Q9Y259;CHKB;ENSG00000100288;Q9Y259;Choline/ethanolamine kinase (Choline kinase beta) (CK) (CKB) (EC 2.7.1.32) (Choline kinase-like protein) (Ethanolamine kinase) (EK) (EC 2.7.1.82) (Ethanolamine kinase beta) (EKB) (choline/ethanolamine kinase beta) (CKEKB)
drug.Protein;P28329;CHAT;ENSG00000070748;P28329;Choline O-acetyltransferase (CHOACTase) (ChAT) (Choline acetylase) (EC 2.3.1.6)
drug.Protein;P35790;CHKA;ENSG00000110721;P35790;Choline kinase alpha (CK) (EC 2.7.1.32) (CHETK-alpha) (Ethanolamine kinase) (EK) (EC 2.7.1.82)
drug.Protein;Q8NE62;CHDH;ENSG00000016391;Q8NE62;Choline dehydrogenase, mitochondrial (CDH) (CHD) (EC 1.1.99.1)
drug.Protein;O15244;SLC22A2;ENSG00000112499;O15244;Solute carrier family 22 member 2 (Organic cation transporter 2) (hOCT2)
drug.Protein;O15245;SLC22A1;ENSG00000175003;O15245;Solute carrier family 22 member 1 (Organic cation transporter 1) (hOCT1)
drug.Protein;O75751;SLC22A3;ENSG00000146477;O75751;Solute carrier family 22 member 3 (Extraneuronal monoamine transporter) (EMT) (Organic cation transporter 3)
drug.Protein;O76082;SLC22A5;ENSG00000197375;O76082;Solute carrier family 22 member 5 (High-affinity sodium-dependent carnitine cotransporter) (Organic cation/carnitine transporter 2)
drug.Protein;Q9H015;SLC22A4;ENSG00000197208;Q9H015;Solute carrier family 22 member 4 (Ergothioneine transporter) (ET transporter) (Organic cation/carnitine transporter 1)
drug.Protein;Q8WWI5;SLC44A1;ENSG00000070214;Q8WWI5;Choline transporter-like protein 1 (CDw92) (Solute carrier family 44 member 1) (CD antigen CD92)
drug.Protein;Q53GD3;SLC44A4;ENSG00000204385;Q53GD3;Choline transporter-like protein 4 (Solute carrier family 44 member 4) (Thiamine pyrophosphate transporter 1) (hTPPT1)
drug.Protein;Q8IWA5;SLC44A2;ENSG00000129353;Q8IWA5;Choline transporter-like protein 2 (Solute carrier family 44 member 2)
drug.Protein;Q8N4M1;SLC44A3;ENSG00000143036;Q8N4M1;Choline transporter-like protein 3 (Solute carrier family 44 member 3)
drug.Protein;Q9GZV3;SLC5A7;ENSG00000115665;Q9GZV3;High affinity choline transporter 1 (Hemicholinium-3-sensitive choline transporter) (CHT) (Solute carrier family 5 member 7)
drug.Protein;P30825;SLC7A1;ENSG00000139514;P30825;High affinity cationic amino acid transporter 1 (CAT-1) (CAT1) (Ecotropic retroviral leukemia receptor homolog) (Ecotropic retrovirus receptor homolog) (Solute carrier family 7 member 1) (System Y+ basic amino acid transporter)
drug.Protein;O43246;SLC7A4;ENSG00000099960;O43246;Cationic amino acid transporter 4 (CAT-4) (CAT4) (Solute carrier family 7 member 4)
drug.Protein;Q8WY07;SLC7A3;ENSG00000165349;Q8WY07;Cationic amino acid transporter 3 (CAT-3) (CAT3) (Cationic amino acid transporter y+) (Solute carrier family 7 member 3)
drug.Protein;P52569;SLC7A2;ENSG00000003989;P52569;Cationic amino acid transporter 2 (CAT-2) (CAT2) (Low affinity cationic amino acid transporter 2) (Solute carrier family 7 member 2)
drug.Protein;Q15046;KARS1;ENSG00000065427;Q15046;Lysine--tRNA ligase (EC 2.7.7.-) (EC 6.1.1.6) (Lysyl-tRNA synthetase) (LysRS)
drug.Protein;P29474;NOS3;ENSG00000164867;P29474;Nitric oxide synthase, endothelial (EC 1.14.13.39) (Constitutive NOS) (cNOS) (EC-NOS) (Endothelial NOS) (eNOS) (NOS type III) (NOSIII)
drug.Protein;P04424;ASL;ENSG00000126522;P04424;Argininosuccinate lyase (ASAL) (EC 4.3.2.1) (Arginosuccinase)
drug.Protein;P35228;NOS2;ENSG00000007171;P35228;Nitric oxide synthase, inducible (EC 1.14.13.39) (Hepatocyte NOS) (HEP-NOS) (Inducible NO synthase) (Inducible NOS) (iNOS) (NOS type II) (Peptidyl-cysteine S-nitrosylase NOS2)
drug.Protein;P78540;ARG2;ENSG00000081181;P78540;Arginase-2, mitochondrial (EC 3.5.3.1) (Arginase II) (Kidney-type arginase) (Non-hepatic arginase) (Type II arginase)
drug.Protein;P00966;ASS1;ENSG00000130707;P00966;Argininosuccinate synthase (EC 6.3.4.5) (Citrulline--aspartate ligase)
drug.Protein;O00469;PLOD2;ENSG00000152952;O00469;Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2 (EC 1.14.11.4) (Lysyl hydroxylase 2) (LH2)
drug.Protein;O60568;PLOD3;ENSG00000106397;O60568;"Multifunctional procollagen lysine hydroxylase and glycosyltransferase LH3 [Includes: Procollagen-lysine,2-oxoglutarate 5-dioxygenase 3 (EC 1.14.11.4) (Lysyl hydroxylase 3) (LH3); Procollagen glycosyltransferase (EC 2.4.1.50) (EC 2.4.1.66) (Galactosylhydroxylysine-glucosyltransferase) (Procollagen galactosyltransferase) (Procollagen glucosyltransferase)]"
drug.Protein;O75936;BBOX1;ENSG00000129151;O75936;Gamma-butyrobetaine dioxygenase (EC 1.14.11.1) (Gamma-butyrobetaine hydroxylase) (Gamma-BBH) (Gamma-butyrobetaine,2-oxoglutarate dioxygenase)
drug.Protein;P09172;DBH;ENSG00000123454;P09172;Dopamine beta-hydroxylase (EC 1.14.17.1) (Dopamine beta-monooxygenase) [Cleaved into: Soluble dopamine beta-hydroxylase]
drug.Protein;P19021;PAM;ENSG00000145730;P19021;"Peptidyl-glycine alpha-amidating monooxygenase (PAM) [Includes: Peptidylglycine alpha-hydroxylating monooxygenase (PHM) (EC 1.14.17.3); Peptidyl-alpha-hydroxyglycine alpha-amidating lyase (EC 4.3.2.5) (Peptidylamidoglycolate lyase) (PAL)]"
drug.Protein;Q32P28;P3H1;ENSG00000117385;Q32P28;Prolyl 3-hydroxylase 1 (EC 1.14.11.7) (Growth suppressor 1) (Leucine- and proline-enriched proteoglycan 1) (Leprecan-1)
drug.Protein;Q8IVL5;P3H2;ENSG00000090530;Q8IVL5;Prolyl 3-hydroxylase 2 (EC 1.14.11.7) (Leprecan-like protein 1) (Myxoid liposarcoma-associated protein 4)
drug.Protein;Q8IVL6;P3H3;ENSG00000110811;Q8IVL6;Prolyl 3-hydroxylase 3 (EC 1.14.11.7) (Leprecan-like protein 2) (Protein B)
drug.Protein;P13674;P4HA1;ENSG00000122884;P13674;Prolyl 4-hydroxylase subunit alpha-1 (4-PH alpha-1) (EC 1.14.11.2) (Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-1)
drug.Protein;Q8N543;OGFOD1;ENSG00000087263;Q8N543;Prolyl 3-hydroxylase OGFOD1 (EC 1.14.11.-) (2-oxoglutarate and iron-dependent oxygenase domain-containing protein 1) (Termination and polyadenylation 1 homolog) (uS12 prolyl 3-hydroxylase)
drug.Protein;Q6N063;OGFOD2;ENSG00000111325;Q6N063;2-oxoglutarate and iron-dependent oxygenase domain-containing protein 2 (EC 1.14.11.-)
drug.Protein;Q6NS38;ALKBH2;ENSG00000189046;Q6NS38;DNA oxidative demethylase ALKBH2 (EC 1.14.11.33) (Alkylated DNA repair protein alkB homolog 2) (Alpha-ketoglutarate-dependent dioxygenase alkB homolog 2) (Oxy DC1)
drug.Protein;Q96Q83;ALKBH3;ENSG00000166199;Q96Q83;Alpha-ketoglutarate-dependent dioxygenase alkB homolog 3 (EC 1.14.11.33) (EC 1.14.11.54) (Alkylated DNA repair protein alkB homolog 3) (hABH3) (DEPC-1) (Prostate cancer antigen 1)
drug.Protein;Q9BY66;KDM5D;ENSG00000012817;Q9BY66;Lysine-specific demethylase 5D (EC 1.14.11.67) (Histocompatibility Y antigen) (H-Y) (Histone demethylase JARID1D) (Jumonji/ARID domain-containing protein 1D) (Protein SmcY) ([histone H3]-trimethyl-L-lysine(4) demethylase 5D)
drug.Protein;Q02809;PLOD1;ENSG00000083444;Q02809;Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1 (EC 1.14.11.4) (Lysyl hydroxylase 1) (LH1)
drug.Protein;Q9NVH6;TMLHE;ENSG00000185973;Q9NVH6;Trimethyllysine dioxygenase, mitochondrial (EC 1.14.11.8) (Epsilon-trimethyllysine 2-oxoglutarate dioxygenase) (Epsilon-trimethyllysine hydroxylase) (TML hydroxylase) (TML-alpha-ketoglutarate dioxygenase) (TML dioxygenase) (TMLD)
drug.Protein;Q9NXG6;P4HTM;ENSG00000178467;Q9NXG6;Transmembrane prolyl 4-hydroxylase (P4H-TM) (EC 1.14.11.29) (Hypoxia-inducible factor prolyl hydroxylase 4) (HIF-PH4) (HIF-prolyl hydroxylase 4) (HPH-4)
drug.Protein;Q9GZT9;EGLN1;ENSG00000135766;Q9GZT9;Egl nine homolog 1 (EC 1.14.11.29) (Hypoxia-inducible factor prolyl hydroxylase 2) (HIF-PH2) (HIF-prolyl hydroxylase 2) (HPH-2) (Prolyl hydroxylase domain-containing protein 2) (PHD2) (SM-20)
drug.Protein;Q96KS0;EGLN2;ENSG00000269858;Q96KS0;Prolyl hydroxylase EGLN2 (EC 1.14.11.-) (Egl nine homolog 2) (EC 1.14.11.29) (Estrogen-induced tag 6) (EIT-6) (HPH-3) (Hypoxia-inducible factor prolyl hydroxylase 1) (HIF-PH1) (HIF-prolyl hydroxylase 1) (HPH-1) (Prolyl hydroxylase domain-containing protein 1) (PHD1)
drug.Protein;Q9H6Z9;EGLN3;ENSG00000129521;Q9H6Z9;Prolyl hydroxylase EGLN3 (EC 1.14.11.-) (Egl nine homolog 3) (EC 1.14.11.29) (HPH-1) (Hypoxia-inducible factor prolyl hydroxylase 3) (HIF-PH3) (HIF-prolyl hydroxylase 3) (HPH-3) (Prolyl hydroxylase domain-containing protein 3) (PHD3)
drug.Protein;Q16881;TXNRD1;ENSG00000198431;Q16881;Thioredoxin reductase 1, cytoplasmic (TR) (EC 1.8.1.9) (Gene associated with retinoic and interferon-induced mortality 12 protein) (GRIM-12) (Gene associated with retinoic and IFN-induced mortality 12 protein) (KM-102-derived reductase-like factor) (Peroxidase TXNRD1) (EC 1.11.1.2) (Thioredoxin reductase TR1)
drug.Protein;Q9UHI7;SLC23A1;ENSG00000170482;Q9UHI7;Solute carrier family 23 member 1 (Na(+)/L-ascorbic acid transporter 1) (Sodium-dependent vitamin C transporter 1) (hSVCT1) (Yolk sac permease-like molecule 3)
drug.Protein;Q9UGH3;SLC23A2;ENSG00000089057;Q9UGH3;Solute carrier family 23 member 2 (Na(+)/L-ascorbic acid transporter 2) (Nucleobase transporter-like 1 protein) (Sodium-dependent vitamin C transporter 2) (hSVCT2) (Yolk sac permease-like molecule 2)
drug.Protein;P11166;SLC2A1;ENSG00000117394;P11166;Solute carrier family 2, facilitated glucose transporter member 1 (Glucose transporter type 1, erythrocyte/brain) (GLUT-1) (HepG2 glucose transporter)
drug.Protein;P11169;SLC2A3;ENSG00000059804;P11169;Solute carrier family 2, facilitated glucose transporter member 3 (Glucose transporter type 3, brain) (GLUT-3)
drug.Protein;P14672;SLC2A4;ENSG00000181856;P14672;Solute carrier family 2, facilitated glucose transporter member 4 (Glucose transporter type 4, insulin-responsive) (GLUT-4)
drug.Protein;P52788;SMS;ENSG00000102172;P52788;Spermine synthase (SPMSY) (EC 2.5.1.22) (Spermidine aminopropyltransferase)
drug.Protein;Q9NWM0;SMOX;ENSG00000088826;Q9NWM0;Spermine oxidase (EC 1.5.3.16) (Polyamine oxidase 1) (PAO-1) (PAOh1)
drug.Protein;P41180;CASR;ENSG00000036828;P41180;Extracellular calcium-sensing receptor (CaR) (CaSR) (hCasR) (Parathyroid cell calcium-sensing receptor 1) (PCaR1)
drug.Protein;P08588;ADRB1;ENSG00000043591;P08588;Beta-1 adrenergic receptor (Beta-1 adrenoreceptor) (Beta-1 adrenoceptor)
drug.Protein;P07550;ADRB2;ENSG00000169252;P07550;Beta-2 adrenergic receptor (Beta-2 adrenoreceptor) (Beta-2 adrenoceptor)
drug.Protein;P21673;SAT1;ENSG00000130066;P21673;Diamine acetyltransferase 1 (EC 2.3.1.57) (Polyamine N-acetyltransferase 1) (Putrescine acetyltransferase) (Spermidine/spermine N(1)-acetyltransferase 1) (SSAT) (SSAT-1)
drug.Protein;Q96F10;SAT2;ENSG00000141504;Q96F10;Thialysine N-epsilon-acetyltransferase (EC 2.3.1.-) (Diamine acetyltransferase 2) (EC 2.3.1.57) (Spermidine/spermine N(1)-acetyltransferase 2) (SSAT-2)
drug.Protein;P07998;RNASE1;ENSG00000129538;P07998;Ribonuclease pancreatic (EC 4.6.1.18) (HP-RNase) (RIB-1) (RNase UpI-1) (Ribonuclease 1) (RNase 1) (Ribonuclease A) (RNase A)
drug.Protein;P61626;LYZ;ENSG00000090382;P61626;Lysozyme C (EC 3.2.1.17) (1,4-beta-N-acetylmuramidase C)
drug.Protein;Q9UJS0;SLC25A13;ENSG00000004864;Q9UJS0;Electrogenic aspartate/glutamate antiporter SLC25A13, mitochondrial (Calcium-binding mitochondrial carrier protein Aralar2) (ARALAR-related gene 2) (ARALAR2) (Citrin) (Mitochondrial aspartate glutamate carrier 2) (Solute carrier family 25 member 13)
drug.Protein;P45381;ASPA;ENSG00000108381;P45381;Aspartoacylase (EC 3.5.1.15) (Aminoacylase-2) (ACY-2)
drug.Protein;P08243;ASNS;ENSG00000070669;P08243;Asparagine synthetase [glutamine-hydrolyzing] (EC 6.3.5.4) (Cell cycle control protein TS11) (Glutamine-dependent asparagine synthetase)
drug.Protein;Q03154;ACY1;ENSG00000243989;Q03154;Aminoacylase-1 (ACY-1) (EC 3.5.1.14) (N-acyl-L-amino-acid amidohydrolase)
drug.Protein;P14868;DARS1;ENSG00000115866;P14868;Aspartate--tRNA ligase, cytoplasmic (EC 6.1.1.12) (Aspartyl-tRNA synthetase) (AspRS) (Cell proliferation-inducing gene 40 protein)
drug.Protein;O75746;SLC25A12;ENSG00000115840;O75746;Electrogenic aspartate/glutamate antiporter SLC25A12, mitochondrial (Araceli hiperlarga) (Aralar) (Aralar1) (Mitochondrial aspartate glutamate carrier 1) (Solute carrier family 25 member 12)
drug.Protein;Q12797;ASPH;ENSG00000198363;Q12797;Aspartyl/asparaginyl beta-hydroxylase (EC 1.14.11.16) (Aspartate beta-hydroxylase) (ASP beta-hydroxylase) (Peptide-aspartate beta-dioxygenase)
drug.Protein;P22234;PAICS;ENSG00000128050;P22234;"Bifunctional phosphoribosylaminoimidazole carboxylase/phosphoribosylaminoimidazole succinocarboxamide synthetase (PAICS) [Includes: Phosphoribosylaminoimidazole carboxylase (EC 4.1.1.21) (AIR carboxylase) (AIRC); Phosphoribosylaminoimidazole succinocarboxamide synthetase (EC 6.3.2.6) (SAICAR synthetase)]"
drug.Protein;P30520;ADSS2;ENSG00000035687;P30520;Adenylosuccinate synthetase isozyme 2 (AMPSase 2) (AdSS 2) (EC 6.3.4.4) (Adenylosuccinate synthetase, acidic isozyme) (Adenylosuccinate synthetase, liver isozyme) (L-type adenylosuccinate synthetase) (IMP--aspartate ligase 2)
drug.Protein;P43005;SLC1A1;ENSG00000106688;P43005;Excitatory amino acid transporter 3 (Excitatory amino-acid carrier 1) (Neuronal and epithelial glutamate transporter) (Sodium-dependent glutamate/aspartate transporter 3) (Solute carrier family 1 member 1)
drug.Protein;Q5T6L4;;;;
drug.Protein;Q6PI48;DARS2;ENSG00000117593;Q6PI48;Aspartate--tRNA ligase, mitochondrial (EC 6.1.1.12) (Aspartyl-tRNA synthetase) (AspRS)
drug.Protein;Q7L266;ASRGL1;ENSG00000162174;Q7L266;"Isoaspartyl peptidase/L-asparaginase (EC 3.4.19.5) (EC 3.5.1.1) (Asparaginase-like protein 1) (Beta-aspartyl-peptidase) (Isoaspartyl dipeptidase) (L-asparagine amidohydrolase) [Cleaved into: Isoaspartyl peptidase/L-asparaginase alpha chain; Isoaspartyl peptidase/L-asparaginase beta chain]"
drug.Protein;P27708;CAD;ENSG00000084774;P27708;"CAD protein [Includes: Glutamine-dependent carbamoyl-phosphate synthase (EC 6.3.5.5); Aspartate carbamoyltransferase (EC 2.1.3.2); Dihydroorotase (EC 3.5.2.3)]"
drug.Protein;P00480;OTC;ENSG00000036473;P00480;Ornithine transcarbamylase, mitochondrial (OTCase) (EC 2.1.3.3) (Ornithine carbamoyltransferase, mitochondrial)
drug.Protein;P05089;ARG1;ENSG00000118520;P05089;Arginase-1 (EC 3.5.3.1) (Liver-type arginase) (Type I arginase)
drug.Protein;P54368;OAZ1;ENSG00000104904;P54368;Ornithine decarboxylase antizyme 1 (AZ1) (ODC-Az)
drug.Protein;Q9BXI2;SLC25A2;ENSG00000120329;Q9BXI2;Mitochondrial ornithine transporter 2 (Solute carrier family 25 member 2)
drug.Protein;Q9Y619;SLC25A15;ENSG00000102743;Q9Y619;Mitochondrial ornithine transporter 1 (Solute carrier family 25 member 15)
drug.Protein;P50440;GATM;ENSG00000171766;P50440;Glycine amidinotransferase, mitochondrial (EC 2.1.4.1) (L-arginine:glycine amidinotransferase) (Transamidinase)
drug.Protein;P17812;CTPS1;ENSG00000171793;P17812;CTP synthase 1 (EC 6.3.4.2) (CTP synthetase 1) (UTP--ammonia ligase 1)
drug.Protein;Q06203;PPAT;ENSG00000128059;Q06203;Amidophosphoribosyltransferase (ATase) (EC 2.4.2.14) (Glutamine phosphoribosylpyrophosphate amidotransferase) (GPAT)
drug.Protein;P00488;F13A1;ENSG00000124491;P00488;Coagulation factor XIII A chain (Coagulation factor XIIIa) (EC 2.3.2.13) (Protein-glutamine gamma-glutamyltransferase A chain) (Transglutaminase A chain)
drug.Protein;O94925;GLS;ENSG00000115419;O94925;"Glutaminase kidney isoform, mitochondrial (GLS) (EC 3.5.1.2) (K-glutaminase) (L-glutamine amidohydrolase) [Cleaved into: Glutaminase kidney isoform, mitochondrial 68 kDa chain; Glutaminase kidney isoform, mitochondrial 65 kDa chain]"
drug.Protein;Q9UI32;GLS2;ENSG00000135423;Q9UI32;Glutaminase liver isoform, mitochondrial (GLS) (EC 3.5.1.2) (L-glutaminase) (L-glutamine amidohydrolase)
drug.Protein;P21980;TGM2;ENSG00000198959;P21980;Protein-glutamine gamma-glutamyltransferase 2 (EC 2.3.2.13) (Erythrocyte transglutaminase) (Heart G alpha(h)) (hhG alpha(h)) (Isopeptidase TGM2) (EC 3.4.-.-) (Protein G alpha(h)) (G(h)) (Protein-glutamine deamidase TGM2) (EC 3.5.1.44) (Protein-glutamine dopaminyltransferase TGM2) (EC 2.3.1.-) (Protein-glutamine histaminyltransferase TGM2) (EC 2.3.1.-) (Protein-glutamine noradrenalinyltransferase TGM2) (EC 2.3.1.-) (Protein-glutamine serotonyltransferase TGM2) (EC 2.3.1.-) (Tissue transglutaminase) (tTG) (tTgase) (Transglutaminase C) (TG(C)) (TGC) (TGase C) (Transglutaminase H) (TGase H) (Transglutaminase II) (TGase II) (Transglutaminase-2) (TG2) (TGase-2) (hTG2)
drug.Protein;O43548;TGM5;ENSG00000104055;O43548;Protein-glutamine gamma-glutamyltransferase 5 (EC 2.3.2.13) (Transglutaminase X) (TG(X)) (TGX) (TGase X) (Transglutaminase-5) (TGase-5)
drug.Protein;O95932;TGM6;ENSG00000166948;O95932;Protein-glutamine gamma-glutamyltransferase 6 (EC 2.3.2.13) (Transglutaminase Y) (TGY) (TGase Y) (Transglutaminase-3-like) (TGase-3-like) (Transglutaminase-6) (TG6) (TGase-6)
drug.Protein;P22735;TGM1;ENSG00000092295;P22735;Protein-glutamine gamma-glutamyltransferase K (EC 2.3.2.13) (Epidermal TGase) (Transglutaminase K) (TG(K)) (TGK) (TGase K) (Transglutaminase-1) (TGase-1)
drug.Protein;P49221;TGM4;ENSG00000163810;P49221;Protein-glutamine gamma-glutamyltransferase 4 (EC 2.3.2.13) (Fibrinoligase) (Prostate transglutaminase) (Prostate-specific transglutaminase) (Transglutaminase P) (TG(P)) (TGP) (TGase P) (Transglutaminase-4) (TGase-4)
drug.Protein;Q08188;TGM3;ENSG00000125780;Q08188;"Protein-glutamine gamma-glutamyltransferase E (EC 2.3.2.13) (Transglutaminase E) (TG(E)) (TGE) (TGase E) (Transglutaminase-3) (TGase-3) [Cleaved into: Protein-glutamine gamma-glutamyltransferase E 50 kDa catalytic chain; Protein-glutamine gamma-glutamyltransferase E 27 kDa non-catalytic chain]"
drug.Protein;Q96PF1;TGM7;ENSG00000159495;Q96PF1;Protein-glutamine gamma-glutamyltransferase Z (Transglutaminase Z) (TG(Z)) (TGZ) (TGase Z) (EC 2.3.2.13) (Transglutaminase-7) (TGase-7)
drug.Protein;P49915;GMPS;ENSG00000163655;P49915;GMP synthase [glutamine-hydrolyzing] (EC 6.3.5.2) (GMP synthetase) (Glutamine amidotransferase)
drug.Protein;O15067;PFAS;ENSG00000178921;O15067;Phosphoribosylformylglycinamidine synthase (FGAM synthase) (FGAMS) (EC 6.3.5.3) (Formylglycinamide ribonucleotide amidotransferase) (FGAR amidotransferase) (FGAR-AT) (Formylglycinamide ribotide amidotransferase) (Phosphoribosylformylglycineamide amidotransferase)
drug.Protein;O75879;GATB;ENSG00000059691;O75879;Glutamyl-tRNA(Gln) amidotransferase subunit B, mitochondrial (Glu-AdT subunit B) (EC 6.3.5.-) (Cytochrome c oxidase assembly factor PET112 homolog)
drug.Protein;O94808;GFPT2;ENSG00000131459;O94808;Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 2 (EC 2.6.1.16) (D-fructose-6-phosphate amidotransferase 2) (Glutamine:fructose-6-phosphate amidotransferase 2) (GFAT 2) (GFAT2) (Hexosephosphate aminotransferase 2)
drug.Protein;P47897;QARS1;ENSG00000172053;P47897;Glutamine--tRNA ligase (EC 6.1.1.18) (Glutaminyl-tRNA synthetase) (GlnRS)
drug.Protein;Q6IA69;NADSYN1;ENSG00000172890;Q6IA69;Glutamine-dependent NAD(+) synthetase (EC 6.3.5.1) (NAD(+) synthase [glutamine-hydrolyzing]) (NAD(+) synthetase)
drug.Protein;Q9H2H9;SLC38A1;ENSG00000111371;Q9H2H9;Sodium-coupled neutral amino acid transporter 1 (Amino acid transporter A1) (N-system amino acid transporter 2) (Solute carrier family 38 member 1) (System A amino acid transporter 1) (System N amino acid transporter 1)
drug.Protein;Q96QD8;SLC38A2;ENSG00000134294;Q96QD8;Sodium-coupled neutral amino acid transporter 2 (Amino acid transporter A2) (Protein 40-9-1) (Solute carrier family 38 member 2) (System A amino acid transporter 2) (System A transporter 1) (System N amino acid transporter 2)
drug.Protein;Q15758;SLC1A5;ENSG00000105281;Q15758;Neutral amino acid transporter B(0) (ATB(0)) (Baboon M7 virus receptor) (RD114/simian type D retrovirus receptor) (Sodium-dependent neutral amino acid transporter type 2) (Solute carrier family 1 member 5)
drug.Protein;Q9UN76;SLC6A14;ENSG00000268104;Q9UN76;Sodium- and chloride-dependent neutral and basic amino acid transporter B(0+) (Amino acid transporter ATB0+) (Solute carrier family 6 member 14)
drug.Protein;Q9UM01;SLC7A7;ENSG00000155465;Q9UM01;Y+L amino acid transporter 1 (Monocyte amino acid permease 2) (MOP-2) (Solute carrier family 7 member 7) (y(+)L-type amino acid transporter 1) (Y+LAT1) (y+LAT-1)
drug.Protein;Q92536;SLC7A6;ENSG00000103064;Q92536;Y+L amino acid transporter 2 (Cationic amino acid transporter, y+ system) (Solute carrier family 7 member 6) (y(+)L-type amino acid transporter 2) (Y+LAT2) (y+LAT-2)
drug.Protein;Q01650;SLC7A5;ENSG00000103257;Q01650;Large neutral amino acids transporter small subunit 1 (4F2 light chain) (4F2 LC) (4F2LC) (CD98 light chain) (Integral membrane protein E16) (E16) (L-type amino acid transporter 1) (hLAT1) (Solute carrier family 7 member 5) (y+ system cationic amino acid transporter)
drug.Protein;P82251;SLC7A9;ENSG00000021488;P82251;b(0,+)-type amino acid transporter 1 (b(0,+)AT1) (Glycoprotein-associated amino acid transporter b0,+AT1) (Solute carrier family 7 member 9)
drug.Protein;P16220;CREB1;ENSG00000118260;P16220;Cyclic AMP-responsive element-binding protein 1 (CREB-1) (cAMP-responsive element-binding protein 1)
drug.Protein;Q07343;PDE4B;ENSG00000184588;Q07343;cAMP-specific 3',5'-cyclic phosphodiesterase 4B (EC 3.1.4.53) (DPDE4) (PDE32)
drug.Protein;Q9Y478;PRKAB1;ENSG00000111725;Q9Y478;5'-AMP-activated protein kinase subunit beta-1 (AMPK subunit beta-1) (AMPKb)
drug.Protein;P49773;HINT1;ENSG00000169567;P49773;Adenosine 5'-monophosphoramidase HINT1 (EC 3.9.1.-) (Desumoylating isopeptidase HINT1) (EC 3.4.22.-) (Histidine triad nucleotide-binding protein 1) (Protein kinase C inhibitor 1) (Protein kinase C-interacting protein 1) (PKCI-1)
drug.Protein;Q08499;PDE4D;ENSG00000113448;Q08499;cAMP-specific 3',5'-cyclic phosphodiesterase 4D (EC 3.1.4.53) (DPDE3) (PDE43)
drug.Protein;Q9NR19;ACSS2;ENSG00000131069;Q9NR19;Acetyl-coenzyme A synthetase, cytoplasmic (EC 6.2.1.1) (Acetate--CoA ligase) (Acetyl-CoA synthetase) (ACS) (AceCS) (Acetyl-CoA synthetase 1) (AceCS1) (Acyl-CoA synthetase short-chain family member 2) (Acyl-activating enzyme) (Propionate--CoA ligase) (EC 6.2.1.17)
drug.Protein;Q13131;PRKAA1;ENSG00000132356;Q13131;5'-AMP-activated protein kinase catalytic subunit alpha-1 (AMPK subunit alpha-1) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) (Tau-protein kinase PRKAA1) (EC 2.7.11.26)
drug.Protein;Q08828;ADCY1;ENSG00000164742;Q08828;Adenylate cyclase type 1 (EC 4.6.1.1) (ATP pyrophosphate-lyase 1) (Adenylate cyclase type I) (Adenylyl cyclase 1) (Ca(2+)/calmodulin-activated adenylyl cyclase)
drug.Protein;P33121;ACSL1;ENSG00000151726;P33121;Long-chain-fatty-acid--CoA ligase 1 (EC 6.2.1.3) (Acyl-CoA synthetase 1) (ACS1) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 1) (LACS 1) (Long-chain acyl-CoA synthetase 2) (LACS 2) (Long-chain fatty acid-CoA ligase 2) (Palmitoyl-CoA ligase 1) (Palmitoyl-CoA ligase 2) (Phytanate--CoA ligase) (EC 6.2.1.24)
drug.Protein;P09467;FBP1;ENSG00000165140;P09467;Fructose-1,6-bisphosphatase 1 (FBPase 1) (EC 3.1.3.11) (D-fructose-1,6-bisphosphate 1-phosphohydrolase 1) (Liver FBPase)
drug.Protein;P55263;ADK;ENSG00000156110;P55263;Adenosine kinase (AK) (EC 2.7.1.20) (Adenosine 5'-phosphotransferase)
drug.Protein;P23109;AMPD1;ENSG00000116748;P23109;AMP deaminase 1 (EC 3.5.4.6) (AMP deaminase isoform M) (Myoadenylate deaminase)
drug.Protein;P07741;APRT;ENSG00000198931;P07741;Adenine phosphoribosyltransferase (APRT) (EC 2.4.2.7)
drug.Protein;O60427;FADS1;ENSG00000149485;O60427;Acyl-CoA (8-3)-desaturase (EC 1.14.19.44) (Delta(5) fatty acid desaturase) (D5D) (Delta(5) desaturase) (Delta-5 desaturase) (Fatty acid desaturase 1)
drug.Protein;O95864;FADS2;ENSG00000134824;O95864;Acyl-CoA 6-desaturase (EC 1.14.19.3) (Delta(6) fatty acid desaturase) (D6D) (Delta(6) desaturase) (Delta-6 desaturase) (Fatty acid desaturase 2)
drug.Protein;P32418;SLC8A1;ENSG00000183023;P32418;Sodium/calcium exchanger 1 (Na(+)/Ca(2+)-exchange protein 1) (Solute carrier family 8 member 1)
drug.Protein;Q8NER1;TRPV1;ENSG00000196689;Q8NER1;Transient receptor potential cation channel subfamily V member 1 (TrpV1) (Capsaicin receptor) (Osm-9-like TRP channel 1) (OTRPC1) (Vanilloid receptor 1)
drug.Protein;Q07869;PPARA;ENSG00000186951;Q07869;Peroxisome proliferator-activated receptor alpha (PPAR-alpha) (Nuclear receptor subfamily 1 group C member 1)
drug.Protein;Q96RI1;NR1H4;ENSG00000012504;Q96RI1;Bile acid receptor (Farnesoid X-activated receptor) (Farnesol receptor HRR-1) (Nuclear receptor subfamily 1 group H member 4) (Retinoid X receptor-interacting protein 14) (RXR-interacting protein 14)
drug.Protein;Q03181;PPARD;ENSG00000112033;Q03181;Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta)
drug.Protein;P37231;PPARG;ENSG00000132170;P37231;Peroxisome proliferator-activated receptor gamma (PPAR-gamma) (Nuclear receptor subfamily 1 group C member 3)
drug.Protein;P19793;RXRA;ENSG00000186350;P19793;Retinoic acid receptor RXR-alpha (Nuclear receptor subfamily 2 group B member 1) (Retinoid X receptor alpha)
drug.Protein;Q9NXB9;ELOVL2;ENSG00000197977;Q9NXB9;Elongation of very long chain fatty acids protein 2 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL2) (ELOVL fatty acid elongase 2) (ELOVL FA elongase 2) (Very long chain 3-ketoacyl-CoA synthase 2) (Very long chain 3-oxoacyl-CoA synthase 2)
drug.Protein;Q9NYP7;ELOVL5;ENSG00000012660;Q9NYP7;Elongation of very long chain fatty acids protein 5 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL5) (ELOVL fatty acid elongase 5) (ELOVL FA elongase 5) (Fatty acid elongase 1) (hELO1) (Very long chain 3-ketoacyl-CoA synthase 5) (Very long chain 3-oxoacyl-CoA synthase 5)
drug.Protein;O15540;FABP7;ENSG00000164434;O15540;Fatty acid-binding protein, brain (Brain lipid-binding protein) (BLBP) (Brain-type fatty acid-binding protein) (B-FABP) (Fatty acid-binding protein 7) (Mammary-derived growth inhibitor related)
drug.Protein;P49591;SARS1;ENSG00000031698;P49591;Serine--tRNA ligase, cytoplasmic (EC 6.1.1.11) (Seryl-tRNA synthetase) (SerRS) (Seryl-tRNA(Ser/Sec) synthetase)
drug.Protein;P50579;METAP2;ENSG00000111142;P50579;Methionine aminopeptidase 2 (MAP 2) (MetAP 2) (EC 3.4.11.18) (Initiation factor 2-associated 67 kDa glycoprotein) (p67) (p67eIF2) (Peptidase M)
drug.Protein;Q93088;BHMT;ENSG00000145692;Q93088;Betaine--homocysteine S-methyltransferase 1 (EC 2.1.1.5)
drug.Protein;Q9H2M3;BHMT2;ENSG00000132840;Q9H2M3;S-methylmethionine--homocysteine S-methyltransferase BHMT2 (SMM-hcy methyltransferase) (EC 2.1.1.10) (Betaine--homocysteine S-methyltransferase 2)
drug.Protein;Q9Y3D2;MSRB2;ENSG00000148450;Q9Y3D2;Methionine-R-sulfoxide reductase B2, mitochondrial (MsrB2) (EC 1.8.4.12) (EC 1.8.4.14)
drug.Protein;Q9NZV6;MSRB1;ENSG00000198736;Q9NZV6;Methionine-R-sulfoxide reductase B1 (MsrB1) (EC 1.8.4.12) (EC 1.8.4.14) (Selenoprotein X) (SelX)
drug.Protein;Q9UJ68;MSRA;ENSG00000175806;Q9UJ68;Mitochondrial peptide methionine sulfoxide reductase (EC 1.8.4.11) (Peptide-methionine (S)-S-oxide reductase) (Peptide Met(O) reductase) (Protein-methionine-S-oxide reductase) (PMSR)
drug.Protein;P56192;MARS1;ENSG00000166986;P56192;Methionine--tRNA ligase, cytoplasmic (EC 6.1.1.10) (Methionyl-tRNA synthetase) (MetRS)
drug.Protein;Q96GW9;MARS2;ENSG00000247626;Q96GW9;Methionine--tRNA ligase, mitochondrial (EC 6.1.1.10) (Methionyl-tRNA synthetase 2) (Mitochondrial methionyl-tRNA synthetase) (MtMetRS)
drug.Protein;Q9NZL9;MAT2B;ENSG00000038274;Q9NZL9;Methionine adenosyltransferase 2 subunit beta (Methionine adenosyltransferase II beta) (MAT II beta) (Putative dTDP-4-keto-6-deoxy-D-glucose 4-reductase)
drug.Protein;Q9Y2Z4;YARS2;ENSG00000139131;Q9Y2Z4;Tyrosine--tRNA ligase, mitochondrial (EC 6.1.1.1) (Tyrosyl-tRNA synthetase) (TyrRS)
drug.Protein;P54577;YARS1;ENSG00000134684;P54577;Tyrosine--tRNA ligase, cytoplasmic (EC 6.1.1.1) (Tyrosyl-tRNA synthetase) (TyrRS) [Cleaved into: Tyrosine--tRNA ligase, cytoplasmic, N-terminally processed]
drug.Protein;P11473;VDR;ENSG00000111424;P11473;Vitamin D3 receptor (VDR) (1,25-dihydroxyvitamin D3 receptor) (Nuclear receptor subfamily 1 group I member 1)
drug.Protein;P31260;HOXA10;ENSG00000253293;P31260;Homeobox protein Hox-A10 (Homeobox protein Hox-1.8) (Homeobox protein Hox-1H) (PL)
drug.Protein;P02774;GC;ENSG00000145321;P02774;Vitamin D-binding protein (DBP) (VDB) (Gc protein-derived macrophage activating factor) (Gc-MAF) (GcMAF) (Gc-globulin) (Group-specific component) (Gc) (Vitamin D-binding protein-macrophage activating factor) (DBP-maf)
drug.Protein;Q07973;CYP24A1;ENSG00000019186;Q07973;1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial (24-OHase) (Vitamin D(3) 24-hydroxylase) (EC 1.14.15.16) (Cytochrome P450 24A1) (Cytochrome P450-CC24)
drug.Protein;Q9UPY5;SLC7A11;ENSG00000151012;Q9UPY5;Cystine/glutamate transporter (Amino acid transport system xc-) (Calcium channel blocker resistance protein CCBR1) (Solute carrier family 7 member 11) (xCT)
drug.Protein;O60931;CTNS;ENSG00000040531;O60931;Cystinosin
drug.Protein;Q07837;SLC3A1;ENSG00000138079;Q07837;Neutral and basic amino acid transport protein rBAT (NBAT) (D2h) (Solute carrier family 3 member 1) (b(0,+)-type amino acid transport protein)
drug.Protein;Q9BXA5;SUCNR1;ENSG00000198829;Q9BXA5;Succinate receptor 1 (G-protein coupled receptor 91) (P2Y purinoceptor 1-like)
drug.Protein;P51649;ALDH5A1;ENSG00000112294;P51649;Succinate-semialdehyde dehydrogenase, mitochondrial (EC 1.2.1.24) (Aldehyde dehydrogenase family 5 member A1) (NAD(+)-dependent succinic semialdehyde dehydrogenase)
drug.Protein;Q99643;SDHC;ENSG00000143252;Q99643;Succinate dehydrogenase cytochrome b560 subunit, mitochondrial (Integral membrane protein CII-3) (QPs-1) (QPs1) (Succinate dehydrogenase complex subunit C) (Succinate-ubiquinone oxidoreductase cytochrome B large subunit) (CYBL)
drug.Protein;P31040;SDHA;ENSG00000073578;P31040;Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial (EC 1.3.5.1) (Flavoprotein subunit of complex II) (Fp)
drug.Protein;Q96I99;SUCLG2;ENSG00000172340;Q96I99;Succinate--CoA ligase [GDP-forming] subunit beta, mitochondrial (EC 6.2.1.4) (GTP-specific succinyl-CoA synthetase subunit beta) (G-SCS) (GTPSCS) (Succinyl-CoA synthetase beta-G chain) (SCS-betaG)
drug.Protein;P55809;OXCT1;ENSG00000083720;P55809;Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial (SCOT) (EC 2.8.3.5) (3-oxoacid CoA-transferase 1) (Somatic-type succinyl-CoA:3-oxoacid CoA-transferase) (SCOT-s) (Succinyl-CoA:3-oxoacid CoA transferase)
drug.Protein;Q8TCC7;SLC22A8;ENSG00000149452;Q8TCC7;Solute carrier family 22 member 8 (Organic anion transporter 3) (hOAT3)
drug.Protein;Q9UBX3;SLC25A10;ENSG00000183048;Q9UBX3;Mitochondrial dicarboxylate carrier (DIC) (Solute carrier family 25 member 10)
drug.Protein;Q9BZW2;SLC13A1;ENSG00000081800;Q9BZW2;Solute carrier family 13 member 1 (Renal sodium/sulfate cotransporter) (Na(+)/sulfate cotransporter) (hNaSi-1)
drug.Protein;Q13183;SLC13A2;ENSG00000007216;Q13183;Solute carrier family 13 member 2 (Na(+)/dicarboxylate cotransporter 1) (NaDC-1) (Renal sodium/dicarboxylate cotransporter)
drug.Protein;Q8WWT9;SLC13A3;ENSG00000158296;Q8WWT9;Solute carrier family 13 member 3 (Na(+)/dicarboxylate cotransporter 3) (NaDC-3) (hNaDC3) (Sodium-dependent high-affinity dicarboxylate transporter 2)
drug.Protein;Q969G6;RFK;ENSG00000135002;Q969G6;Riboflavin kinase (EC 2.7.1.26) (ATP:riboflavin 5'-phosphotransferase) (Flavokinase)
drug.Protein;P30043;BLVRB;ENSG00000090013;P30043;Flavin reductase (NADPH) (FR) (EC 1.5.1.30) (Biliverdin reductase B) (BVR-B) (EC 1.3.1.24) (Biliverdin-IX beta-reductase) (Green heme-binding protein) (GHBP) (NADPH-dependent diaphorase) (NADPH-flavin reductase) (FLR)
drug.Protein;P21397;MAOA;ENSG00000189221;P21397;Amine oxidase [flavin-containing] A (EC 1.4.3.21) (EC 1.4.3.4) (Monoamine oxidase type A) (MAO-A)
drug.Protein;P15291;B4GALT1;ENSG00000086062;P15291;Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase) (Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase) (EC 2.4.1.38) (Lactose synthase A protein) (EC 2.4.1.22) (N-acetyllactosamine synthase) (EC 2.4.1.90) (Nal synthase) (Neolactotriaosylceramide beta-1,4-galactosyltransferase) (EC 2.4.1.275) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1]
drug.Protein;O60513;B4GALT4;ENSG00000121578;O60513;Beta-1,4-galactosyltransferase 4 (Beta-1,4-GalTase 4) (Beta4Gal-T4) (b4Gal-T4) (EC 2.4.1.-) (Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase) (Lactotriaosylceramide beta-1,4-galactosyltransferase) (EC 2.4.1.275) (N-acetyllactosamine synthase) (EC 2.4.1.90) (Nal synthase) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 4) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 4)
drug.Protein;Q9UJ70;NAGK;ENSG00000124357;Q9UJ70;N-acetyl-D-glucosamine kinase (N-acetylglucosamine kinase) (EC 2.7.1.59) (GlcNAc kinase)
drug.Protein;Q9UK23;NAGPA;ENSG00000103174;Q9UK23;N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase (EC 3.1.4.45) (Mannose 6-phosphate-uncovering enzyme) (Phosphodiester alpha-GlcNAcase)
drug.Protein;P54802;NAGLU;ENSG00000108784;P54802;"Alpha-N-acetylglucosaminidase (EC 3.2.1.50) (N-acetyl-alpha-glucosaminidase) (NAG) [Cleaved into: Alpha-N-acetylglucosaminidase 82 kDa form; Alpha-N-acetylglucosaminidase 77 kDa form]"
drug.Protein;P51606;RENBP;ENSG00000102032;P51606;N-acylglucosamine 2-epimerase (AGE) (EC 5.1.3.8) (GlcNAc 2-epimerase) (N-acetyl-D-glucosamine 2-epimerase) (Renin-binding protein) (RnBP)
drug.Protein;Q13255;GRM1;ENSG00000152822;Q13255;Metabotropic glutamate receptor 1 (mGluR1)
drug.Protein;Q14833;GRM4;ENSG00000124493;Q14833;Metabotropic glutamate receptor 4 (mGluR4)
drug.Protein;Q16099;GRIK4;ENSG00000149403;Q16099;Glutamate receptor ionotropic, kainate 4 (GluK4) (Excitatory amino acid receptor 1) (EAA1) (Glutamate receptor KA-1) (KA1)
drug.Protein;Q16478;GRIK5;ENSG00000105737;Q16478;Glutamate receptor ionotropic, kainate 5 (GluK5) (Excitatory amino acid receptor 2) (EAA2) (Glutamate receptor KA-2) (KA2)
drug.Protein;Q14831;GRM7;ENSG00000196277;Q14831;Metabotropic glutamate receptor 7 (mGluR7)
drug.Protein;O00222;GRM8;ENSG00000179603;O00222;Metabotropic glutamate receptor 8 (mGluR8)
drug.Protein;O00341;SLC1A7;ENSG00000162383;O00341;Excitatory amino acid transporter 5 (Retinal glutamate transporter) (Solute carrier family 1 member 7)
drug.Protein;O14841;OPLAH;ENSG00000178814;O14841;5-oxoprolinase (EC 3.5.2.9) (5-oxo-L-prolinase) (5-OPase) (Pyroglutamase)
drug.Protein;O15399;GRIN2D;ENSG00000105464;O15399;Glutamate receptor ionotropic, NMDA 2D (GluN2D) (EB11) (Glutamate [NMDA] receptor subunit epsilon-4) (N-methyl D-aspartate receptor subtype 2D) (NMDAR2D) (NR2D)
drug.Protein;P07814;EPRS1;ENSG00000136628;P07814;"Bifunctional glutamate/proline--tRNA ligase (Bifunctional aminoacyl-tRNA synthetase) (Cell proliferation-inducing gene 32 protein) (Glutamatyl-prolyl-tRNA synthetase) [Includes: Glutamate--tRNA ligase (EC 6.1.1.17) (Glutamyl-tRNA synthetase) (GluRS); Proline--tRNA ligase (EC 6.1.1.15) (Prolyl-tRNA synthetase)]"
drug.Protein;P43003;SLC1A3;ENSG00000079215;P43003;Excitatory amino acid transporter 1 (Sodium-dependent glutamate/aspartate transporter 1) (GLAST-1) (Solute carrier family 1 member 3)
drug.Protein;P43004;SLC1A2;ENSG00000110436;P43004;Excitatory amino acid transporter 2 (Glutamate/aspartate transporter II) (Sodium-dependent glutamate/aspartate transporter 2) (Solute carrier family 1 member 2)
drug.Protein;P48506;GCLC;ENSG00000001084;P48506;Glutamate--cysteine ligase catalytic subunit (EC 6.3.2.2) (GCS heavy chain) (Gamma-ECS) (Gamma-glutamylcysteine synthetase)
drug.Protein;P48664;SLC1A6;ENSG00000105143;P48664;Excitatory amino acid transporter 4 (Sodium-dependent glutamate/aspartate transporter) (Solute carrier family 1 member 6)
drug.Protein;P49448;GLUD2;ENSG00000182890;P49448;Glutamate dehydrogenase 2, mitochondrial (GDH 2) (EC 1.4.1.3)
drug.Protein;Q05586;GRIN1;ENSG00000176884;Q05586;Glutamate receptor ionotropic, NMDA 1 (GluN1) (Glutamate [NMDA] receptor subunit zeta-1) (N-methyl-D-aspartate receptor subunit NR1) (NMD-R1)
drug.Protein;Q05932;FPGS;ENSG00000136877;Q05932;Folylpolyglutamate synthase, mitochondrial (EC 6.3.2.17) (Folylpoly-gamma-glutamate synthetase) (FPGS) (Tetrahydrofolylpolyglutamate synthase) (Tetrahydrofolate synthase)
drug.Protein;Q07075;ENPEP;ENSG00000138792;Q07075;Glutamyl aminopeptidase (EAP) (EC 3.4.11.7) (Aminopeptidase A) (AP-A) (Differentiation antigen gp160) (CD antigen CD249)
drug.Protein;Q12879;GRIN2A;ENSG00000183454;Q12879;Glutamate receptor ionotropic, NMDA 2A (GluN2A) (Glutamate [NMDA] receptor subunit epsilon-1) (N-methyl D-aspartate receptor subtype 2A) (NMDAR2A) (NR2A) (hNR2A)
drug.Protein;Q13224;GRIN2B;ENSG00000273079;Q13224;Glutamate receptor ionotropic, NMDA 2B (GluN2B) (Glutamate [NMDA] receptor subunit epsilon-2) (N-methyl D-aspartate receptor subtype 2B) (NMDAR2B) (NR2B) (N-methyl-D-aspartate receptor subunit 3) (NR3) (hNR3)
drug.Protein;Q14957;GRIN2C;ENSG00000161509;Q14957;Glutamate receptor ionotropic, NMDA 2C (GluN2C) (Glutamate [NMDA] receptor subunit epsilon-3) (N-methyl D-aspartate receptor subtype 2C) (NMDAR2C) (NR2C)
drug.Protein;Q5JPH6;EARS2;ENSG00000103356;Q5JPH6;Probable glutamate--tRNA ligase, mitochondrial (EC 6.1.1.17) (Glutamyl-tRNA synthetase) (GluRS)
drug.Protein;Q8N159;NAGS;ENSG00000161653;Q8N159;"N-acetylglutamate synthase, mitochondrial (EC 2.3.1.1) (Amino-acid acetyltransferase) [Cleaved into: N-acetylglutamate synthase long form; N-acetylglutamate synthase short form; N-acetylglutamate synthase conserved domain form]"
drug.Protein;Q8TCU5;GRIN3A;ENSG00000198785;Q8TCU5;Glutamate receptor ionotropic, NMDA 3A (GluN3A) (N-methyl-D-aspartate receptor subtype 3A) (NMDAR3A) (NR3A) (NMDAR-L)
drug.Protein;Q9UDR5;AASS;ENSG00000008311;Q9UDR5;"Alpha-aminoadipic semialdehyde synthase, mitochondrial (LKR/SDH) [Includes: Lysine ketoglutarate reductase (LKR) (LOR) (EC 1.5.1.8); Saccharopine dehydrogenase (SDH) (EC 1.5.1.9)]"
drug.Protein;Q9ULA0;DNPEP;ENSG00000123992;Q9ULA0;Aspartyl aminopeptidase (EC 3.4.11.21)
drug.Protein;Q9Y646;CPQ;ENSG00000104324;Q9Y646;Carboxypeptidase Q (EC 3.4.17.-) (Lysosomal dipeptidase) (Plasma glutamate carboxypeptidase)
drug.Protein;P00367;GLUD1;ENSG00000148672;P00367;Glutamate dehydrogenase 1, mitochondrial (GDH 1) (EC 1.4.1.3)
drug.Protein;P39086;GRIK1;ENSG00000171189;P39086;Glutamate receptor ionotropic, kainate 1 (GluK1) (Excitatory amino acid receptor 3) (EAA3) (Glutamate receptor 5) (GluR-5) (GluR5)
drug.Protein;P42261;GRIA1;ENSG00000155511;P42261;Glutamate receptor 1 (GluR-1) (AMPA-selective glutamate receptor 1) (GluR-A) (GluR-K1) (Glutamate receptor ionotropic, AMPA 1) (GluA1)
drug.Protein;P48507;GCLM;ENSG00000023909;P48507;Glutamate--cysteine ligase regulatory subunit (GCS light chain) (Gamma-ECS regulatory subunit) (Gamma-glutamylcysteine synthetase regulatory subunit) (Glutamate--cysteine ligase modifier subunit)
drug.Protein;Q05329;GAD2;ENSG00000136750;Q05329;Glutamate decarboxylase 2 (EC 4.1.1.15) (65 kDa glutamic acid decarboxylase) (GAD-65) (Glutamate decarboxylase 65 kDa isoform)
drug.Protein;P42262;GRIA2;ENSG00000120251;P42262;Glutamate receptor 2 (GluR-2) (AMPA-selective glutamate receptor 2) (GluR-B) (GluR-K2) (Glutamate receptor ionotropic, AMPA 2) (GluA2)
drug.Protein;P42263;GRIA3;ENSG00000125675;P42263;Glutamate receptor 3 (GluR-3) (AMPA-selective glutamate receptor 3) (GluR-C) (GluR-K3) (Glutamate receptor ionotropic, AMPA 3) (GluA3)
drug.Protein;P48058;GRIA4;ENSG00000152578;P48058;Glutamate receptor 4 (GluR-4) (GluR4) (AMPA-selective glutamate receptor 4) (GluR-D) (Glutamate receptor ionotropic, AMPA 4) (GluA4)
drug.Protein;P54886;ALDH18A1;ENSG00000059573;P54886;"Delta-1-pyrroline-5-carboxylate synthase (P5CS) (Aldehyde dehydrogenase family 18 member A1) [Includes: Glutamate 5-kinase (GK) (EC 2.7.2.11) (Gamma-glutamyl kinase); Gamma-glutamyl phosphate reductase (GPR) (EC 1.2.1.41) (Glutamate-5-semialdehyde dehydrogenase) (Glutamyl-gamma-semialdehyde dehydrogenase)]"
drug.Protein;Q13002;GRIK2;ENSG00000164418;Q13002;Glutamate receptor ionotropic, kainate 2 (GluK2) (Excitatory amino acid receptor 4) (EAA4) (Glutamate receptor 6) (GluR-6) (GluR6)
drug.Protein;Q13003;GRIK3;ENSG00000163873;Q13003;Glutamate receptor ionotropic, kainate 3 (GluK3) (Excitatory amino acid receptor 5) (EAA5) (Glutamate receptor 7) (GluR-7) (GluR7)
drug.Protein;Q9H1K4;SLC25A18;ENSG00000182902;Q9H1K4;Mitochondrial glutamate carrier 2 (GC-2) (Glutamate/H(+) symporter 2) (Solute carrier family 25 member 18)
drug.Protein;Q9H936;SLC25A22;ENSG00000177542;Q9H936;Mitochondrial glutamate carrier 1 (GC-1) (Glutamate/H(+) symporter 1) (Solute carrier family 25 member 22)
drug.Protein;O14880;MGST3;ENSG00000143198;O14880;Microsomal glutathione S-transferase 3 (Microsomal GST-3) (Glutathione peroxidase MGST3) (EC 1.11.1.-) (LTC4 synthase MGST3) (EC 4.4.1.20) (Microsomal glutathione S-transferase III) (Microsomal GST-III)
drug.Protein;O60760;HPGDS;ENSG00000163106;O60760;Hematopoietic prostaglandin D synthase (H-PGDS) (EC 5.3.99.2) (GST class-sigma) (Glutathione S-transferase) (EC 2.5.1.18) (Glutathione-dependent PGD synthase) (Glutathione-requiring prostaglandin D synthase) (Prostaglandin-H2 D-isomerase)
drug.Protein;P08263;GSTA1;ENSG00000243955;P08263;Glutathione S-transferase A1 (EC 2.5.1.18) (13-hydroperoxyoctadecadienoate peroxidase) (EC 1.11.1.-) (Androst-5-ene-3,17-dione isomerase) (EC 5.3.3.-) (GST HA subunit 1) (GST class-alpha member 1) (GST-epsilon) (GSTA1-1) (GTH1) [Cleaved into: Glutathione S-transferase A1, N-terminally processed]
drug.Protein;P09210;GSTA2;ENSG00000244067;P09210;Glutathione S-transferase A2 (EC 2.5.1.18) (GST HA subunit 2) (GST class-alpha member 2) (GST-gamma) (GSTA2-2) (GTH2)
drug.Protein;P10620;MGST1;ENSG00000008394;P10620;Microsomal glutathione S-transferase 1 (Microsomal GST-1) (EC 2.5.1.18) (Microsomal GST-I)
drug.Protein;P10768;ESD;ENSG00000139684;P10768;S-formylglutathione hydrolase (FGH) (EC 3.1.2.12) (Esterase D) (Methylumbelliferyl-acetate deacetylase) (EC 3.1.1.56)
drug.Protein;P19440;GGT1;ENSG00000100031;P19440;"Glutathione hydrolase 1 proenzyme (EC 3.4.19.13) (Gamma-glutamyltransferase 1) (Gamma-glutamyltranspeptidase 1) (GGT 1) (EC 2.3.2.2) (Leukotriene-C4 hydrolase) (EC 3.4.19.14) (CD antigen CD224) [Cleaved into: Glutathione hydrolase 1 heavy chain; Glutathione hydrolase 1 light chain]"
drug.Protein;P28161;GSTM2;ENSG00000213366;P28161;Glutathione S-transferase Mu 2 (EC 2.5.1.18) (GST class-mu 2) (GSTM2-2)
drug.Protein;P35754;GLRX;ENSG00000173221;P35754;Glutaredoxin-1 (Thioltransferase-1) (TTase-1)
drug.Protein;P36969;GPX4;ENSG00000167468;P36969;Phospholipid hydroperoxide glutathione peroxidase (PHGPx) (EC 1.11.1.12) (Glutathione peroxidase 4) (GPx-4) (GSHPx-4)
drug.Protein;P46439;GSTM5;ENSG00000134201;P46439;Glutathione S-transferase Mu 5 (EC 2.5.1.18) (GST class-mu 5) (GSTM5-5)
drug.Protein;P59796;GPX6;ENSG00000198704;P59796;Glutathione peroxidase 6 (GPx-6) (GSHPx-6) (EC 1.11.1.9)
drug.Protein;Q16775;HAGH;ENSG00000063854;Q16775;Hydroxyacylglutathione hydrolase, mitochondrial (EC 3.1.2.6) (Glyoxalase II) (Glx II)
drug.Protein;Q6NSD4;;;;
drug.Protein;Q96SL4;GPX7;ENSG00000116157;Q96SL4;Glutathione peroxidase 7 (GPx-7) (GSHPx-7) (EC 1.11.1.9) (CL683)
drug.Protein;Q99735;MGST2;ENSG00000085871;Q99735;Microsomal glutathione S-transferase 2 (Microsomal GST-2) (EC 2.5.1.18) (Glutathione peroxidase MGST2) (EC 1.11.1.-) (Leukotriene C4 synthase MGST2) (EC 4.4.1.20) (Microsomal glutathione S-transferase II) (Microsomal GST-II)
drug.Protein;Q9H4Y5;GSTO2;ENSG00000065621;Q9H4Y5;Glutathione S-transferase omega-2 (GSTO-2) (EC 2.5.1.18) (Glutathione S-transferase omega 2-2) (GSTO 2-2) (Glutathione-dependent dehydroascorbate reductase) (EC 1.8.5.1) (Monomethylarsonic acid reductase) (MMA(V) reductase) (EC 1.20.4.2)
drug.Protein;Q9NS18;GLRX2;ENSG00000023572;Q9NS18;Glutaredoxin-2, mitochondrial
drug.Protein;Q04760;GLO1;ENSG00000124767;Q04760;Lactoylglutathione lyase (EC 4.4.1.5) (Aldoketomutase) (Glyoxalase I) (Glx I) (Ketone-aldehyde mutase) (Methylglyoxalase) (S-D-lactoylglutathione methylglyoxal lyase)
drug.Protein;Q16873;LTC4S;ENSG00000213316;Q16873;Leukotriene C4 synthase (LTC4 synthase) (EC 4.4.1.20) (Glutathione S-transferase LTC4) (EC 2.5.1.-) (Leukotriene-C(4) synthase) (Leukotriene-C4 synthase)
drug.Protein;P00390;GSR;ENSG00000104687;P00390;Glutathione reductase, mitochondrial (GR) (GRase) (EC 1.8.1.7)
drug.Protein;P48637;GSS;ENSG00000100983;P48637;Glutathione synthetase (GSH synthetase) (GSH-S) (EC 6.3.2.3) (Glutathione synthase)
drug.Protein;P09488;GSTM1;ENSG00000134184;P09488;Glutathione S-transferase Mu 1 (EC 2.5.1.18) (GST HB subunit 4) (GST class-mu 1) (GSTM1-1) (GSTM1a-1a) (GSTM1b-1b) (GTH4)
drug.Protein;Q9Y2Q3;GSTK1;ENSG00000197448;Q9Y2Q3;Glutathione S-transferase kappa 1 (EC 2.5.1.18) (GST 13-13) (GST class-kappa) (GSTK1-1) (hGSTK1) (Glutathione S-transferase subunit 13)
drug.Protein;Q16772;GSTA3;ENSG00000174156;Q16772;Glutathione S-transferase A3 (EC 2.5.1.18) (GST class-alpha member 3) (Glutathione S-transferase A3-3)
drug.Protein;P21266;GSTM3;ENSG00000134202;P21266;Glutathione S-transferase Mu 3 (EC 2.5.1.18) (GST class-mu 3) (GSTM3-3) (hGSTM3-3)
drug.Protein;O15217;GSTA4;ENSG00000170899;O15217;Glutathione S-transferase A4 (EC 2.5.1.18) (GST class-alpha member 4) (Glutathione S-transferase A4-4)
drug.Protein;Q03013;GSTM4;ENSG00000168765;Q03013;Glutathione S-transferase Mu 4 (EC 2.5.1.18) (GST class-mu 4) (GST-Mu2) (GSTM4-4) (Leukotriene C4 synthase GSTM4) (EC 4.4.1.20)
drug.Protein;Q7RTV2;GSTA5;ENSG00000182793;Q7RTV2;Glutathione S-transferase A5 (EC 2.5.1.18) (GST class-alpha member 5) (Glutathione S-transferase A5-5)
drug.Protein;P09211;GSTP1;ENSG00000084207;P09211;Glutathione S-transferase P (EC 2.5.1.18) (GST class-pi) (GSTP1-1)
drug.Protein;P78417;GSTO1;ENSG00000148834;P78417;Glutathione S-transferase omega-1 (GSTO-1) (EC 2.5.1.18) (Glutathione S-transferase omega 1-1) (GSTO 1-1) (Glutathione-dependent dehydroascorbate reductase) (EC 1.8.5.1) (Monomethylarsonic acid reductase) (MMA(V) reductase) (EC 1.20.4.2) (S-(Phenacyl)glutathione reductase) (SPG-R)
drug.Protein;P07203;GPX1;ENSG00000233276;P07203;Glutathione peroxidase 1 (GPx-1) (GSHPx-1) (EC 1.11.1.9) (Cellular glutathione peroxidase)
drug.Protein;P18283;GPX2;ENSG00000176153;P18283;Glutathione peroxidase 2 (GPx-2) (GSHPx-2) (EC 1.11.1.9) (Gastrointestinal glutathione peroxidase) (Glutathione peroxidase-gastrointestinal) (GPx-GI) (GSHPx-GI) (Glutathione peroxidase-related protein 2) (GPRP-2)
drug.Protein;P30711;GSTT1;;P30711;Glutathione S-transferase theta-1 (EC 2.5.1.18) (GST class-theta-1) (Glutathione transferase T1-1)
drug.Protein;O43708;GSTZ1;ENSG00000100577;O43708;Maleylacetoacetate isomerase (MAAI) (EC 5.2.1.2) (GSTZ1-1) (Glutathione S-transferase zeta 1) (EC 2.5.1.18)
drug.Protein;O75715;GPX5;ENSG00000224586;O75715;Epididymal secretory glutathione peroxidase (EC 1.11.1.9) (Epididymis-specific glutathione peroxidase-like protein) (EGLP) (Glutathione peroxidase 5) (GPx-5) (GSHPx-5)
drug.Protein;P22352;GPX3;ENSG00000211445;P22352;Glutathione peroxidase 3 (GPx-3) (GSHPx-3) (EC 1.11.1.9) (Extracellular glutathione peroxidase) (Plasma glutathione peroxidase) (GPx-P) (GSHPx-P)
drug.Protein;P15121;AKR1B1;ENSG00000085662;P15121;Aldo-keto reductase family 1 member B1 (EC 1.1.1.300) (EC 1.1.1.372) (EC 1.1.1.54) (Aldehyde reductase) (Aldose reductase) (AR) (EC 1.1.1.21)
drug.Protein;P14780;MMP9;ENSG00000100985;P14780;"Matrix metalloproteinase-9 (MMP-9) (EC 3.4.24.35) (92 kDa gelatinase) (92 kDa type IV collagenase) (Gelatinase B) (GELB) [Cleaved into: 67 kDa matrix metalloproteinase-9; 82 kDa matrix metalloproteinase-9]"
drug.Protein;O15438;ABCC3;ENSG00000108846;O15438;ATP-binding cassette sub-family C member 3 (EC 7.6.2.-) (EC 7.6.2.2) (EC 7.6.2.3) (Canalicular multispecific organic anion transporter 2) (Multi-specific organic anion transporter D) (MOAT-D) (Multidrug resistance-associated protein 3)
drug.Protein;O15439;ABCC4;ENSG00000125257;O15439;ATP-binding cassette sub-family C member 4 (EC 7.6.2.-) (EC 7.6.2.2) (EC 7.6.2.3) (MRP/cMOAT-related ABC transporter) (Multi-specific organic anion transporter B) (MOAT-B) (Multidrug resistance-associated protein 4)
drug.Protein;O15440;ABCC5;ENSG00000114770;O15440;ATP-binding cassette sub-family C member 5 (EC 7.6.2.-) (EC 7.6.2.2) (Multi-specific organic anion transporter C) (MOAT-C) (Multidrug resistance-associated protein 5) (SMRP) (pABC11)
drug.Protein;P49619;DGKG;ENSG00000058866;P49619;Diacylglycerol kinase gamma (DAG kinase gamma) (EC 2.7.1.107) (Diglyceride kinase gamma) (DGK-gamma)
drug.Protein;Q16760;DGKD;ENSG00000077044;Q16760;Diacylglycerol kinase delta (DAG kinase delta) (EC 2.7.1.107) (130 kDa diacylglycerol kinase) (Diglyceride kinase delta) (DGK-delta)
drug.Protein;Q9BVG9;PTDSS2;ENSG00000174915;Q9BVG9;Phosphatidylserine synthase 2 (PSS-2) (PtdSer synthase 2) (EC 2.7.8.29) (Serine-exchange enzyme II)
drug.Protein;Q9NXE4;SMPD4;ENSG00000136699;Q9NXE4;Sphingomyelin phosphodiesterase 4 (EC 3.1.4.12) (Neutral sphingomyelinase 3) (nSMase-3) (nSMase3) (Neutral sphingomyelinase III)
drug.Protein;Q9NY59;SMPD3;ENSG00000103056;Q9NY59;Sphingomyelin phosphodiesterase 3 (EC 3.1.4.12) (Neutral sphingomyelinase 2) (nSMase-2) (nSMase2) (Neutral sphingomyelinase II)
drug.Protein;Q9Y2Q0;ATP8A1;ENSG00000124406;Q9Y2Q0;Phospholipid-transporting ATPase IA (EC 7.6.2.1) (ATPase class I type 8A member 1) (Chromaffin granule ATPase II) (P4-ATPase flippase complex alpha subunit ATP8A1)
drug.Protein;P17252;PRKCA;ENSG00000154229;P17252;Protein kinase C alpha type (PKC-A) (PKC-alpha) (EC 2.7.11.13)
drug.Protein;P48651;PTDSS1;ENSG00000156471;P48651;Phosphatidylserine synthase 1 (PSS-1) (PtdSer synthase 1) (EC 2.7.8.29) (Serine-exchange enzyme I)
drug.Protein;Q9UG56;PISD;ENSG00000241878;Q9UG56;"Phosphatidylserine decarboxylase proenzyme, mitochondrial (EC 4.1.1.65) [Cleaved into: Phosphatidylserine decarboxylase beta chain; Phosphatidylserine decarboxylase alpha chain]"
drug.Protein;Q8WTV0;SCARB1;ENSG00000073060;Q8WTV0;Scavenger receptor class B member 1 (SRB1) (CD36 and LIMPII analogous 1) (CLA-1) (CD36 antigen-like 1) (Collagen type I receptor, thrombospondin receptor-like 1) (SR-BI) (CD antigen CD36)
drug.Protein;P41250;GARS1;ENSG00000106105;P41250;Glycine--tRNA ligase (EC 6.1.1.14) (Diadenosine tetraphosphate synthetase) (Ap4A synthetase) (EC 2.7.7.-) (Glycyl-tRNA synthetase) (GlyRS) (Glycyl-tRNA synthetase 1)
drug.Protein;Q14032;BAAT;ENSG00000136881;Q14032;Bile acid-CoA:amino acid N-acyltransferase (BACAT) (BAT) (EC 2.3.1.65) (Bile acid-CoA thioesterase) (Choloyl-CoA hydrolase) (EC 3.1.2.27) (Glycine N-choloyltransferase) (Long-chain fatty-acyl-CoA hydrolase) (EC 3.1.2.2)
drug.Protein;Q14330;GPR18;ENSG00000125245;Q14330;N-arachidonyl glycine receptor (NAGly receptor) (G-protein coupled receptor 18)
drug.Protein;Q6IB77;GLYAT;ENSG00000149124;Q6IB77;Glycine N-acyltransferase (EC 2.3.1.13) (Acyl-CoA:glycine N-acyltransferase) (AAc) (Aralkyl acyl-CoA N-acyltransferase) (Aralkyl acyl-CoA:amino acid N-acyltransferase) (Benzoyl-coenzyme A:glycine N-acyltransferase) (Glycine N-benzoyltransferase) (EC 2.3.1.71) (HRP-1(CLP))
drug.Protein;Q8WU03;GLYATL2;ENSG00000156689;Q8WU03;Glycine N-acyltransferase-like protein 2 (EC 2.3.1.13) (Acyl-CoA:glycine N-acyltransferase-like protein 2)
drug.Protein;Q969I3;GLYATL1;ENSG00000166840;Q969I3;Glycine N-acyltransferase-like protein 1 (EC 2.3.1.68) (Acyl-CoA:glycine N-acyltransferase-like protein 1) (Glutamine N-acyltransferase)
drug.Protein;Q9P0Z9;PIPOX;ENSG00000179761;Q9P0Z9;Peroxisomal sarcosine oxidase (PSO) (EC 1.5.3.1) (EC 1.5.3.7) (L-pipecolate oxidase) (L-pipecolic acid oxidase)
drug.Protein;O60391;GRIN3B;ENSG00000116032;O60391;Glutamate receptor ionotropic, NMDA 3B (GluN3B) (N-methyl-D-aspartate receptor subtype 3B) (NMDAR3B) (NR3B)
drug.Protein;P23415;GLRA1;ENSG00000145888;P23415;Glycine receptor subunit alpha-1 (Glycine receptor 48 kDa subunit) (Glycine receptor strychnine-binding subunit)
drug.Protein;P48167;GLRB;ENSG00000109738;P48167;Glycine receptor subunit beta (Glycine receptor 58 kDa subunit)
drug.Protein;O75311;GLRA3;ENSG00000145451;O75311;Glycine receptor subunit alpha-3
drug.Protein;P23416;GLRA2;ENSG00000101958;P23416;Glycine receptor subunit alpha-2
drug.Protein;P09622;DLD;ENSG00000091140;P09622;Dihydrolipoyl dehydrogenase, mitochondrial (EC 1.8.1.4) (Dihydrolipoamide dehydrogenase) (Glycine cleavage system L protein)
drug.Protein;P23434;GCSH;ENSG00000140905;P23434;Glycine cleavage system H protein, mitochondrial (Lipoic acid-containing protein)
drug.Protein;Q7Z2H8;SLC36A1;ENSG00000123643;Q7Z2H8;Proton-coupled amino acid transporter 1 (Proton/amino acid transporter 1) (hPAT1) (Solute carrier family 36 member 1)
drug.Protein;Q9H598;SLC32A1;ENSG00000101438;Q9H598;Vesicular inhibitory amino acid transporter (GABA and glycine transporter) (Solute carrier family 32 member 1) (Vesicular GABA transporter) (hVIAAT)
drug.Protein;Q9Y345;SLC6A5;ENSG00000165970;Q9Y345;Sodium- and chloride-dependent glycine transporter 2 (GlyT-2) (GlyT2) (Solute carrier family 6 member 5)
drug.Protein;P48067;SLC6A9;ENSG00000196517;P48067;Sodium- and chloride-dependent glycine transporter 1 (GlyT-1) (GlyT1) (Solute carrier family 6 member 9)
drug.Protein;O15528;CYP27B1;ENSG00000111012;O15528;25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial (EC 1.14.15.18) (25-OHD-1 alpha-hydroxylase) (25-hydroxyvitamin D(3) 1-alpha-hydroxylase) (VD3 1A hydroxylase) (Calcidiol 1-monooxygenase) (Cytochrome P450 subfamily XXVIIB polypeptide 1) (Cytochrome P450C1 alpha) (Cytochrome P450VD1-alpha) (Cytochrome p450 27B1)
drug.Protein;O00764;PDXK;ENSG00000160209;O00764;Pyridoxal kinase (EC 2.7.1.35) (Pyridoxine kinase)
drug.Protein;P06732;CKM;ENSG00000104879;P06732;Creatine kinase M-type (EC 2.7.3.2) (Creatine kinase M chain) (Creatine phosphokinase M-type) (CPK-M) (M-CK)
drug.Protein;P12532;"CKMT1A; CKMT1B";ENSG00000223572;P12532;Creatine kinase U-type, mitochondrial (EC 2.7.3.2) (Acidic-type mitochondrial creatine kinase) (Mia-CK) (Ubiquitous mitochondrial creatine kinase) (U-MtCK)
drug.Protein;P12277;CKB;ENSG00000166165;P12277;Creatine kinase B-type (EC 2.7.3.2) (Brain creatine kinase) (B-CK) (Creatine kinase B chain) (Creatine phosphokinase B-type) (CPK-B)
drug.Protein;P17540;CKMT2;ENSG00000131730;P17540;Creatine kinase S-type, mitochondrial (EC 2.7.3.2) (Basic-type mitochondrial creatine kinase) (Mib-CK) (Sarcomeric mitochondrial creatine kinase) (S-MtCK)
drug.Protein;P48029;SLC6A8;ENSG00000130821;P48029;Sodium- and chloride-dependent creatine transporter 1 (CT1) (Creatine transporter 1) (Solute carrier family 6 member 8)
drug.Protein;Q14353;GAMT;ENSG00000130005;Q14353;Guanidinoacetate N-methyltransferase (EC 2.1.1.2)
drug.Protein;Q15031;LARS2;ENSG00000011376;Q15031;Leucine--tRNA ligase, mitochondrial (EC 6.1.1.4) (Leucyl-tRNA synthetase) (LeuRS)
drug.Protein;O60294;LCMT2;ENSG00000168806;O60294;tRNA wybutosine-synthesizing protein 4 (tRNA yW-synthesizing protein 4) (EC 2.1.1.290) (EC 2.3.1.231) (Leucine carboxyl methyltransferase 2) (tRNA(Phe) (7-(3-amino-3-(methoxycarbonyl)propyl)wyosine(37)-N)-methoxycarbonyltransferase) (tRNA(Phe) (7-(3-amino-3-carboxypropyl)wyosine(37)-O)-methyltransferase)
drug.Protein;Q9UIC8;LCMT1;ENSG00000205629;Q9UIC8;Leucine carboxyl methyltransferase 1 (EC 2.1.1.233) (Protein-leucine O-methyltransferase) ([Phosphatase 2A protein]-leucine-carboxy methyltransferase 1)
drug.Protein;Q9P2J5;LARS1;ENSG00000133706;Q9P2J5;Leucine--tRNA ligase, cytoplasmic (EC 6.1.1.4) (Leucyl-tRNA synthetase) (LeuRS)
drug.Protein;Q9UGM6;WARS2;ENSG00000116874;Q9UGM6;Tryptophan--tRNA ligase, mitochondrial (EC 6.1.1.2) ((Mt)TrpRS) (Tryptophanyl-tRNA synthetase) (TrpRS)
drug.Protein;P23381;WARS1;ENSG00000140105;P23381;"Tryptophan--tRNA ligase, cytoplasmic (EC 6.1.1.2) (Interferon-induced protein 53) (IFP53) (Tryptophanyl-tRNA synthetase) (TrpRS) (hWRS) [Cleaved into: T1-TrpRS; T2-TrpRS]"
drug.Protein;P48775;TDO2;ENSG00000151790;P48775;Tryptophan 2,3-dioxygenase (TDO) (EC 1.13.11.11) (Tryptamin 2,3-dioxygenase) (Tryptophan oxygenase) (TO) (TRPO) (Tryptophan pyrrolase) (Tryptophanase)
drug.Protein;P17752;TPH1;ENSG00000129167;P17752;Tryptophan 5-hydroxylase 1 (EC 1.14.16.4) (Tryptophan 5-monooxygenase 1)
drug.Protein;Q8IWU9;TPH2;ENSG00000139287;Q8IWU9;Tryptophan 5-hydroxylase 2 (EC 1.14.16.4) (Neuronal tryptophan hydroxylase) (Tryptophan 5-monooxygenase 2)
drug.Protein;P14902;IDO1;ENSG00000131203;P14902;Indoleamine 2,3-dioxygenase 1 (IDO-1) (EC 1.13.11.52) (Indoleamine-pyrrole 2,3-dioxygenase)
drug.Protein;P49589;CARS1;ENSG00000110619;P49589;Cysteine--tRNA ligase, cytoplasmic (EC 6.1.1.16) (Cysteinyl-tRNA synthetase) (CysRS)
drug.Protein;P16455;MGMT;ENSG00000170430;P16455;Methylated-DNA--protein-cysteine methyltransferase (EC 2.1.1.63) (6-O-methylguanine-DNA methyltransferase) (MGMT) (O-6-methylguanine-DNA-alkyltransferase)
drug.Protein;Q9HA77;CARS2;ENSG00000134905;Q9HA77;Probable cysteine--tRNA ligase, mitochondrial (EC 6.1.1.16) (Cysteinyl-tRNA synthetase) (CysRS)
drug.Protein;Q16878;CDO1;ENSG00000129596;Q16878;Cysteine dioxygenase type 1 (EC 1.13.11.20) (Cysteine dioxygenase type I) (CDO) (CDO-I)
drug.Protein;Q9H3S4;TPK1;ENSG00000196511;Q9H3S4;Thiamin pyrophosphokinase 1 (hTPK1) (EC 2.7.6.2) (Placental protein 20) (PP20) (Thiamine pyrophosphokinase 1)
drug.Protein;P13584;CYP4B1;ENSG00000142973;P13584;Cytochrome P450 4B1 (EC 1.14.14.1) (CYPIVB1) (Cytochrome P450-HP)
drug.Protein;O75356;ENTPD5;ENSG00000187097;O75356;Nucleoside diphosphate phosphatase ENTPD5 (EC 3.6.1.6) (CD39 antigen-like 4) (ER-UDPase) (Ectonucleoside triphosphate diphosphohydrolase 5) (NTPDase 5) (Guanosine-diphosphatase ENTPD5) (GDPase ENTPD5) (Inosine diphosphate phosphatase ENTPD5) (Nucleoside diphosphatase) (Uridine-diphosphatase ENTPD5) (UDPase ENTPD5)
drug.Protein;Q9BU02;THTPA;ENSG00000259431;Q9BU02;Thiamine-triphosphatase (ThTPase) (EC 3.6.1.28)
drug.Protein;O60779;SLC19A2;ENSG00000117479;O60779;Thiamine transporter 1 (ThTr-1) (ThTr1) (Solute carrier family 19 member 2) (Thiamine carrier 1) (TC1)
drug.Protein;Q9BZV2;SLC19A3;ENSG00000135917;Q9BZV2;Thiamine transporter 2 (ThTr-2) (ThTr2) (Solute carrier family 19 member 3)
drug.Protein;Q6VVX0;CYP2R1;ENSG00000186104;Q6VVX0;Vitamin D 25-hydroxylase (EC 1.14.14.24) (Cytochrome P450 2R1)
drug.Protein;Q96AT9;RPE;ENSG00000197713;Q96AT9;Ribulose-phosphate 3-epimerase (EC 5.1.3.1) (Ribulose-5-phosphate-3-epimerase)
drug.Protein;P05108;CYP11A1;ENSG00000140459;P05108;Cholesterol side-chain cleavage enzyme, mitochondrial (EC 1.14.15.6) (CYPXIA1) (Cholesterol desmolase) (Cytochrome P450 11A1) (Cytochrome P450(scc))
drug.Protein;O95865;DDAH2;ENSG00000213722;O95865;N(G),N(G)-dimethylarginine dimethylaminohydrolase 2 (DDAH-2) (Dimethylarginine dimethylaminohydrolase 2) (EC 3.5.3.18) (DDAHII) (Dimethylargininase-2) (Protein G6a) (S-phase protein)
drug.Protein;O94760;DDAH1;ENSG00000153904;O94760;N(G),N(G)-dimethylarginine dimethylaminohydrolase 1 (DDAH-1) (Dimethylarginine dimethylaminohydrolase 1) (EC 3.5.3.18) (DDAHI) (Dimethylargininase-1)
drug.Protein;P29475;NOS1;ENSG00000089250;P29475;Nitric oxide synthase, brain (EC 1.14.13.39) (Constitutive NOS) (NC-NOS) (NOS type I) (Neuronal NOS) (N-NOS) (nNOS) (Peptidyl-cysteine S-nitrosylase NOS1) (bNOS)
drug.Protein;Q6TGC4;PADI6;ENSG00000276747;Q6TGC4;Protein-arginine deiminase type-6 (EC 3.5.3.15) (Peptidyl arginine deiminase-like protein) (Peptidylarginine deiminase VI) (hPADVI) (Protein-arginine deiminase type VI)
drug.Protein;Q9ULC6;PADI1;ENSG00000142623;Q9ULC6;Protein-arginine deiminase type-1 (EC 3.5.3.15) (Peptidylarginine deiminase I) (Protein-arginine deiminase type I)
drug.Protein;Q9ULW8;PADI3;ENSG00000142619;Q9ULW8;Protein-arginine deiminase type-3 (EC 3.5.3.15) (Peptidylarginine deiminase III) (Protein-arginine deiminase type III)
drug.Protein;Q9Y2J8;PADI2;ENSG00000117115;Q9Y2J8;Protein-arginine deiminase type-2 (EC 3.5.3.15) (PAD-H19) (Peptidylarginine deiminase II) (Protein-arginine deiminase type II)
drug.Protein;Q9UM07;PADI4;ENSG00000159339;Q9UM07;Protein-arginine deiminase type-4 (EC 3.5.3.15) (HL-60 PAD) (Peptidylarginine deiminase IV) (Protein-arginine deiminase type IV)
drug.Protein;P26639;TARS1;ENSG00000113407;P26639;Threonine--tRNA ligase 1, cytoplasmic (EC 6.1.1.3) (Threonyl-tRNA synthetase) (ThrRS) (Threonyl-tRNA synthetase 1)
drug.Protein;Q9BW92;TARS2;ENSG00000143374;Q9BW92;Threonine--tRNA ligase, mitochondrial (EC 6.1.1.3) (Threonyl-tRNA synthetase) (ThrRS) (Threonyl-tRNA synthetase-like 1)
drug.Protein;O60701;UGDH;ENSG00000109814;O60701;UDP-glucose 6-dehydrogenase (UDP-Glc dehydrogenase) (UDP-GlcDH) (UDPGDH) (EC 1.1.1.22)
drug.Protein;P07327;ADH1A;ENSG00000187758;P07327;Alcohol dehydrogenase 1A (EC 1.1.1.1) (Alcohol dehydrogenase subunit alpha)
drug.Protein;Q00796;SORD;ENSG00000140263;Q00796;Sorbitol dehydrogenase (SDH) (EC 1.1.1.-) ((R,R)-butanediol dehydrogenase) (EC 1.1.1.4) (L-iditol 2-dehydrogenase) (EC 1.1.1.14) (Polyol dehydrogenase) (Ribitol dehydrogenase) (RDH) (EC 1.1.1.56) (Xylitol dehydrogenase) (XDH) (EC 1.1.1.9)
drug.Protein;P08319;ADH4;ENSG00000198099;P08319;All-trans-retinol dehydrogenase [NAD(+)] ADH4 (EC 1.1.1.105) (Alcohol dehydrogenase 4) (Alcohol dehydrogenase class II pi chain)
drug.Protein;P00326;ADH1C;ENSG00000248144;P00326;Alcohol dehydrogenase 1C (EC 1.1.1.1) (Alcohol dehydrogenase subunit gamma)
drug.Protein;P00325;ADH1B;ENSG00000196616;P00325;All-trans-retinol dehydrogenase [NAD(+)] ADH1B (EC 1.1.1.105) (Alcohol dehydrogenase 1B) (Alcohol dehydrogenase subunit beta)
drug.Protein;P40394;ADH7;ENSG00000196344;P40394;All-trans-retinol dehydrogenase [NAD(+)] ADH7 (EC 1.1.1.105) (Alcohol dehydrogenase class 4 mu/sigma chain) (EC 1.1.1.1) (Alcohol dehydrogenase class IV mu/sigma chain) (Gastric alcohol dehydrogenase) (Omega-hydroxydecanoate dehydrogenase ADH7) (EC 1.1.1.66) (Retinol dehydrogenase)
drug.Protein;P21695;GPD1;ENSG00000167588;P21695;Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic (GPD-C) (GPDH-C) (EC 1.1.1.8)
drug.Protein;Q6ZMR3;LDHAL6A;ENSG00000166800;Q6ZMR3;L-lactate dehydrogenase A-like 6A (LDHA-like protein 6A) (EC 1.1.1.27)
drug.Protein;P11766;ADH5;ENSG00000197894;P11766;Alcohol dehydrogenase class-3 (EC 1.1.1.1) (Alcohol dehydrogenase 5) (Alcohol dehydrogenase class chi chain) (Alcohol dehydrogenase class-III) (Glutathione-dependent formaldehyde dehydrogenase) (FALDH) (FDH) (GSH-FDH) (EC 1.1.1.-) (S-(hydroxymethyl)glutathione dehydrogenase) (EC 1.1.1.284)
drug.Protein;Q99714;HSD17B10;ENSG00000072506;Q99714;3-hydroxyacyl-CoA dehydrogenase type-2 (EC 1.1.1.35) (17-beta-estradiol 17-dehydrogenase) (EC 1.1.1.62) (2-methyl-3-hydroxybutyryl-CoA dehydrogenase) (MHBD) (3-alpha-(17-beta)-hydroxysteroid dehydrogenase (NAD(+))) (EC 1.1.1.239) (3-hydroxy-2-methylbutyryl-CoA dehydrogenase) (EC 1.1.1.178) (3-hydroxyacyl-CoA dehydrogenase type II) (3alpha(or 20beta)-hydroxysteroid dehydrogenase) (EC 1.1.1.53) (7-alpha-hydroxysteroid dehydrogenase) (EC 1.1.1.159) (Endoplasmic reticulum-associated amyloid beta-peptide-binding protein) (Mitochondrial ribonuclease P protein 2) (Mitochondrial RNase P protein 2) (Short chain dehydrogenase/reductase family 5C member 1) (Short-chain type dehydrogenase/reductase XH98G2) (Type II HADH)
drug.Protein;P40926;MDH2;ENSG00000146701;P40926;Malate dehydrogenase, mitochondrial (EC 1.1.1.37)
drug.Protein;P00338;LDHA;ENSG00000134333;P00338;L-lactate dehydrogenase A chain (LDH-A) (EC 1.1.1.27) (Cell proliferation-inducing gene 19 protein) (LDH muscle subunit) (LDH-M) (Renal carcinoma antigen NY-REN-59)
drug.Protein;P23368;ME2;ENSG00000082212;P23368;NAD-dependent malic enzyme, mitochondrial (NAD-ME) (EC 1.1.1.38) (Malic enzyme 2)
drug.Protein;P51659;HSD17B4;ENSG00000133835;P51659;"Peroxisomal multifunctional enzyme type 2 (MFE-2) (17-beta-hydroxysteroid dehydrogenase 4) (17-beta-HSD 4) (D-bifunctional protein) (DBP) (Multifunctional protein 2) (MFP-2) (Short chain dehydrogenase/reductase family 8C member 1) [Cleaved into: (3R)-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.n12); Enoyl-CoA hydratase 2 (EC 4.2.1.107) (EC 4.2.1.119) (3-alpha,7-alpha,12-alpha-trihydroxy-5-beta-cholest-24-enoyl-CoA hydratase)]"
drug.Protein;Q9BYZ2;LDHAL6B;ENSG00000171989;Q9BYZ2;L-lactate dehydrogenase A-like 6B (EC 1.1.1.27)
drug.Protein;P07864;LDHC;ENSG00000166796;P07864;L-lactate dehydrogenase C chain (LDH-C) (EC 1.1.1.27) (Cancer/testis antigen 32) (CT32) (LDH testis subunit) (LDH-X)
drug.Protein;P07195;LDHB;ENSG00000111716;P07195;L-lactate dehydrogenase B chain (LDH-B) (EC 1.1.1.27) (LDH heart subunit) (LDH-H) (Renal carcinoma antigen NY-REN-46)
drug.Protein;Q08426;EHHADH;ENSG00000113790;Q08426;"Peroxisomal bifunctional enzyme (PBE) (PBFE) (L-bifunctional protein) (LBP) (Multifunctional enzyme 1) (MFE1) [Includes: Enoyl-CoA hydratase/3,2-trans-enoyl-CoA isomerase (EC 4.2.1.17) (EC 5.3.3.8); 3-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.35)]"
drug.Protein;Q16836;HADH;ENSG00000138796;Q16836;Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial (HCDH) (EC 1.1.1.35) (Medium and short-chain L-3-hydroxyacyl-coenzyme A dehydrogenase) (Short-chain 3-hydroxyacyl-CoA dehydrogenase)
drug.Protein;Q16798;ME3;ENSG00000151376;Q16798;NADP-dependent malic enzyme, mitochondrial (NADP-ME) (EC 1.1.1.40) (Malic enzyme 3)
drug.Protein;Q02338;BDH1;ENSG00000161267;Q02338;D-beta-hydroxybutyrate dehydrogenase, mitochondrial (EC 1.1.1.30) (3-hydroxybutyrate dehydrogenase) (BDH) (Short chain dehydrogenase/reductase family 9C member 1)
drug.Protein;P40925;MDH1;ENSG00000014641;P40925;Malate dehydrogenase, cytoplasmic (EC 1.1.1.37) (Cytosolic malate dehydrogenase) (Diiodophenylpyruvate reductase) (EC 1.1.1.96)
drug.Protein;P31937;HIBADH;ENSG00000106049;P31937;3-hydroxyisobutyrate dehydrogenase, mitochondrial (HIBADH) (EC 1.1.1.31)
drug.Protein;P37058;HSD17B3;ENSG00000130948;P37058;17-beta-hydroxysteroid dehydrogenase type 3 (17-beta-HSD 3) (Estradiol 17-beta-dehydrogenase 2) (EC 1.1.1.62) (Short chain dehydrogenase/reductase family 12C member 2) (Testicular 17-beta-hydroxysteroid dehydrogenase) (Testosterone 17-beta-dehydrogenase 3) (EC 1.1.1.64)
drug.Protein;P04035;HMGCR;ENSG00000113161;P04035;3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMG-CoA reductase) (EC 1.1.1.34)
drug.Protein;P48163;ME1;ENSG00000065833;P48163;NADP-dependent malic enzyme (NADP-ME) (EC 1.1.1.40) (Malic enzyme 1)
drug.Protein;O43175;PHGDH;ENSG00000092621;O43175;D-3-phosphoglycerate dehydrogenase (3-PGDH) (EC 1.1.1.95) (2-oxoglutarate reductase) (EC 1.1.1.399) (Malate dehydrogenase) (EC 1.1.1.37)
drug.Protein;P56937;HSD17B7;ENSG00000132196;P56937;3-keto-steroid reductase/17-beta-hydroxysteroid dehydrogenase 7 (17-beta-hydroxysteroid dehydrogenase 7) (17-beta-HSD 7) (3-keto-steroid reductase) (EC 1.1.1.270) (Dihydrotestosterone oxidoreductase) (EC 1.1.1.210) (Estradiol 17-beta-dehydrogenase 7) (EC 1.1.1.62) (Short chain dehydrogenase/reductase family 37C member 1)
drug.Protein;P51553;IDH3G;ENSG00000067829;P51553;Isocitrate dehydrogenase [NAD] subunit gamma, mitochondrial (Isocitric dehydrogenase subunit gamma) (NAD(+)-specific ICDH subunit gamma)
drug.Protein;O43837;IDH3B;ENSG00000101365;O43837;Isocitrate dehydrogenase [NAD] subunit beta, mitochondrial (Isocitric dehydrogenase subunit beta) (NAD(+)-specific ICDH subunit beta)
drug.Protein;P50213;IDH3A;ENSG00000166411;P50213;Isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial (EC 1.1.1.41) (Isocitric dehydrogenase subunit alpha) (NAD(+)-specific ICDH subunit alpha)
drug.Protein;P14061;HSD17B1;ENSG00000108786;P14061;17-beta-hydroxysteroid dehydrogenase type 1 (17-beta-HSD 1) (EC 1.1.1.51) (20 alpha-hydroxysteroid dehydrogenase) (20-alpha-HSD) (E2DH) (Estradiol 17-beta-dehydrogenase 1) (EC 1.1.1.62) (Placental 17-beta-hydroxysteroid dehydrogenase) (Short chain dehydrogenase/reductase family 28C member 1)
drug.Protein;P37059;HSD17B2;ENSG00000086696;P37059;17-beta-hydroxysteroid dehydrogenase type 2 (17-beta-HSD 2) (20 alpha-hydroxysteroid dehydrogenase) (20-alpha-HSD) (E2DH) (Estradiol 17-beta-dehydrogenase 2) (EC 1.1.1.62) (Microsomal 17-beta-hydroxysteroid dehydrogenase) (Short chain dehydrogenase/reductase family 9C member 2) (Testosterone 17-beta-dehydrogenase) (EC 1.1.1.239)
drug.Protein;Q92781;RDH5;ENSG00000135437;Q92781;Retinol dehydrogenase 5 (EC 1.1.1.209) (EC 1.1.1.315) (EC 1.1.1.53) (11-cis retinol dehydrogenase) (11-cis RDH) (11-cis RoDH) (9-cis retinol dehydrogenase) (9cRDH) (Short chain dehydrogenase/reductase family 9C member 5)
drug.Protein;O95479;H6PD;ENSG00000049239;O95479;"GDH/6PGL endoplasmic bifunctional protein [Includes: Hexose-6-phosphate dehydrogenase (Glucose 1-dehydrogenase) (GDH) (EC 1.1.1.47) (Glucose-6-phosphate dehydrogenase) (EC 1.1.1.363); 6-phosphogluconolactonase (6PGL) (EC 3.1.1.31)]"
drug.Protein;Q92506;HSD17B8;ENSG00000204228;Q92506;(3R)-3-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.n12) (17-beta-hydroxysteroid dehydrogenase 8) (17-beta-HSD 8) (HSD17B8) (3-ketoacyl-[acyl-carrier-protein] reductase alpha subunit) (KAR alpha subunit) (3-oxoacyl-[acyl-carrier-protein] reductase) (Estradiol 17-beta-dehydrogenase 8) (EC 1.1.1.62) (Protein Ke6) (Ke6) (Short chain dehydrogenase/reductase family 30C member 1) (Testosterone 17-beta-dehydrogenase 8) (EC 1.1.1.239)
drug.Protein;P17516;AKR1C4;ENSG00000198610;P17516;Aldo-keto reductase family 1 member C4 (EC 1.1.1.-) (EC 1.1.1.209) (EC 1.1.1.210) (EC 1.1.1.51) (EC 1.1.1.53) (EC 1.1.1.62) (3-alpha-hydroxysteroid dehydrogenase type I) (3-alpha-HSD1) (EC 1.1.1.357) (3alpha-hydroxysteroid 3-dehydrogenase) (Chlordecone reductase) (CDR) (EC 1.1.1.225) (Dihydrodiol dehydrogenase 4) (DD-4) (DD4) (HAKRA)
drug.Protein;P12268;IMPDH2;ENSG00000178035;P12268;Inosine-5'-monophosphate dehydrogenase 2 (IMP dehydrogenase 2) (IMPD 2) (IMPDH 2) (EC 1.1.1.205) (Inosine-5'-monophosphate dehydrogenase type II) (IMP dehydrogenase II) (IMPDH-II)
drug.Protein;P42330;AKR1C3;ENSG00000196139;P42330;Aldo-keto reductase family 1 member C3 (EC 1.1.1.-) (EC 1.1.1.210) (EC 1.1.1.53) (EC 1.1.1.62) (17-beta-hydroxysteroid dehydrogenase type 5) (17-beta-HSD 5) (3-alpha-HSD type II, brain) (3-alpha-hydroxysteroid dehydrogenase type 2) (3-alpha-HSD type 2) (EC 1.1.1.357) (Chlordecone reductase homolog HAKRb) (Dihydrodiol dehydrogenase 3) (DD-3) (DD3) (Dihydrodiol dehydrogenase type I) (HA1753) (Prostaglandin F synthase) (PGFS) (EC 1.1.1.188) (Testosterone 17-beta-dehydrogenase 5) (EC 1.1.1.239, EC 1.1.1.64)
drug.Protein;P15428;HPGD;ENSG00000164120;P15428;15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Eicosanoid/docosanoid dehydrogenase [NAD(+)]) (EC 1.1.1.-, EC 1.1.1.232) (Prostaglandin dehydrogenase 1) (Short chain dehydrogenase/reductase family 36C member 1)
drug.Protein;Q13630;GFUS;ENSG00000104522;Q13630;GDP-L-fucose synthase (EC 1.1.1.271) (GDP-4-keto-6-deoxy-D-mannose-3,5-epimerase-4-reductase) (Protein FX) (Red cell NADP(H)-binding protein) (Short-chain dehydrogenase/reductase family 4E member 1)
drug.Protein;Q04828;AKR1C1;ENSG00000187134;Q04828;Aldo-keto reductase family 1 member C1 (EC 1.1.1.-) (EC 1.1.1.112) (EC 1.1.1.209) (EC 1.1.1.210) (EC 1.1.1.357) (EC 1.1.1.51) (EC 1.1.1.53) (EC 1.1.1.62) (EC 1.3.1.20) (20-alpha-hydroxysteroid dehydrogenase) (20-alpha-HSD) (EC 1.1.1.149) (Chlordecone reductase homolog HAKRC) (Dihydrodiol dehydrogenase 1) (DD1) (High-affinity hepatic bile acid-binding protein) (HBAB)
drug.Protein;P28845;HSD11B1;ENSG00000117594;P28845;11-beta-hydroxysteroid dehydrogenase 1 (11-DH) (11-beta-HSD1) (EC 1.1.1.146) (7-oxosteroid reductase) (EC 1.1.1.201) (Corticosteroid 11-beta-dehydrogenase isozyme 1) (Short chain dehydrogenase/reductase family 26C member 1)
drug.Protein;P26439;HSD3B2;ENSG00000203859;P26439;"3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 2 (3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type II) (3-beta-HSD II) (3-beta-HSD adrenal and gonadal type) [Includes: 3-beta-hydroxy-Delta(5)-steroid dehydrogenase (EC 1.1.1.145) (3-beta-hydroxy-5-ene steroid dehydrogenase) (Progesterone reductase); Steroid Delta-isomerase (EC 5.3.3.1) (Delta-5-3-ketosteroid isomerase)]"
drug.Protein;P14060;HSD3B1;ENSG00000203857;P14060;3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1 (3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type I) (3-beta-HSD I) (3-beta-hydroxy-5-ene steroid dehydrogenase) (3-beta-hydroxy-Delta(5)-steroid dehydrogenase) (EC 1.1.1.145) (3-beta-hydroxysteroid 3-dehydrogenase) (EC 1.1.1.270) (Delta-5-3-ketosteroid isomerase) (Dihydrotestosterone oxidoreductase) (EC 1.1.1.210) (Steroid Delta-isomerase) (EC 5.3.3.1) (Trophoblast antigen FDO161G)
drug.Protein;P20839;IMPDH1;ENSG00000106348;P20839;Inosine-5'-monophosphate dehydrogenase 1 (IMP dehydrogenase 1) (IMPD 1) (IMPDH 1) (EC 1.1.1.205) (IMPDH-I)
drug.Protein;P40939;HADHA;ENSG00000084754;P40939;"Trifunctional enzyme subunit alpha, mitochondrial (78 kDa gastrin-binding protein) (Monolysocardiolipin acyltransferase) (EC 2.3.1.-) (TP-alpha) [Includes: Long-chain enoyl-CoA hydratase (EC 4.2.1.17); Long chain 3-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.211)]"
drug.Protein;P05091;ALDH2;ENSG00000111275;P05091;Aldehyde dehydrogenase, mitochondrial (EC 1.2.1.3) (ALDH class 2) (ALDH-E2) (ALDHI)
drug.Protein;P80365;HSD11B2;ENSG00000176387;P80365;11-beta-hydroxysteroid dehydrogenase type 2 (11-DH2) (11-beta-HSD2) (EC 1.1.1.-) (11-beta-hydroxysteroid dehydrogenase type II) (11-HSD type II) (11-beta-HSD type II) (Corticosteroid 11-beta-dehydrogenase isozyme 2) (NAD-dependent 11-beta-hydroxysteroid dehydrogenase) (Short chain dehydrogenase/reductase family 9C member 3)
drug.Protein;P52895;AKR1C2;ENSG00000151632;P52895;Aldo-keto reductase family 1 member C2 (EC 1.-.-.-) (EC 1.1.1.112) (EC 1.1.1.209) (EC 1.1.1.53) (EC 1.1.1.62) (EC 1.3.1.20) (3-alpha-HSD3) (Chlordecone reductase homolog HAKRD) (Dihydrodiol dehydrogenase 2) (DD-2) (DD2) (Dihydrodiol dehydrogenase/bile acid-binding protein) (DD/BABP) (Type III 3-alpha-hydroxysteroid dehydrogenase) (EC 1.1.1.357)
drug.Protein;Q15738;NSDHL;ENSG00000147383;Q15738;Sterol-4-alpha-carboxylate 3-dehydrogenase, decarboxylating (EC 1.1.1.170) (Protein H105e3)
drug.Protein;P48448;ALDH3B2;ENSG00000132746;P48448;Aldehyde dehydrogenase family 3 member B2 (EC 1.2.1.3) (Aldehyde dehydrogenase 8)
drug.Protein;Q02252;ALDH6A1;ENSG00000119711;Q02252;Methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial (MMSDH) (Malonate-semialdehyde dehydrogenase [acylating]) (EC 1.2.1.18) (EC 1.2.1.27) (Aldehyde dehydrogenase family 6 member A1)
drug.Protein;P30838;ALDH3A1;ENSG00000108602;P30838;Aldehyde dehydrogenase, dimeric NADP-preferring (EC 1.2.1.5) (ALDHIII) (Aldehyde dehydrogenase 3) (Aldehyde dehydrogenase family 3 member A1)
drug.Protein;P00352;ALDH1A1;ENSG00000165092;P00352;Aldehyde dehydrogenase 1A1 (EC 1.2.1.19) (EC 1.2.1.28) (EC 1.2.1.3) (EC 1.2.1.36) (3-deoxyglucosone dehydrogenase) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) (Retinal dehydrogenase 1) (RALDH 1) (RalDH1)
drug.Protein;O14556;GAPDHS;ENSG00000105679;O14556;Glyceraldehyde-3-phosphate dehydrogenase, testis-specific (EC 1.2.1.12) (Spermatogenic cell-specific glyceraldehyde 3-phosphate dehydrogenase 2) (GAPDH-2) (Spermatogenic glyceraldehyde-3-phosphate dehydrogenase)
drug.Protein;P49189;ALDH9A1;ENSG00000143149;P49189;4-trimethylaminobutyraldehyde dehydrogenase (TMABA-DH) (TMABALDH) (EC 1.2.1.47) (Aldehyde dehydrogenase E3 isozyme) (Aldehyde dehydrogenase family 9 member A1) (EC 1.2.1.3) (Gamma-aminobutyraldehyde dehydrogenase) (EC 1.2.1.19) (R-aminobutyraldehyde dehydrogenase) [Cleaved into: 4-trimethylaminobutyraldehyde dehydrogenase, N-terminally processed]
drug.Protein;P47895;ALDH1A3;ENSG00000184254;P47895;Aldehyde dehydrogenase family 1 member A3 (EC 1.2.1.36) (Aldehyde dehydrogenase 6) (Retinaldehyde dehydrogenase 3) (RALDH-3) (RalDH3)
drug.Protein;P30837;ALDH1B1;ENSG00000137124;P30837;Aldehyde dehydrogenase X, mitochondrial (EC 1.2.1.3) (Aldehyde dehydrogenase 5) (Aldehyde dehydrogenase family 1 member B1)
drug.Protein;P43353;ALDH3B1;ENSG00000006534;P43353;Aldehyde dehydrogenase family 3 member B1 (EC 1.2.1.28) (EC 1.2.1.5) (EC 1.2.1.7) (Aldehyde dehydrogenase 7)
drug.Protein;P04406;GAPDH;ENSG00000111640;P04406;Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (EC 1.2.1.12) (Peptidyl-cysteine S-nitrosylase GAPDH) (EC 2.6.99.-)
drug.Protein;O94788;ALDH1A2;ENSG00000128918;O94788;Retinal dehydrogenase 2 (RALDH 2) (RalDH2) (EC 1.2.1.36) (Aldehyde dehydrogenase family 1 member A2) (Retinaldehyde-specific dehydrogenase type 2) (RALDH(II))
drug.Protein;P51648;ALDH3A2;ENSG00000072210;P51648;Aldehyde dehydrogenase family 3 member A2 (EC 1.2.1.3) (EC 1.2.1.94) (Aldehyde dehydrogenase 10) (Fatty aldehyde dehydrogenase) (Microsomal aldehyde dehydrogenase)
drug.Protein;P49419;ALDH7A1;ENSG00000164904;P49419;Alpha-aminoadipic semialdehyde dehydrogenase (Alpha-AASA dehydrogenase) (EC 1.2.1.31) (Aldehyde dehydrogenase family 7 member A1) (EC 1.2.1.3) (Antiquitin-1) (Betaine aldehyde dehydrogenase) (EC 1.2.1.8) (Delta1-piperideine-6-carboxylate dehydrogenase) (P6c dehydrogenase)
drug.Protein;Q96C36;PYCR2;ENSG00000143811;Q96C36;Pyrroline-5-carboxylate reductase 2 (P5C reductase 2) (P5CR 2) (EC 1.5.1.2)
drug.Protein;P32322;PYCR1;ENSG00000183010;P32322;Pyrroline-5-carboxylate reductase 1, mitochondrial (P5C reductase 1) (P5CR 1) (EC 1.5.1.2)
drug.Protein;P29803;PDHA2;ENSG00000163114;P29803;Pyruvate dehydrogenase E1 component subunit alpha, testis-specific form, mitochondrial (EC 1.2.4.1) (PDHE1-A type II)
drug.Protein;P08559;PDHA1;ENSG00000131828;P08559;Pyruvate dehydrogenase E1 component subunit alpha, somatic form, mitochondrial (EC 1.2.4.1) (PDHE1-A type I)
drug.Protein;P53004;BLVRA;ENSG00000106605;P53004;Biliverdin reductase A (BVR A) (EC 1.3.1.24) (Biliverdin-IX alpha-reductase)
drug.Protein;P16219;ACADS;ENSG00000122971;P16219;Short-chain specific acyl-CoA dehydrogenase, mitochondrial (SCAD) (EC 1.3.8.1) (Butyryl-CoA dehydrogenase)
drug.Protein;P00374;DHFR;ENSG00000228716;P00374;Dihydrofolate reductase (EC 1.5.1.3)
drug.Protein;Q02218;OGDH;ENSG00000105953;Q02218;2-oxoglutarate dehydrogenase complex component E1 (E1o) (OGDC-E1) (OGDH-E1) (EC 1.2.4.2) (2-oxoglutarate dehydrogenase, mitochondrial) (Alpha-ketoglutarate dehydrogenase) (Alpha-KGDH-E1) (Thiamine diphosphate (ThDP)-dependent 2-oxoglutarate dehydrogenase)
drug.Protein;Q9UBM7;DHCR7;ENSG00000172893;Q9UBM7;7-dehydrocholesterol reductase (7-DHC reductase) (EC 1.3.1.21) (Delta7-sterol reductase) (Sterol Delta(7)-reductase) (Sterol reductase SR-2)
drug.Protein;P16083;NQO2;ENSG00000124588;P16083;Ribosyldihydronicotinamide dehydrogenase [quinone] (EC 1.10.5.1) (NRH dehydrogenase [quinone] 2) (NRH:quinone oxidoreductase 2) (Quinone reductase 2) (QR2)
drug.Protein;P03891;MT-ND2;ENSG00000198763;P03891;NADH-ubiquinone oxidoreductase chain 2 (EC 7.1.1.2) (NADH dehydrogenase subunit 2)
drug.Protein;P03897;MT-ND3;ENSG00000198840;P03897;NADH-ubiquinone oxidoreductase chain 3 (EC 7.1.1.2) (NADH dehydrogenase subunit 3)
drug.Protein;O75251;NDUFS7;ENSG00000115286;O75251;NADH dehydrogenase [ubiquinone] iron-sulfur protein 7, mitochondrial (EC 7.1.1.2) (Complex I-20kD) (CI-20kD) (NADH-ubiquinone oxidoreductase 20 kDa subunit) (PSST subunit)
drug.Protein;P30038;ALDH4A1;ENSG00000159423;P30038;Delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial (P5C dehydrogenase) (EC 1.2.1.88) (Aldehyde dehydrogenase family 4 member A1) (L-glutamate gamma-semialdehyde dehydrogenase)
drug.Protein;P00387;CYB5R3;ENSG00000100243;P00387;"NADH-cytochrome b5 reductase 3 (B5R) (Cytochrome b5 reductase) (EC 1.6.2.2) (Diaphorase-1) [Cleaved into: NADH-cytochrome b5 reductase 3 membrane-bound form; NADH-cytochrome b5 reductase 3 soluble form]"
drug.Protein;Q86Y39;NDUFA11;ENSG00000174886;Q86Y39;NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 11 (Complex I-B14.7) (CI-B14.7) (NADH-ubiquinone oxidoreductase subunit B14.7)
drug.Protein;P03905;MT-ND4;ENSG00000198886;P03905;NADH-ubiquinone oxidoreductase chain 4 (EC 7.1.1.2) (NADH dehydrogenase subunit 4)
drug.Protein;P09417;QDPR;ENSG00000151552;P09417;Dihydropteridine reductase (EC 1.5.1.34) (HDHPR) (Quinoid dihydropteridine reductase) (Short chain dehydrogenase/reductase family 33C member 1)
drug.Protein;P03886;MT-ND1;ENSG00000198888;P03886;NADH-ubiquinone oxidoreductase chain 1 (EC 7.1.1.2) (NADH dehydrogenase subunit 1)
drug.Protein;Q13423;NNT;ENSG00000112992;Q13423;NAD(P) transhydrogenase, mitochondrial (EC 7.1.1.1) (Nicotinamide nucleotide transhydrogenase) (Pyridine nucleotide transhydrogenase)
drug.Protein;Q16718;NDUFA5;ENSG00000128609;Q16718;NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5 (Complex I subunit B13) (Complex I-13kD-B) (CI-13kD-B) (NADH-ubiquinone oxidoreductase 13 kDa-B subunit)
drug.Protein;Q16795;NDUFA9;ENSG00000139180;Q16795;NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 9, mitochondrial (Complex I-39kD) (CI-39kD) (NADH-ubiquinone oxidoreductase 39 kDa subunit)
drug.Protein;P03901;MT-ND4L;ENSG00000212907;P03901;NADH-ubiquinone oxidoreductase chain 4L (EC 7.1.1.2) (NADH dehydrogenase subunit 4L)
drug.Protein;O95299;NDUFA10;ENSG00000130414;O95299;NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10, mitochondrial (Complex I-42kD) (CI-42kD) (NADH-ubiquinone oxidoreductase 42 kDa subunit)
drug.Protein;O95182;NDUFA7;ENSG00000267855;O95182;NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 7 (Complex I-B14.5a) (CI-B14.5a) (NADH-ubiquinone oxidoreductase subunit B14.5a)
drug.Protein;O15239;NDUFA1;ENSG00000125356;O15239;NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1 (Complex I-MWFE) (CI-MWFE) (NADH-ubiquinone oxidoreductase MWFE subunit)
drug.Protein;P03923;MT-ND6;ENSG00000198695;P03923;NADH-ubiquinone oxidoreductase chain 6 (EC 7.1.1.2) (NADH dehydrogenase subunit 6)
drug.Protein;P03915;MT-ND5;ENSG00000198786;P03915;NADH-ubiquinone oxidoreductase chain 5 (EC 7.1.1.2) (NADH dehydrogenase subunit 5)
drug.Protein;O00483;NDUFA4;ENSG00000189043;O00483;Cytochrome c oxidase subunit NDUFA4 (Complex I-MLRQ) (CI-MLRQ) (NADH-ubiquinone oxidoreductase MLRQ subunit)
drug.Protein;P56556;NDUFA6;ENSG00000184983;P56556;NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6 (Complex I-B14) (CI-B14) (LYR motif-containing protein 6) (NADH-ubiquinone oxidoreductase B14 subunit)
drug.Protein;O14561;NDUFAB1;ENSG00000004779;O14561;Acyl carrier protein, mitochondrial (ACP) (CI-SDAP) (NADH-ubiquinone oxidoreductase 9.6 kDa subunit)
drug.Protein;O43678;NDUFA2;ENSG00000131495;O43678;NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 2 (Complex I-B8) (CI-B8) (NADH-ubiquinone oxidoreductase B8 subunit)
drug.Protein;P51970;NDUFA8;ENSG00000119421;P51970;NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 8 (Complex I-19kD) (CI-19kD) (Complex I-PGIV) (CI-PGIV) (NADH-ubiquinone oxidoreductase 19 kDa subunit)
drug.Protein;O95167;NDUFA3;ENSG00000170906;O95167;NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 3 (Complex I-B9) (CI-B9) (NADH-ubiquinone oxidoreductase B9 subunit)
drug.Protein;O95169;NDUFB8;ENSG00000166136;O95169;NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 8, mitochondrial (Complex I-ASHI) (CI-ASHI) (NADH-ubiquinone oxidoreductase ASHI subunit)
drug.Protein;O95298;NDUFC2;ENSG00000151366;O95298;NADH dehydrogenase [ubiquinone] 1 subunit C2 (Complex I-B14.5b) (CI-B14.5b) (Human lung cancer oncogene 1 protein) (HLC-1) (NADH-ubiquinone oxidoreductase subunit B14.5b)
drug.Protein;O75438;NDUFB1;ENSG00000183648;O75438;NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 1 (Complex I-MNLL) (CI-MNLL) (NADH-ubiquinone oxidoreductase MNLL subunit)
drug.Protein;P28331;NDUFS1;ENSG00000023228;P28331;NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial (EC 7.1.1.2) (Complex I-75kD) (CI-75kD)
drug.Protein;O96000;NDUFB10;ENSG00000140990;O96000;NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 10 (Complex I-PDSW) (CI-PDSW) (NADH-ubiquinone oxidoreductase PDSW subunit)
drug.Protein;O95168;NDUFB4;ENSG00000065518;O95168;NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 4 (Complex I-B15) (CI-B15) (NADH-ubiquinone oxidoreductase B15 subunit)
drug.Protein;O43676;NDUFB3;ENSG00000119013;O43676;NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 3 (Complex I-B12) (CI-B12) (NADH-ubiquinone oxidoreductase B12 subunit)
drug.Protein;O95178;NDUFB2;ENSG00000090266;O95178;NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 2, mitochondrial (Complex I-AGGG) (CI-AGGG) (NADH-ubiquinone oxidoreductase AGGG subunit)
drug.Protein;P17568;NDUFB7;ENSG00000099795;P17568;NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7 (Cell adhesion protein SQM1) (Complex I-B18) (CI-B18) (NADH-ubiquinone oxidoreductase B18 subunit)
drug.Protein;Q9Y6M9;NDUFB9;ENSG00000147684;Q9Y6M9;NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 9 (Complex I-B22) (CI-B22) (LYR motif-containing protein 3) (NADH-ubiquinone oxidoreductase B22 subunit)
drug.Protein;O75306;NDUFS2;ENSG00000158864;O75306;NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 7.1.1.2) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)
drug.Protein;O43674;NDUFB5;ENSG00000136521;O43674;NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 5, mitochondrial (Complex I-SGDH) (CI-SGDH) (NADH-ubiquinone oxidoreductase SGDH subunit)
drug.Protein;O43677;NDUFC1;ENSG00000109390;O43677;NADH dehydrogenase [ubiquinone] 1 subunit C1, mitochondrial (Complex I-KFYI) (CI-KFYI) (NADH-ubiquinone oxidoreductase KFYI subunit)
drug.Protein;O95139;NDUFB6;ENSG00000165264;O95139;NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 6 (Complex I-B17) (CI-B17) (NADH-ubiquinone oxidoreductase B17 subunit)
drug.Protein;P56181;NDUFV3;ENSG00000160194;P56181;NADH dehydrogenase [ubiquinone] flavoprotein 3, mitochondrial (Complex I-9kD) (CI-9kD) (NADH-ubiquinone oxidoreductase 9 kDa subunit) (Renal carcinoma antigen NY-REN-4)
drug.Protein;O75489;NDUFS3;ENSG00000213619;O75489;NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, mitochondrial (EC 7.1.1.2) (Complex I-30kD) (CI-30kD) (NADH-ubiquinone oxidoreductase 30 kDa subunit)
drug.Protein;Q9UI09;NDUFA12;ENSG00000184752;Q9UI09;NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 12 (13 kDa differentiation-associated protein) (Complex I-B17.2) (CI-B17.2) (CIB17.2) (NADH-ubiquinone oxidoreductase subunit B17.2)
drug.Protein;O43920;NDUFS5;ENSG00000168653;O43920;NADH dehydrogenase [ubiquinone] iron-sulfur protein 5 (Complex I-15 kDa) (CI-15 kDa) (NADH-ubiquinone oxidoreductase 15 kDa subunit)
drug.Protein;O43181;NDUFS4;ENSG00000164258;O43181;NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial (Complex I-18 kDa) (CI-18 kDa) (Complex I-AQDQ) (CI-AQDQ) (NADH-ubiquinone oxidoreductase 18 kDa subunit)
drug.Protein;P49821;NDUFV1;ENSG00000167792;P49821;NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial (EC 7.1.1.2) (Complex I-51kD) (CI-51kD) (NADH dehydrogenase flavoprotein 1) (NADH-ubiquinone oxidoreductase 51 kDa subunit)
drug.Protein;P19404;NDUFV2;ENSG00000178127;P19404;NADH dehydrogenase [ubiquinone] flavoprotein 2, mitochondrial (EC 7.1.1.2) (NADH-ubiquinone oxidoreductase 24 kDa subunit)
drug.Protein;Q9P0J0;NDUFA13;ENSG00000186010;Q9P0J0;NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13 (Cell death regulatory protein GRIM-19) (Complex I-B16.6) (CI-B16.6) (Gene associated with retinoic and interferon-induced mortality 19 protein) (GRIM-19) (Gene associated with retinoic and IFN-induced mortality 19 protein) (NADH-ubiquinone oxidoreductase B16.6 subunit)
drug.Protein;O75380;NDUFS6;ENSG00000145494;O75380;NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial (Complex I-13kD-A) (CI-13kD-A) (NADH-ubiquinone oxidoreductase 13 kDa-A subunit)
drug.Protein;Q9NRX3;NDUFA4L2;ENSG00000185633;Q9NRX3;NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 4-like 2 (NADH-ubiquinone oxidoreductase MLRQ subunit homolog) (NUOMS)
drug.Protein;O00217;NDUFS8;ENSG00000110717;O00217;NADH dehydrogenase [ubiquinone] iron-sulfur protein 8, mitochondrial (EC 7.1.1.2) (Complex I-23kD) (CI-23kD) (NADH-ubiquinone oxidoreductase 23 kDa subunit) (TYKY subunit)
drug.Protein;P10515;DLAT;ENSG00000150768;P10515;Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial (EC 2.3.1.12) (70 kDa mitochondrial autoantigen of primary biliary cirrhosis) (PBC) (Dihydrolipoamide acetyltransferase component of pyruvate dehydrogenase complex) (M2 antigen complex 70 kDa subunit) (Pyruvate dehydrogenase complex component E2) (PDC-E2) (PDCE2)
drug.Protein;Q15800;MSMO1;ENSG00000052802;Q15800;Methylsterol monooxygenase 1 (EC 1.14.18.9) (C-4 methylsterol oxidase) (Sterol-C4-methyl oxidase)
drug.Protein;P09601;HMOX1;ENSG00000100292;P09601;Heme oxygenase 1 (HO-1) (EC 1.14.14.18) [Cleaved into: Heme oxygenase 1 soluble form]
drug.Protein;P30519;HMOX2;ENSG00000103415;P30519;Heme oxygenase 2 (HO-2) (EC 1.14.14.18) [Cleaved into: Heme oxygenase 2 soluble form]
drug.Protein;P05093;CYP17A1;ENSG00000148795;P05093;Steroid 17-alpha-hydroxylase/17,20 lyase (EC 1.14.14.19) (17-alpha-hydroxyprogesterone aldolase) (EC 1.14.14.32) (CYPXVII) (Cytochrome P450 17A1) (Cytochrome P450-C17) (Cytochrome P450c17) (Steroid 17-alpha-monooxygenase)
drug.Protein;P14679;TYR;ENSG00000077498;P14679;Tyrosinase (EC 1.14.18.1) (LB24-AB) (Monophenol monooxygenase) (SK29-AB) (Tumor rejection antigen AB)
drug.Protein;Q06278;AOX1;ENSG00000138356;Q06278;Aldehyde oxidase (EC 1.2.3.1) (Aldehyde oxidase 1) (Azaheterocycle hydroxylase) (EC 1.17.3.-)
drug.Protein;P28332;ADH6;ENSG00000172955;P28332;Alcohol dehydrogenase 6 (EC 1.1.1.1)
drug.Protein;P14550;AKR1A1;ENSG00000117448;P14550;Aldo-keto reductase family 1 member A1 (EC 1.1.1.2) (EC 1.1.1.372) (EC 1.1.1.54) (Alcohol dehydrogenase [NADP(+)]) (Aldehyde reductase) (Glucuronate reductase) (EC 1.1.1.19) (Glucuronolactone reductase) (EC 1.1.1.20)
drug.Protein;P41439;FOLR3;ENSG00000110203;P41439;Folate receptor gamma (FR-gamma) (Folate receptor 3)
drug.Protein;P14207;FOLR2;ENSG00000165457;P14207;Folate receptor beta (FR-beta) (Folate receptor 2) (Folate receptor, fetal/placental) (Placental folate-binding protein) (FBP)
drug.Protein;P15328;FOLR1;ENSG00000110195;P15328;Folate receptor alpha (FR-alpha) (Adult folate-binding protein) (FBP) (Folate receptor 1) (Folate receptor, adult) (KB cells FBP) (Ovarian tumor-associated antigen MOv18)
drug.Protein;Q92820;GGH;ENSG00000137563;Q92820;Gamma-glutamyl hydrolase (EC 3.4.19.9) (Conjugase) (GH) (Gamma-Glu-X carboxypeptidase)
drug.Protein;Q96J66;ABCC11;ENSG00000121270;Q96J66;ATP-binding cassette sub-family C member 11 (EC 7.6.2.2) (EC 7.6.2.3) (Multidrug resistance-associated protein 8)
drug.Protein;Q96NT5;SLC46A1;ENSG00000076351;Q96NT5;Proton-coupled folate transporter (HsPCFT) (hPCFT) (Heme carrier protein 1) (PCFT/HCP1) (Solute carrier family 46 member 1)
drug.Protein;Q9H2D1;SLC25A32;ENSG00000164933;Q9H2D1;Mitochondrial folate transporter/carrier (Solute carrier family 25 member 32)
drug.Protein;O60488;ACSL4;ENSG00000068366;O60488;Long-chain-fatty-acid--CoA ligase 4 (EC 6.2.1.3) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 4) (LACS 4)
drug.Protein;O14842;FFAR1;ENSG00000126266;O14842;Free fatty acid receptor 1 (G-protein coupled receptor 40)
drug.Protein;Q5JTZ9;AARS2;ENSG00000124608;Q5JTZ9;Alanine--tRNA ligase, mitochondrial (EC 6.1.1.7) (Alanyl-tRNA synthetase) (AlaRS)
drug.Protein;P49588;AARS1;ENSG00000090861;P49588;Alanine--tRNA ligase, cytoplasmic (EC 6.1.1.7) (Alanyl-tRNA synthetase) (AlaRS) (Renal carcinoma antigen NY-REN-42)
drug.Protein;P43007;SLC1A4;ENSG00000115902;P43007;Neutral amino acid transporter A (Alanine/serine/cysteine/threonine transporter 1) (ASCT-1) (Solute carrier family 1 member 4)
drug.Protein;P26640;VARS1;ENSG00000204394;P26640;Valine--tRNA ligase (EC 6.1.1.9) (Protein G7a) (Valyl-tRNA synthetase) (ValRS)
drug.Protein;Q96NR8;RDH12;ENSG00000139988;Q96NR8;Retinol dehydrogenase 12 (EC 1.1.1.300) (All-trans and 9-cis retinol dehydrogenase) (Short chain dehydrogenase/reductase family 7C member 2)
drug.Protein;O75911;DHRS3;ENSG00000162496;O75911;Short-chain dehydrogenase/reductase 3 (EC 1.1.1.300) (DD83.1) (Retinal short-chain dehydrogenase/reductase 1) (retSDR1) (Retinol dehydrogenase 17) (Short chain dehydrogenase/reductase family 16C member 1)
drug.Protein;Q6NUM9;RETSAT;ENSG00000042445;Q6NUM9;All-trans-retinol 13,14-reductase (EC 1.3.99.23) (All-trans-13,14-dihydroretinol saturase) (RetSat) (PPAR-alpha-regulated and starvation-induced gene protein)
drug.Protein;Q8TC12;RDH11;ENSG00000072042;Q8TC12;Retinol dehydrogenase 11 (EC 1.1.1.300) (Androgen-regulated short-chain dehydrogenase/reductase 1) (HCV core-binding protein HCBP12) (Prostate short-chain dehydrogenase/reductase 1) (Retinal reductase 1) (RalR1) (Short chain dehydrogenase/reductase family 7C member 1)
drug.Protein;Q9BTZ2;DHRS4;ENSG00000157326;Q9BTZ2;Dehydrogenase/reductase SDR family member 4 (EC 1.1.1.184) (NADPH-dependent carbonyl reductase) (CR) (NADPH-dependent retinol dehydrogenase/reductase) (NRDR) (humNRDR) (Peroxisomal short-chain alcohol dehydrogenase) (PSCD) (SCAD-SRL) (Short chain dehydrogenase/reductase family 25C member 2) (Protein SDR25C2) (Short-chain dehydrogenase/reductase family member 4)
drug.Protein;Q9HBH5;RDH14;ENSG00000240857;Q9HBH5;Retinol dehydrogenase 14 (EC 1.1.1.300) (Alcohol dehydrogenase PAN2) (Short chain dehydrogenase/reductase family 7C member 4)
drug.Protein;Q9NYR8;RDH8;ENSG00000080511;Q9NYR8;Retinol dehydrogenase 8 (EC 1.1.1.300) (Photoreceptor outer segment all-trans retinol dehydrogenase) (Short chain dehydrogenase/reductase family 28C member 2)
drug.Protein;O95237;LRAT;ENSG00000121207;O95237;Lecithin retinol acyltransferase (EC 2.3.1.135) (Phosphatidylcholine--retinol O-acyltransferase)
drug.Protein;Q8NBN7;RDH13;ENSG00000160439;Q8NBN7;Retinol dehydrogenase 13 (EC 1.1.1.300) (Short chain dehydrogenase/reductase family 7C member 3)
drug.Protein;P05090;APOD;ENSG00000189058;P05090;Apolipoprotein D (Apo-D) (ApoD)
drug.Protein;P41222;PTGDS;ENSG00000107317;P41222;Prostaglandin-H2 D-isomerase (EC 5.3.99.2) (Beta-trace protein) (Cerebrin-28) (Glutathione-independent PGD synthase) (Lipocalin-type prostaglandin-D synthase) (L-PGDS) (Prostaglandin-D2 synthase) (PGD2 synthase) (PGDS) (PGDS2)
drug.Protein;P82980;RBP5;ENSG00000139194;P82980;Retinol-binding protein 5 (Cellular retinol-binding protein III) (CRBP-III) (HRBPiso)
drug.Protein;Q96R05;RBP7;ENSG00000162444;Q96R05;Retinoid-binding protein 7 (Cellular retinoic acid-binding protein 4) (CRABP4) (CRBP4) (Cellular retinoic acid-binding protein IV) (CRABP-IV)
drug.Protein;P02753;RBP4;ENSG00000138207;P02753;"Retinol-binding protein 4 (Plasma retinol-binding protein) (PRBP) (RBP) [Cleaved into: Plasma retinol-binding protein(1-182); Plasma retinol-binding protein(1-181); Plasma retinol-binding protein(1-179); Plasma retinol-binding protein(1-176)]"
drug.Protein;P50120;RBP2;ENSG00000114113;P50120;Retinol-binding protein 2 (Cellular retinol-binding protein II) (CRBP-II)
drug.Protein;P12271;RLBP1;ENSG00000140522;P12271;Retinaldehyde-binding protein 1 (Cellular retinaldehyde-binding protein)
drug.Protein;P10745;RBP3;ENSG00000265203;P10745;Retinol-binding protein 3 (Interphotoreceptor retinoid-binding protein) (IRBP) (Interstitial retinol-binding protein)
drug.Protein;P09455;RBP1;ENSG00000114115;P09455;Retinol-binding protein 1 (Cellular retinol-binding protein) (CRBP) (Cellular retinol-binding protein I) (CRBP-I)
drug.Protein;O43174;CYP26A1;ENSG00000095596;O43174;Cytochrome P450 26A1 (EC 1.14.13.-) (Cytochrome P450 retinoic acid-inactivating 1) (Cytochrome P450RAI) (hP450RAI) (Retinoic acid 4-hydroxylase) (Retinoic acid-metabolizing cytochrome)
drug.Protein;Q9BX79;STRA6;ENSG00000137868;Q9BX79;Receptor for retinol uptake STRA6 (Retinol-binding protein receptor STRA6) (Stimulated by retinoic acid gene 6 protein homolog)
drug.Protein;O75469;NR1I2;ENSG00000144852;O75469;Nuclear receptor subfamily 1 group I member 2 (Orphan nuclear receptor PAR1) (Orphan nuclear receptor PXR) (Pregnane X receptor) (Steroid and xenobiotic receptor) (SXR)
drug.Protein;P05771;PRKCB;ENSG00000166501;P05771;Protein kinase C beta type (PKC-B) (PKC-beta) (EC 2.7.11.13)
drug.Protein;P09917;ALOX5;ENSG00000012779;P09917;Polyunsaturated fatty acid 5-lipoxygenase (EC 1.13.11.-) (Arachidonate 5-lipoxygenase) (5-LO) (5-lipoxygenase) (EC 1.13.11.34)
drug.Protein;P23743;DGKA;ENSG00000065357;P23743;Diacylglycerol kinase alpha (DAG kinase alpha) (EC 2.7.1.107) (80 kDa diacylglycerol kinase) (Diglyceride kinase alpha) (DGK-alpha)
drug.Protein;P62714;PPP2CB;ENSG00000104695;P62714;Serine/threonine-protein phosphatase 2A catalytic subunit beta isoform (PP2A-beta) (EC 3.1.3.16)
drug.Protein;P67775;PPP2CA;ENSG00000113575;P67775;Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform (PP2A-alpha) (EC 3.1.3.16) (Replication protein C) (RP-C)
drug.Protein;Q9UDX3;SEC14L4;ENSG00000133488;Q9UDX3;SEC14-like protein 4 (Tocopherol-associated protein 3)
drug.Protein;Q9UDX4;SEC14L3;ENSG00000100012;Q9UDX4;SEC14-like protein 3 (Tocopherol-associated protein 2)
drug.Protein;O76054;SEC14L2;ENSG00000100003;O76054;SEC14-like protein 2 (Alpha-tocopherol-associated protein) (TAP) (hTAP) (Squalene transfer protein) (Supernatant protein factor) (SPF)
drug.Protein;P49638;TTPA;ENSG00000137561;P49638;Alpha-tocopherol transfer protein (Alpha-TTP)
drug.Protein;P55058;PLTP;ENSG00000100979;P55058;Phospholipid transfer protein (Lipid transfer protein II)
drug.Protein;P15559;NQO1;ENSG00000181019;P15559;NAD(P)H dehydrogenase [quinone] 1 (EC 1.6.5.2) (Azoreductase) (DT-diaphorase) (DTD) (Menadione reductase) (NAD(P)H:quinone oxidoreductase 1) (Phylloquinone reductase) (Quinone reductase 1) (QR1)
drug.Protein;P00441;SOD1;ENSG00000142168;P00441;Superoxide dismutase [Cu-Zn] (EC 1.15.1.1) (Superoxide dismutase 1) (hSod1)
drug.Protein;O95477;ABCA1;ENSG00000165029;O95477;Phospholipid-transporting ATPase ABCA1 (EC 7.6.2.1) (ATP-binding cassette sub-family A member 1) (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) (Cholesterol efflux regulatory protein)
drug.Protein;Q9UHC9;NPC1L1;ENSG00000015520;Q9UHC9;NPC1-like intracellular cholesterol transporter 1 (NPC1L1) (Niemann-Pick C1-like protein 1)
drug.Protein;P45844;ABCG1;ENSG00000160179;P45844;ATP-binding cassette sub-family G member 1 (EC 7.6.2.-) (ATP-binding cassette transporter 8) (White protein homolog)
drug.Protein;P04798;CYP1A1;ENSG00000140465;P04798;Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)
drug.Protein;P05186;ALPL;ENSG00000162551;P05186;Alkaline phosphatase, tissue-nonspecific isozyme (AP-TNAP) (TNS-ALP) (TNSALP) (EC 3.1.3.1) (Alkaline phosphatase liver/bone/kidney isozyme) (Phosphoamidase) (Phosphocreatine phosphatase) (EC 3.9.1.1)
drug.Protein;Q9Y234;LIPT1;ENSG00000144182;Q9Y234;Lipoyltransferase 1, mitochondrial (EC 2.3.1.-) (Lipoate biosynthesis protein) (Lipoate-protein ligase) (Lipoyl ligase)
drug.Protein;O43766;LIAS;ENSG00000121897;O43766;Lipoyl synthase, mitochondrial (EC 2.8.1.8) (Lipoate synthase) (LS) (Lip-syn) (Lipoic acid synthase)
drug.Protein;P16435;POR;ENSG00000127948;P16435;NADPH--cytochrome P450 reductase (CPR) (P450R) (EC 1.6.2.4)
drug.Protein;Q9NSE4;IARS2;ENSG00000067704;Q9NSE4;Isoleucine--tRNA ligase, mitochondrial (EC 6.1.1.5) (Isoleucyl-tRNA synthetase) (IleRS)
drug.Protein;P45954;ACADSB;ENSG00000196177;P45954;Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial (SBCAD) (EC 1.3.8.5) (2-methyl branched chain acyl-CoA dehydrogenase) (2-MEBCAD) (2-methylbutyryl-coenzyme A dehydrogenase) (2-methylbutyryl-CoA dehydrogenase)
drug.Protein;P41252;IARS1;ENSG00000196305;P41252;Isoleucine--tRNA ligase, cytoplasmic (EC 6.1.1.5) (Isoleucyl-tRNA synthetase) (IRS) (IleRS)
drug.Protein;Q8TE23;TAS1R2;ENSG00000179002;Q8TE23;Taste receptor type 1 member 2 (G-protein coupled receptor 71) (Sweet taste receptor T1R2)
drug.Protein;Q7RTX0;TAS1R3;ENSG00000169962;Q7RTX0;Taste receptor type 1 member 3 (Sweet taste receptor T1R3)
drug.Protein;Q9NSA0;SLC22A11;ENSG00000168065;Q9NSA0;Solute carrier family 22 member 11 (Organic anion transporter 4)
drug.Protein;P51589;CYP2J2;ENSG00000134716;P51589;Cytochrome P450 2J2 (EC 1.14.14.-) (Albendazole monooxygenase (hydroxylating)) (EC 1.14.14.74) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Arachidonic acid epoxygenase) (CYPIIJ2) (Hydroperoxy icosatetraenoate isomerase) (EC 5.4.4.7)
drug.Protein;P10632;CYP2C8;ENSG00000138115;P10632;Cytochrome P450 2C8 (EC 1.14.14.1) (CYPIIC8) (Cytochrome P450 IIC2) (Cytochrome P450 MP-12) (Cytochrome P450 MP-20) (Cytochrome P450 form 1) (S-mephenytoin 4-hydroxylase)
drug.Protein;Q9BQB6;VKORC1;ENSG00000167397;Q9BQB6;Vitamin K epoxide reductase complex subunit 1 (EC 1.17.4.4) (Vitamin K1 2,3-epoxide reductase subunit 1)
drug.Protein;Q8N0U8;VKORC1L1;ENSG00000196715;Q8N0U8;Vitamin K epoxide reductase complex subunit 1-like protein 1 (VKORC1-like protein 1) (EC 1.17.4.4)
drug.Protein;P02818;BGLAP;ENSG00000242252;P02818;Osteocalcin (Bone Gla protein) (BGP) (Gamma-carboxyglutamic acid-containing protein)
drug.Protein;P11509;CYP2A6;ENSG00000255974;P11509;Cytochrome P450 2A6 (EC 1.14.14.-) (1,4-cineole 2-exo-monooxygenase) (CYPIIA6) (Coumarin 7-hydroxylase) (Cytochrome P450 IIA3) (Cytochrome P450(I))
drug.Protein;P20813;CYP2B6;ENSG00000197408;P20813;Cytochrome P450 2B6 (EC 1.14.13.-) (1,4-cineole 2-exo-monooxygenase) (CYPIIB6) (Cytochrome P450 IIB1)
drug.Protein;P24462;CYP3A7;ENSG00000160870;P24462;Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)
drug.Protein;P42684;ABL2;ENSG00000143322;P42684;Tyrosine-protein kinase ABL2 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 2) (Abelson tyrosine-protein kinase 2) (Abelson-related gene protein) (Tyrosine-protein kinase ARG)
drug.Protein;Q9UM73;ALK;ENSG00000171094;Q9UM73;ALK tyrosine kinase receptor (EC 2.7.10.1) (Anaplastic lymphoma kinase) (CD antigen CD246)
drug.Protein;Q13564;NAE1;ENSG00000159593;Q13564;NEDD8-activating enzyme E1 regulatory subunit (Amyloid beta precursor protein-binding protein 1, 59 kDa) (APP-BP1) (Amyloid protein-binding protein 1) (Proto-oncogene protein 1)
drug.Protein;P10398;ARAF;ENSG00000078061;P10398;Serine/threonine-protein kinase A-Raf (EC 2.7.11.1) (Proto-oncogene A-Raf) (Proto-oncogene A-Raf-1) (Proto-oncogene Pks)
drug.Protein;P37023;ACVRL1;ENSG00000139567;P37023;Serine/threonine-protein kinase receptor R3 (SKR3) (EC 2.7.11.30) (Activin receptor-like kinase 1) (ALK-1) (TGF-B superfamily receptor type I) (TSR-I)
drug.Protein;P49902;NT5C2;ENSG00000076685;P49902;Cytosolic purine 5'-nucleotidase (EC 3.1.3.5) (EC 3.1.3.99) (Cytosolic 5'-nucleotidase II) (cN-II) (Cytosolic IMP/GMP-specific 5'-nucleotidase) (Cytosolic nucleoside phosphotransferase 5'N) (EC 2.7.1.77) (High Km 5'-nucleotidase)
drug.Protein;O43681;GET3;ENSG00000198356;O43681;ATPase GET3 (EC 3.6.-.-) (Arsenical pump-driving ATPase) (Arsenite-stimulated ATPase) (Guided entry of tail-anchored proteins factor 3, ATPase) (Transmembrane domain recognition complex 40 kDa ATPase subunit) (hARSA-I) (hASNA-I)
drug.Protein;O60706;ABCC9;ENSG00000069431;O60706;ATP-binding cassette sub-family C member 9 (Sulfonylurea receptor 2)
drug.Protein;P31749;AKT1;ENSG00000142208;P31749;RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase B) (PKB) (Protein kinase B alpha) (PKB alpha) (Proto-oncogene c-Akt) (RAC-PK-alpha)
drug.Protein;P25098;GRK2;ENSG00000173020;P25098;Beta-adrenergic receptor kinase 1 (Beta-ARK-1) (EC 2.7.11.15) (G-protein coupled receptor kinase 2)
drug.Protein;O14727;APAF1;ENSG00000120868;O14727;Apoptotic protease-activating factor 1 (APAF-1)
drug.Protein;Q9NUB1;ACSS1;ENSG00000154930;Q9NUB1;Acetyl-coenzyme A synthetase 2-like, mitochondrial (EC 6.2.1.1) (Acetate--CoA ligase 2) (Acetyl-CoA synthetase 2) (AceCS2) (Acyl-CoA synthetase short-chain family member 1) (Propionate--CoA ligase) (EC 6.2.1.17)
drug.Protein;P36896;ACVR1B;ENSG00000135503;P36896;Activin receptor type-1B (EC 2.7.11.30) (Activin receptor type IB) (ACTR-IB) (Activin receptor-like kinase 4) (ALK-4) (Serine/threonine-protein kinase receptor R2) (SKR2)
drug.Protein;Q04771;ACVR1;ENSG00000115170;Q04771;Activin receptor type-1 (EC 2.7.11.30) (Activin receptor type I) (ACTR-I) (Activin receptor-like kinase 2) (ALK-2) (Serine/threonine-protein kinase receptor R1) (SKR1) (TGF-B superfamily receptor type I) (TSR-I)
drug.Protein;Q96Q40;CDK15;ENSG00000138395;Q96Q40;Cyclin-dependent kinase 15 (EC 2.7.11.22) (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 7 protein) (Cell division protein kinase 15) (Serine/threonine-protein kinase ALS2CR7) (Serine/threonine-protein kinase PFTAIRE-2)
drug.Protein;P12235;SLC25A4;ENSG00000151729;P12235;ADP/ATP translocase 1 (ADP,ATP carrier protein 1) (ADP,ATP carrier protein, heart/skeletal muscle isoform T1) (Adenine nucleotide translocator 1) (ANT 1) (Solute carrier family 25 member 4)
drug.Protein;Q09428;ABCC8;ENSG00000006071;Q09428;ATP-binding cassette sub-family C member 8 (Sulfonylurea receptor 1)
drug.Protein;Q9Y4W6;AFG3L2;ENSG00000141385;Q9Y4W6;AFG3-like protein 2 (EC 3.4.24.-) (Paraplegin-like protein)
drug.Protein;P35626;GRK3;ENSG00000100077;P35626;Beta-adrenergic receptor kinase 2 (Beta-ARK-2) (EC 2.7.11.15) (G-protein-coupled receptor kinase 3)
drug.Protein;Q16671;AMHR2;ENSG00000135409;Q16671;Anti-Muellerian hormone type-2 receptor (EC 2.7.11.30) (Anti-Muellerian hormone type II receptor) (AMH type II receptor) (MIS type II receptor) (MISRII) (MRII)
drug.Protein;Q07912;TNK2;ENSG00000061938;Q07912;Activated CDC42 kinase 1 (ACK-1) (EC 2.7.10.2) (EC 2.7.11.1) (Tyrosine kinase non-receptor protein 2)
drug.Protein;P00519;ABL1;ENSG00000097007;P00519;Tyrosine-protein kinase ABL1 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 1) (Abelson tyrosine-protein kinase 1) (Proto-oncogene c-Abl) (p150)
drug.Protein;O95255;ABCC6;ENSG00000091262;O95255;ATP-binding cassette sub-family C member 6 (EC 7.6.2.-) (EC 7.6.2.3) (Anthracycline resistance-associated protein) (Multi-specific organic anion transporter E) (MOAT-E) (Multidrug resistance-associated protein 6)
drug.Protein;P13569;CFTR;ENSG00000001626;P13569;Cystic fibrosis transmembrane conductance regulator (CFTR) (ATP-binding cassette sub-family C member 7) (Channel conductance-controlling ATPase) (EC 5.6.1.6) (cAMP-dependent chloride channel)
drug.Protein;P42336;PIK3CA;ENSG00000121879;P42336;Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (PI3-kinase subunit alpha) (PI3K-alpha) (PI3Kalpha) (PtdIns-3-kinase subunit alpha) (EC 2.7.1.137) (EC 2.7.1.153) (Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit alpha) (PtdIns-3-kinase subunit p110-alpha) (p110alpha) (Phosphoinositide 3-kinase alpha) (Phosphoinositide-3-kinase catalytic alpha polypeptide) (Serine/threonine protein kinase PIK3CA) (EC 2.7.11.1)
drug.Protein;P68400;CSNK2A1;ENSG00000101266;P68400;Casein kinase II subunit alpha (CK II alpha) (EC 2.7.11.1)
drug.Protein;P67870;CSNK2B;ENSG00000204435;P67870;Casein kinase II subunit beta (CK II beta) (Phosvitin) (Protein G5a)
drug.Protein;Q96G91;P2RY11;ENSG00000244165;Q96G91;P2Y purinoceptor 11 (P2Y11)
drug.Protein;P53041;PPP5C;ENSG00000011485;P53041;Serine/threonine-protein phosphatase 5 (PP5) (EC 3.1.3.16) (Protein phosphatase T) (PP-T) (PPT)
drug.Protein;O15460;P4HA2;ENSG00000072682;O15460;Prolyl 4-hydroxylase subunit alpha-2 (4-PH alpha-2) (EC 1.14.11.2) (Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-2)
drug.Protein;O43272;PRODH;ENSG00000100033;O43272;Proline dehydrogenase 1, mitochondrial (EC 1.5.5.2) (Proline oxidase) (Proline oxidase 2) (p53-induced gene 6 protein)
drug.Protein;O43447;PPIH;ENSG00000171960;O43447;Peptidyl-prolyl cis-trans isomerase H (PPIase H) (EC 5.2.1.8) (Rotamase H) (Small nuclear ribonucleoprotein particle-specific cyclophilin H) (CypH) (U-snRNP-associated cyclophilin SnuCyp-20) (USA-CYP)
drug.Protein;P23284;PPIB;ENSG00000166794;P23284;Peptidyl-prolyl cis-trans isomerase B (PPIase B) (EC 5.2.1.8) (CYP-S1) (Cyclophilin B) (Rotamase B) (S-cyclophilin) (SCYLP)
drug.Protein;P45877;PPIC;ENSG00000168938;P45877;Peptidyl-prolyl cis-trans isomerase C (PPIase C) (EC 5.2.1.8) (Cyclophilin C) (Rotamase C)
drug.Protein;Q13427;PPIG;ENSG00000138398;Q13427;Peptidyl-prolyl cis-trans isomerase G (PPIase G) (Peptidyl-prolyl isomerase G) (EC 5.2.1.8) (CASP10) (Clk-associating RS-cyclophilin) (CARS-Cyp) (CARS-cyclophilin) (SR-cyclophilin) (SR-cyp) (SRcyp) (Cyclophilin G) (Rotamase G)
drug.Protein;Q4W8W1;;;;
drug.Protein;Q7L3T8;PARS2;ENSG00000162396;Q7L3T8;Probable proline--tRNA ligase, mitochondrial (EC 6.1.1.15) (Prolyl-tRNA synthetase) (ProRS)
drug.Protein;Q53H96;PYCR3;ENSG00000104524;Q53H96;Pyrroline-5-carboxylate reductase 3 (P5C reductase 3) (P5CR 3) (EC 1.5.1.2) (Pyrroline-5-carboxylate reductase-like protein)
drug.Protein;Q96EM0;L3HYPDH;ENSG00000126790;Q96EM0;Trans-3-hydroxy-L-proline dehydratase (EC 4.2.1.77) (Trans-L-3-hydroxyproline dehydratase)
drug.Protein;Q99884;SLC6A7;ENSG00000011083;Q99884;Sodium-dependent proline transporter (Solute carrier family 6 member 7)
drug.Protein;P24666;ACP1;ENSG00000143727;P24666;Low molecular weight phosphotyrosine protein phosphatase (LMW-PTP) (LMW-PTPase) (EC 3.1.3.48) (Adipocyte acid phosphatase) (Low molecular weight cytosolic acid phosphatase) (EC 3.1.3.2) (Red cell acid phosphatase 1)
drug.Protein;Q9BY49;PECR;ENSG00000115425;Q9BY49;Peroxisomal trans-2-enoyl-CoA reductase (TERP) (EC 1.3.1.38) (2,4-dienoyl-CoA reductase-related protein) (DCR-RP) (HPDHase) (Short chain dehydrogenase/reductase family 29C member 1) (pVI-ARL)
drug.Protein;P78362;SRPK2;ENSG00000135250;P78362;"SRSF protein kinase 2 (EC 2.7.11.1) (SFRS protein kinase 2) (Serine/arginine-rich protein-specific kinase 2) (SR-protein-specific kinase 2) [Cleaved into: SRSF protein kinase 2 N-terminal; SRSF protein kinase 2 C-terminal]"
drug.Protein;Q13126;MTAP;ENSG00000099810;Q13126;S-methyl-5'-thioadenosine phosphorylase (EC 2.4.2.28) (5'-methylthioadenosine phosphorylase) (MTA phosphorylase) (MTAP) (MTAPase)
drug.Protein;P22309;UGT1A1;ENSG00000241635;P22309;UDP-glucuronosyltransferase 1A1 (UGT1A1) (EC 2.4.1.17) (Bilirubin-specific UDPGT isozyme 1) (hUG-BR1) (UDP-glucuronosyltransferase 1-1) (UDPGT 1-1) (UGT1*1) (UGT1-01) (UGT1.1) (UDP-glucuronosyltransferase 1A isoform 1)
drug.Protein;Q96I59;NARS2;ENSG00000137513;Q96I59;Probable asparagine--tRNA ligase, mitochondrial (EC 6.1.1.22) (Asparaginyl-tRNA synthetase) (AsnRS)
drug.Protein;O43776;NARS1;ENSG00000134440;O43776;Asparagine--tRNA ligase, cytoplasmic (EC 6.1.1.22) (Asparaginyl-tRNA synthetase) (AsnRS) (Asparaginyl-tRNA synthetase 1)
drug.Protein;Q92769;HDAC2;ENSG00000196591;Q92769;Histone deacetylase 2 (HD2) (EC 3.5.1.98) (Protein deacylase HDAC2) (EC 3.5.1.-)
drug.Protein;O94956;SLCO2B1;ENSG00000137491;O94956;Solute carrier organic anion transporter family member 2B1 (Organic anion transporter B) (OATP-B) (Organic anion transporter polypeptide-related protein 2) (OATP-RP2) (OATPRP2) (Solute carrier family 21 member 9)
drug.Protein;P46721;SLCO1A2;ENSG00000084453;P46721;Solute carrier organic anion transporter family member 1A2 (OATP-A) (Organic anion-transporting polypeptide 1) (OATP-1) (Sodium-independent organic anion transporter) (Solute carrier family 21 member 3)
drug.Protein;Q9Y694;SLC22A7;ENSG00000137204;Q9Y694;Solute carrier family 22 member 7 (Novel liver transporter) (Organic anion transporter 2) (hOAT2)
drug.Protein;P31645;SLC6A4;ENSG00000108576;P31645;Sodium-dependent serotonin transporter (SERT) (5HT transporter) (5HTT) (Solute carrier family 6 member 4)
drug.Protein;Q12809;KCNH2;ENSG00000055118;Q12809;Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)
drug.Protein;P30556;AGTR1;ENSG00000144891;P30556;Type-1 angiotensin II receptor (AT1AR) (AT1BR) (Angiotensin II type-1 receptor) (AT1 receptor)
drug.Protein;P12821;ACE;ENSG00000159640;P12821;Angiotensin-converting enzyme (ACE) (EC 3.4.15.1) (Dipeptidyl carboxypeptidase I) (Kininase II) (CD antigen CD143) [Cleaved into: Angiotensin-converting enzyme, soluble form]
drug.Protein;P46663;BDKRB1;ENSG00000100739;P46663;B1 bradykinin receptor (B1R) (BK-1 receptor)
drug.Protein;P46059;SLC15A1;ENSG00000088386;P46059;Solute carrier family 15 member 1 (Intestinal H(+)/peptide cotransporter) (Oligopeptide transporter, small intestine isoform) (Peptide transporter 1)
drug.Protein;Q16348;SLC15A2;ENSG00000163406;Q16348;Solute carrier family 15 member 2 (Kidney H(+)/peptide cotransporter) (Oligopeptide transporter, kidney isoform) (Peptide transporter 2)
drug.Protein;P04150;NR3C1;ENSG00000113580;P04150;Glucocorticoid receptor (GR) (Nuclear receptor subfamily 3 group C member 1)
drug.Protein;P08185;SERPINA6;ENSG00000170099;P08185;Corticosteroid-binding globulin (CBG) (Serpin A6) (Transcortin)
drug.Protein;Q9UBS5;GABBR1;ENSG00000204681;Q9UBS5;Gamma-aminobutyric acid type B receptor subunit 1 (GABA-B receptor 1) (GABA-B-R1) (GABA-BR1) (GABABR1) (Gb1)
drug.Protein;O75899;GABBR2;ENSG00000136928;O75899;Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20)
drug.Protein;Q05940;SLC18A2;ENSG00000165646;Q05940;Synaptic vesicular amine transporter (Monoamine transporter) (Solute carrier family 18 member 2) (Vesicular amine transporter 2) (VAT2)
drug.Protein;Q01959;SLC6A3;ENSG00000142319;Q01959;Sodium-dependent dopamine transporter (DA transporter) (DAT) (Solute carrier family 6 member 3)
drug.Protein;Q16568;CARTPT;ENSG00000164326;Q16568;"Cocaine- and amphetamine-regulated transcript protein [Cleaved into: CART(1-39); CART(42-89)]"
drug.Protein;Q96RJ0;TAAR1;ENSG00000146399;Q96RJ0;Trace amine-associated receptor 1 (TaR-1) (Trace amine receptor 1)
drug.Protein;P23975;SLC6A2;ENSG00000103546;P23975;Sodium-dependent noradrenaline transporter (Norepinephrine transporter) (NET) (Solute carrier family 6 member 2)
drug.Protein;P14416;DRD2;ENSG00000149295;P14416;D(2) dopamine receptor (Dopamine D2 receptor)
drug.Protein;P27338;MAOB;ENSG00000069535;P27338;Amine oxidase [flavin-containing] B (EC 1.4.3.21) (EC 1.4.3.4) (Monoamine oxidase type B) (MAO-B)
drug.Protein;Q99870;;;;
drug.Protein;P32239;CCKBR;ENSG00000110148;P32239;Gastrin/cholecystokinin type B receptor (CCK-B receptor) (CCK-BR) (Cholecystokinin-2 receptor) (CCK2-R)
drug.Protein;P43681;CHRNA4;ENSG00000101204;P43681;Neuronal acetylcholine receptor subunit alpha-4
drug.Protein;P17787;CHRNB2;ENSG00000160716;P17787;Neuronal acetylcholine receptor subunit beta-2
drug.Protein;Q15822;CHRNA2;ENSG00000120903;Q15822;Neuronal acetylcholine receptor subunit alpha-2
drug.Protein;P32297;CHRNA3;ENSG00000080644;P32297;Neuronal acetylcholine receptor subunit alpha-3
drug.Protein;P30532;CHRNA5;ENSG00000169684;P30532;Neuronal acetylcholine receptor subunit alpha-5
drug.Protein;Q15825;CHRNA6;ENSG00000147434;Q15825;Neuronal acetylcholine receptor subunit alpha-6
drug.Protein;Q9UGM1;CHRNA9;ENSG00000174343;Q9UGM1;Neuronal acetylcholine receptor subunit alpha-9 (Nicotinic acetylcholine receptor subunit alpha-9) (NACHR alpha-9)
drug.Protein;Q9GZZ6;CHRNA10;ENSG00000129749;Q9GZZ6;Neuronal acetylcholine receptor subunit alpha-10 (Nicotinic acetylcholine receptor subunit alpha-10) (NACHR alpha-10)
drug.Protein;Q05901;CHRNB3;ENSG00000147432;Q05901;Neuronal acetylcholine receptor subunit beta-3
drug.Protein;P30926;CHRNB4;ENSG00000117971;P30926;Neuronal acetylcholine receptor subunit beta-4
drug.Protein;P11511;CYP19A1;ENSG00000137869;P11511;Aromatase (EC 1.14.14.14) (CYPXIX) (Cytochrome P-450AROM) (Cytochrome P450 19A1) (Estrogen synthase)
drug.Protein;Q16696;CYP2A13;ENSG00000197838;Q16696;Cytochrome P450 2A13 (EC 1.14.14.1) (CYPIIA13)
drug.Protein;P20309;CHRM3;ENSG00000133019;P20309;Muscarinic acetylcholine receptor M3
drug.Protein;P11229;CHRM1;ENSG00000168539;P11229;Muscarinic acetylcholine receptor M1
drug.Protein;Q01740;FMO1;ENSG00000010932;Q01740;Dimethylaniline monooxygenase [N-oxide-forming] 1 (EC 1.14.13.8) (Dimethylaniline oxidase 1) (Fetal hepatic flavin-containing monooxygenase 1) (FMO 1)
drug.Protein;P54855;UGT2B15;ENSG00000196620;P54855;UDP-glucuronosyltransferase 2B15 (UDPGT 2B15) (UGT2B15) (EC 2.4.1.17) (HLUG4) (UDP-glucuronosyltransferase 2B8) (UDPGT 2B8) (UDPGTh-3)
drug.Protein;P28074;PSMB5;ENSG00000100804;P28074;Proteasome subunit beta type-5 (EC 3.4.25.1) (Macropain epsilon chain) (Multicatalytic endopeptidase complex epsilon chain) (Proteasome chain 6) (Proteasome epsilon chain) (Proteasome subunit MB1) (Proteasome subunit X)
drug.Protein;P20618;PSMB1;ENSG00000008018;P20618;Proteasome subunit beta type-1 (Macropain subunit C5) (Multicatalytic endopeptidase complex subunit C5) (Proteasome component C5) (Proteasome gamma chain)
drug.Protein;P01303;NPY;ENSG00000122585;P01303;"Pro-neuropeptide Y [Cleaved into: Neuropeptide Y (Neuropeptide tyrosine) (NPY); C-flanking peptide of NPY (CPON)]"
drug.Protein;Q14524;SCN5A;ENSG00000183873;Q14524;Sodium channel protein type 5 subunit alpha (Sodium channel protein cardiac muscle subunit alpha) (Sodium channel protein type V subunit alpha) (Voltage-gated sodium channel subunit alpha Nav1.5) (hH1)
drug.Protein;P35372;OPRM1;ENSG00000112038;P35372;Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)
drug.Protein;P28335;HTR2C;ENSG00000147246;P28335;5-hydroxytryptamine receptor 2C (5-HT-2C) (5-HT2C) (5-HTR2C) (5-hydroxytryptamine receptor 1C) (5-HT-1C) (5-HT1C) (Serotonin receptor 2C)
drug.Protein;P41145;OPRK1;ENSG00000082556;P41145;Kappa-type opioid receptor (K-OR-1) (KOR-1)
drug.Protein;P41143;OPRD1;ENSG00000116329;P41143;Delta-type opioid receptor (D-OR-1) (DOR-1)
drug.Protein;Q693P7;;;;
drug.Protein;P25103;TACR1;ENSG00000115353;P25103;Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)
drug.Protein;Q99250;SCN2A;ENSG00000136531;Q99250;Sodium channel protein type 2 subunit alpha (HBSC II) (Sodium channel protein brain II subunit alpha) (Sodium channel protein type II subunit alpha) (Voltage-gated sodium channel subunit alpha Nav1.2)
drug.Protein;P30542;ADORA1;ENSG00000163485;P30542;Adenosine receptor A1
drug.Protein;P00813;ADA;ENSG00000196839;P00813;Adenosine deaminase (EC 3.5.4.4) (Adenosine aminohydrolase)
drug.Protein;Q99808;SLC29A1;ENSG00000112759;Q99808;Equilibrative nucleoside transporter 1 (Equilibrative nitrobenzylmercaptopurine riboside-sensitive nucleoside transporter) (Equilibrative NBMPR-sensitive nucleoside transporter) (Nucleoside transporter, es-type) (Solute carrier family 29 member 1)
drug.Protein;P62508;ESRRG;ENSG00000196482;P62508;Estrogen-related receptor gamma (ERR gamma-2) (Estrogen receptor-related protein 3) (Nuclear receptor subfamily 3 group B member 3)
drug.Protein;P11474;ESRRA;ENSG00000173153;P11474;Steroid hormone receptor ERR1 (Estrogen receptor-like 1) (Estrogen-related receptor alpha) (ERR-alpha) (Nuclear receptor subfamily 3 group B member 1)
drug.Protein;P35503;UGT1A3;ENSG00000288702;P35503;UDP-glucuronosyltransferase 1A3 (UGT1A3) (EC 2.4.1.17) (UDP-glucuronosyltransferase 1-3) (UDPGT 1-3) (UGT1*3) (UGT1-03) (UGT1.3) (UDP-glucuronosyltransferase 1-C) (UGT-1C) (UGT1C) (UDP-glucuronosyltransferase 1A isoform 3)
drug.Protein;P22310;UGT1A4;ENSG00000244474;P22310;UDP-glucuronosyltransferase 1A4 (UGT1A4) (EC 2.4.1.17) (Bilirubin-specific UDPGT isozyme 2) (hUG-BR2) (UDP-glucuronosyltransferase 1-4) (UDPGT 1-4) (UGT1*4) (UGT1-04) (UGT1.4) (UDP-glucuronosyltransferase 1-D) (UGT-1D) (UGT1D)
drug.Protein;P19224;UGT1A6;ENSG00000167165;P19224;UDP-glucuronosyltransferase 1-6 (UDPGT 1-6) (UGT1*6) (UGT1-06) (UGT1.6) (EC 2.4.1.17) (Phenol-metabolizing UDP-glucuronosyltransferase) (UDP-glucuronosyltransferase 1-F) (UGT-1F) (UGT1F) (UDP-glucuronosyltransferase 1A6)
drug.Protein;Q9HAW7;UGT1A7;ENSG00000244122;Q9HAW7;UDP-glucuronosyltransferase 1A7 (UGT1A7) (EC 2.4.1.17) (UDP-glucuronosyltransferase 1-7) (UDPGT 1-7) (UGT1*7) (UGT1-07) (UGT1.7) (UDP-glucuronosyltransferase 1-G) (UGT-1G) (UGT1G)
drug.Protein;Q9HAW9;UGT1A8;ENSG00000242366;Q9HAW9;UDP-glucuronosyltransferase 1A8 (UGT1A8) (EC 2.4.1.17) (UDP-glucuronosyltransferase 1-8) (UDPGT 1-8) (UGT1*8) (UGT1-08) (UGT1.8) (UDP-glucuronosyltransferase 1-H) (UGT-1H) (UGT1H)
drug.Protein;O60656;UGT1A9;ENSG00000241119;O60656;UDP-glucuronosyltransferase 1A9 (UGT1A9) (EC 2.4.1.17) (UDP-glucuronosyltransferase 1-9) (UDPGT 1-9) (UGT1*9) (UGT1-09) (UGT1.9) (UDP-glucuronosyltransferase 1-I) (UGT-1I) (UGT1I) (lugP4)
drug.Protein;Q9HAW8;UGT1A10;ENSG00000242515;Q9HAW8;UDP-glucuronosyltransferase 1A10 (UGT1A10) (EC 2.4.1.17) (UDP-glucuronosyltransferase 1-10) (UDPGT 1-10) (UGT1*10) (UGT1-10) (UGT1.10) (UDP-glucuronosyltransferase 1-J) (UGT-1J) (UGT1J)
drug.Protein;P16662;UGT2B7;ENSG00000171234;P16662;UDP-glucuronosyltransferase 2B7 (UDPGT 2B7) (UGT2B7) (EC 2.4.1.17) (3,4-catechol estrogen-specific UDPGT) (UDP-glucuronosyltransferase 2B9) (UDPGT 2B9) (UDPGTh-2)
drug.Protein;Q99519;NEU1;ENSG00000204386;Q99519;Sialidase-1 (EC 3.2.1.18) (Acetylneuraminyl hydrolase) (G9 sialidase) (Lysosomal sialidase) (N-acetyl-alpha-neuraminidase 1)
drug.Protein;Q9Y3R4;NEU2;ENSG00000115488;Q9Y3R4;Sialidase-2 (EC 3.2.1.18) (Cytosolic sialidase) (N-acetyl-alpha-neuraminidase 2)
drug.Protein;P23141;CES1;ENSG00000198848;P23141;Liver carboxylesterase 1 (Acyl-coenzyme A:cholesterol acyltransferase) (ACAT) (Brain carboxylesterase hBr1) (Carboxylesterase 1) (CE-1) (hCE-1) (EC 3.1.1.1) (Cholesteryl ester hydrolase) (CEH) (EC 3.1.1.13) (Cocaine carboxylesterase) (Egasyn) (HMSE) (Methylumbelliferyl-acetate deacetylase 1) (EC 3.1.1.56) (Monocyte/macrophage serine esterase) (Retinyl ester hydrolase) (REH) (Serine esterase 1) (Triacylglycerol hydrolase) (TGH)
drug.Protein;O43193;MLNR;ENSG00000102539;O43193;Motilin receptor (G-protein coupled receptor 38)
drug.Protein;P29274;ADORA2A;ENSG00000128271;P29274;Adenosine receptor A2a
drug.Protein;P21817;RYR1;ENSG00000196218;P21817;Ryanodine receptor 1 (RYR-1) (RyR1) (Skeletal muscle calcium release channel) (Skeletal muscle ryanodine receptor) (Skeletal muscle-type ryanodine receptor) (Type 1 ryanodine receptor)
drug.Protein;P78527;PRKDC;ENSG00000253729;P78527;DNA-dependent protein kinase catalytic subunit (DNA-PK catalytic subunit) (DNA-PKcs) (EC 2.7.11.1) (DNPK1) (p460)
drug.Protein;O00329;PIK3CD;ENSG00000171608;O00329;Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform (PI3-kinase subunit delta) (PI3K-delta) (PI3Kdelta) (PtdIns-3-kinase subunit delta) (EC 2.7.1.137) (EC 2.7.1.153) (Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit delta) (PtdIns-3-kinase subunit p110-delta) (p110delta)
drug.Protein;P42338;PIK3CB;ENSG00000051382;P42338;Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform (PI3-kinase subunit beta) (PI3K-beta) (PI3Kbeta) (PtdIns-3-kinase subunit beta) (EC 2.7.1.153) (Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit beta) (PtdIns-3-kinase subunit p110-beta) (p110beta) (Serine/threonine protein kinase PIK3CB) (EC 2.7.11.1)
drug.Protein;Q13315;ATM;ENSG00000149311;Q13315;Serine-protein kinase ATM (EC 2.7.11.1) (Ataxia telangiectasia mutated) (A-T mutated)
drug.Protein;P29275;ADORA2B;ENSG00000170425;P29275;Adenosine receptor A2b
drug.Protein;P0DMS8;ADORA3;ENSG00000282608;P0DMS8;Adenosine receptor A3
drug.Protein;P08172;CHRM2;ENSG00000181072;P08172;Muscarinic acetylcholine receptor M2
drug.Protein;O76074;PDE5A;ENSG00000138735;O76074;cGMP-specific 3',5'-cyclic phosphodiesterase (EC 3.1.4.35) (cGMP-binding cGMP-specific phosphodiesterase) (CGB-PDE)
drug.Protein;P18545;PDE6G;ENSG00000185527;P18545;Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma (GMP-PDE gamma) (EC 3.1.4.35)
drug.Protein;Q13956;PDE6H;ENSG00000139053;Q13956;Retinal cone rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma (GMP-PDE gamma) (EC 3.1.4.35)
drug.Protein;O95069;KCNK2;ENSG00000082482;O95069;Potassium channel subfamily K member 2 (Outward rectifying potassium channel protein TREK-1) (TREK-1 K(+) channel subunit) (Two pore domain potassium channel TREK-1) (Two pore potassium channel TPKC1)
drug.Protein;Q14500;KCNJ12;ENSG00000184185;Q14500;ATP-sensitive inward rectifier potassium channel 12 (Inward rectifier K(+) channel Kir2.2) (IRK-2) (Inward rectifier K(+) channel Kir2.2v) (Potassium channel, inwardly rectifying subfamily J member 12)
drug.Protein;P07686;HEXB;ENSG00000049860;P07686;"Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (Cervical cancer proto-oncogene 7 protein) (HCC-7) (N-acetyl-beta-glucosaminidase subunit beta) [Cleaved into: Beta-hexosaminidase subunit beta chain B; Beta-hexosaminidase subunit beta chain A]"
drug.Protein;Q96FL8;SLC47A1;ENSG00000142494;Q96FL8;Multidrug and toxin extrusion protein 1 (MATE-1) (hMATE-1) (Solute carrier family 47 member 1)
drug.Protein;Q86VL8;SLC47A2;ENSG00000180638;Q86VL8;Multidrug and toxin extrusion protein 2 (MATE-2) (hMATE-2) (Kidney-specific H(+)/organic cation antiporter) (Solute carrier family 47 member 2)
drug.Protein;P54219;SLC18A1;ENSG00000036565;P54219;Chromaffin granule amine transporter (Solute carrier family 18 member 1) (Vesicular amine transporter 1) (VAT1)
drug.Protein;O15392;BIRC5;ENSG00000089685;O15392;Baculoviral IAP repeat-containing protein 5 (Apoptosis inhibitor 4) (Apoptosis inhibitor survivin)
drug.Protein;Q9H244;P2RY12;ENSG00000169313;Q9H244;P2Y purinoceptor 12 (P2Y12) (ADP-glucose receptor) (ADPG-R) (P2T(AC)) (P2Y(AC)) (P2Y(cyc)) (P2Y12 platelet ADP receptor) (P2Y(ADP)) (SP1999)
drug.Protein;P10826;RARB;ENSG00000077092;P10826;Retinoic acid receptor beta (RAR-beta) (HBV-activated protein) (Nuclear receptor subfamily 1 group B member 2) (RAR-epsilon)
drug.Protein;P13631;RARG;ENSG00000172819;P13631;Retinoic acid receptor gamma (RAR-gamma) (Nuclear receptor subfamily 1 group B member 3)
drug.Protein;P28702;RXRB;ENSG00000204231;P28702;Retinoic acid receptor RXR-beta (Nuclear receptor subfamily 2 group B member 2) (Retinoid X receptor beta)
drug.Protein;P48443;RXRG;ENSG00000143171;P48443;Retinoic acid receptor RXR-gamma (Nuclear receptor subfamily 2 group B member 3) (Retinoid X receptor gamma)
drug.Protein;P05412;JUN;ENSG00000177606;P05412;Transcription factor Jun (Activator protein 1) (AP1) (Proto-oncogene c-Jun) (Transcription factor AP-1 subunit Jun) (V-jun avian sarcoma virus 17 oncogene homolog) (p39)
drug.Protein;P10276;RARA;ENSG00000131759;P10276;Retinoic acid receptor alpha (RAR-alpha) (Nuclear receptor subfamily 1 group B member 1)
drug.Protein;P35348;ADRA1A;ENSG00000120907;P35348;Alpha-1A adrenergic receptor (Alpha-1A adrenoreceptor) (Alpha-1A adrenoceptor) (Alpha-1C adrenergic receptor) (Alpha-adrenergic receptor 1c)
drug.Protein;P35368;ADRA1B;ENSG00000170214;P35368;Alpha-1B adrenergic receptor (Alpha-1B adrenoreceptor) (Alpha-1B adrenoceptor)
drug.Protein;P25100;ADRA1D;ENSG00000171873;P25100;Alpha-1D adrenergic receptor (Alpha-1A adrenergic receptor) (Alpha-1D adrenoreceptor) (Alpha-1D adrenoceptor) (Alpha-adrenergic receptor 1a)
drug.Protein;P00797;REN;ENSG00000143839;P00797;Renin (EC 3.4.23.15) (Angiotensinogenase)
drug.Protein;P20648;ATP4A;ENSG00000105675;P20648;Potassium-transporting ATPase alpha chain 1 (EC 7.2.2.19) (Gastric H(+)/K(+) ATPase subunit alpha) (Proton pump)
drug.Protein;Q13621;SLC12A1;ENSG00000074803;Q13621;Solute carrier family 12 member 1 (Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 2) (Kidney-specific Na-K-Cl symporter)
drug.Protein;P55011;SLC12A2;ENSG00000064651;P55011;Solute carrier family 12 member 2 (Basolateral Na-K-Cl symporter) (Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 2)
drug.Protein;P35367;HRH1;ENSG00000196639;P35367;Histamine H1 receptor (H1R) (HH1R)
drug.Protein;P28221;HTR1D;ENSG00000179546;P28221;5-hydroxytryptamine receptor 1D (5-HT-1D) (5-HT1D) (Serotonin 1D alpha receptor) (5-HT-1D-alpha) (Serotonin receptor 1D)
drug.Protein;P28222;HTR1B;ENSG00000135312;P28222;5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)
drug.Protein;P30939;HTR1F;ENSG00000179097;P30939;5-hydroxytryptamine receptor 1F (5-HT-1F) (5-HT1F) (Serotonin receptor 1F)
drug.Protein;P08908;HTR1A;ENSG00000178394;P08908;5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A)
drug.Protein;P48048;KCNJ1;ENSG00000151704;P48048;ATP-sensitive inward rectifier potassium channel 1 (ATP-regulated potassium channel ROM-K) (Inward rectifier K(+) channel Kir1.1) (Potassium channel, inwardly rectifying subfamily J member 1)
drug.Protein;P11388;TOP2A;ENSG00000131747;P11388;DNA topoisomerase 2-alpha (EC 5.6.2.2) (DNA topoisomerase II, alpha isozyme)
drug.Protein;Q14654;KCNJ11;ENSG00000187486;Q14654;ATP-sensitive inward rectifier potassium channel 11 (IKATP) (Inward rectifier K(+) channel Kir6.2) (Potassium channel, inwardly rectifying subfamily J member 11)
drug.Protein;Q15166;PON3;ENSG00000105852;Q15166;Serum paraoxonase/lactonase 3 (EC 3.1.1.2) (EC 3.1.1.81) (EC 3.1.8.1)
drug.Protein;P98194;ATP2C1;ENSG00000017260;P98194;Calcium-transporting ATPase type 2C member 1 (ATPase 2C1) (EC 7.2.2.10) (ATP-dependent Ca(2+) pump PMR1) (Ca(2+)/Mn(2+)-ATPase 2C1) (Secretory pathway Ca(2+)-transporting ATPase type 1) (SPCA1)
drug.Protein;O14983;ATP2A1;ENSG00000196296;O14983;Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 (SERCA1) (SR Ca(2+)-ATPase 1) (EC 7.2.2.10) (Calcium pump 1) (Calcium-transporting ATPase sarcoplasmic reticulum type, fast twitch skeletal muscle isoform) (Endoplasmic reticulum class 1/2 Ca(2+) ATPase)
drug.Protein;P54289;CACNA2D1;ENSG00000153956;P54289;"Voltage-dependent calcium channel subunit alpha-2/delta-1 (Voltage-gated calcium channel subunit alpha-2/delta-1) [Cleaved into: Voltage-dependent calcium channel subunit alpha-2-1; Voltage-dependent calcium channel subunit delta-1]"
drug.Protein;P00915;CA1;ENSG00000133742;P00915;Carbonic anhydrase 1 (EC 4.2.1.1) (Carbonate dehydratase I) (Carbonic anhydrase B) (CAB) (Carbonic anhydrase I) (CA-I) (Cyanamide hydratase CA1) (EC 4.2.1.69)
drug.Protein;P00918;CA2;ENSG00000104267;P00918;Carbonic anhydrase 2 (EC 4.2.1.1) (Carbonate dehydratase II) (Carbonic anhydrase C) (CAC) (Carbonic anhydrase II) (CA-II) (Cyanamide hydratase CA2) (EC 4.2.1.69)
drug.Protein;P22748;CA4;ENSG00000167434;P22748;Carbonic anhydrase 4 (EC 4.2.1.1) (Carbonate dehydratase IV) (Carbonic anhydrase IV) (CA-IV)
drug.Protein;O15111;CHUK;ENSG00000213341;O15111;Inhibitor of nuclear factor kappa-B kinase subunit alpha (I-kappa-B kinase alpha) (IKK-A) (IKK-alpha) (IkBKA) (IkappaB kinase) (EC 2.7.11.10) (Conserved helix-loop-helix ubiquitous kinase) (I-kappa-B kinase 1) (IKK1) (Nuclear factor NF-kappa-B inhibitor kinase alpha) (NFKBIKA) (Transcription factor 16) (TCF-16)
drug.Protein;Q9NZK7;PLA2G2E;ENSG00000188784;Q9NZK7;Group IIE secretory phospholipase A2 (GIIE sPLA2) (sPLA2-IIE) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase 2E)
drug.Protein;Q14432;PDE3A;ENSG00000172572;Q14432;cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A (EC 3.1.4.17) (Cyclic GMP-inhibited phosphodiesterase A) (CGI-PDE A) (cGMP-inhibited cAMP phosphodiesterase) (cGI-PDE)
drug.Protein;P14867;GABRA1;ENSG00000022355;P14867;Gamma-aminobutyric acid receptor subunit alpha-1 (GABA(A) receptor subunit alpha-1)
drug.Protein;P47869;GABRA2;ENSG00000151834;P47869;Gamma-aminobutyric acid receptor subunit alpha-2 (GABA(A) receptor subunit alpha-2)
drug.Protein;P34903;GABRA3;ENSG00000011677;P34903;Gamma-aminobutyric acid receptor subunit alpha-3 (GABA(A) receptor subunit alpha-3)
drug.Protein;P48169;GABRA4;ENSG00000109158;P48169;Gamma-aminobutyric acid receptor subunit alpha-4 (GABA(A) receptor subunit alpha-4)
drug.Protein;P31644;GABRA5;ENSG00000186297;P31644;Gamma-aminobutyric acid receptor subunit alpha-5 (GABA(A) receptor subunit alpha-5)
drug.Protein;Q16445;GABRA6;ENSG00000145863;Q16445;Gamma-aminobutyric acid receptor subunit alpha-6 (GABA(A) receptor subunit alpha-6)
drug.Protein;P23921;RRM1;ENSG00000167325;P23921;Ribonucleoside-diphosphate reductase large subunit (EC 1.17.4.1) (Ribonucleoside-diphosphate reductase subunit M1) (Ribonucleotide reductase large subunit)
drug.Protein;P31350;RRM2;ENSG00000171848;P31350;Ribonucleoside-diphosphate reductase subunit M2 (EC 1.17.4.1) (Ribonucleotide reductase small chain) (Ribonucleotide reductase small subunit)
drug.Protein;Q7LG56;RRM2B;ENSG00000048392;Q7LG56;Ribonucleoside-diphosphate reductase subunit M2 B (EC 1.17.4.1) (TP53-inducible ribonucleotide reductase M2 B) (p53-inducible ribonucleotide reductase small subunit 2-like protein) (p53R2)
drug.Protein;P09884;POLA1;ENSG00000101868;P09884;DNA polymerase alpha catalytic subunit (EC 2.7.7.7) (DNA polymerase alpha catalytic subunit p180)
drug.Protein;Q07864;POLE;ENSG00000177084;Q07864;DNA polymerase epsilon catalytic subunit A (EC 2.7.7.7) (3'-5' exodeoxyribonuclease) (EC 3.1.11.-) (DNA polymerase II subunit A)
drug.Protein;P56282;POLE2;ENSG00000100479;P56282;DNA polymerase epsilon subunit 2 (DNA polymerase II subunit 2) (DNA polymerase epsilon subunit B)
drug.Protein;Q9NRF9;POLE3;ENSG00000148229;Q9NRF9;DNA polymerase epsilon subunit 3 (Arsenic-transactivated protein) (AsTP) (Chromatin accessibility complex 17 kDa protein) (CHRAC-17) (HuCHRAC17) (DNA polymerase II subunit 3) (DNA polymerase epsilon subunit p17)
drug.Protein;Q9NR33;POLE4;ENSG00000115350;Q9NR33;DNA polymerase epsilon subunit 4 (DNA polymerase II subunit 4) (DNA polymerase epsilon subunit p12)
drug.Protein;P00491;PNP;ENSG00000198805;P00491;Purine nucleoside phosphorylase (PNP) (EC 2.4.2.1) (Inosine phosphorylase) (Inosine-guanosine phosphorylase)
drug.Protein;P27707;DCK;ENSG00000156136;P27707;Deoxycytidine kinase (dCK) (EC 2.7.1.74) (Deoxyadenosine kinase) (EC 2.7.1.76) (Deoxyguanosine kinase) (EC 2.7.1.113)
drug.Protein;Q9HAS3;SLC28A3;ENSG00000197506;Q9HAS3;Solute carrier family 28 member 3 (Concentrative Na(+)-nucleoside cotransporter 3) (CNT 3) (hCNT3)
drug.Protein;O14920;IKBKB;ENSG00000104365;O14920;Inhibitor of nuclear factor kappa-B kinase subunit beta (I-kappa-B-kinase beta) (IKK-B) (IKK-beta) (IkBKB) (EC 2.7.11.10) (I-kappa-B kinase 2) (IKK2) (Nuclear factor NF-kappa-B inhibitor kinase beta) (NFKBIKB) (Serine/threonine protein kinase IKBKB) (EC 2.7.11.1)
drug.Protein;P18440;NAT1;ENSG00000171428;P18440;Arylamine N-acetyltransferase 1 (EC 2.3.1.5) (Arylamide acetylase 1) (Monomorphic arylamine N-acetyltransferase) (MNAT) (N-acetyltransferase type 1) (NAT-1)
drug.Protein;P21728;DRD1;ENSG00000184845;P21728;D(1A) dopamine receptor (Dopamine D1 receptor)
drug.Protein;P21918;DRD5;ENSG00000169676;P21918;D(1B) dopamine receptor (D(5) dopamine receptor) (D1beta dopamine receptor) (Dopamine D5 receptor)
drug.Protein;P28223;HTR2A;ENSG00000102468;P28223;5-hydroxytryptamine receptor 2A (5-HT-2) (5-HT-2A) (Serotonin receptor 2A)
drug.Protein;P35462;DRD3;ENSG00000151577;P35462;D(3) dopamine receptor (Dopamine D3 receptor)
drug.Protein;P21917;DRD4;ENSG00000069696;P21917;D(4) dopamine receptor (D(2C) dopamine receptor) (Dopamine D4 receptor)
drug.Protein;P28566;HTR1E;ENSG00000168830;P28566;5-hydroxytryptamine receptor 1E (5-HT-1E) (5-HT1E) (S31) (Serotonin receptor 1E)
drug.Protein;P50406;HTR6;ENSG00000158748;P50406;5-hydroxytryptamine receptor 6 (5-HT-6) (5-HT6) (Serotonin receptor 6)
drug.Protein;P34969;HTR7;ENSG00000148680;P34969;5-hydroxytryptamine receptor 7 (5-HT-7) (5-HT7) (5-HT-X) (Serotonin receptor 7)
drug.Protein;P08913;ADRA2A;ENSG00000150594;P08913;Alpha-2A adrenergic receptor (Alpha-2 adrenergic receptor subtype C10) (Alpha-2A adrenoreceptor) (Alpha-2A adrenoceptor) (Alpha-2AAR)
drug.Protein;P18089;ADRA2B;ENSG00000274286;P18089;Alpha-2B adrenergic receptor (Alpha-2 adrenergic receptor subtype C2) (Alpha-2B adrenoreceptor) (Alpha-2B adrenoceptor) (Alpha-2BAR)
drug.Protein;P18825;ADRA2C;ENSG00000184160;P18825;Alpha-2C adrenergic receptor (Alpha-2 adrenergic receptor subtype C4) (Alpha-2C adrenoreceptor) (Alpha-2C adrenoceptor) (Alpha-2CAR)
drug.Protein;P08173;CHRM4;ENSG00000180720;P08173;Muscarinic acetylcholine receptor M4
drug.Protein;P08912;CHRM5;ENSG00000184984;P08912;Muscarinic acetylcholine receptor M5
drug.Protein;P47898;HTR5A;ENSG00000157219;P47898;5-hydroxytryptamine receptor 5A (5-HT-5) (5-HT-5A) (5-HT5A) (Serotonin receptor 5A)
drug.Protein;P41595;HTR2B;ENSG00000135914;P41595;5-hydroxytryptamine receptor 2B (5-HT-2B) (5-HT2B) (Serotonin receptor 2B)
drug.Protein;P31513;FMO3;ENSG00000007933;P31513;Dimethylaniline monooxygenase [N-oxide-forming] 3 (EC 1.14.13.8) (EC 1.14.14.73) (Dimethylaniline oxidase 3) (FMO II) (FMO form 2) (Hepatic flavin-containing monooxygenase 3) (FMO 3) (Trimethylamine monooxygenase) (EC 1.14.13.148)
drug.Protein;P11245;NAT2;ENSG00000156006;P11245;Arylamine N-acetyltransferase 2 (EC 2.3.1.5) (Arylamide acetylase 2) (N-acetyltransferase type 2) (NAT-2) (Polymorphic arylamine N-acetyltransferase) (PNAT)
drug.Protein;P33260;CYP2C18;ENSG00000108242;P33260;Cytochrome P450 2C18 (EC 1.14.14.1) (CYPIIC18) (Cytochrome P450-6b/29c)
drug.Protein;P35498;SCN1A;ENSG00000144285;P35498;Sodium channel protein type 1 subunit alpha (Sodium channel protein brain I subunit alpha) (Sodium channel protein type I subunit alpha) (Voltage-gated sodium channel subunit alpha Nav1.1)
drug.Protein;Q07699;SCN1B;ENSG00000105711;Q07699;Sodium channel subunit beta-1
drug.Protein;Q9NY46;SCN3A;ENSG00000153253;Q9NY46;Sodium channel protein type 3 subunit alpha (Sodium channel protein brain III subunit alpha) (Sodium channel protein type III subunit alpha) (Voltage-gated sodium channel subtype III) (Voltage-gated sodium channel subunit alpha Nav1.3)
drug.Protein;Q9UQD0;SCN8A;ENSG00000196876;Q9UQD0;Sodium channel protein type 8 subunit alpha (Sodium channel protein type VIII subunit alpha) (Voltage-gated sodium channel subunit alpha Nav1.6)
drug.Protein;P15538;CYP11B1;ENSG00000160882;P15538;Cytochrome P450 11B1, mitochondrial (CYPXIB1) (Cytochrome P-450c11) (Cytochrome P450C11) (Steroid 11-beta-hydroxylase, CYP11B1) (EC 1.14.15.4)
drug.Protein;P07099;EPHX1;ENSG00000143819;P07099;Epoxide hydrolase 1 (EC 3.3.2.9) (Epoxide hydratase) (Microsomal epoxide hydrolase) (mEH)
drug.Protein;Q9NYB5;SLCO1C1;ENSG00000139155;Q9NYB5;Solute carrier organic anion transporter family member 1C1 (Organic anion transporter F) (OATP-F) (Organic anion transporter polypeptide-related protein 5) (OAT-RP-5) (OATPRP5) (Organic anion-transporting polypeptide 14) (OATP-14) (Solute carrier family 21 member 14) (Thyroxine transporter)
drug.Protein;Q2M3G0;ABCB5;ENSG00000004846;Q2M3G0;ATP-binding cassette sub-family B member 5 (ABCB5 P-gp) (P-glycoprotein ABCB5) (EC 7.6.2.2)
drug.Protein;P03372;ESR1;ENSG00000091831;P03372;Estrogen receptor (ER) (ER-alpha) (Estradiol receptor) (Nuclear receptor subfamily 3 group A member 1)
drug.Protein;Q92731;ESR2;ENSG00000140009;Q92731;Estrogen receptor beta (ER-beta) (Nuclear receptor subfamily 3 group A member 2)
drug.Protein;O95718;ESRRB;ENSG00000119715;O95718;Steroid hormone receptor ERR2 (ERR beta-2) (Estrogen receptor-like 2) (Estrogen-related receptor beta) (ERR-beta) (Nuclear receptor subfamily 3 group B member 2)
drug.Protein;Q15596;NCOA2;ENSG00000140396;Q15596;Nuclear receptor coactivator 2 (NCoA-2) (Class E basic helix-loop-helix protein 75) (bHLHe75) (Transcriptional intermediary factor 2) (hTIF2)
drug.Protein;P10275;AR;ENSG00000169083;P10275;Androgen receptor (Dihydrotestosterone receptor) (Nuclear receptor subfamily 3 group C member 4)
drug.Protein;P02766;TTR;ENSG00000118271;P02766;Transthyretin (ATTR) (Prealbumin) (TBPA)
drug.Protein;O15554;KCNN4;ENSG00000104783;O15554;Intermediate conductance calcium-activated potassium channel protein 4 (SK4) (SKCa 4) (SKCa4) (IKCa1) (IK1) (KCa3.1) (KCa4) (Putative Gardos channel)
drug.Protein;Q8TDS4;HCAR2;ENSG00000182782;Q8TDS4;Hydroxycarboxylic acid receptor 2 (G-protein coupled receptor 109A) (G-protein coupled receptor HM74A) (Niacin receptor 1) (Nicotinic acid receptor)
drug.Protein;Q495M3;SLC36A2;ENSG00000186335;Q495M3;Proton-coupled amino acid transporter 2 (Proton/amino acid transporter 2) (Solute carrier family 36 member 2) (Transmembrane domain rich protein 1) (Tramdorin-1)
drug.Protein;Q08257;CRYZ;ENSG00000116791;Q08257;Quinone oxidoreductase (EC 1.6.5.5) (NADPH:quinone reductase) (Zeta-crystallin)
drug.Protein;Q13936;CACNA1C;ENSG00000151067;Q13936;Voltage-dependent L-type calcium channel subunit alpha-1C (Calcium channel, L type, alpha-1 polypeptide, isoform 1, cardiac muscle) (Voltage-gated calcium channel subunit alpha Cav1.2)
drug.Protein;Q08289;CACNB2;ENSG00000165995;Q08289;Voltage-dependent L-type calcium channel subunit beta-2 (CAB2) (Calcium channel voltage-dependent subunit beta 2) (Lambert-Eaton myasthenic syndrome antigen B) (MYSB)
drug.Protein;O95180;CACNA1H;ENSG00000196557;O95180;Voltage-dependent T-type calcium channel subunit alpha-1H (Low-voltage-activated calcium channel alpha1 3.2 subunit) (Voltage-gated calcium channel subunit alpha Cav3.2)
drug.Protein;Q9NY47;CACNA2D2;ENSG00000007402;Q9NY47;"Voltage-dependent calcium channel subunit alpha-2/delta-2 (Voltage-gated calcium channel subunit alpha-2/delta-2) [Cleaved into: Voltage-dependent calcium channel subunit alpha-2-2; Voltage-dependent calcium channel subunit delta-2]"
drug.Protein;Q01668;CACNA1D;ENSG00000157388;Q01668;Voltage-dependent L-type calcium channel subunit alpha-1D (Calcium channel, L type, alpha-1 polypeptide, isoform 2) (Voltage-gated calcium channel subunit alpha Cav1.3)
drug.Protein;Q13698;CACNA1S;ENSG00000081248;Q13698;Voltage-dependent L-type calcium channel subunit alpha-1S (Calcium channel, L type, alpha-1 polypeptide, isoform 3, skeletal muscle) (Voltage-gated calcium channel subunit alpha Cav1.1)
drug.Protein;P25021;HRH2;ENSG00000113749;P25021;Histamine H2 receptor (H2R) (HH2R) (Gastric receptor I)
drug.Protein;P07451;CA3;ENSG00000164879;P07451;Carbonic anhydrase 3 (EC 4.2.1.1) (Carbonate dehydratase III) (Carbonic anhydrase III) (CA-III)
drug.Protein;Q15878;CACNA1E;ENSG00000198216;Q15878;Voltage-dependent R-type calcium channel subunit alpha-1E (Brain calcium channel II) (BII) (Calcium channel, L type, alpha-1 polypeptide, isoform 6) (Voltage-gated calcium channel subunit alpha Cav2.3)
drug.Protein;P27815;PDE4A;ENSG00000065989;P27815;cAMP-specific 3',5'-cyclic phosphodiesterase 4A (EC 3.1.4.53) (DPDE2) (PDE46)
drug.Protein;Q99829;CPNE1;ENSG00000214078;Q99829;Copine-1 (Chromobindin 17) (Copine I)
drug.Protein;Q8TCT9;HM13;ENSG00000101294;Q8TCT9;Minor histocompatibility antigen H13 (EC 3.4.23.-) (Intramembrane protease 1) (IMP-1) (IMPAS-1) (hIMP1) (Presenilin-like protein 3) (Signal peptide peptidase)
drug.Protein;Q15155;NOMO1;ENSG00000103512;Q15155;Nodal modulator 1 (pM5 protein)
drug.Protein;P09874;PARP1;ENSG00000143799;P09874;Poly [ADP-ribose] polymerase 1 (PARP-1) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 1) (ARTD1) (DNA ADP-ribosyltransferase PARP1) (EC 2.4.2.-) (NAD(+) ADP-ribosyltransferase 1) (ADPRT 1) (Poly[ADP-ribose] synthase 1) (Protein poly-ADP-ribosyltransferase PARP1) (EC 2.4.2.-)
drug.Protein;Q7Z5B4;RIC3;ENSG00000166405;Q7Z5B4;Protein RIC-3 (Resistant to inhibitor of cholinesterase 3)
drug.Protein;Q9Y4R7;TTLL3;ENSG00000214021;Q9Y4R7;Tubulin monoglycylase TTLL3 (EC 6.3.2.-) (HOTTL) (Tubulin--tyrosine ligase-like protein 3)
drug.Protein;P10827;THRA;ENSG00000126351;P10827;Thyroid hormone receptor alpha (Nuclear receptor subfamily 1 group A member 1) (V-erbA-related protein 7) (EAR-7) (c-erbA-1) (c-erbA-alpha)
drug.Protein;P10828;THRB;ENSG00000151090;P10828;Thyroid hormone receptor beta (Nuclear receptor subfamily 1 group A member 2) (c-erbA-2) (c-erbA-beta)
drug.Protein;P12004;PCNA;ENSG00000132646;P12004;Proliferating cell nuclear antigen (PCNA) (Cyclin)
drug.Protein;Q6ZQN7;SLCO4C1;ENSG00000173930;Q6ZQN7;Solute carrier organic anion transporter family member 4C1 (OATP-H) (Organic anion transporter M1) (OATP-M1) (Solute carrier family 21 member 20)
drug.Protein;Q96BD0;SLCO4A1;ENSG00000101187;Q96BD0;Solute carrier organic anion transporter family member 4A1 (OATP4A1) (Colon organic anion transporter) (Organic anion transporter polypeptide-related protein 1) (OATP-RP1) (OATPRP1) (POAT) (Organic anion-transporting polypeptide E) (OATP-E) (Sodium-independent organic anion transporter E) (Solute carrier family 21 member 12)
drug.Protein;Q9NZV8;KCND2;ENSG00000184408;Q9NZV8;Potassium voltage-gated channel subfamily D member 2 (Voltage-gated potassium channel subunit Kv4.2)
drug.Protein;Q9UK17;KCND3;ENSG00000171385;Q9UK17;Potassium voltage-gated channel subfamily D member 3 (Voltage-gated potassium channel subunit Kv4.3)
drug.Protein;P19652;ORM2;ENSG00000228278;P19652;Alpha-1-acid glycoprotein 2 (AGP 2) (Orosomucoid-2) (OMD 2)
drug.Protein;Q9Y5Y9;SCN10A;ENSG00000185313;Q9Y5Y9;Sodium channel protein type 10 subunit alpha (Peripheral nerve sodium channel 3) (PN3) (hPN3) (Sodium channel protein type X subunit alpha) (Voltage-gated sodium channel subunit alpha Nav1.8)
drug.Protein;Q15858;SCN9A;ENSG00000169432;Q15858;Sodium channel protein type 9 subunit alpha (Neuroendocrine sodium channel) (hNE-Na) (Peripheral sodium channel 1) (PN1) (Sodium channel protein type IX subunit alpha) (Voltage-gated sodium channel subunit alpha Nav1.7)
drug.Protein;P35499;SCN4A;ENSG00000007314;P35499;Sodium channel protein type 4 subunit alpha (SkM1) (Sodium channel protein skeletal muscle subunit alpha) (Sodium channel protein type IV subunit alpha) (Voltage-gated sodium channel subunit alpha Nav1.4)
drug.Protein;P14324;FDPS;ENSG00000160752;P14324;Farnesyl pyrophosphate synthase (FPP synthase) (FPS) (EC 2.5.1.10) ((2E,6E)-farnesyl diphosphate synthase) (Dimethylallyltranstransferase) (EC 2.5.1.1) (Farnesyl diphosphate synthase) (Geranyltranstransferase)
drug.Protein;O95749;GGPS1;ENSG00000152904;O95749;Geranylgeranyl pyrophosphate synthase (GGPP synthase) (GGPPSase) (EC 2.5.1.-) ((2E,6E)-farnesyl diphosphate synthase) (Dimethylallyltranstransferase) (EC 2.5.1.1) (Farnesyl diphosphate synthase) (Farnesyltranstransferase) (EC 2.5.1.29) (Geranylgeranyl diphosphate synthase) (Geranyltranstransferase) (EC 2.5.1.10)
drug.Protein;P42574;CASP3;ENSG00000164305;P42574;"Caspase-3 (CASP-3) (EC 3.4.22.56) (Apopain) (Cysteine protease CPP32) (CPP-32) (Protein Yama) (SREBP cleavage activity 1) (SCA-1) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12]"
drug.Protein;P55211;CASP9;ENSG00000132906;P55211;"Caspase-9 (CASP-9) (EC 3.4.22.62) (Apoptotic protease Mch-6) (Apoptotic protease-activating factor 3) (APAF-3) (ICE-like apoptotic protease 6) (ICE-LAP6) [Cleaved into: Caspase-9 subunit p35; Caspase-9 subunit p10]"
drug.Protein;O43451;MGAM;ENSG00000257335;O43451;Maltase-glucoamylase (Alpha-1,4-glucosidase) (EC 3.2.1.20)
drug.Protein;P14410;SI;ENSG00000090402;P14410;"Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]"
drug.Protein;P04746;AMY2A;ENSG00000243480;P04746;Pancreatic alpha-amylase (PA) (EC 3.2.1.1) (1,4-alpha-D-glucan glucanohydrolase)
drug.Protein;P10253;GAA;ENSG00000171298;P10253;"Lysosomal alpha-glucosidase (EC 3.2.1.20) (Acid maltase) (Aglucosidase alfa) [Cleaved into: 76 kDa lysosomal alpha-glucosidase; 70 kDa lysosomal alpha-glucosidase]"
drug.Protein;Q63ZE4;SLC22A10;ENSG00000184999;Q63ZE4;Solute carrier family 22 member 10 (Organic anion transporter 5)
drug.Protein;Q86UW1;SLC51A;ENSG00000163959;Q86UW1;Organic solute transporter subunit alpha (OST-alpha) (Solute carrier family 51 subunit alpha)
drug.Protein;Q86UW2;SLC51B;ENSG00000186198;Q86UW2;Organic solute transporter subunit beta (OST-beta) (Solute carrier family 51 subunit beta)
drug.Protein;Q9UIG8;SLCO3A1;ENSG00000176463;Q9UIG8;Solute carrier organic anion transporter family member 3A1 (OATP3A1) (Organic anion transporter polypeptide-related protein 3) (OATP-RP3) (OATPRP3) (Organic anion-transporting polypeptide D) (OATP-D) (PGE1 transporter) (Sodium-independent organic anion transporter D) (Solute carrier family 21 member 11)
drug.Protein;P43088;PTGFR;ENSG00000122420;P43088;Prostaglandin F2-alpha receptor (PGF receptor) (PGF2-alpha receptor) (Prostanoid FP receptor)
drug.Protein;P04083;ANXA1;ENSG00000135046;P04083;Annexin A1 (Annexin I) (Annexin-1) (Calpactin II) (Calpactin-2) (Chromobindin-9) (Lipocortin I) (Phospholipase A2 inhibitory protein) (p35) [Cleaved into: Annexin Ac2-26]
drug.Protein;P48549;KCNJ3;ENSG00000162989;P48549;G protein-activated inward rectifier potassium channel 1 (GIRK-1) (Inward rectifier K(+) channel Kir3.1) (Potassium channel, inwardly rectifying subfamily J member 3)
drug.Protein;P18858;LIG1;ENSG00000105486;P18858;DNA ligase 1 (EC 6.5.1.1) (DNA ligase I) (Polydeoxyribonucleotide synthase [ATP] 1)
drug.Protein;P49916;LIG3;ENSG00000005156;P49916;DNA ligase 3 (EC 6.5.1.1) (DNA ligase III) (Polydeoxyribonucleotide synthase [ATP] 3)
drug.Protein;Q13867;BLMH;ENSG00000108578;Q13867;Bleomycin hydrolase (BH) (BLM hydrolase) (BMH) (EC 3.4.22.40)
drug.Protein;P19099;CYP11B2;ENSG00000179142;P19099;Cytochrome P450 11B2, mitochondrial (Aldosterone synthase) (ALDOS) (Aldosterone-synthesizing enzyme) (CYPXIB2) (Corticosterone 18-monooxygenase, CYP11B2) (EC 1.14.15.5) (Cytochrome P-450Aldo) (Cytochrome P-450C18) (Steroid 11-beta-hydroxylase, CYP11B2) (EC 1.14.15.4) (Steroid 18-hydroxylase)
drug.Protein;P04818;TYMS;ENSG00000176890;P04818;Thymidylate synthase (TS) (TSase) (EC 2.1.1.45)
drug.Protein;P06401;PGR;ENSG00000082175;P06401;Progesterone receptor (PR) (Nuclear receptor subfamily 3 group C member 3)
drug.Protein;Q9Y6Y9;LY96;ENSG00000154589;Q9Y6Y9;Lymphocyte antigen 96 (Ly-96) (ESOP-1) (Protein MD-2)
drug.Protein;P06133;UGT2B4;ENSG00000156096;P06133;UDP-glucuronosyltransferase 2B4 (UDPGT 2B4) (UGT2B4) (EC 2.4.1.17) (HLUG25) (Hyodeoxycholic acid-specific UDPGT) (UDPGTh-1)
drug.Protein;P34995;PTGER1;ENSG00000160951;P34995;Prostaglandin E2 receptor EP1 subtype (PGE receptor EP1 subtype) (PGE2 receptor EP1 subtype) (Prostanoid EP1 receptor)
drug.Protein;P54819;AK2;ENSG00000004455;P54819;Adenylate kinase 2, mitochondrial (AK 2) (EC 2.7.4.3) (ATP-AMP transphosphorylase 2) (ATP:AMP phosphotransferase) (Adenylate monophosphate kinase) [Cleaved into: Adenylate kinase 2, mitochondrial, N-terminally processed]
drug.Protein;P27144;AK4;ENSG00000162433;P27144;Adenylate kinase 4, mitochondrial (AK 4) (EC 2.7.4.10) (EC 2.7.4.6) (Adenylate kinase 3-like) (GTP:AMP phosphotransferase AK4)
drug.Protein;Q02641;CACNB1;ENSG00000067191;Q02641;Voltage-dependent L-type calcium channel subunit beta-1 (CAB1) (Calcium channel voltage-dependent subunit beta 1)
drug.Protein;Q06432;CACNG1;ENSG00000108878;Q06432;Voltage-dependent calcium channel gamma-1 subunit (Dihydropyridine-sensitive L-type, skeletal muscle calcium channel subunit gamma)
drug.Protein;O00180;KCNK1;ENSG00000135750;O00180;Potassium channel subfamily K member 1 (Inward rectifying potassium channel protein TWIK-1) (Potassium channel K2P1) (Potassium channel KCNO1)
drug.Protein;Q9Y257;KCNK6;ENSG00000099337;Q9Y257;Potassium channel subfamily K member 6 (Inward rectifying potassium channel protein TWIK-2) (TWIK-originated similarity sequence)
drug.Protein;Q9H252;KCNH6;ENSG00000173826;Q9H252;Potassium voltage-gated channel subfamily H member 6 (Ether-a-go-go-related gene potassium channel 2) (ERG-2) (Eag-related protein 2) (Ether-a-go-go-related protein 2) (hERG-2) (hERG2) (Voltage-gated potassium channel subunit Kv11.2)
drug.Protein;Q9NS40;KCNH7;ENSG00000184611;Q9NS40;Potassium voltage-gated channel subfamily H member 7 (Ether-a-go-go-related gene potassium channel 3) (ERG-3) (Eag-related protein 3) (Ether-a-go-go-related protein 3) (hERG-3) (Voltage-gated potassium channel subunit Kv11.3)
drug.Protein;Q9H4B7;TUBB1;ENSG00000101162;Q9H4B7;Tubulin beta-1 chain
drug.Protein;P43166;CA7;ENSG00000168748;P43166;Carbonic anhydrase 7 (EC 4.2.1.1) (Carbonate dehydratase VII) (Carbonic anhydrase VII) (CA-VII)
drug.Protein;Q9UKV0;HDAC9;ENSG00000048052;Q9UKV0;Histone deacetylase 9 (HD9) (EC 3.5.1.98) (Histone deacetylase 7B) (HD7) (HD7b) (Histone deacetylase-related protein) (MEF2-interacting transcription repressor MITR)
drug.Protein;Q15185;PTGES3;ENSG00000110958;Q15185;Prostaglandin E synthase 3 (EC 5.3.99.3) (Cytosolic prostaglandin E2 synthase) (cPGES) (Hsp90 co-chaperone) (Progesterone receptor complex p23) (Telomerase-binding protein p23)
drug.Protein;P50225;SULT1A1;ENSG00000196502;P50225;Sulfotransferase 1A1 (ST1A1) (EC 2.8.2.1) (Aryl sulfotransferase 1) (HAST1/HAST2) (Phenol sulfotransferase 1) (Phenol-sulfating phenol sulfotransferase 1) (P-PST 1) (ST1A3) (Thermostable phenol sulfotransferase) (Ts-PST)
drug.Protein;P0DMM9;SULT1A3;ENSG00000261052;P0DMM9;Sulfotransferase 1A3 (ST1A3) (EC 2.8.2.1) (Aryl sulfotransferase 1A3/1A4) (Catecholamine-sulfating phenol sulfotransferase) (HAST3) (M-PST) (Monoamine-sulfating phenol sulfotransferase) (Placental estrogen sulfotransferase) (Sulfotransferase 1A3/1A4) (Sulfotransferase, monoamine-preferring) (Thermolabile phenol sulfotransferase) (TL-PST)
drug.Protein;O00519;FAAH;ENSG00000117480;O00519;Fatty-acid amide hydrolase 1 (EC 3.5.1.99) (Anandamide amidohydrolase 1) (Fatty acid ester hydrolase) (EC 3.1.1.-) (Oleamide hydrolase 1)
drug.Protein;Q13639;HTR4;ENSG00000164270;Q13639;5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4)
drug.Protein;P13945;ADRB3;ENSG00000188778;P13945;Beta-3 adrenergic receptor (Beta-3 adrenoreceptor) (Beta-3 adrenoceptor)
drug.Protein;P04629;NTRK1;ENSG00000198400;P04629;High affinity nerve growth factor receptor (EC 2.7.10.1) (Neurotrophic tyrosine kinase receptor type 1) (TRK1-transforming tyrosine kinase protein) (Tropomyosin-related kinase A) (Tyrosine kinase receptor) (Tyrosine kinase receptor A) (Trk-A) (gp140trk) (p140-TrkA)
drug.Protein;Q16620;NTRK2;ENSG00000148053;Q16620;BDNF/NT-3 growth factors receptor (EC 2.7.10.1) (GP145-TrkB) (Trk-B) (Neurotrophic tyrosine kinase receptor type 2) (TrkB tyrosine kinase) (Tropomyosin-related kinase B)
drug.Protein;O43526;KCNQ2;ENSG00000075043;O43526;Potassium voltage-gated channel subfamily KQT member 2 (KQT-like 2) (Neuroblastoma-specific potassium channel subunit alpha KvLQT2) (Voltage-gated potassium channel subunit Kv7.2)
drug.Protein;Q09470;KCNA1;ENSG00000111262;Q09470;Potassium voltage-gated channel subfamily A member 1 (Voltage-gated K(+) channel HuKI) (Voltage-gated potassium channel HBK1) (Voltage-gated potassium channel subunit Kv1.1)
drug.Protein;Q9H3N8;HRH4;ENSG00000134489;Q9H3N8;Histamine H4 receptor (H4R) (HH4R) (AXOR35) (G-protein coupled receptor 105) (GPRv53) (Pfi-013) (SP9144)
drug.Protein;Q99720;SIGMAR1;ENSG00000147955;Q99720;Sigma non-opioid intracellular receptor 1 (Aging-associated gene 8 protein) (SR31747-binding protein) (SR-BP) (Sigma 1-type opioid receptor) (SIG-1R) (Sigma1-receptor) (Sigma1R) (hSigmaR1)
drug.Protein;O43525;KCNQ3;ENSG00000184156;O43525;Potassium voltage-gated channel subfamily KQT member 3 (KQT-like 3) (Potassium channel subunit alpha KvLQT3) (Voltage-gated potassium channel subunit Kv7.3)
drug.Protein;P36537;UGT2B10;ENSG00000109181;P36537;UDP-glucuronosyltransferase 2B10 (UDPGT 2B10) (EC 2.4.1.17)
drug.Protein;P19971;TYMP;ENSG00000025708;P19971;Thymidine phosphorylase (TP) (EC 2.4.2.4) (Gliostatin) (Platelet-derived endothelial cell growth factor) (PD-ECGF) (TdRPase)
drug.Protein;P16066;NPR1;ENSG00000169418;P16066;Atrial natriuretic peptide receptor 1 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type A) (ANP-A) (ANPR-A) (NPR-A) (Guanylate cyclase A) (GC-A)
drug.Protein;P14555;PLA2G2A;ENSG00000188257;P14555;Phospholipase A2, membrane associated (EC 3.1.1.4) (GIIC sPLA2) (Group IIA phospholipase A2) (Non-pancreatic secretory phospholipase A2) (NPS-PLA2) (Phosphatidylcholine 2-acylhydrolase 2A)
drug.Protein;Q8N8N7;PTGR2;ENSG00000140043;Q8N8N7;Prostaglandin reductase 2 (PRG-2) (EC 1.3.1.48) (15-oxoprostaglandin 13-reductase) (Zinc-binding alcohol dehydrogenase domain-containing protein 1)
drug.Protein;Q9Y5Y4;PTGDR2;ENSG00000183134;Q9Y5Y4;Prostaglandin D2 receptor 2 (Chemoattractant receptor-homologous molecule expressed on Th2 cells) (G-protein coupled receptor 44) (CD antigen CD294)
drug.Protein;P19525;EIF2AK2;ENSG00000055332;P19525;Interferon-induced, double-stranded RNA-activated protein kinase (EC 2.7.11.1) (Eukaryotic translation initiation factor 2-alpha kinase 2) (eIF-2A protein kinase 2) (Interferon-inducible RNA-dependent protein kinase) (P1/eIF-2A protein kinase) (Protein kinase RNA-activated) (PKR) (Protein kinase R) (Tyrosine-protein kinase EIF2AK2) (EC 2.7.10.2) (p68 kinase)
drug.Protein;Q16134;ETFDH;ENSG00000171503;Q16134;Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial (ETF-QO) (ETF-ubiquinone oxidoreductase) (EC 1.5.5.1) (Electron-transferring-flavoprotein dehydrogenase) (ETF dehydrogenase)
drug.Protein;Q7RTT9;SLC29A4;ENSG00000164638;Q7RTT9;Equilibrative nucleoside transporter 4 (hENT4) (Plasma membrane monoamine transporter) (Solute carrier family 29 member 4)
drug.Protein;P46098;HTR3A;ENSG00000166736;P46098;5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)
drug.Protein;P42345;MTOR;ENSG00000198793;P42345;Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin and FKBP12 target 1) (Rapamycin target protein 1)
drug.Protein;P62942;FKBP1A;ENSG00000088832;P62942;Peptidyl-prolyl cis-trans isomerase FKBP1A (PPIase FKBP1A) (EC 5.2.1.8) (12 kDa FK506-binding protein) (12 kDa FKBP) (FKBP-12) (Calstabin-1) (FK506-binding protein 1A) (FKBP-1A) (Immunophilin FKBP12) (Rotamase)
drug.Protein;P35869;AHR;ENSG00000106546;P35869;Aryl hydrocarbon receptor (Ah receptor) (AhR) (Class E basic helix-loop-helix protein 76) (bHLHe76)
drug.Protein;O43497;CACNA1G;ENSG00000006283;O43497;Voltage-dependent T-type calcium channel subunit alpha-1G (Cav3.1c) (NBR13) (Voltage-gated calcium channel subunit alpha Cav3.1)
drug.Protein;P32754;HPD;ENSG00000158104;P32754;4-hydroxyphenylpyruvate dioxygenase (EC 1.13.11.27) (4-hydroxyphenylpyruvic acid oxidase) (4HPPD) (HPD) (HPPDase)
drug.Protein;P00492;HPRT1;ENSG00000165704;P00492;Hypoxanthine-guanine phosphoribosyltransferase (HGPRT) (HGPRTase) (EC 2.4.2.8)
drug.Protein;Q12791;KCNMA1;ENSG00000156113;Q12791;Calcium-activated potassium channel subunit alpha-1 (BK channel) (BKCA alpha) (Calcium-activated potassium channel, subfamily M subunit alpha-1) (K(VCA)alpha) (KCa1.1) (Maxi K channel) (MaxiK) (Slo-alpha) (Slo1) (Slowpoke homolog) (Slo homolog) (hSlo)
drug.Protein;P07437;TUBB;ENSG00000196230;P07437;Tubulin beta chain (Tubulin beta-5 chain)
drug.Protein;Q9NYX4;CALY;ENSG00000130643;Q9NYX4;Neuron-specific vesicular protein calcyon
drug.Protein;P0DJD9;PGA5;ENSG00000256713;P0DJD9;Pepsin A-5 (EC 3.4.23.1) (Pepsinogen-5)
drug.Protein;P09038;FGF2;ENSG00000138685;P09038;Fibroblast growth factor 2 (FGF-2) (Basic fibroblast growth factor) (bFGF) (Heparin-binding growth factor 2) (HBGF-2)
drug.Protein;P01133;EGF;ENSG00000138798;P01133;Pro-epidermal growth factor (EGF) [Cleaved into: Epidermal growth factor (Urogastrone)]
drug.Protein;Q14994;NR1I3;ENSG00000143257;Q14994;Nuclear receptor subfamily 1 group I member 3 (Constitutive activator of retinoid response) (Constitutive active response) (Constitutive androstane receptor) (CAR) (Orphan nuclear receptor MB67)
drug.Protein;Q14097;;;;
drug.Protein;P18405;SRD5A1;ENSG00000145545;P18405;3-oxo-5-alpha-steroid 4-dehydrogenase 1 (EC 1.3.1.22) (SR type 1) (Steroid 5-alpha-reductase 1) (S5AR 1)
drug.Protein;Q01860;POU5F1;ENSG00000204531;Q01860;POU domain, class 5, transcription factor 1 (Octamer-binding protein 3) (Oct-3) (Octamer-binding protein 4) (Oct-4) (Octamer-binding transcription factor 3) (OTF-3)
drug.Protein;Q9UE69;;;;
drug.Protein;P43119;PTGIR;ENSG00000160013;P43119;Prostacyclin receptor (Prostaglandin I2 receptor) (PGI receptor) (PGI2 receptor) (Prostanoid IP receptor)
drug.Protein;Q02880;TOP2B;ENSG00000077097;Q02880;DNA topoisomerase 2-beta (EC 5.6.2.2) (DNA topoisomerase II, beta isozyme)
drug.Protein;Q00975;CACNA1B;ENSG00000148408;Q00975;Voltage-dependent N-type calcium channel subunit alpha-1B (Brain calcium channel III) (BIII) (Calcium channel, L type, alpha-1 polypeptide isoform 5) (Voltage-gated calcium channel subunit alpha Cav2.2)
drug.Protein;Q8IZS8;CACNA2D3;ENSG00000157445;Q8IZS8;"Voltage-dependent calcium channel subunit alpha-2/delta-3 (Voltage-gated calcium channel subunit alpha-2/delta-3) [Cleaved into: Voltage-dependent calcium channel subunit alpha-2-3; Voltage-dependent calcium channel subunit delta-3]"
drug.Protein;P17405;SMPD1;ENSG00000166311;P17405;Sphingomyelin phosphodiesterase (EC 3.1.4.12) (EC 3.1.4.3) (Acid sphingomyelinase) (aSMase)
drug.Protein;Q9P0X4;CACNA1I;ENSG00000100346;Q9P0X4;Voltage-dependent T-type calcium channel subunit alpha-1I (Voltage-gated calcium channel subunit alpha Cav3.3) (Ca(v)3.3)
drug.Protein;P51170;SCNN1G;ENSG00000166828;P51170;Amiloride-sensitive sodium channel subunit gamma (Epithelial Na(+) channel subunit gamma) (ENaCG) (Gamma-ENaC) (Gamma-NaCH) (Nonvoltage-gated sodium channel 1 subunit gamma) (SCNEG)
drug.Protein;P37088;SCNN1A;ENSG00000111319;P37088;Amiloride-sensitive sodium channel subunit alpha (Alpha-NaCH) (Epithelial Na(+) channel subunit alpha) (Alpha-ENaC) (ENaCA) (Nonvoltage-gated sodium channel 1 subunit alpha) (SCNEA)
drug.Protein;P51168;SCNN1B;ENSG00000168447;P51168;Amiloride-sensitive sodium channel subunit beta (Beta-NaCH) (Epithelial Na(+) channel subunit beta) (Beta-ENaC) (ENaCB) (Nonvoltage-gated sodium channel 1 subunit beta) (SCNEB)
drug.Protein;P51172;SCNN1D;ENSG00000162572;P51172;Amiloride-sensitive sodium channel subunit delta (Delta-NaCH) (Epithelial Na(+) channel subunit delta) (Delta-ENaC) (ENaCD) (Nonvoltage-gated sodium channel 1 subunit delta) (SCNED)
drug.Protein;P07202;TPO;ENSG00000115705;P07202;Thyroid peroxidase (TPO) (EC 1.11.1.8)
drug.Protein;P05023;ATP1A1;ENSG00000163399;P05023;Sodium/potassium-transporting ATPase subunit alpha-1 (Na(+)/K(+) ATPase alpha-1 subunit) (EC 7.2.2.13) (Sodium pump subunit alpha-1)
drug.Protein;O60840;CACNA1F;ENSG00000102001;O60840;Voltage-dependent L-type calcium channel subunit alpha-1F (Voltage-gated calcium channel subunit alpha Cav1.4)
drug.Protein;P54284;CACNB3;ENSG00000167535;P54284;Voltage-dependent L-type calcium channel subunit beta-3 (CAB3) (Calcium channel voltage-dependent subunit beta 3)
drug.Protein;O00305;CACNB4;ENSG00000182389;O00305;Voltage-dependent L-type calcium channel subunit beta-4 (CAB4) (Calcium channel voltage-dependent subunit beta 4)
drug.Protein;P08235;NR3C2;ENSG00000151623;P08235;Mineralocorticoid receptor (MR) (Nuclear receptor subfamily 3 group C member 2)
drug.Protein;P47870;GABRB2;ENSG00000145864;P47870;Gamma-aminobutyric acid receptor subunit beta-2 (GABA(A) receptor subunit beta-2)
drug.Protein;P18507;GABRG2;ENSG00000113327;P18507;Gamma-aminobutyric acid receptor subunit gamma-2 (GABA(A) receptor subunit gamma-2)
drug.Protein;P15056;BRAF;ENSG00000157764;P15056;Serine/threonine-protein kinase B-raf (EC 2.7.11.1) (Proto-oncogene B-Raf) (p94) (v-Raf murine sarcoma viral oncogene homolog B1)
drug.Protein;P04049;RAF1;ENSG00000132155;P04049;RAF proto-oncogene serine/threonine-protein kinase (EC 2.7.11.1) (Proto-oncogene c-RAF) (cRaf) (Raf-1)
drug.Protein;P35916;FLT4;ENSG00000037280;P35916;Vascular endothelial growth factor receptor 3 (VEGFR-3) (EC 2.7.10.1) (Fms-like tyrosine kinase 4) (FLT-4) (Tyrosine-protein kinase receptor FLT4)
drug.Protein;P35968;KDR;ENSG00000128052;P35968;Vascular endothelial growth factor receptor 2 (VEGFR-2) (EC 2.7.10.1) (Fetal liver kinase 1) (FLK-1) (Kinase insert domain receptor) (KDR) (Protein-tyrosine kinase receptor flk-1) (CD antigen CD309)
drug.Protein;P36888;FLT3;ENSG00000122025;P36888;Receptor-type tyrosine-protein kinase FLT3 (EC 2.7.10.1) (FL cytokine receptor) (Fetal liver kinase-2) (FLK-2) (Fms-like tyrosine kinase 3) (FLT-3) (Stem cell tyrosine kinase 1) (STK-1) (CD antigen CD135)
drug.Protein;P10721;KIT;ENSG00000157404;P10721;Mast/stem cell growth factor receptor Kit (SCFR) (EC 2.7.10.1) (Piebald trait protein) (PBT) (Proto-oncogene c-Kit) (Tyrosine-protein kinase Kit) (p145 c-kit) (v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog) (CD antigen CD117)
drug.Protein;P07949;RET;ENSG00000165731;P07949;"Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) (Cadherin family member 12) (Proto-oncogene c-Ret) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment]"
drug.Protein;P17948;FLT1;ENSG00000102755;P17948;Vascular endothelial growth factor receptor 1 (VEGFR-1) (EC 2.7.10.1) (Fms-like tyrosine kinase 1) (FLT-1) (Tyrosine-protein kinase FRT) (Tyrosine-protein kinase receptor FLT) (FLT) (Vascular permeability factor receptor)
drug.Protein;Q15311;RALBP1;ENSG00000017797;Q15311;RalA-binding protein 1 (RalBP1) (76 kDa Ral-interacting protein) (Dinitrophenyl S-glutathione ATPase) (DNP-SG ATPase) (EC 7.6.2.2, EC 7.6.2.3) (Ral-interacting protein 1)
drug.Protein;Q99456;KRT12;ENSG00000187242;Q99456;Keratin, type I cytoskeletal 12 (Cytokeratin-12) (CK-12) (Keratin-12) (K12)
drug.Protein;P32238;CCKAR;ENSG00000163394;P32238;Cholecystokinin receptor type A (CCK-A receptor) (CCK-AR) (Cholecystokinin-1 receptor) (CCK1-R)
drug.Protein;P01008;SERPINC1;ENSG00000117601;P01008;Antithrombin-III (ATIII) (Serpin C1)
drug.Protein;P05546;SERPIND1;ENSG00000099937;P05546;Heparin cofactor 2 (Heparin cofactor II) (HC-II) (Protease inhibitor leuserpin-2) (HLS2) (Serpin D1)
drug.Protein;P16152;CBR1;ENSG00000159228;P16152;Carbonyl reductase [NADPH] 1 (EC 1.1.1.184) (15-hydroxyprostaglandin dehydrogenase [NADP(+)]) (EC 1.1.1.196, EC 1.1.1.197) (20-beta-hydroxysteroid dehydrogenase) (Alcohol dehydrogenase [NAD(P)+] CBR1) (EC 1.1.1.71) (NADPH-dependent carbonyl reductase 1) (Prostaglandin 9-ketoreductase) (PG-9-KR) (Prostaglandin-E(2) 9-reductase) (EC 1.1.1.189) (Short chain dehydrogenase/reductase family 21C member 1)
drug.Protein;Q02763;TEK;ENSG00000120156;Q02763;Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (Tunica interna endothelial cell kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TEK) (Tyrosine-protein kinase receptor TIE-2) (hTIE2) (p140 TEK) (CD antigen CD202b)
drug.Protein;Q16739;UGCG;ENSG00000148154;Q16739;Ceramide glucosyltransferase (EC 2.4.1.80) (GLCT-1) (Glucosylceramide synthase) (GCS) (Glycosylceramide synthase) (UDP-glucose ceramide glucosyltransferase) (UDP-glucose:N-acylsphingosine D-glucosyltransferase)
drug.Protein;Q6LAP9;;;;
drug.Protein;P11168;SLC2A2;ENSG00000163581;P11168;Solute carrier family 2, facilitated glucose transporter member 2 (Glucose transporter type 2, liver) (GLUT-2)
drug.Protein;O60502;OGA;ENSG00000198408;O60502;Protein O-GlcNAcase (OGA) (EC 3.2.1.169) (Beta-N-acetylglucosaminidase) (Beta-N-acetylhexosaminidase) (Beta-hexosaminidase) (Meningioma-expressed antigen 5) (N-acetyl-beta-D-glucosaminidase) (N-acetyl-beta-glucosaminidase) (Nuclear cytoplasmic O-GlcNAcase and acetyltransferase) (NCOAT)
drug.Protein;P18505;GABRB1;ENSG00000163288;P18505;Gamma-aminobutyric acid receptor subunit beta-1 (GABA(A) receptor subunit beta-1)
drug.Protein;P28472;GABRB3;ENSG00000166206;P28472;Gamma-aminobutyric acid receptor subunit beta-3 (GABA(A) receptor subunit beta-3)
drug.Protein;P24046;GABRR1;ENSG00000146276;P24046;Gamma-aminobutyric acid receptor subunit rho-1 (GABA(A) receptor subunit rho-1) (GABA(C) receptor)
drug.Protein;P04183;TK1;ENSG00000167900;P04183;Thymidine kinase, cytosolic (EC 2.7.1.21)
drug.Protein;O00337;SLC28A1;ENSG00000156222;O00337;Sodium/nucleoside cotransporter 1 (Concentrative nucleoside transporter 1) (CNT 1) (hCNT1) (Na(+)/nucleoside cotransporter 1) (Sodium-coupled nucleoside transporter 1) (Solute carrier family 28 member 1)
drug.Protein;Q14542;SLC29A2;ENSG00000174669;Q14542;Equilibrative nucleoside transporter 2 (36 kDa nucleolar protein HNP36) (Delayed-early response protein 12) (Equilibrative nitrobenzylmercaptopurine riboside-insensitive nucleoside transporter) (Equilibrative NBMPR-insensitive nucleoside transporter) (Hydrophobic nucleolar protein, 36 kDa) (Nucleoside transporter, ei-type) (Solute carrier family 29 member 2)
drug.Protein;P33402;GUCY1A2;ENSG00000152402;P33402;Guanylate cyclase soluble subunit alpha-2 (GCS-alpha-2) (EC 4.6.1.2)
drug.Protein;P04731;MT1A;ENSG00000205362;P04731;Metallothionein-1A (MT-1A) (Metallothionein-IA) (MT-IA)
drug.Protein;P55017;SLC12A3;ENSG00000070915;P55017;Solute carrier family 12 member 3 (Na-Cl cotransporter) (NCC) (Na-Cl symporter) (Thiazide-sensitive sodium-chloride cotransporter)
drug.Protein;P51580;TPMT;ENSG00000137364;P51580;Thiopurine S-methyltransferase (EC 2.1.1.67) (Thiopurine methyltransferase)
drug.Protein;P30085;CMPK1;ENSG00000162368;P30085;UMP-CMP kinase (EC 2.7.4.14) (Deoxycytidylate kinase) (CK) (dCMP kinase) (Nucleoside-diphosphate kinase) (EC 2.7.4.6) (Uridine monophosphate/cytidine monophosphate kinase) (UMP/CMP kinase) (UMP/CMPK)
drug.Protein;P32320;CDA;ENSG00000158825;P32320;Cytidine deaminase (EC 3.5.4.5) (Cytidine aminohydrolase)
drug.Protein;O00142;TK2;ENSG00000166548;O00142;Thymidine kinase 2, mitochondrial (EC 2.7.1.21) (2'-deoxyuridine kinase TK2) (EC 2.7.1.74) (Deoxycytidine kinase TK2) (EC 2.7.1.-) (Mt-TK)
drug.Protein;P15531;NME1;ENSG00000239672;P15531;Nucleoside diphosphate kinase A (NDK A) (NDP kinase A) (EC 2.7.4.6) (Granzyme A-activated DNase) (GAAD) (Metastasis inhibition factor nm23) (NM23-H1) (Tumor metastatic process-associated protein)
drug.Protein;P08174;CD55;ENSG00000196352;P08174;Complement decay-accelerating factor (CD antigen CD55)
drug.Protein;P10636;MAPT;ENSG00000186868;P10636;Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau)
drug.Protein;P61073;CXCR4;ENSG00000121966;P61073;C-X-C chemokine receptor type 4 (CXC-R4) (CXCR-4) (FB22) (Fusin) (HM89) (LCR1) (Leukocyte-derived seven transmembrane domain receptor) (LESTR) (Lipopolysaccharide-associated protein 3) (LAP-3) (LPS-associated protein 3) (NPYRL) (Stromal cell-derived factor 1 receptor) (SDF-1 receptor) (CD antigen CD184)
drug.Protein;O95259;KCNH1;ENSG00000143473;O95259;Potassium voltage-gated channel subfamily H member 1 (Ether-a-go-go potassium channel 1) (EAG channel 1) (h-eag) (hEAG1) (Voltage-gated potassium channel subunit Kv10.1)
drug.Protein;P14770;GP9;ENSG00000169704;P14770;Platelet glycoprotein IX (GP-IX) (GPIX) (Glycoprotein 9) (CD antigen CD42a)
drug.Protein;P21554;CNR1;ENSG00000118432;P21554;Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)
drug.Protein;P34972;CNR2;ENSG00000188822;P34972;Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5)
drug.Protein;Q9Y271;CYSLTR1;ENSG00000173198;Q9Y271;Cysteinyl leukotriene receptor 1 (CysLTR1) (Cysteinyl leukotriene D4 receptor) (LTD4 receptor) (G-protein coupled receptor HG55) (HMTMF81)
drug.Protein;P61024;CKS1B;ENSG00000173207;P61024;Cyclin-dependent kinases regulatory subunit 1 (CKS-1)
drug.Protein;P0DP23;CALM1;ENSG00000198668;P0DP23;Calmodulin-1
drug.Protein;Q96SW2;CRBN;ENSG00000113851;Q96SW2;Protein cereblon
drug.Protein;O14788;TNFSF11;ENSG00000120659;O14788;"Tumor necrosis factor ligand superfamily member 11 (Osteoclast differentiation factor) (ODF) (Osteoprotegerin ligand) (OPGL) (Receptor activator of nuclear factor kappa-B ligand) (RANKL) (TNF-related activation-induced cytokine) (TRANCE) (CD antigen CD254) [Cleaved into: Tumor necrosis factor ligand superfamily member 11, membrane form; Tumor necrosis factor ligand superfamily member 11, soluble form]"
drug.Protein;P33151;CDH5;ENSG00000179776;P33151;Cadherin-5 (7B4 antigen) (Vascular endothelial cadherin) (VE-cadherin) (CD antigen CD144)
drug.Protein;P50453;SERPINB9;ENSG00000170542;P50453;Serpin B9 (Cytoplasmic antiproteinase 3) (CAP-3) (CAP3) (Peptidase inhibitor 9) (PI-9)
drug.Protein;P04155;TFF1;ENSG00000160182;P04155;Trefoil factor 1 (Breast cancer estrogen-inducible protein) (PNR-2) (Polypeptide P1.A) (hP1.A) (Protein pS2)
drug.Protein;O15530;PDPK1;ENSG00000140992;O15530;3-phosphoinositide-dependent protein kinase 1 (hPDK1) (EC 2.7.11.1)
drug.Protein;H3BUU9;;;;
drug.Protein;Q14697;GANAB;ENSG00000089597;Q14697;Neutral alpha-glucosidase AB (EC 3.2.1.207) (Alpha-glucosidase 2) (Glucosidase II subunit alpha)
drug.Protein;Q8TET4;GANC;ENSG00000214013;Q8TET4;Neutral alpha-glucosidase C (EC 3.2.1.20)
drug.Protein;O14746;TERT;ENSG00000164362;O14746;Telomerase reverse transcriptase (EC 2.7.7.49) (HEST2) (Telomerase catalytic subunit) (Telomerase-associated protein 2) (TP2)
drug.Protein;Q99705;MCHR1;ENSG00000128285;Q99705;Melanin-concentrating hormone receptor 1 (MCH receptor 1) (MCH-R1) (MCHR-1) (G-protein coupled receptor 24) (MCH-1R) (MCH1R) (MCHR) (SLC-1) (Somatostatin receptor-like protein)
drug.Protein;P00750;PLAT;ENSG00000104368;P00750;"Tissue-type plasminogen activator (t-PA) (t-plasminogen activator) (tPA) (EC 3.4.21.68) (Alteplase) (Reteplase) [Cleaved into: Tissue-type plasminogen activator chain A; Tissue-type plasminogen activator chain B]"
drug.Protein;P08519;LPA;ENSG00000198670;P08519;Apolipoprotein(a) (Apo(a)) (Lp(a)) (EC 3.4.21.-)
drug.Protein;Q5T1J1;;;;
drug.Protein;O00264;PGRMC1;ENSG00000101856;O00264;Membrane-associated progesterone receptor component 1 (mPR) (Dap1) (IZA)
drug.Protein;O75795;UGT2B17;ENSG00000197888;O75795;UDP-glucuronosyltransferase 2B17 (UDPGT 2B17) (UGT2B17) (EC 2.4.1.17) (C19-steroid-specific UDP-glucuronosyltransferase) (C19-steroid-specific UDPGT)
drug.Protein;P29372;MPG;ENSG00000103152;P29372;DNA-3-methyladenine glycosylase (EC 3.2.2.21) (3-alkyladenine DNA glycosylase) (3-methyladenine DNA glycosidase) (ADPG) (N-methylpurine-DNA glycosylase)
drug.Protein;P02787;TF;ENSG00000091513;P02787;Serotransferrin (Transferrin) (Beta-1 metal-binding globulin) (Siderophilin)
drug.Protein;O00244;ATOX1;ENSG00000177556;O00244;Copper transport protein ATOX1 (Metal transport protein ATX1)
drug.Protein;P02795;MT2A;ENSG00000125148;P02795;Metallothionein-2 (MT-2) (Metallothionein-2A) (Metallothionein-II) (MT-II)
drug.Protein;O15431;SLC31A1;ENSG00000136868;O15431;High affinity copper uptake protein 1 (Copper transporter 1) (hCTR1) (Solute carrier family 31 member 1)
drug.Protein;O15432;SLC31A2;ENSG00000136867;O15432;Probable low affinity copper uptake protein 2 (Copper transporter 2) (hCTR2) (Solute carrier family 31 member 2)
drug.Protein;P35670;ATP7B;ENSG00000123191;P35670;Copper-transporting ATPase 2 (EC 7.2.2.8) (Copper pump 2) (Wilson disease-associated protein) [Cleaved into: WND/140 kDa]
drug.Protein;Q04656;ATP7A;ENSG00000165240;Q04656;Copper-transporting ATPase 1 (EC 7.2.2.8) (Copper pump 1) (Menkes disease-associated protein)
drug.Protein;Q71U36;TUBA1A;ENSG00000167552;Q71U36;Tubulin alpha-1A chain (Alpha-tubulin 3) (Tubulin B-alpha-1) (Tubulin alpha-3 chain) [Cleaved into: Detyrosinated tubulin alpha-1A chain]
drug.Protein;P68371;TUBB4B;ENSG00000188229;P68371;Tubulin beta-4B chain (Tubulin beta-2 chain) (Tubulin beta-2C chain)
drug.Protein;P05981;HPN;ENSG00000105707;P05981;"Serine protease hepsin (EC 3.4.21.106) (Transmembrane protease serine 1) [Cleaved into: Serine protease hepsin non-catalytic chain; Serine protease hepsin catalytic chain]"
drug.Protein;P17936;IGFBP3;ENSG00000146674;P17936;Insulin-like growth factor-binding protein 3 (IBP-3) (IGF-binding protein 3) (IGFBP-3)
drug.Protein;Q15238;PSG5;ENSG00000204941;Q15238;Pregnancy-specific beta-1-glycoprotein 5 (PS-beta-G-5) (PSBG-5) (Pregnancy-specific glycoprotein 5) (Fetal liver non-specific cross-reactive antigen 3) (FL-NCA-3)
drug.Protein;Q6V0L0;CYP26C1;ENSG00000187553;Q6V0L0;Cytochrome P450 26C1 (EC 1.14.-.-)
drug.Protein;P29373;CRABP2;ENSG00000143320;P29373;Cellular retinoic acid-binding protein 2 (Cellular retinoic acid-binding protein II) (CRABP-II)
drug.Protein;P29762;CRABP1;ENSG00000166426;P29762;Cellular retinoic acid-binding protein 1 (Cellular retinoic acid-binding protein I) (CRABP-I)
drug.Protein;P15502;ELN;ENSG00000049540;P15502;Elastin (Tropoelastin)
drug.Protein;P78352;DLG4;ENSG00000132535;P78352;Disks large homolog 4 (Postsynaptic density protein 95) (PSD-95) (Synapse-associated protein 90) (SAP-90) (SAP90)
drug.Protein;P68366;TUBA4A;ENSG00000127824;P68366;Tubulin alpha-4A chain (Alpha-tubulin 1) (Testis-specific alpha-tubulin) (Tubulin H2-alpha) (Tubulin alpha-1 chain)
drug.Protein;Q12882;DPYD;ENSG00000188641;Q12882;Dihydropyrimidine dehydrogenase [NADP(+)] (DHPDHase) (DPD) (EC 1.3.1.2) (Dihydrothymine dehydrogenase) (Dihydrouracil dehydrogenase)
drug.Protein;Q16831;UPP1;ENSG00000183696;Q16831;Uridine phosphorylase 1 (UPase 1) (UrdPase 1) (EC 2.4.2.3)
drug.Protein;O95045;UPP2;ENSG00000007001;O95045;Uridine phosphorylase 2 (UPase 2) (UrdPase 2) (EC 2.4.2.3)
drug.Protein;P11172;UMPS;ENSG00000114491;P11172;"Uridine 5'-monophosphate synthase (UMP synthase) [Includes: Orotate phosphoribosyltransferase (OPRT) (OPRTase) (EC 2.4.2.10); Orotidine 5'-phosphate decarboxylase (ODC) (OMPD) (EC 4.1.1.23) (OMPdecase)]"
drug.Protein;P51857;AKR1D1;ENSG00000122787;P51857;Aldo-keto reductase family 1 member D1 (EC 1.3.1.3) (3-oxo-5-beta-steroid 4-dehydrogenase) (Delta(4)-3-ketosteroid 5-beta-reductase) (Delta(4)-3-oxosteroid 5-beta-reductase)
drug.Protein;P31213;SRD5A2;ENSG00000277893;P31213;3-oxo-5-alpha-steroid 4-dehydrogenase 2 (EC 1.3.1.22) (5 alpha-SR2) (SR type 2) (Steroid 5-alpha-reductase 2) (S5AR 2) (Type II 5-alpha reductase)
drug.Protein;P02708;CHRNA1;ENSG00000138435;P02708;Acetylcholine receptor subunit alpha
drug.Protein;P25101;EDNRA;ENSG00000151617;P25101;Endothelin-1 receptor (Endothelin receptor type A) (ET-A) (ETA-R) (hET-AR)
drug.Protein;P24530;EDNRB;ENSG00000136160;P24530;Endothelin receptor type B (ET-B) (ET-BR) (Endothelin receptor non-selective type)
drug.Protein;O14649;KCNK3;ENSG00000171303;O14649;Potassium channel subfamily K member 3 (Acid-sensitive potassium channel protein TASK-1) (TWIK-related acid-sensitive K(+) channel 1) (Two pore potassium channel KT3.1) (Two pore K(+) channel KT3.1)
drug.Protein;Q9NPC2;KCNK9;ENSG00000169427;Q9NPC2;Potassium channel subfamily K member 9 (Acid-sensitive potassium channel protein TASK-3) (TWIK-related acid-sensitive K(+) channel 3) (Two pore potassium channel KT3.2) (Two pore K(+) channel KT3.2)
drug.Protein;Q16790;CA9;ENSG00000107159;Q16790;Carbonic anhydrase 9 (EC 4.2.1.1) (Carbonate dehydratase IX) (Carbonic anhydrase IX) (CA-IX) (CAIX) (Membrane antigen MN) (P54/58N) (Renal cell carcinoma-associated antigen G250) (RCC-associated antigen G250) (pMW1)
drug.Protein;O43570;CA12;ENSG00000074410;O43570;Carbonic anhydrase 12 (EC 4.2.1.1) (Carbonate dehydratase XII) (Carbonic anhydrase XII) (CA-XII) (Tumor antigen HOM-RCC-3.1.3)
drug.Protein;P52209;PGD;ENSG00000142657;P52209;6-phosphogluconate dehydrogenase, decarboxylating (EC 1.1.1.44)
drug.Protein;P41440;SLC19A1;ENSG00000173638;P41440;Reduced folate transporter (FOLT) (Cyclic dinucleotide:anion antiporter SLC19A1) (Folate:anion antiporter SLC19A1) (Intestinal folate carrier 1) (IFC-1) (Placental folate transporter) (Reduced folate carrier protein) (RFC) (hRFC) (Reduced folate transporter 1) (RFT-1) (Solute carrier family 19 member 1) (hSLC19A1)
drug.Protein;Q9UJT1;TUBD1;ENSG00000108423;Q9UJT1;Tubulin delta chain (Delta-tubulin)
drug.Protein;P23258;TUBG1;ENSG00000131462;P23258;Tubulin gamma-1 chain (Gamma-1-tubulin) (Gamma-tubulin complex component 1) (GCP-1)
drug.Protein;Q9UJT0;TUBE1;ENSG00000074935;Q9UJT0;Tubulin epsilon chain (Epsilon-tubulin)
drug.Protein;Q16774;GUK1;ENSG00000143774;Q16774;Guanylate kinase (EC 2.7.4.8) (GMP kinase) (Guanylate kinase 1)
drug.Protein;P43155;CRAT;ENSG00000095321;P43155;Carnitine O-acetyltransferase (Carnitine acetylase) (EC 2.3.1.137) (EC 2.3.1.7) (Carnitine acetyltransferase) (CAT) (CrAT)
drug.Protein;Q8N8R3;SLC25A29;ENSG00000197119;Q8N8R3;Mitochondrial basic amino acids transporter (Carnitine/acylcarnitine translocase-like) (CACT-like) (Mitochondrial carnitine/acylcarnitine carrier protein CACL) (Mitochondrial ornithine transporter 3) (Solute carrier family 25 member 29)
drug.Protein;O43772;SLC25A20;ENSG00000178537;O43772;Mitochondrial carnitine/acylcarnitine carrier protein (Carnitine/acylcarnitine translocase) (CAC) (CACT) (Solute carrier family 25 member 20)
drug.Protein;Q9UKG9;CROT;ENSG00000005469;Q9UKG9;Peroxisomal carnitine O-octanoyltransferase (COT) (EC 2.3.1.137)
drug.Protein;P23786;CPT2;ENSG00000157184;P23786;Carnitine O-palmitoyltransferase 2, mitochondrial (EC 2.3.1.21) (Carnitine palmitoyltransferase II) (CPT II)
drug.Protein;P50416;CPT1A;ENSG00000110090;P50416;Carnitine O-palmitoyltransferase 1, liver isoform (CPT1-L) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, liver isoform) (CPT I) (CPTI-L) (Carnitine palmitoyltransferase 1A)
drug.Protein;Q86VW1;SLC22A16;ENSG00000004809;Q86VW1;Solute carrier family 22 member 16 (Carnitine transporter 2) (CT2) (Fly-like putative transporter 2) (FLIPT2) (Flipt 2) (Organic cation transporter OKB1) (Organic cation/carnitine transporter 6)
drug.Protein;P78348;ASIC1;ENSG00000110881;P78348;Acid-sensing ion channel 1 (ASIC1) (Amiloride-sensitive cation channel 2, neuronal) (Brain sodium channel 2) (BNaC2)
drug.Protein;P12429;ANXA3;ENSG00000138772;P12429;Annexin A3 (35-alpha calcimedin) (Annexin III) (Annexin-3) (Inositol 1,2-cyclic phosphate 2-phosphohydrolase) (Lipocortin III) (Placental anticoagulant protein III) (PAP-III)
drug.Protein;P09525;ANXA4;ENSG00000196975;P09525;Annexin A4 (35-beta calcimedin) (Annexin IV) (Annexin-4) (Carbohydrate-binding protein p33/p41) (Chromobindin-4) (Endonexin I) (Lipocortin IV) (P32.5) (PP4-X) (Placental anticoagulant protein II) (PAP-II) (Protein II)
drug.Protein;P08758;ANXA5;ENSG00000164111;P08758;Annexin A5 (Anchorin CII) (Annexin V) (Annexin-5) (Calphobindin I) (CPB-I) (Endonexin II) (Lipocortin V) (Placental anticoagulant protein 4) (PP4) (Placental anticoagulant protein I) (PAP-I) (Thromboplastin inhibitor) (Vascular anticoagulant-alpha) (VAC-alpha)
drug.Protein;P19801;AOC1;ENSG00000002726;P19801;Amiloride-sensitive amine oxidase [copper-containing] (DAO) (Diamine oxidase) (EC 1.4.3.22) (Amiloride-binding protein 1) (Amine oxidase copper domain-containing protein 1) (Histaminase) (Kidney amine oxidase) (KAO)
drug.Protein;Q16515;ASIC2;ENSG00000108684;Q16515;Acid-sensing ion channel 2 (ASIC2) (Amiloride-sensitive brain sodium channel) (Amiloride-sensitive cation channel 1, neuronal) (Amiloride-sensitive cation channel neuronal 1) (Brain sodium channel 1) (BNC1) (BNaC1) (Mammalian degenerin homolog) (MDEG)
drug.Protein;P19634;SLC9A1;ENSG00000090020;P19634;Sodium/hydrogen exchanger 1 (APNH) (Na(+)/H(+) antiporter, amiloride-sensitive) (Na(+)/H(+) exchanger 1) (NHE-1) (Solute carrier family 9 member 1)
drug.Protein;P00749;PLAU;ENSG00000122861;P00749;"Urokinase-type plasminogen activator (U-plasminogen activator) (uPA) (EC 3.4.21.73) [Cleaved into: Urokinase-type plasminogen activator long chain A; Urokinase-type plasminogen activator short chain A; Urokinase-type plasminogen activator chain B]"
drug.Protein;P27361;MAPK3;ENSG00000102882;P27361;Mitogen-activated protein kinase 3 (MAP kinase 3) (MAPK 3) (EC 2.7.11.24) (ERT2) (Extracellular signal-regulated kinase 1) (ERK-1) (Insulin-stimulated MAP2 kinase) (MAP kinase isoform p44) (p44-MAPK) (Microtubule-associated protein 2 kinase) (p44-ERK1)
drug.Protein;O60218;AKR1B10;ENSG00000198074;O60218;Aldo-keto reductase family 1 member B10 (EC 1.1.1.300) (EC 1.1.1.54) (ARL-1) (Aldose reductase-like) (Aldose reductase-related protein) (ARP) (hARP) (Small intestine reductase) (SI reductase)
drug.Protein;P54710;FXYD2;ENSG00000137731;P54710;Sodium/potassium-transporting ATPase subunit gamma (Na(+)/K(+) ATPase subunit gamma) (FXYD domain-containing ion transport regulator 2) (Sodium pump gamma chain)
drug.Protein;Q6FHJ7;SFRP4;ENSG00000106483;Q6FHJ7;Secreted frizzled-related protein 4 (sFRP-4) (Frizzled protein, human endometrium) (FrpHE)
drug.Protein;Q9NR96;TLR9;ENSG00000239732;Q9NR96;Toll-like receptor 9 (CD antigen CD289)
drug.Protein;P09429;HMGB1;ENSG00000189403;P09429;High mobility group protein B1 (High mobility group protein 1) (HMG-1)
drug.Protein;Q9BYF1;ACE2;ENSG00000130234;Q9BYF1;Angiotensin-converting enzyme 2 (EC 3.4.17.23) (Angiotensin-converting enzyme homolog) (ACEH) (Angiotensin-converting enzyme-related carboxypeptidase) (ACE-related carboxypeptidase) (EC 3.4.17.-) (Metalloprotease MPROT15) [Cleaved into: Processed angiotensin-converting enzyme 2]
drug.Protein;P50135;HNMT;ENSG00000150540;P50135;Histamine N-methyltransferase (HMT) (EC 2.1.1.8)
drug.Protein;P07900;HSP90AA1;ENSG00000080824;P07900;Heat shock protein HSP 90-alpha (EC 3.6.4.10) (Heat shock 86 kDa) (HSP 86) (HSP86) (Lipopolysaccharide-associated protein 2) (LAP-2) (LPS-associated protein 2) (Renal carcinoma antigen NY-REN-38)
drug.Protein;P14625;HSP90B1;ENSG00000166598;P14625;Endoplasmin (94 kDa glucose-regulated protein) (GRP-94) (Heat shock protein 90 kDa beta member 1) (Tumor rejection antigen 1) (gp96 homolog)
drug.Protein;P08473;MME;ENSG00000196549;P08473;Neprilysin (EC 3.4.24.11) (Atriopeptidase) (Common acute lymphocytic leukemia antigen) (CALLA) (Enkephalinase) (Neutral endopeptidase 24.11) (NEP) (Neutral endopeptidase) (Skin fibroblast elastase) (SFE) (CD antigen CD10)
drug.Protein;P11274;BCR;ENSG00000186716;P11274;Breakpoint cluster region protein (EC 2.7.11.1) (Renal carcinoma antigen NY-REN-26)
drug.Protein;O43519;;;;
drug.Protein;P07333;CSF1R;ENSG00000182578;P07333;Macrophage colony-stimulating factor 1 receptor (CSF-1 receptor) (CSF-1-R) (CSF-1R) (M-CSF-R) (EC 2.7.10.1) (Proto-oncogene c-Fms) (CD antigen CD115)
drug.Protein;Q08345;DDR1;ENSG00000204580;Q08345;Epithelial discoidin domain-containing receptor 1 (Epithelial discoidin domain receptor 1) (EC 2.7.10.1) (CD167 antigen-like family member A) (Cell adhesion kinase) (Discoidin receptor tyrosine kinase) (HGK2) (Mammary carcinoma kinase 10) (MCK-10) (Protein-tyrosine kinase 3A) (Protein-tyrosine kinase RTK-6) (TRK E) (Tyrosine kinase DDR) (Tyrosine-protein kinase CAK) (CD antigen CD167a)
drug.Protein;Q99758;ABCA3;ENSG00000167972;Q99758;Phospholipid-transporting ATPase ABCA3 (EC 7.6.2.1) (ABC-C transporter) (ATP-binding cassette sub-family A member 3) (ATP-binding cassette transporter 3) (ATP-binding cassette 3) (Xenobiotic-transporting ATPase ABCA3) (EC 7.6.2.2) [Cleaved into: 150 Kda mature form]
drug.Protein;P54750;PDE1A;ENSG00000115252;P54750;Dual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A (Cam-PDE 1A) (EC 3.1.4.17) (61 kDa Cam-PDE) (hCam-1)
drug.Protein;Q01064;PDE1B;ENSG00000123360;Q01064;Dual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B (Cam-PDE 1B) (EC 3.1.4.17) (63 kDa Cam-PDE)
drug.Protein;Q9HB55;CYP3A43;ENSG00000021461;Q9HB55;Cytochrome P450 3A43 (EC 1.14.14.1)
drug.Protein;P49019;HCAR3;ENSG00000255398;P49019;Hydroxycarboxylic acid receptor 3 (G-protein coupled receptor 109B) (G-protein coupled receptor HM74) (G-protein coupled receptor HM74B) (Niacin receptor 2) (Nicotinic acid receptor 2)
drug.Protein;Q15274;QPRT;ENSG00000103485;Q15274;Nicotinate-nucleotide pyrophosphorylase [carboxylating] (EC 2.4.2.19) (Quinolinate phosphoribosyltransferase [decarboxylating]) (QAPRTase) (QPRTase)
drug.Protein;P40261;NNMT;ENSG00000166741;P40261;Nicotinamide N-methyltransferase (EC 2.1.1.1)
drug.Protein;P29074;PTPN4;ENSG00000088179;P29074;Tyrosine-protein phosphatase non-receptor type 4 (EC 3.1.3.48) (Protein-tyrosine phosphatase MEG1) (MEG) (PTPase-MEG1)
drug.Protein;Q13332;PTPRS;ENSG00000105426;Q13332;Receptor-type tyrosine-protein phosphatase S (R-PTP-S) (EC 3.1.3.48) (Receptor-type tyrosine-protein phosphatase sigma) (R-PTP-sigma)
drug.Protein;P23469;PTPRE;ENSG00000132334;P23469;Receptor-type tyrosine-protein phosphatase epsilon (Protein-tyrosine phosphatase epsilon) (R-PTP-epsilon) (EC 3.1.3.48)
drug.Protein;P38606;ATP6V1A;ENSG00000114573;P38606;V-type proton ATPase catalytic subunit A (V-ATPase subunit A) (EC 7.1.2.2) (V-ATPase 69 kDa subunit) (Vacuolar ATPase isoform VA68) (Vacuolar proton pump subunit alpha)
drug.Protein;P00568;AK1;ENSG00000106992;P00568;Adenylate kinase isoenzyme 1 (AK 1) (EC 2.7.4.3) (EC 2.7.4.6) (ATP-AMP transphosphorylase 1) (ATP:AMP phosphotransferase) (Adenylate monophosphate kinase) (Myokinase)
drug.Protein;P22392;NME2;ENSG00000243678;P22392;Nucleoside diphosphate kinase B (NDK B) (NDP kinase B) (EC 2.7.4.6) (C-myc purine-binding transcription factor PUF) (Histidine protein kinase NDKB) (EC 2.7.13.3) (nm23-H2)
drug.Protein;Q9BZD2;SLC29A3;ENSG00000198246;Q9BZD2;Equilibrative nucleoside transporter 3 (hENT3) (Solute carrier family 29 member 3)
drug.Protein;O43868;SLC28A2;ENSG00000137860;O43868;Sodium/nucleoside cotransporter 2 (Concentrative nucleoside transporter 2) (CNT 2) (hCNT2) (Na(+)/nucleoside cotransporter 2) (Sodium-coupled nucleoside transporter 2) (Sodium/purine nucleoside co-transporter) (SPNT) (Solute carrier family 28 member 2)
drug.Protein;P17302;GJA1;ENSG00000152661;P17302;Gap junction alpha-1 protein (Connexin-43) (Cx43) (Gap junction 43 kDa heart protein)
drug.Protein;P22102;GART;ENSG00000159131;P22102;"Trifunctional purine biosynthetic protein adenosine-3 [Includes: Phosphoribosylamine--glycine ligase (EC 6.3.4.13) (Glycinamide ribonucleotide synthetase) (GARS) (Phosphoribosylglycinamide synthetase); Phosphoribosylformylglycinamidine cyclo-ligase (EC 6.3.3.1) (AIR synthase) (AIRS) (Phosphoribosyl-aminoimidazole synthetase); Phosphoribosylglycinamide formyltransferase (EC 2.1.2.2) (5'-phosphoribosylglycinamide transformylase) (GAR transformylase) (GART)]"
drug.Protein;Q96P88;GNRHR2;ENSG00000211451;Q96P88;Putative gonadotropin-releasing hormone II receptor (GnRH II receptor) (GnRH-II-R) (Type II GnRH receptor)
drug.Protein;P10109;FDX1;ENSG00000137714;P10109;Adrenodoxin, mitochondrial (Adrenal ferredoxin) (Ferredoxin-1) (Hepatoredoxin)
drug.Protein;Q08493;PDE4C;ENSG00000105650;Q08493;cAMP-specific 3',5'-cyclic phosphodiesterase 4C (EC 3.1.4.53) (DPDE1) (PDE21)
drug.Protein;P41594;GRM5;ENSG00000168959;P41594;Metabotropic glutamate receptor 5 (mGluR5)
drug.Protein;O00555;CACNA1A;ENSG00000141837;O00555;Voltage-dependent P/Q-type calcium channel subunit alpha-1A (Brain calcium channel I) (BI) (Calcium channel, L type, alpha-1 polypeptide isoform 4) (Voltage-gated calcium channel subunit alpha Cav2.1)
drug.Protein;A9X444;;;;
drug.Protein;Q15125;EBP;ENSG00000147155;Q15125;3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase (EC 5.3.3.5) (Cholestenol Delta-isomerase) (Delta(8)-Delta(7) sterol isomerase) (D8-D7 sterol isomerase) (Emopamil-binding protein)
drug.Protein;P45983;MAPK8;ENSG00000107643;P45983;Mitogen-activated protein kinase 8 (MAP kinase 8) (MAPK 8) (EC 2.7.11.24) (JNK-46) (Stress-activated protein kinase 1c) (SAPK1c) (Stress-activated protein kinase JNK1) (c-Jun N-terminal kinase 1)
drug.Protein;Q06520;SULT2A1;ENSG00000105398;Q06520;Sulfotransferase 2A1 (ST2A1) (EC 2.8.2.2) (Bile salt sulfotransferase) (EC 2.8.2.14) (Dehydroepiandrosterone sulfotransferase) (DHEA-ST) (DHEA-ST8) (Hydroxysteroid Sulfotransferase) (HST) (ST2) (SULT2A3)
drug.Protein;P49888;SULT1E1;ENSG00000109193;P49888;Sulfotransferase 1E1 (ST1E1) (EC 2.8.2.4) (EST-1) (Estrogen sulfotransferase) (Sulfotransferase, estrogen-preferring)
drug.Protein;Q96S37;SLC22A12;ENSG00000197891;Q96S37;Solute carrier family 22 member 12 (Organic anion transporter 4-like protein) (Renal-specific transporter) (RST) (Urate anion exchanger 1)
drug.Protein;Q9NRM0;SLC2A9;ENSG00000109667;Q9NRM0;Solute carrier family 2, facilitated glucose transporter member 9 (Glucose transporter type 9) (GLUT-9) (Urate transporter)
drug.Protein;P05230;FGF1;ENSG00000113578;P05230;Fibroblast growth factor 1 (FGF-1) (Acidic fibroblast growth factor) (aFGF) (Endothelial cell growth factor) (ECGF) (Heparin-binding growth factor 1) (HBGF-1)
drug.Protein;P08620;FGF4;ENSG00000075388;P08620;Fibroblast growth factor 4 (FGF-4) (Heparin secretory-transforming protein 1) (HST) (HST-1) (HSTF-1) (Heparin-binding growth factor 4) (HBGF-4) (Transforming protein KS3)
drug.Protein;Q03393;PTS;ENSG00000150787;Q03393;6-pyruvoyl tetrahydrobiopterin synthase (PTP synthase) (PTPS) (EC 4.2.3.12)
drug.Protein;Q6IPK9;;;;
drug.Protein;P06310;IGKV2-30;ENSG00000243238;P06310;Immunoglobulin kappa variable 2-30 (Ig kappa chain V-II region RPMI 6410)
drug.Protein;O75828;CBR3;ENSG00000159231;O75828;Carbonyl reductase [NADPH] 3 (EC 1.1.1.184) (NADPH-dependent carbonyl reductase 3) (Quinone reductase CBR3) (EC 1.6.5.10) (Short chain dehydrogenase/reductase family 21C member 2)
drug.Protein;Q9HC97;GPR35;ENSG00000178623;Q9HC97;G-protein coupled receptor 35 (Kynurenic acid receptor) (KYNA receptor)
drug.Protein;Q9Y2I1;NISCH;ENSG00000010322;Q9Y2I1;Nischarin (Imidazoline receptor 1) (I-1) (IR1) (Imidazoline receptor antisera-selected protein) (hIRAS) (Imidazoline-1 receptor) (I1R) (Imidazoline-1 receptor candidate protein) (I-1 receptor candidate protein) (I1R candidate protein)
drug.Protein;P00558;PGK1;ENSG00000102144;P00558;Phosphoglycerate kinase 1 (EC 2.7.2.3) (Cell migration-inducing gene 10 protein) (Primer recognition protein 2) (PRP 2)
drug.Protein;Q99447;PCYT2;ENSG00000185813;Q99447;Ethanolamine-phosphate cytidylyltransferase (EC 2.7.7.14) (CTP:phosphoethanolamine cytidylyltransferase) (Phosphorylethanolamine transferase)
drug.Protein;Q8TCD5;NT5C;ENSG00000125458;Q8TCD5;5'(3')-deoxyribonucleotidase, cytosolic type (EC 3.1.3.-) (Cytosolic 5',3'-pyrimidine nucleotidase) (Deoxy-5'-nucleotidase 1) (dNT-1)
drug.Protein;P50226;SULT1A2;ENSG00000197165;P50226;Sulfotransferase 1A2 (ST1A2) (EC 2.8.2.1) (Aryl sulfotransferase 2) (Phenol sulfotransferase 2) (Phenol-sulfating phenol sulfotransferase 2) (P-PST 2)
drug.Protein;O43704;SULT1B1;ENSG00000173597;O43704;Sulfotransferase 1B1 (ST1B1) (EC 2.8.2.1) (Sulfotransferase 1B2) (Sulfotransferase family cytosolic 1B member 1) (Thyroid hormone sulfotransferase)
drug.Protein;Q9NS75;CYSLTR2;ENSG00000152207;Q9NS75;Cysteinyl leukotriene receptor 2 (CysLTR2) (G-protein coupled receptor GPCR21) (hGPCR21) (G-protein coupled receptor HG57) (HPN321)
drug.Protein;P21462;FPR1;ENSG00000171051;P21462;fMet-Leu-Phe receptor (fMLP receptor) (N-formyl peptide receptor) (FPR) (N-formylpeptide chemoattractant receptor)
drug.Protein;Q13258;PTGDR;ENSG00000168229;Q13258;Prostaglandin D2 receptor (PGD receptor) (PGD2 receptor) (Prostanoid DP receptor)
drug.Protein;P05141;SLC25A5;ENSG00000005022;P05141;ADP/ATP translocase 2 (ADP,ATP carrier protein 2) (ADP,ATP carrier protein, fibroblast isoform) (Adenine nucleotide translocator 2) (ANT 2) (Solute carrier family 25 member 5) [Cleaved into: ADP/ATP translocase 2, N-terminally processed]
drug.Protein;P12236;SLC25A6;ENSG00000169100;P12236;ADP/ATP translocase 3 (ADP,ATP carrier protein 3) (ADP,ATP carrier protein, isoform T2) (ANT 2) (Adenine nucleotide translocator 3) (ANT 3) (Solute carrier family 25 member 6) [Cleaved into: ADP/ATP translocase 3, N-terminally processed]
drug.Protein;Q86U10;ASPG;ENSG00000166183;Q86U10;"60 kDa lysophospholipase (LysoLP) (EC 3.1.1.5) (Lysophospholipase-transacylase) [Includes: L-asparaginase (EC 3.5.1.1) (L-asparagine amidohydrolase); 1-alkyl-2-acetylglycerophosphocholine esterase (EC 3.1.1.47) (Platelet-activating factor acetylhydrolase) (PAF acetylhydrolase)]"
drug.Protein;P26358;DNMT1;ENSG00000130816;P26358;DNA (cytosine-5)-methyltransferase 1 (Dnmt1) (EC 2.1.1.37) (CXXC-type zinc finger protein 9) (DNA methyltransferase HsaI) (DNA MTase HsaI) (M.HsaI) (MCMT)
drug.Protein;Q9Y6K1;DNMT3A;ENSG00000119772;Q9Y6K1;DNA (cytosine-5)-methyltransferase 3A (Dnmt3a) (EC 2.1.1.37) (Cysteine methyltransferase DNMT3A) (EC 2.1.1.-) (DNA methyltransferase HsaIIIA) (DNA MTase HsaIIIA) (M.HsaIIIA)
drug.Protein;Q9NYK1;TLR7;ENSG00000196664;Q9NYK1;Toll-like receptor 7
drug.Protein;Q9NR97;TLR8;ENSG00000101916;Q9NR97;Toll-like receptor 8 (CD antigen CD288)
drug.Protein;Q14534;SQLE;ENSG00000104549;Q14534;Squalene monooxygenase (EC 1.14.14.17) (Squalene epoxidase) (SE)
drug.Protein;O14717;TRDMT1;ENSG00000107614;O14717;tRNA (cytosine(38)-C(5))-methyltransferase (EC 2.1.1.204) (DNA (cytosine-5)-methyltransferase-like protein 2) (Dnmt2) (DNA methyltransferase homolog HsaIIP) (DNA MTase homolog HsaIIP) (M.HsaIIP) (PuMet)
drug.Protein;P05067;APP;ENSG00000142192;P05067;"Amyloid-beta precursor protein (APP) (ABPP) (APPI) (Alzheimer disease amyloid A4 protein homolog) (Alzheimer disease amyloid protein) (Amyloid precursor protein) (Amyloid-beta (A4) precursor protein) (Amyloid-beta A4 protein) (Cerebral vascular amyloid peptide) (CVAP) (PreA4) (Protease nexin-II) (PN-II) [Cleaved into: N-APP; Soluble APP-alpha (S-APP-alpha); Soluble APP-beta (S-APP-beta); C99 (Beta-secretase C-terminal fragment) (Beta-CTF); Amyloid-beta protein 42 (Abeta42) (Beta-APP42); Amyloid-beta protein 40 (Abeta40) (Beta-APP40); C83 (Alpha-secretase C-terminal fragment) (Alpha-CTF); P3(42); P3(40); C80; Gamma-secretase C-terminal fragment 59 (Amyloid intracellular domain 59) (AICD-59) (AID(59)) (Gamma-CTF(59)); Gamma-secretase C-terminal fragment 57 (Amyloid intracellular domain 57) (AICD-57) (AID(57)) (Gamma-CTF(57)); Gamma-secretase C-terminal fragment 50 (Amyloid intracellular domain 50) (AICD-50) (AID(50)) (Gamma-CTF(50)); C31]"
drug.Protein;P30049;ATP5F1D;ENSG00000099624;P30049;ATP synthase subunit delta, mitochondrial (ATP synthase F1 subunit delta) (F-ATPase delta subunit)
drug.Protein;Q8NFJ5;GPRC5A;ENSG00000013588;Q8NFJ5;Retinoic acid-induced protein 3 (G-protein coupled receptor family C group 5 member A) (Phorbol ester induced gene 1) (PEIG-1) (Retinoic acid-induced gene 1 protein) (RAIG-1)
drug.Protein;P49788;RARRES1;ENSG00000118849;P49788;Retinoic acid receptor responder protein 1 (Phorbol ester-induced gene 1 protein) (PERG-1) (RAR-responsive protein TIG1) (Tazarotene-induced gene 1 protein)
drug.Protein;P31025;LCN1;ENSG00000160349;P31025;Lipocalin-1 (Tear lipocalin) (Tlc) (Tear prealbumin) (TP) (von Ebner gland protein) (VEG protein)
drug.Protein;Q9NY56;OBP2A;ENSG00000122136;Q9NY56;Odorant-binding protein 2a (Odorant-binding protein IIa) (OBPIIa)
drug.Protein;Q16654;PDK4;ENSG00000004799;Q16654;[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrial (EC 2.7.11.2) (Pyruvate dehydrogenase kinase isoform 4)
drug.Protein;Q9NR63;CYP26B1;ENSG00000003137;Q9NR63;Cytochrome P450 26B1 (EC 1.14.13.-) (Cytochrome P450 26A2) (Cytochrome P450 retinoic acid-inactivating 2) (Cytochrome P450RAI-2) (Retinoic acid-metabolizing cytochrome)
drug.Protein;O14521;SDHD;ENSG00000204370;O14521;Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial (CybS) (CII-4) (QPs3) (Succinate dehydrogenase complex subunit D) (Succinate-ubiquinone oxidoreductase cytochrome b small subunit) (Succinate-ubiquinone reductase membrane anchor subunit)
drug.Protein;P04156;PRNP;ENSG00000171867;P04156;Major prion protein (PrP) (ASCR) (PrP27-30) (PrP33-35C) (CD antigen CD230)
drug.Protein;Q9H2X9;SLC12A5;ENSG00000124140;Q9H2X9;Solute carrier family 12 member 5 (Electroneutral potassium-chloride cotransporter 2) (K-Cl cotransporter 2) (hKCC2) (Neuronal K-Cl cotransporter)
drug.Protein;Q9UHW9;SLC12A6;ENSG00000140199;Q9UHW9;Solute carrier family 12 member 6 (Electroneutral potassium-chloride cotransporter 3) (K-Cl cotransporter 3)
drug.Protein;Q9Y666;SLC12A7;ENSG00000113504;Q9Y666;Solute carrier family 12 member 7 (Electroneutral potassium-chloride cotransporter 4) (K-Cl cotransporter 4)
drug.Protein;Q9UP95;SLC12A4;ENSG00000124067;Q9UP95;Solute carrier family 12 member 4 (Electroneutral potassium-chloride cotransporter 1) (Erythroid K-Cl cotransporter 1) (hKCC1)
drug.Protein;P11387;TOP1;ENSG00000198900;P11387;DNA topoisomerase 1 (EC 5.6.2.1) (DNA topoisomerase I)
drug.Protein;Q969P6;TOP1MT;ENSG00000184428;Q969P6;DNA topoisomerase I, mitochondrial (TOP1mt) (EC 5.6.2.1)
drug.Protein;O00748;CES2;ENSG00000172831;O00748;Cocaine esterase (EC 3.1.1.84) (Carboxylesterase 2) (CE-2) (hCE-2) (EC 3.1.1.1) (Methylumbelliferyl-acetate deacetylase 2) (EC 3.1.1.56)
drug.Protein;P13866;SLC5A1;ENSG00000100170;P13866;Sodium/glucose cotransporter 1 (Na(+)/glucose cotransporter 1) (High affinity sodium-glucose cotransporter) (Solute carrier family 5 member 1)
drug.Protein;Q9Y5N1;HRH3;ENSG00000101180;Q9Y5N1;Histamine H3 receptor (H3R) (HH3R) (G-protein coupled receptor 97)
drug.Protein;P23297;S100A1;ENSG00000160678;P23297;Protein S100-A1 (S-100 protein alpha chain) (S-100 protein subunit alpha) (S100 calcium-binding protein A1)
drug.Protein;P80511;S100A12;ENSG00000163221;P80511;Protein S100-A12 (CGRP) (Calcium-binding protein in amniotic fluid 1) (CAAF1) (Calgranulin-C) (CAGC) (Extracellular newly identified RAGE-binding protein) (EN-RAGE) (Migration inhibitory factor-related protein 6) (MRP-6) (p6) (Neutrophil S100 protein) (S100 calcium-binding protein A12) [Cleaved into: Calcitermin]
drug.Protein;P04271;S100B;ENSG00000160307;P04271;Protein S100-B (S-100 protein beta chain) (S-100 protein subunit beta) (S100 calcium-binding protein B)
drug.Protein;Q99584;S100A13;ENSG00000189171;Q99584;Protein S100-A13 (S100 calcium-binding protein A13)
drug.Protein;P29034;S100A2;ENSG00000196754;P29034;Protein S100-A2 (CAN19) (Protein S-100L) (S100 calcium-binding protein A2)
drug.Protein;P43116;PTGER2;ENSG00000125384;P43116;Prostaglandin E2 receptor EP2 subtype (PGE receptor EP2 subtype) (PGE2 receptor EP2 subtype) (Prostanoid EP2 receptor)
drug.Protein;Q16853;AOC3;ENSG00000131471;Q16853;Membrane primary amine oxidase (EC 1.4.3.21) (Copper amine oxidase) (HPAO) (Semicarbazide-sensitive amine oxidase) (SSAO) (Vascular adhesion protein 1) (VAP-1)
drug.Protein;Q99527;GPER1;ENSG00000164850;Q99527;G-protein coupled estrogen receptor 1 (Chemoattractant receptor-like 2) (Flow-induced endothelial G-protein coupled receptor 1) (FEG-1) (G protein-coupled estrogen receptor 1) (G-protein coupled receptor 30) (GPCR-Br) (IL8-related receptor DRY12) (Lymphocyte-derived G-protein coupled receptor) (LYGPR) (Membrane estrogen receptor) (mER)
drug.Protein;P00846;MT-ATP6;ENSG00000198899;P00846;ATP synthase subunit a (F-ATPase protein 6)
drug.Protein;Q14457;BECN1;ENSG00000126581;Q14457;"Beclin-1 (Coiled-coil myosin-like BCL2-interacting protein) (Protein GT197) [Cleaved into: Beclin-1-C 35 kDa; Beclin-1-C 37 kDa]"
drug.Protein;P12104;FABP2;ENSG00000145384;P12104;Fatty acid-binding protein, intestinal (Fatty acid-binding protein 2) (Intestinal-type fatty acid-binding protein) (I-FABP)
drug.Protein;P03956;MMP1;ENSG00000196611;P03956;"Interstitial collagenase (EC 3.4.24.7) (Fibroblast collagenase) (Matrix metalloproteinase-1) (MMP-1) [Cleaved into: 22 kDa interstitial collagenase; 27 kDa interstitial collagenase]"
drug.Protein;P08253;MMP2;ENSG00000087245;P08253;72 kDa type IV collagenase (EC 3.4.24.24) (72 kDa gelatinase) (Gelatinase A) (Matrix metalloproteinase-2) (MMP-2) (TBE-1) [Cleaved into: PEX]
drug.Protein;P08254;MMP3;ENSG00000149968;P08254;Stromelysin-1 (SL-1) (EC 3.4.24.17) (Matrix metalloproteinase-3) (MMP-3) (Transin-1)
drug.Protein;P09237;MMP7;ENSG00000137673;P09237;Matrilysin (EC 3.4.24.23) (Matrin) (Matrix metalloproteinase-7) (MMP-7) (Pump-1 protease) (Uterine metalloproteinase)
drug.Protein;P22894;MMP8;ENSG00000118113;P22894;Neutrophil collagenase (EC 3.4.24.34) (Matrix metalloproteinase-8) (MMP-8) (PMNL collagenase) (PMNL-CL)
drug.Protein;P09238;MMP10;ENSG00000166670;P09238;Stromelysin-2 (SL-2) (EC 3.4.24.22) (Matrix metalloproteinase-10) (MMP-10) (Transin-2)
drug.Protein;P24347;MMP11;ENSG00000099953;P24347;Stromelysin-3 (SL-3) (ST3) (EC 3.4.24.-) (Matrix metalloproteinase-11) (MMP-11)
drug.Protein;P45452;MMP13;ENSG00000137745;P45452;Collagenase 3 (EC 3.4.24.-) (Matrix metalloproteinase-13) (MMP-13)
drug.Protein;P50281;MMP14;ENSG00000157227;P50281;Matrix metalloproteinase-14 (MMP-14) (EC 3.4.24.80) (MMP-X1) (Membrane-type matrix metalloproteinase 1) (MT-MMP 1) (MTMMP1) (Membrane-type-1 matrix metalloproteinase) (MT1-MMP) (MT1MMP)
drug.Protein;P51511;MMP15;ENSG00000102996;P51511;Matrix metalloproteinase-15 (MMP-15) (EC 3.4.24.-) (Membrane-type matrix metalloproteinase 2) (MT-MMP 2) (MTMMP2) (Membrane-type-2 matrix metalloproteinase) (MT2-MMP) (MT2MMP) (SMCP-2)
drug.Protein;P51512;MMP16;ENSG00000156103;P51512;Matrix metalloproteinase-16 (MMP-16) (EC 3.4.24.-) (MMP-X2) (Membrane-type matrix metalloproteinase 3) (MT-MMP 3) (MTMMP3) (Membrane-type-3 matrix metalloproteinase) (MT3-MMP) (MT3MMP)
drug.Protein;Q9ULZ9;MMP17;ENSG00000198598;Q9ULZ9;Matrix metalloproteinase-17 (MMP-17) (EC 3.4.24.-) (Membrane-type matrix metalloproteinase 4) (MT-MMP 4) (MTMMP4) (Membrane-type-4 matrix metalloproteinase) (MT4-MMP) (MT4MMP)
drug.Protein;Q99542;MMP19;ENSG00000123342;Q99542;Matrix metalloproteinase-19 (MMP-19) (EC 3.4.24.-) (Matrix metalloproteinase RASI) (Matrix metalloproteinase-18) (MMP-18)
drug.Protein;O60882;MMP20;ENSG00000137674;O60882;Matrix metalloproteinase-20 (MMP-20) (EC 3.4.24.-) (Enamel metalloproteinase) (Enamelysin)
drug.Protein;Q8N119;MMP21;ENSG00000154485;Q8N119;Matrix metalloproteinase-21 (MMP-21) (EC 3.4.24.-)
drug.Protein;O75900;MMP23B;ENSG00000189409;O75900;Matrix metalloproteinase-23 (MMP-23) (EC 3.4.24.-) (Femalysin) (MIFR-1) (Matrix metalloproteinase-21) (MMP-21) (Matrix metalloproteinase-22) (MMP-22) [Cleaved into: Matrix metalloproteinase-23, soluble form]
drug.Protein;Q9Y5R2;MMP24;ENSG00000125966;Q9Y5R2;Matrix metalloproteinase-24 (MMP-24) (EC 3.4.24.-) (Membrane-type matrix metalloproteinase 5) (MT-MMP 5) (MTMMP5) (Membrane-type-5 matrix metalloproteinase) (MT5-MMP) (MT5MMP) [Cleaved into: Processed matrix metalloproteinase-24]
drug.Protein;Q9NPA2;MMP25;ENSG00000008516;Q9NPA2;Matrix metalloproteinase-25 (MMP-25) (EC 3.4.24.-) (Leukolysin) (Membrane-type matrix metalloproteinase 6) (MT-MMP 6) (MTMMP6) (Membrane-type-6 matrix metalloproteinase) (MT6-MMP) (MT6MMP)
drug.Protein;Q9NRE1;MMP26;ENSG00000167346;Q9NRE1;Matrix metalloproteinase-26 (MMP-26) (EC 3.4.24.-) (Endometase) (Matrilysin-2)
drug.Protein;Q9H306;MMP27;ENSG00000137675;Q9H306;Matrix metalloproteinase-27 (MMP-27) (EC 3.4.24.-)
drug.Protein;Q9H239;MMP28;ENSG00000271447;Q9H239;Matrix metalloproteinase-28 (MMP-28) (EC 3.4.24.-) (Epilysin)
drug.Protein;Q9HCF6;TRPM3;ENSG00000083067;Q9HCF6;Transient receptor potential cation channel subfamily M member 3 (Long transient receptor potential channel 3) (LTrpC-3) (LTrpC3) (Melastatin-2) (MLSN2)
drug.Protein;P24752;ACAT1;ENSG00000075239;P24752;Acetyl-CoA acetyltransferase, mitochondrial (EC 2.3.1.9) (Acetoacetyl-CoA thiolase) (T2)
drug.Protein;P24557;TBXAS1;ENSG00000059377;P24557;Thromboxane-A synthase (TXA synthase) (TXS) (EC 5.3.99.5) (Cytochrome P450 5A1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)
drug.Protein;P04054;PLA2G1B;ENSG00000170890;P04054;Phospholipase A2 (EC 3.1.1.4) (Group IB phospholipase A2) (Phosphatidylcholine 2-acylhydrolase 1B)
drug.Protein;P21589;NT5E;ENSG00000135318;P21589;5'-nucleotidase (5'-NT) (EC 3.1.3.5) (Ecto-5'-nucleotidase) (CD antigen CD73)
drug.Protein;Q16647;PTGIS;ENSG00000124212;Q16647;Prostacyclin synthase (EC 5.3.99.4) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152) (Prostaglandin I2 synthase)
drug.Protein;Q9ULX7;CA14;ENSG00000118298;Q9ULX7;Carbonic anhydrase 14 (EC 4.2.1.1) (Carbonate dehydratase XIV) (Carbonic anhydrase XIV) (CA-XIV)
drug.Protein;P29972;AQP1;ENSG00000240583;P29972;Aquaporin-1 (AQP-1) (Aquaporin-CHIP) (Urine water channel) (Water channel protein for red blood cells and kidney proximal tubule)
drug.Protein;Q9HCR9;PDE11A;ENSG00000128655;Q9HCR9;Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A (EC 3.1.4.35) (EC 3.1.4.53) (cAMP and cGMP phosphodiesterase 11A)
drug.Protein;Q7Z2W7;TRPM8;ENSG00000144481;Q7Z2W7;Transient receptor potential cation channel subfamily M member 8 (Long transient receptor potential channel 6) (LTrpC-6) (LTrpC6) (Transient receptor potential p8) (Trp-p8)
drug.Protein;O75762;TRPA1;ENSG00000104321;O75762;Transient receptor potential cation channel subfamily A member 1 (Ankyrin-like with transmembrane domains protein 1) (Transformation-sensitive protein p120) (p120) (Wasabi receptor)
drug.Protein;Q8NET8;TRPV3;ENSG00000167723;Q8NET8;Transient receptor potential cation channel subfamily V member 3 (TrpV3) (Vanilloid receptor-like 3) (VRL-3)
drug.Protein;P63316;TNNC1;ENSG00000114854;P63316;Troponin C, slow skeletal and cardiac muscles (TN-C)
drug.Protein;P26447;S100A4;ENSG00000196154;P26447;Protein S100-A4 (Calvasculin) (Metastasin) (Placental calcium-binding protein) (Protein Mts1) (S100 calcium-binding protein A4)
drug.Protein;P07288;KLK3;ENSG00000142515;P07288;Prostate-specific antigen (PSA) (EC 3.4.21.77) (Gamma-seminoprotein) (Seminin) (Kallikrein-3) (P-30 antigen) (Semenogelase)
drug.Protein;P01189;POMC;ENSG00000115138;P01189;"Pro-opiomelanocortin (POMC) (Corticotropin-lipotropin) [Cleaved into: NPP; Melanotropin gamma (Gamma-MSH); Potential peptide; Corticotropin (Adrenocorticotropic hormone) (ACTH); Melanocyte-stimulating hormone alpha (Alpha-MSH) (Melanotropin alpha); Corticotropin-like intermediary peptide (CLIP); Lipotropin beta (Beta-LPH); Lipotropin gamma (Gamma-LPH); Melanocyte-stimulating hormone beta (Beta-MSH) (Melanotropin beta); Beta-endorphin; Met-enkephalin]"
drug.Protein;P98066;TNFAIP6;ENSG00000123610;P98066;Tumor necrosis factor-inducible gene 6 protein (EC 3.1.1.-) (Hyaluronate-binding protein) (TNF-stimulated gene 6 protein) (TSG-6) (Tumor necrosis factor alpha-induced protein 6) (TNF alpha-induced protein 6)
drug.Protein;P01584;IL1B;ENSG00000125538;P01584;Interleukin-1 beta (IL-1 beta) (Catabolin)
drug.Protein;P22001;KCNA3;ENSG00000177272;P22001;Potassium voltage-gated channel subfamily A member 3 (HGK5) (HLK3) (HPCN3) (Voltage-gated K(+) channel HuKIII) (Voltage-gated potassium channel subunit Kv1.3)
drug.Protein;P49146;NPY2R;ENSG00000185149;P49146;Neuropeptide Y receptor type 2 (NPY2-R) (NPY-Y2 receptor) (Y2 receptor)
drug.Protein;P10696;ALPG;ENSG00000163286;P10696;Alkaline phosphatase, germ cell type (EC 3.1.3.1) (ALP-1) (Alkaline phosphatase Nagao isozyme) (Alkaline phosphatase, placental-like) (Germ cell alkaline phosphatase) (GCAP) (Placental alkaline phosphatase-like) (PLAP-like)
drug.Protein;Q14181;POLA2;ENSG00000014138;Q14181;DNA polymerase alpha subunit B (DNA polymerase alpha 70 kDa subunit)
drug.Protein;O95644;NFATC1;ENSG00000131196;O95644;Nuclear factor of activated T-cells, cytoplasmic 1 (NF-ATc1) (NFATc1) (NFAT transcription complex cytosolic component) (NF-ATc) (NFATc)
drug.Protein;P19838;NFKB1;ENSG00000109320;P19838;Nuclear factor NF-kappa-B p105 subunit (DNA-binding factor KBF1) (EBP-1) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) [Cleaved into: Nuclear factor NF-kappa-B p50 subunit]
drug.Protein;P60568;IL2;ENSG00000109471;P60568;Interleukin-2 (IL-2) (T-cell growth factor) (TCGF) (Aldesleukin)
drug.Protein;P13716;ALAD;ENSG00000148218;P13716;Delta-aminolevulinic acid dehydratase (ALADH) (EC 4.2.1.24) (Porphobilinogen synthase)
drug.Protein;Q8WWZ7;ABCA5;ENSG00000154265;Q8WWZ7;Cholesterol transporter ABCA5 (EC 7.6.2.-) (ATP-binding cassette sub-family A member 5)
drug.Protein;P27169;PON1;ENSG00000005421;P27169;Serum paraoxonase/arylesterase 1 (PON 1) (EC 3.1.1.2) (EC 3.1.1.81) (EC 3.1.8.1) (Aromatic esterase 1) (A-esterase 1) (K-45) (Serum aryldialkylphosphatase 1)
drug.Protein;P68871;HBB;ENSG00000244734;P68871;"Hemoglobin subunit beta (Beta-globin) (Hemoglobin beta chain) [Cleaved into: LVV-hemorphin-7; Spinorphin]"
drug.Protein;P69905;"HBA1; HBA2";ENSG00000206172;P69905;Hemoglobin subunit alpha (Alpha-globin) (Hemoglobin alpha chain) [Cleaved into: Hemopressin]
drug.Protein;P02794;FTH1;ENSG00000167996;P02794;Ferritin heavy chain (Ferritin H subunit) (EC 1.16.3.1) (Cell proliferation-inducing gene 15 protein) [Cleaved into: Ferritin heavy chain, N-terminally processed]
drug.Protein;P02792;FTL;ENSG00000087086;P02792;Ferritin light chain (Ferritin L subunit)
drug.Protein;P30273;FCER1G;ENSG00000158869;P30273;High affinity immunoglobulin epsilon receptor subunit gamma (Fc receptor gamma-chain) (FcRgamma) (Fc-epsilon RI-gamma) (IgE Fc receptor subunit gamma) (FceRI gamma)
drug.Protein;P48051;KCNJ6;ENSG00000157542;P48051;G protein-activated inward rectifier potassium channel 2 (GIRK-2) (BIR1) (Inward rectifier K(+) channel Kir3.2) (KATP-2) (Potassium channel, inwardly rectifying subfamily J member 6)
drug.Protein;P19320;VCAM1;ENSG00000162692;P19320;Vascular cell adhesion protein 1 (V-CAM 1) (VCAM-1) (INCAM-100) (CD antigen CD106)
drug.Protein;P48544;KCNJ5;ENSG00000120457;P48544;G protein-activated inward rectifier potassium channel 4 (GIRK-4) (Cardiac inward rectifier) (CIR) (Heart KATP channel) (Inward rectifier K(+) channel Kir3.4) (IRK-4) (KATP-1) (Potassium channel, inwardly rectifying subfamily J member 5)
drug.Protein;Q8N1C3;GABRG1;ENSG00000163285;Q8N1C3;Gamma-aminobutyric acid receptor subunit gamma-1 (GABA(A) receptor subunit gamma-1)
drug.Protein;Q99928;GABRG3;ENSG00000182256;Q99928;Gamma-aminobutyric acid receptor subunit gamma-3 (GABA(A) receptor subunit gamma-3)
drug.Protein;P78334;GABRE;ENSG00000102287;P78334;Gamma-aminobutyric acid receptor subunit epsilon (GABA(A) receptor subunit epsilon)
drug.Protein;O00591;GABRP;ENSG00000094755;O00591;Gamma-aminobutyric acid receptor subunit pi (GABA(A) receptor subunit pi)
drug.Protein;Q9UN88;GABRQ;ENSG00000268089;Q9UN88;Gamma-aminobutyric acid receptor subunit theta (GABA(A) receptor subunit theta)
drug.Protein;O14764;GABRD;ENSG00000187730;O14764;Gamma-aminobutyric acid receptor subunit delta (GABA(A) receptor subunit delta)
drug.Protein;A5X5Y0;HTR3E;ENSG00000186038;A5X5Y0;5-hydroxytryptamine receptor 3E (5-HT3-E) (5-HT3E) (Serotonin receptor 3E)
drug.Protein;O95264;HTR3B;ENSG00000149305;O95264;5-hydroxytryptamine receptor 3B (5-HT3-B) (5-HT3B) (Serotonin receptor 3B)
drug.Protein;Q70Z44;HTR3D;ENSG00000186090;Q70Z44;5-hydroxytryptamine receptor 3D (5-HT3-D) (5-HT3D) (Serotonin receptor 3D)
drug.Protein;Q8WXA8;HTR3C;ENSG00000178084;Q8WXA8;5-hydroxytryptamine receptor 3C (5-HT3-C) (5-HT3C) (Serotonin receptor 3C)
drug.Protein;Q9Y698;CACNG2;ENSG00000166862;Q9Y698;Voltage-dependent calcium channel gamma-2 subunit (Neuronal voltage-gated calcium channel gamma-2 subunit) (Transmembrane AMPAR regulatory protein gamma-2) (TARP gamma-2)
drug.Protein;Q92806;KCNJ9;ENSG00000162728;Q92806;G protein-activated inward rectifier potassium channel 3 (GIRK-3) (Inward rectifier K(+) channel Kir3.3) (Potassium channel, inwardly rectifying subfamily J member 9)
drug.Protein;P32004;L1CAM;ENSG00000198910;P32004;Neural cell adhesion molecule L1 (N-CAM-L1) (NCAM-L1) (CD antigen CD171)
drug.Protein;Q9UJU2;LEF1;ENSG00000138795;Q9UJU2;Lymphoid enhancer-binding factor 1 (LEF-1) (T cell-specific transcription factor 1-alpha) (TCF1-alpha)
drug.Protein;P43115;PTGER3;ENSG00000050628;P43115;Prostaglandin E2 receptor EP3 subtype (PGE receptor EP3 subtype) (PGE2 receptor EP3 subtype) (PGE2-R) (Prostanoid EP3 receptor)
drug.Protein;P30531;SLC6A1;ENSG00000157103;P30531;Sodium- and chloride-dependent GABA transporter 1 (GAT-1) (Solute carrier family 6 member 1)
drug.Protein;Q9UI33;SCN11A;ENSG00000168356;Q9UI33;Sodium channel protein type 11 subunit alpha (Peripheral nerve sodium channel 5) (PN5) (Sensory neuron sodium channel 2) (Sodium channel protein type XI subunit alpha) (Voltage-gated sodium channel subunit alpha Nav1.9) (hNaN)
drug.Protein;O60939;SCN2B;ENSG00000149575;O60939;Sodium channel subunit beta-2
drug.Protein;Q9NY72;SCN3B;ENSG00000166257;Q9NY72;Sodium channel subunit beta-3
drug.Protein;Q8IWT1;SCN4B;ENSG00000177098;Q8IWT1;Sodium channel subunit beta-4
drug.Protein;P35218;CA5A;ENSG00000174990;P35218;Carbonic anhydrase 5A, mitochondrial (EC 4.2.1.1) (Carbonate dehydratase VA) (Carbonic anhydrase VA) (CA-VA)
drug.Protein;Q9Y2D0;CA5B;ENSG00000169239;Q9Y2D0;Carbonic anhydrase 5B, mitochondrial (EC 4.2.1.1) (Carbonate dehydratase VB) (Carbonic anhydrase VB) (CA-VB)
drug.Protein;P23280;CA6;ENSG00000131686;P23280;Carbonic anhydrase 6 (EC 4.2.1.1) (Carbonate dehydratase VI) (Carbonic anhydrase VI) (CA-VI) (Salivary carbonic anhydrase) (Secreted carbonic anhydrase)
drug.Protein;P35219;CA8;ENSG00000178538;P35219;Carbonic anhydrase-related protein (CARP) (Carbonic anhydrase VIII) (CA-VIII)
drug.Protein;Q9NS85;CA10;ENSG00000154975;Q9NS85;Carbonic anhydrase-related protein 10 (Carbonic anhydrase-related protein X) (CA-RP X) (CARP X) (Cerebral protein 15)
drug.Protein;O75493;CA11;ENSG00000063180;O75493;Carbonic anhydrase-related protein 11 (CA-RP XI) (CA-XI) (CARP XI) (Carbonic anhydrase-related protein 2) (CA-RP II) (CARP-2)
drug.Protein;Q8N1Q1;CA13;ENSG00000185015;Q8N1Q1;Carbonic anhydrase 13 (EC 4.2.1.1) (Carbonate dehydratase XIII) (Carbonic anhydrase XIII) (CA-XIII)
drug.Protein;Q15842;KCNJ8;ENSG00000121361;Q15842;ATP-sensitive inward rectifier potassium channel 8 (Inward rectifier K(+) channel Kir6.1) (Potassium channel, inwardly rectifying subfamily J member 8) (uKATP-1)
drug.Protein;P35408;PTGER4;ENSG00000171522;P35408;Prostaglandin E2 receptor EP4 subtype (PGE receptor EP4 subtype) (PGE2 receptor EP4 subtype) (Prostanoid EP4 receptor)
drug.Protein;P41146;OPRL1;ENSG00000125510;P41146;Nociceptin receptor (Kappa-type 3 opioid receptor) (KOR-3) (Orphanin FQ receptor)
drug.Protein;O00206;TLR4;ENSG00000136869;O00206;Toll-like receptor 4 (hToll) (CD antigen CD284)
drug.Protein;P04637;TP53;ENSG00000141510;P04637;Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53)
drug.Protein;P51812;RPS6KA3;ENSG00000177189;P51812;Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)
drug.Protein;P25963;NFKBIA;ENSG00000100906;P25963;NF-kappa-B inhibitor alpha (I-kappa-B-alpha) (IkB-alpha) (IkappaBalpha) (Major histocompatibility complex enhancer-binding protein MAD3)
drug.Protein;P29466;CASP1;ENSG00000137752;P29466;"Caspase-1 (CASP-1) (EC 3.4.22.36) (Interleukin-1 beta convertase) (IL-1BC) (Interleukin-1 beta-converting enzyme) (ICE) (IL-1 beta-converting enzyme) (p45) [Cleaved into: Caspase-1 subunit p20; Caspase-1 subunit p10]"
drug.Protein;P24385;CCND1;ENSG00000110092;P24385;G1/S-specific cyclin-D1 (B-cell lymphoma 1 protein) (BCL-1) (BCL-1 oncogene) (PRAD1 oncogene)
drug.Protein;P01106;MYC;ENSG00000136997;P01106;Myc proto-oncogene protein (Class E basic helix-loop-helix protein 39) (bHLHe39) (Proto-oncogene c-Myc) (Transcription factor p64)
drug.Protein;P11086;PNMT;ENSG00000141744;P11086;Phenylethanolamine N-methyltransferase (PNMTase) (EC 2.1.1.28) (Noradrenaline N-methyltransferase)
drug.Protein;P35610;SOAT1;ENSG00000057252;P35610;Sterol O-acyltransferase 1 (EC 2.3.1.26) (Acyl-coenzyme A:cholesterol acyltransferase 1) (ACAT-1) (Cholesterol acyltransferase 1)
drug.Protein;P15144;ANPEP;ENSG00000166825;P15144;Aminopeptidase N (AP-N) (hAPN) (EC 3.4.11.2) (Alanyl aminopeptidase) (Aminopeptidase M) (AP-M) (Microsomal aminopeptidase) (Myeloid plasma membrane glycoprotein CD13) (gp150) (CD antigen CD13)
drug.Protein;Q9Y233;PDE10A;ENSG00000112541;Q9Y233;cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A (EC 3.1.4.17)
drug.Protein;P53805;RCAN1;ENSG00000159200;P53805;Calcipressin-1 (Adapt78) (Down syndrome critical region protein 1) (Myocyte-enriched calcineurin-interacting protein 1) (MCIP1) (Regulator of calcineurin 1)
drug.Protein;P48039;MTNR1A;ENSG00000168412;P48039;Melatonin receptor type 1A (Mel-1A-R) (Mel1a receptor)
drug.Protein;P49286;MTNR1B;ENSG00000134640;P49286;Melatonin receptor type 1B (Mel-1B-R) (Mel1b receptor)
drug.Protein;P06746;POLB;ENSG00000070501;P06746;DNA polymerase beta (EC 2.7.7.7) (EC 4.2.99.-)
drug.Protein;P32321;DCTD;ENSG00000129187;P32321;Deoxycytidylate deaminase (EC 3.5.4.12) (dCMP deaminase)
drug.Protein;P63000;RAC1;ENSG00000136238;P63000;Ras-related C3 botulinum toxin substrate 1 (EC 3.6.5.2) (Cell migration-inducing gene 5 protein) (Ras-like protein TC25) (p21-Rac1)
drug.Protein;Q9NV35;NUDT15;ENSG00000136159;Q9NV35;Nucleotide triphosphate diphosphatase NUDT15 (EC 3.6.1.9) (MutT homolog 2) (MTH2) (Nucleoside diphosphate-linked moiety X motif 15) (Nudix motif 15) (Nucleoside diphosphate-linked to another moiety X hydrolase 15) (Nudix hydrolase 15)
drug.Protein;Q9BY32;ITPA;ENSG00000125877;Q9BY32;Inosine triphosphate pyrophosphatase (ITPase) (Inosine triphosphatase) (EC 3.6.1.9) (Non-canonical purine NTP pyrophosphatase) (Non-standard purine NTP pyrophosphatase) (Nucleoside-triphosphate diphosphatase) (Nucleoside-triphosphate pyrophosphatase) (NTPase) (Putative oncogene protein hlc14-06-p)
drug.Protein;Q8NBI5;SLC43A3;ENSG00000134802;Q8NBI5;Equilibrative nucleobase transporter 1 (Protein FOAP-13) (Solute carrier family 43 member 3)
drug.Protein;P30044;PRDX5;ENSG00000126432;P30044;Peroxiredoxin-5, mitochondrial (EC 1.11.1.24) (Alu corepressor 1) (Antioxidant enzyme B166) (AOEB166) (Liver tissue 2D-page spot 71B) (PLP) (Peroxiredoxin V) (Prx-V) (Peroxisomal antioxidant enzyme) (TPx type VI) (Thioredoxin peroxidase PMP20) (Thioredoxin-dependent peroxiredoxin 5)
drug.Protein;Q9NR82;KCNQ5;ENSG00000185760;Q9NR82;Potassium voltage-gated channel subfamily KQT member 5 (KQT-like 5) (Potassium channel subunit alpha KvLQT5) (Voltage-gated potassium channel subunit Kv7.5)
drug.Protein;Q14978;NOLC1;ENSG00000166197;Q14978;Nucleolar and coiled-body phosphoprotein 1 (140 kDa nucleolar phosphoprotein) (Nopp140) (Hepatitis C virus NS5A-transactivated protein 13) (HCV NS5A-transactivated protein 13) (Nucleolar 130 kDa protein) (Nucleolar phosphoprotein p130)
drug.Protein;Q9NUT2;ABCB8;ENSG00000197150;Q9NUT2;Mitochondrial potassium channel ATP-binding subunit (ATP-binding cassette sub-family B member 8, mitochondrial) (ABCB8) (Mitochondrial ATP-binding cassette 1) (M-ABC1) (Mitochondrial sulfonylurea-receptor) (MITOSUR)
drug.Protein;P25815;S100P;ENSG00000163993;P25815;Protein S100-P (Migration-inducing gene 9 protein) (MIG9) (Protein S100-E) (S100 calcium-binding protein P)
drug.Protein;Q16850;CYP51A1;ENSG00000001630;Q16850;Lanosterol 14-alpha demethylase (LDM) (EC 1.14.14.154) (CYPLI) (Cytochrome P450 51A1) (Cytochrome P450-14DM) (Cytochrome P45014DM) (Cytochrome P450LI) (Sterol 14-alpha demethylase)
drug.Protein;P25024;CXCR1;ENSG00000163464;P25024;C-X-C chemokine receptor type 1 (CXC-R1) (CXCR-1) (CDw128a) (High affinity interleukin-8 receptor A) (IL-8R A) (IL-8 receptor type 1) (CD antigen CD181)
drug.Protein;Q8TD43;TRPM4;ENSG00000130529;Q8TD43;Transient receptor potential cation channel subfamily M member 4 (hTRPM4) (Calcium-activated non-selective cation channel 1) (Long transient receptor potential channel 4) (LTrpC-4) (LTrpC4) (Melastatin-4)
drug.Protein;P99999;CYCS;ENSG00000172115;P99999;Cytochrome c
drug.Protein;P78329;CYP4F2;ENSG00000186115;P78329;Cytochrome P450 4F2 (EC 1.14.14.1) (20-hydroxyeicosatetraenoic acid synthase) (20-HETE synthase) (Arachidonic acid omega-hydroxylase) (CYPIVF2) (Cytochrome P450-LTB-omega) (Docosahexaenoic acid omega-hydroxylase) (EC 1.14.14.79) (Leukotriene-B(4) 20-monooxygenase 1) (Leukotriene-B(4) omega-hydroxylase 1) (EC 1.14.14.94) (Phylloquinone omega-hydroxylase CYP4F2) (EC 1.14.14.78)
drug.Protein;Q9Y5Z9;UBIAD1;ENSG00000120942;Q9Y5Z9;UbiA prenyltransferase domain-containing protein 1 (EC 2.5.1.-) (Transitional epithelial response protein 1)
drug.Protein;P02585;TNNC2;ENSG00000101470;P02585;Troponin C, skeletal muscle
drug.Protein;P08700;IL3;ENSG00000164399;P08700;Interleukin-3 (IL-3) (Hematopoietic growth factor) (Mast cell growth factor) (MCGF) (Multipotential colony-stimulating factor) (P-cell-stimulating factor)
drug.Protein;P08686;CYP21A2;ENSG00000231852;P08686;Steroid 21-hydroxylase (EC 1.14.14.16) (21-OHase) (Cytochrome P-450c21) (Cytochrome P450 21) (Cytochrome P450 XXI) (Cytochrome P450-C21) (Cytochrome P450-C21B)
drug.Protein;Q9HCS2;CYP4F12;ENSG00000186204;Q9HCS2;Cytochrome P450 4F12 (EC 1.14.14.1) (CYPIVF12)
drug.Protein;Q96RD7;PANX1;ENSG00000110218;Q96RD7;Pannexin-1
drug.Protein;Q9NYV7;TAS2R16;ENSG00000128519;Q9NYV7;Taste receptor type 2 member 16 (T2R16)
drug.Protein;P49327;FASN;ENSG00000169710;P49327;"Fatty acid synthase (EC 2.3.1.85) (Type I fatty acid synthase) [Includes: [Acyl-carrier-protein] S-acetyltransferase (EC 2.3.1.38); [Acyl-carrier-protein] S-malonyltransferase (EC 2.3.1.39); 3-oxoacyl-[acyl-carrier-protein] synthase (EC 2.3.1.41); 3-oxoacyl-[acyl-carrier-protein] reductase (EC 1.1.1.100); 3-hydroxyacyl-[acyl-carrier-protein] dehydratase (EC 4.2.1.59); Enoyl-[acyl-carrier-protein] reductase (EC 1.3.1.39); Acyl-[acyl-carrier-protein] hydrolase (EC 3.1.2.14)]"
drug.Protein;P51788;CLCN2;ENSG00000114859;P51788;Chloride channel protein 2 (ClC-2)
drug.Protein;Q99835;SMO;ENSG00000128602;Q99835;Smoothened homolog (SMO) (Protein Gx)
drug.Protein;P01889;HLA-B;ENSG00000234745;P01889;HLA class I histocompatibility antigen, B alpha chain (Human leukocyte antigen B) (HLA-B)
drug.Protein;P10415;BCL2;ENSG00000171791;P10415;Apoptosis regulator Bcl-2
drug.Protein;P07359;GP1BA;ENSG00000185245;P07359;Platelet glycoprotein Ib alpha chain (GP-Ib alpha) (GPIb-alpha) (GPIbA) (Glycoprotein Ibalpha) (Antigen CD42b-alpha) (CD antigen CD42b) [Cleaved into: Glycocalicin]
drug.Protein;P31151;S100A7;ENSG00000143556;P31151;Protein S100-A7 (Psoriasin) (S100 calcium-binding protein A7)
drug.Protein;D6RB81;;;;
drug.Protein;P13500;CCL2;ENSG00000108691;P13500;C-C motif chemokine 2 (HC11) (Monocyte chemoattractant protein 1) (Monocyte chemotactic and activating factor) (MCAF) (Monocyte chemotactic protein 1) (MCP-1) (Monocyte secretory protein JE) (Small-inducible cytokine A2)
drug.Protein;Q92753;RORB;ENSG00000198963;Q92753;Nuclear receptor ROR-beta (Nuclear receptor RZR-beta) (Nuclear receptor subfamily 1 group F member 2) (Retinoid-related orphan receptor-beta)
drug.Protein;P11678;EPX;ENSG00000121053;P11678;"Eosinophil peroxidase (EPO) (EC 1.11.1.7) [Cleaved into: Eosinophil peroxidase light chain; Eosinophil peroxidase heavy chain]"
drug.Protein;P46597;ASMT;ENSG00000196433;P46597;Acetylserotonin O-methyltransferase (EC 2.1.1.4) (Hydroxyindole O-methyltransferase) (HIOMT)
drug.Protein;P27487;DPP4;ENSG00000197635;P27487;"Dipeptidyl peptidase 4 (EC 3.4.14.5) (ADABP) (Adenosine deaminase complexing protein 2) (ADCP-2) (Dipeptidyl peptidase IV) (DPP IV) (T-cell activation antigen CD26) (TP103) (CD antigen CD26) [Cleaved into: Dipeptidyl peptidase 4 membrane form (Dipeptidyl peptidase IV membrane form); Dipeptidyl peptidase 4 soluble form (Dipeptidyl peptidase IV soluble form)]"
drug.Protein;P16233;PNLIP;ENSG00000175535;P16233;Pancreatic triacylglycerol lipase (PL) (PTL) (Pancreatic lipase) (EC 3.1.1.3)
drug.Protein;P07098;LIPF;ENSG00000182333;P07098;Gastric triacylglycerol lipase (GL) (Gastric lipase) (EC 3.1.1.3)
drug.Protein;P08729;KRT7;ENSG00000135480;P08729;Keratin, type II cytoskeletal 7 (Cytokeratin-7) (CK-7) (Keratin-7) (K7) (Sarcolectin) (Type-II keratin Kb7)
drug.Protein;P50993;ATP1A2;ENSG00000018625;P50993;Sodium/potassium-transporting ATPase subunit alpha-2 (Na(+)/K(+) ATPase alpha-2 subunit) (EC 7.2.2.13) (Sodium pump subunit alpha-2)
drug.Protein;P13637;ATP1A3;ENSG00000105409;P13637;Sodium/potassium-transporting ATPase subunit alpha-3 (Na(+)/K(+) ATPase alpha-3 subunit) (EC 7.2.2.13) (Na(+)/K(+) ATPase alpha(III) subunit) (Sodium pump subunit alpha-3)
drug.Protein;O75908;SOAT2;ENSG00000167780;O75908;Sterol O-acyltransferase 2 (EC 2.3.1.26) (Acyl-coenzyme A:cholesterol acyltransferase 2) (ACAT-2) (Cholesterol acyltransferase 2)
drug.Protein;P55157;MTTP;ENSG00000138823;P55157;Microsomal triglyceride transfer protein large subunit
drug.Protein;Q02127;DHODH;ENSG00000102967;Q02127;Dihydroorotate dehydrogenase (quinone), mitochondrial (DHOdehase) (EC 1.3.5.2) (Dihydroorotate oxidase)
drug.Protein;Q14289;PTK2B;ENSG00000120899;Q14289;Protein-tyrosine kinase 2-beta (EC 2.7.10.2) (Calcium-dependent tyrosine kinase) (CADTK) (Calcium-regulated non-receptor proline-rich tyrosine kinase) (Cell adhesion kinase beta) (CAK-beta) (CAKB) (Focal adhesion kinase 2) (FADK 2) (Proline-rich tyrosine kinase 2) (Related adhesion focal tyrosine kinase) (RAFTK)
drug.Protein;O60733;PLA2G6;ENSG00000184381;O60733;85/88 kDa calcium-independent phospholipase A2 (CaI-PLA2) (EC 3.1.1.4) (2-lysophosphatidylcholine acylhydrolase) (EC 3.1.1.5) (Group VI phospholipase A2) (GVI PLA2) (Intracellular membrane-associated calcium-independent phospholipase A2 beta) (iPLA2-beta) (Palmitoyl-CoA hydrolase) (EC 3.1.2.2) (Patatin-like phospholipase domain-containing protein 9) (PNPLA9)
drug.Protein;Q15111;PLCL1;ENSG00000115896;Q15111;Inactive phospholipase C-like protein 1 (PLC-L1) (Phospholipase C-deleted in lung carcinoma) (Phospholipase C-related but catalytically inactive protein) (PRIP)
drug.Protein;O95665;NTSR2;ENSG00000169006;O95665;Neurotensin receptor type 2 (NT-R-2) (NTR2) (Levocabastine-sensitive neurotensin receptor)
drug.Protein;P16109;SELP;ENSG00000174175;P16109;P-selectin (CD62 antigen-like family member P) (Granule membrane protein 140) (GMP-140) (Leukocyte-endothelial cell adhesion molecule 3) (LECAM3) (Platelet activation dependent granule-external membrane protein) (PADGEM) (CD antigen CD62P)
drug.Protein;P22455;FGFR4;ENSG00000160867;P22455;Fibroblast growth factor receptor 4 (FGFR-4) (EC 2.7.10.1) (CD antigen CD334)
drug.Protein;O95750;FGF19;ENSG00000162344;O95750;Fibroblast growth factor 19 (FGF-19)
drug.Protein;P14210;HGF;ENSG00000019991;P14210;"Hepatocyte growth factor (Hepatopoietin-A) (Scatter factor) (SF) [Cleaved into: Hepatocyte growth factor alpha chain; Hepatocyte growth factor beta chain]"
drug.Protein;Q9Y251;HPSE;ENSG00000173083;Q9Y251;"Heparanase (EC 3.2.1.166) (Endo-glucoronidase) (Heparanase-1) (Hpa1) [Cleaved into: Heparanase 8 kDa subunit; Heparanase 50 kDa subunit]"
drug.Protein;Q86YN6;PPARGC1B;ENSG00000155846;Q86YN6;Peroxisome proliferator-activated receptor gamma coactivator 1-beta (PGC-1-beta) (PPAR-gamma coactivator 1-beta) (PPARGC-1-beta) (PGC-1-related estrogen receptor alpha coactivator)
drug.Protein;Q05209;PTPN12;ENSG00000127947;Q05209;Tyrosine-protein phosphatase non-receptor type 12 (EC 3.1.3.48) (PTP-PEST) (Protein-tyrosine phosphatase G1) (PTPG1)
drug.Protein;P29350;PTPN6;ENSG00000111679;P29350;Tyrosine-protein phosphatase non-receptor type 6 (EC 3.1.3.48) (Hematopoietic cell protein-tyrosine phosphatase) (Protein-tyrosine phosphatase 1C) (PTP-1C) (Protein-tyrosine phosphatase SHP-1) (SH-PTP1)
drug.Protein;P16860;NPPB;ENSG00000120937;P16860;"Natriuretic peptides B (Brain natriuretic factor prohormone) (preproBNP) (proBNP) (Gamma-brain natriuretic peptide) (Iso-ANP) [Cleaved into: NT-proBNP (NT-pro-BNP) (NT-proBNP(1-76)); proBNP(3-108); Brain natriuretic peptide 32 (BNP(1-32)) (BNP-32) (Brain natriuretic peptide) (BNP); BNP(1-30); BNP(1-29); BNP(1-28); BNP(2-31); BNP(3-32) (des-SerPro-BNP) (proBNP(79-108)); BNP(3-30); BNP(3-29); Brain natriuretic peptide 29 (BNP(4-32)); BNP(4-31); BNP(4-30); BNP(4-29); BNP(4-27); BNP(5-32); BNP(5-31); BNP(5-29)]"
drug.Protein;P16581;SELE;ENSG00000007908;P16581;E-selectin (CD62 antigen-like family member E) (Endothelial leukocyte adhesion molecule 1) (ELAM-1) (Leukocyte-endothelial cell adhesion molecule 2) (LECAM2) (CD antigen CD62E)
drug.Protein;Q16665;HIF1A;ENSG00000100644;Q16665;Hypoxia-inducible factor 1-alpha (HIF-1-alpha) (HIF1-alpha) (ARNT-interacting protein) (Basic-helix-loop-helix-PAS protein MOP1) (Class E basic helix-loop-helix protein 78) (bHLHe78) (Member of PAS protein 1) (PAS domain-containing protein 8)
drug.Protein;P48050;KCNJ4;ENSG00000168135;P48050;Inward rectifier potassium channel 4 (HIRK2) (HRK1) (Hippocampal inward rectifier) (HIR) (Inward rectifier K(+) channel Kir2.3) (IRK-3) (Potassium channel, inwardly rectifying subfamily J member 4)
drug.Protein;P63252;KCNJ2;ENSG00000123700;P63252;Inward rectifier potassium channel 2 (Cardiac inward rectifier potassium channel) (Inward rectifier K(+) channel Kir2.1) (IRK-1) (hIRK1) (Potassium channel, inwardly rectifying subfamily J member 2)
drug.Protein;P15289;ARSA;ENSG00000100299;P15289;"Arylsulfatase A (ASA) (EC 3.1.6.8) (Cerebroside-sulfatase) [Cleaved into: Arylsulfatase A component B; Arylsulfatase A component C]"
drug.Protein;P08100;RHO;ENSG00000163914;P08100;Rhodopsin (Opsin-2)
drug.Protein;P59768;GNG2;ENSG00000186469;P59768;Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2 (G gamma-I)
drug.Protein;Q6W5P4;NPSR1;ENSG00000187258;Q6W5P4;Neuropeptide S receptor (G-protein coupled receptor 154) (G-protein coupled receptor PGR14) (G-protein coupled receptor for asthma susceptibility)
drug.Protein;P28482;MAPK1;ENSG00000100030;P28482;Mitogen-activated protein kinase 1 (MAP kinase 1) (MAPK 1) (EC 2.7.11.24) (ERT1) (Extracellular signal-regulated kinase 2) (ERK-2) (MAP kinase isoform p42) (p42-MAPK) (Mitogen-activated protein kinase 2) (MAP kinase 2) (MAPK 2)
drug.Protein;P38936;CDKN1A;ENSG00000124762;P38936;Cyclin-dependent kinase inhibitor 1 (CDK-interacting protein 1) (Melanoma differentiation-associated protein 6) (MDA-6) (p21)
drug.Protein;Q13547;HDAC1;ENSG00000116478;Q13547;Histone deacetylase 1 (HD1) (EC 3.5.1.98) (Protein deacetylase HDAC1) (EC 3.5.1.-) (Protein decrotonylase HDAC1) (EC 3.5.1.-)
drug.Protein;P29590;PML;ENSG00000140464;P29590;Protein PML (E3 SUMO-protein ligase PML) (EC 2.3.2.-) (Promyelocytic leukemia protein) (RING finger protein 71) (RING-type E3 SUMO transferase PML) (Tripartite motif-containing protein 19) (TRIM19)
drug.Protein;P30536;TSPO;ENSG00000100300;P30536;Translocator protein (Mitochondrial benzodiazepine receptor) (PKBS) (Peripheral-type benzodiazepine receptor) (PBR)
drug.Protein;Q92736;RYR2;ENSG00000198626;Q92736;Ryanodine receptor 2 (RYR-2) (RyR2) (hRYR-2) (Cardiac muscle ryanodine receptor) (Cardiac muscle ryanodine receptor-calcium release channel) (Type 2 ryanodine receptor)
drug.Protein;P11137;MAP2;ENSG00000078018;P11137;Microtubule-associated protein 2 (MAP-2)
drug.Protein;P78559;MAP1A;ENSG00000166963;P78559;"Microtubule-associated protein 1A (MAP-1A) (Proliferation-related protein p80) [Cleaved into: MAP1A heavy chain; MAP1 light chain LC2]"
drug.Protein;P09960;LTA4H;ENSG00000111144;P09960;Leukotriene A-4 hydrolase (LTA-4 hydrolase) (EC 3.3.2.6) (Leukotriene A(4) hydrolase) (Tripeptide aminopeptidase LTA4H) (EC 3.4.11.4)
drug.Protein;Q7L0J3;SV2A;ENSG00000159164;Q7L0J3;Synaptic vesicle glycoprotein 2A
drug.Protein;P14859;POU2F1;ENSG00000143190;P14859;POU domain, class 2, transcription factor 1 (NF-A1) (Octamer-binding protein 1) (Oct-1) (Octamer-binding transcription factor 1) (OTF-1)
drug.Protein;P09086;POU2F2;ENSG00000028277;P09086;POU domain, class 2, transcription factor 2 (Lymphoid-restricted immunoglobulin octamer-binding protein NF-A2) (Octamer-binding protein 2) (Oct-2) (Octamer-binding transcription factor 2) (OTF-2)
drug.Protein;Q9H169;STMN4;ENSG00000015592;Q9H169;Stathmin-4 (Stathmin-like protein B3) (RB3)
drug.Protein;P21731;TBXA2R;ENSG00000006638;P21731;Thromboxane A2 receptor (TXA2-R) (Prostanoid TP receptor)
drug.Protein;P04040;CAT;ENSG00000121691;P04040;Catalase (EC 1.11.1.6)
drug.Protein;P27816;MAP4;ENSG00000047849;P27816;Microtubule-associated protein 4 (MAP-4)
drug.Protein;P51843;NR0B1;ENSG00000169297;P51843;Nuclear receptor subfamily 0 group B member 1 (DSS-AHC critical region on the X chromosome protein 1) (Nuclear receptor DAX-1)
drug.Protein;Q96ER9;CCDC51;ENSG00000164051;Q96ER9;Mitochondrial potassium channel (MITOK) (Coiled-coil domain-containing protein 51)
drug.Protein;P51787;KCNQ1;ENSG00000053918;P51787;Potassium voltage-gated channel subfamily KQT member 1 (IKs producing slow voltage-gated potassium channel subunit alpha KvLQT1) (KQT-like 1) (Voltage-gated potassium channel subunit Kv7.1)
drug.Protein;P01579;IFNG;ENSG00000111537;P01579;Interferon gamma (IFN-gamma) (Immune interferon)
drug.Protein;P12931;SRC;ENSG00000197122;P12931;Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)
drug.Protein;P29317;EPHA2;ENSG00000142627;P29317;Ephrin type-A receptor 2 (EC 2.7.10.1) (Epithelial cell kinase) (Tyrosine-protein kinase receptor ECK)
drug.Protein;P06239;LCK;ENSG00000182866;P06239;Tyrosine-protein kinase Lck (EC 2.7.10.2) (Leukocyte C-terminal Src kinase) (LSK) (Lymphocyte cell-specific protein-tyrosine kinase) (Protein YT16) (Proto-oncogene Lck) (T cell-specific protein-tyrosine kinase) (p56-LCK)
drug.Protein;P07947;YES1;ENSG00000176105;P07947;Tyrosine-protein kinase Yes (EC 2.7.10.2) (Proto-oncogene c-Yes) (p61-Yes)
drug.Protein;P51692;STAT5B;ENSG00000173757;P51692;Signal transducer and activator of transcription 5B
drug.Protein;P06241;FYN;ENSG00000010810;P06241;Tyrosine-protein kinase Fyn (EC 2.7.10.2) (Proto-oncogene Syn) (Proto-oncogene c-Fyn) (Src-like kinase) (SLK) (p59-Fyn)
drug.Protein;Q06187;BTK;ENSG00000010671;Q06187;Tyrosine-protein kinase BTK (EC 2.7.10.2) (Agammaglobulinemia tyrosine kinase) (ATK) (B-cell progenitor kinase) (BPK) (Bruton tyrosine kinase)
drug.Protein;Q92570;NR4A3;ENSG00000119508;Q92570;Nuclear receptor subfamily 4 group A member 3 (Mitogen-induced nuclear orphan receptor) (Neuron-derived orphan receptor 1) (Nuclear hormone receptor NOR-1)
drug.Protein;P41240;CSK;ENSG00000103653;P41240;Tyrosine-protein kinase CSK (EC 2.7.10.2) (C-Src kinase) (Protein-tyrosine kinase CYL)
drug.Protein;P54756;EPHA5;ENSG00000145242;P54756;Ephrin type-A receptor 5 (EC 2.7.10.1) (Brain-specific kinase) (EPH homology kinase 1) (EHK-1) (EPH-like kinase 7) (EK7) (hEK7)
drug.Protein;P54760;EPHB4;ENSG00000196411;P54760;Ephrin type-B receptor 4 (EC 2.7.10.1) (Hepatoma transmembrane kinase) (Tyrosine-protein kinase TYRO11)
drug.Protein;P09769;FGR;ENSG00000000938;P09769;Tyrosine-protein kinase Fgr (EC 2.7.10.2) (Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog) (Proto-oncogene c-Fgr) (p55-Fgr) (p58-Fgr) (p58c-Fgr)
drug.Protein;P42685;FRK;ENSG00000111816;P42685;Tyrosine-protein kinase FRK (EC 2.7.10.2) (FYN-related kinase) (Nuclear tyrosine protein kinase RAK) (Protein-tyrosine kinase 5)
drug.Protein;P11142;HSPA8;ENSG00000109971;P11142;Heat shock cognate 71 kDa protein (EC 3.6.4.10) (Heat shock 70 kDa protein 8) (Lipopolysaccharide-associated protein 1) (LAP-1) (LPS-associated protein 1)
drug.Protein;P07948;LYN;ENSG00000254087;P07948;Tyrosine-protein kinase Lyn (EC 2.7.10.2) (Lck/Yes-related novel protein tyrosine kinase) (V-yes-1 Yamaguchi sarcoma viral related oncogene homolog) (p53Lyn) (p56Lyn)
drug.Protein;Q9NYL2;MAP3K20;ENSG00000091436;Q9NYL2;Mitogen-activated protein kinase kinase kinase 20 (EC 2.7.11.25) (Human cervical cancer suppressor gene 4 protein) (HCCS-4) (Leucine zipper- and sterile alpha motif-containing kinase) (MLK-like mitogen-activated protein triple kinase) (Mitogen-activated protein kinase kinase kinase MLT) (Mixed lineage kinase-related kinase) (MLK-related kinase) (MRK) (Sterile alpha motif- and leucine zipper-containing kinase AZK)
drug.Protein;Q16539;MAPK14;ENSG00000112062;Q16539;Mitogen-activated protein kinase 14 (MAP kinase 14) (MAPK 14) (EC 2.7.11.24) (Cytokine suppressive anti-inflammatory drug-binding protein) (CSAID-binding protein) (CSBP) (MAP kinase MXI2) (MAX-interacting protein 2) (Mitogen-activated protein kinase p38 alpha) (MAP kinase p38 alpha) (Stress-activated protein kinase 2a) (SAPK2a)
drug.Protein;Q03518;TAP1;ENSG00000168394;Q03518;Antigen peptide transporter 1 (APT1) (EC 7.4.2.-) (ATP-binding cassette sub-family B member 2) (Peptide supply factor 1) (Peptide transporter PSF1) (PSF-1) (Peptide transporter TAP1) (Peptide transporter involved in antigen processing 1) (Really interesting new gene 4 protein) (RING4)
drug.Protein;Q9UBC3;DNMT3B;ENSG00000088305;Q9UBC3;DNA (cytosine-5)-methyltransferase 3B (Dnmt3b) (EC 2.1.1.37) (DNA methyltransferase HsaIIIB) (DNA MTase HsaIIIB) (M.HsaIIIB)
drug.Protein;O60664;PLIN3;ENSG00000105355;O60664;Perilipin-3 (47 kDa mannose 6-phosphate receptor-binding protein) (47 kDa MPR-binding protein) (Cargo selection protein TIP47) (Mannose-6-phosphate receptor-binding protein 1) (Placental protein 17) (PP17)
drug.Protein;P11717;IGF2R;ENSG00000197081;P11717;Cation-independent mannose-6-phosphate receptor (CI Man-6-P receptor) (CI-MPR) (M6PR) (300 kDa mannose 6-phosphate receptor) (MPR 300) (Insulin-like growth factor 2 receptor) (Insulin-like growth factor II receptor) (IGF-II receptor) (M6P/IGF2 receptor) (M6P/IGF2R) (CD antigen CD222)
drug.Protein;P35858;IGFALS;ENSG00000099769;P35858;Insulin-like growth factor-binding protein complex acid labile subunit (ALS)
drug.Protein;P08833;IGFBP1;ENSG00000146678;P08833;Insulin-like growth factor-binding protein 1 (IBP-1) (IGF-binding protein 1) (IGFBP-1) (Placental protein 12) (PP12)
drug.Protein;P18065;IGFBP2;ENSG00000115457;P18065;Insulin-like growth factor-binding protein 2 (IBP-2) (IGF-binding protein 2) (IGFBP-2)
drug.Protein;P22692;IGFBP4;ENSG00000141753;P22692;Insulin-like growth factor-binding protein 4 (IBP-4) (IGF-binding protein 4) (IGFBP-4)
drug.Protein;P24593;IGFBP5;ENSG00000115461;P24593;Insulin-like growth factor-binding protein 5 (IBP-5) (IGF-binding protein 5) (IGFBP-5)
drug.Protein;P24592;IGFBP6;ENSG00000167779;P24592;Insulin-like growth factor-binding protein 6 (IBP-6) (IGF-binding protein 6) (IGFBP-6)
drug.Protein;O60894;RAMP1;ENSG00000132329;O60894;Receptor activity-modifying protein 1 (Calcitonin-receptor-like receptor activity-modifying protein 1) (CRLR activity-modifying protein 1)
drug.Protein;O60895;RAMP2;ENSG00000131477;O60895;Receptor activity-modifying protein 2 (Calcitonin-receptor-like receptor activity-modifying protein 2) (CRLR activity-modifying protein 2)
drug.Protein;O60896;RAMP3;ENSG00000122679;O60896;Receptor activity-modifying protein 3 (Calcitonin-receptor-like receptor activity-modifying protein 3) (CRLR activity-modifying protein 3)
drug.Protein;Q16854;DGUOK;ENSG00000114956;Q16854;Deoxyguanosine kinase, mitochondrial (EC 2.7.1.113) (Deoxyadenosine kinase, mitochondrial) (EC 2.7.1.76)
drug.Protein;P33681;CD80;ENSG00000121594;P33681;T-lymphocyte activation antigen CD80 (Activation B7-1 antigen) (BB1) (CTLA-4 counter-receptor B7.1) (B7) (CD antigen CD80)
drug.Protein;Q01718;MC2R;ENSG00000185231;Q01718;Adrenocorticotropic hormone receptor (ACTH receptor) (ACTH-R) (Adrenocorticotropin receptor) (Melanocortin receptor 2) (MC2-R)
drug.Protein;P06850;CRH;ENSG00000147571;P06850;Corticoliberin (Corticotropin-releasing factor) (CRF) (Corticotropin-releasing hormone)
drug.Protein;Q04206;RELA;ENSG00000173039;Q04206;Transcription factor p65 (Nuclear factor NF-kappa-B p65 subunit) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 3)
drug.Protein;P40933;IL15;ENSG00000164136;P40933;Interleukin-15 (IL-15)
drug.Protein;P50052;AGTR2;ENSG00000180772;P50052;Type-2 angiotensin II receptor (Angiotensin II type-2 receptor) (AT2 receptor)
drug.Protein;P49841;GSK3B;ENSG00000082701;P49841;Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1)
drug.Protein;P29218;IMPA1;ENSG00000133731;P29218;Inositol monophosphatase 1 (IMP 1) (IMPase 1) (EC 3.1.3.25) (D-galactose 1-phosphate phosphatase) (EC 3.1.3.94) (Inositol-1(or 4)-monophosphatase 1) (Lithium-sensitive myo-inositol monophosphatase A1)
drug.Protein;O14732;IMPA2;ENSG00000141401;O14732;Inositol monophosphatase 2 (IMP 2) (IMPase 2) (EC 3.1.3.25) (Inositol-1(or 4)-monophosphatase 2) (Myo-inositol monophosphatase A2)
drug.Protein;P06870;KLK1;ENSG00000167748;P06870;Kallikrein-1 (EC 3.4.21.35) (Kidney/pancreas/salivary gland kallikrein) (Tissue kallikrein)
drug.Protein;Q01082;SPTBN1;ENSG00000115306;Q01082;Spectrin beta chain, non-erythrocytic 1 (Beta-II spectrin) (Fodrin beta chain) (Spectrin, non-erythroid beta chain 1)
drug.Protein;P20810;CAST;ENSG00000153113;P20810;Calpastatin (Calpain inhibitor) (Sperm BS-17 component)
drug.Protein;P49747;COMP;ENSG00000105664;P49747;Cartilage oligomeric matrix protein (COMP) (Thrombospondin-5) (TSP5)
drug.Protein;P05187;ALPP;ENSG00000163283;P05187;Alkaline phosphatase, placental type (EC 3.1.3.1) (Alkaline phosphatase Regan isozyme) (Placental alkaline phosphatase 1) (PLAP-1)
drug.Protein;P05109;S100A8;ENSG00000143546;P05109;Protein S100-A8 (Calgranulin-A) (Calprotectin L1L subunit) (Cystic fibrosis antigen) (CFAG) (Leukocyte L1 complex light chain) (Migration inhibitory factor-related protein 8) (MRP-8) (p8) (S100 calcium-binding protein A8) (Urinary stone protein band A)
drug.Protein;P06702;S100A9;ENSG00000163220;P06702;Protein S100-A9 (Calgranulin-B) (Calprotectin L1H subunit) (Leukocyte L1 complex heavy chain) (Migration inhibitory factor-related protein 14) (MRP-14) (p14) (S100 calcium-binding protein A9)
drug.Protein;P00450;CP;ENSG00000047457;P00450;Ceruloplasmin (EC 1.16.3.1) (Ferroxidase)
drug.Protein;P12644;BMP4;ENSG00000125378;P12644;Bone morphogenetic protein 4 (BMP-4) (Bone morphogenetic protein 2B) (BMP-2B)
drug.Protein;P08493;MGP;ENSG00000111341;P08493;Matrix Gla protein (MGP) (Cell growth-inhibiting gene 36 protein)
drug.Protein;Q8TAB3;PCDH19;ENSG00000165194;Q8TAB3;Protocadherin-19
drug.Protein;O75340;PDCD6;ENSG00000249915;O75340;Programmed cell death protein 6 (Apoptosis-linked gene 2 protein homolog) (ALG-2)
drug.Protein;P21796;VDAC1;ENSG00000213585;P21796;Voltage-dependent anion-selective channel protein 1 (VDAC-1) (hVDAC1) (Outer mitochondrial membrane protein porin 1) (Plasmalemmal porin) (Porin 31HL) (Porin 31HM)
drug.Protein;P45880;VDAC2;ENSG00000165637;P45880;Voltage-dependent anion-selective channel protein 2 (VDAC-2) (hVDAC2) (Outer mitochondrial membrane protein porin 2)
drug.Protein;Q9Y277;VDAC3;ENSG00000078668;Q9Y277;Voltage-dependent anion-selective channel protein 3 (VDAC-3) (hVDAC3) (Outer mitochondrial membrane protein porin 3)
drug.Protein;Q9Y6R1;SLC4A4;ENSG00000080493;Q9Y6R1;Electrogenic sodium bicarbonate cotransporter 1 (Sodium bicarbonate cotransporter) (Na(+)/HCO3(-) cotransporter) (Solute carrier family 4 member 4) (kNBC1)
drug.Protein;Q9Y6M7;SLC4A7;ENSG00000033867;Q9Y6M7;Sodium bicarbonate cotransporter 3 (Electroneutral Na/HCO(3) cotransporter) (Sodium bicarbonate cotransporter 2) (Sodium bicarbonate cotransporter 2b) (Bicarbonate transporter) (Solute carrier family 4 member 7)
drug.Protein;Q2Y0W8;SLC4A8;ENSG00000050438;Q2Y0W8;Electroneutral sodium bicarbonate exchanger 1 (Electroneutral Na(+)-driven Cl-HCO3 exchanger) (Solute carrier family 4 member 8) (k-NBC3)
drug.Protein;Q9BY07;SLC4A5;ENSG00000188687;Q9BY07;Electrogenic sodium bicarbonate cotransporter 4 (NBCe2) (Solute carrier family 4 member 5)
drug.Protein;Q6U841;SLC4A10;ENSG00000144290;Q6U841;Sodium-driven chloride bicarbonate exchanger (Solute carrier family 4 member 10)
drug.Protein;P05231;IL6;ENSG00000136244;P05231;Interleukin-6 (IL-6) (B-cell stimulatory factor 2) (BSF-2) (CTL differentiation factor) (CDF) (Hybridoma growth factor) (Interferon beta-2) (IFN-beta-2)
drug.Protein;P01138;NGF;ENSG00000134259;P01138;Beta-nerve growth factor (Beta-NGF)
drug.Protein;P05113;IL5;ENSG00000113525;P05113;Interleukin-5 (IL-5) (B-cell differentiation factor I) (Eosinophil differentiation factor) (T-cell replacing factor) (TRF)
drug.Protein;P12724;RNASE3;ENSG00000169397;P12724;Eosinophil cationic protein (ECP) (EC 3.1.27.-) (Ribonuclease 3) (RNase 3)
drug.Protein;Q02817;MUC2;ENSG00000198788;Q02817;Mucin-2 (MUC-2) (Intestinal mucin-2)
drug.Protein;Q13370;PDE3B;ENSG00000152270;Q13370;cGMP-inhibited 3',5'-cyclic phosphodiesterase 3B (EC 3.1.4.17) (CGIPDE1) (CGIP1) (Cyclic GMP-inhibited phosphodiesterase B) (CGI-PDE B)
drug.Protein;V9H1D9;;;;
drug.Protein;Q9HAB3;SLC52A2;ENSG00000185803;Q9HAB3;Solute carrier family 52, riboflavin transporter, member 2 (Porcine endogenous retrovirus A receptor 1) (PERV-A receptor 1) (Protein GPR172A) (Riboflavin transporter 3) (hRFT3)
drug.Protein;O60858;TRIM13;ENSG00000204977;O60858;E3 ubiquitin-protein ligase TRIM13 (EC 2.3.2.27) (B-cell chronic lymphocytic leukemia tumor suppressor Leu5) (Leukemia-associated protein 5) (Putative tumor suppressor RFP2) (RING finger protein 77) (RING-type E3 ubiquitin transferase TRIM13) (Ret finger protein 2) (Tripartite motif-containing protein 13)
drug.Protein;P28476;GABRR2;ENSG00000111886;P28476;Gamma-aminobutyric acid receptor subunit rho-2 (GABA(A) receptor subunit rho-2) (GABA(C) receptor)
drug.Protein;A8MPY1;GABRR3;ENSG00000183185;A8MPY1;Gamma-aminobutyric acid receptor subunit rho-3 (GABA(A) receptor subunit rho-3) (GABA(C) receptor)
drug.Protein;P02786;TFRC;ENSG00000072274;P02786;Transferrin receptor protein 1 (TR) (TfR) (TfR1) (Trfr) (T9) (p90) (CD antigen CD71) [Cleaved into: Transferrin receptor protein 1, serum form (sTfR)]
drug.Protein;Q9BY41;HDAC8;ENSG00000147099;Q9BY41;Histone deacetylase 8 (HD8) (EC 3.5.1.98) (Protein deacetylase HDAC8) (EC 3.5.1.-) (Protein decrotonylase HDAC8) (EC 3.5.1.-)
drug.Protein;Q9NZD4;AHSP;ENSG00000169877;Q9NZD4;Alpha-hemoglobin-stabilizing protein (Erythroid differentiation-related factor) (Erythroid-associated factor)
drug.Protein;Q16595;FXN;ENSG00000165060;Q16595;"Frataxin, mitochondrial (EC 1.16.3.1) (Friedreich ataxia protein) (Fxn) [Cleaved into: Frataxin intermediate form (i-FXN); Frataxin(56-210) (m56-FXN); Frataxin(78-210) (d-FXN) (m78-FXN); Frataxin mature form (Frataxin(81-210)) (m81-FXN)]"
drug.Protein;P39748;FEN1;ENSG00000168496;P39748;Flap endonuclease 1 (FEN-1) (EC 3.1.-.-) (DNase IV) (Flap structure-specific endonuclease 1) (Maturation factor 1) (MF1) (hFEN-1)
drug.Protein;Q96FI4;NEIL1;ENSG00000140398;Q96FI4;Endonuclease 8-like 1 (EC 3.2.2.-) (EC 4.2.99.18) (DNA glycosylase/AP lyase Neil1) (DNA-(apurinic or apyrimidinic site) lyase Neil1) (Endonuclease VIII-like 1) (FPG1) (Nei homolog 1) (NEH1) (Nei-like protein 1)
drug.Protein;Q969S2;NEIL2;ENSG00000154328;Q969S2;Endonuclease 8-like 2 (EC 3.2.2.-) (EC 4.2.99.18) (DNA glycosylase/AP lyase Neil2) (DNA-(apurinic or apyrimidinic site) lyase Neil2) (Endonuclease VIII-like 2) (Nei homolog 2) (NEH2) (Nei-like protein 2)
drug.Protein;P04075;ALDOA;ENSG00000149925;P04075;Fructose-bisphosphate aldolase A (EC 4.1.2.13) (Lung cancer antigen NY-LU-1) (Muscle-type aldolase)
drug.Protein;P68104;EEF1A1;ENSG00000156508;P68104;Elongation factor 1-alpha 1 (EF-1-alpha-1) (Elongation factor Tu) (EF-Tu) (Eukaryotic elongation factor 1 A-1) (eEF1A-1) (Leukocyte receptor cluster member 7)
drug.Protein;P06733;ENO1;ENSG00000074800;P06733;Alpha-enolase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase) (C-myc promoter-binding protein) (Enolase 1) (MBP-1) (MPB-1) (Non-neural enolase) (NNE) (Phosphopyruvate hydratase) (Plasminogen-binding protein)
drug.Protein;P07237;P4HB;ENSG00000185624;P07237;Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta) (p55)
drug.Protein;P30101;PDIA3;ENSG00000167004;P30101;Protein disulfide-isomerase A3 (EC 5.3.4.1) (58 kDa glucose-regulated protein) (58 kDa microsomal protein) (p58) (Disulfide isomerase ER-60) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Endoplasmic reticulum resident protein 60) (ER protein 60) (ERp60)
drug.Protein;Q06830;PRDX1;ENSG00000117450;Q06830;Peroxiredoxin-1 (EC 1.11.1.24) (Natural killer cell-enhancing factor A) (NKEF-A) (Proliferation-associated gene protein) (PAG) (Thioredoxin peroxidase 2) (Thioredoxin-dependent peroxide reductase 2) (Thioredoxin-dependent peroxiredoxin 1)
drug.Protein;P78330;PSPH;ENSG00000146733;P78330;Phosphoserine phosphatase (PSP) (PSPase) (EC 3.1.3.3) (L-3-phosphoserine phosphatase) (O-phosphoserine phosphohydrolase)
drug.Protein;P60174;TPI1;ENSG00000111669;P60174;Triosephosphate isomerase (TIM) (EC 5.3.1.1) (Methylglyoxal synthase) (EC 4.2.3.3) (Triose-phosphate isomerase)
drug.Protein;P49411;TUFM;ENSG00000178952;P49411;Elongation factor Tu, mitochondrial (EF-Tu) (P43)
drug.Protein;O14618;CCS;ENSG00000173992;O14618;Copper chaperone for superoxide dismutase (Superoxide dismutase copper chaperone)
drug.Protein;P56524;HDAC4;ENSG00000068024;P56524;Histone deacetylase 4 (HD4) (EC 3.5.1.98)
drug.Protein;P04279;SEMG1;ENSG00000124233;P04279;"Semenogelin-1 (Cancer/testis antigen 103) (Semenogelin I) (SGI) [Cleaved into: Alpha-inhibin-92; Alpha-inhibin-31; Seminal basic protein]"
drug.Protein;O15304;SIVA1;ENSG00000184990;O15304;Apoptosis regulatory protein Siva (CD27-binding protein) (CD27BP)
drug.Protein;Q00987;MDM2;ENSG00000135679;Q00987;E3 ubiquitin-protein ligase Mdm2 (EC 2.3.2.27) (Double minute 2 protein) (Hdm2) (Oncoprotein Mdm2) (RING-type E3 ubiquitin transferase Mdm2) (p53-binding protein Mdm2)
drug.Protein;P01308;INS;ENSG00000254647;P01308;"Insulin [Cleaved into: Insulin B chain; Insulin A chain]"
drug.Protein;P46939;UTRN;ENSG00000152818;P46939;Utrophin (Dystrophin-related protein 1) (DRP-1)
drug.Protein;O15350;TP73;ENSG00000078900;O15350;Tumor protein p73 (p53-like transcription factor) (p53-related protein)
drug.Protein;P25713;MT3;ENSG00000087250;P25713;Metallothionein-3 (MT-3) (GIFB) (GIF) (Growth inhibitory factor) (Metallothionein-III) (MT-III)
drug.Protein;Q8N907;DAND5;ENSG00000179284;Q8N907;DAN domain family member 5 (Cerberus-like protein 2) (Cerl-2) (Cysteine knot superfamily 1, BMP antagonist 3) (Gremlin-3)
drug.Protein;P04217;A1BG;ENSG00000121410;P04217;Alpha-1B-glycoprotein (Alpha-1-B glycoprotein)
drug.Protein;P01019;AGT;ENSG00000135744;P01019;"Angiotensinogen (Serpin A8) [Cleaved into: Angiotensin-1 (Angiotensin 1-10) (Angiotensin I) (Ang I); Angiotensin-2 (Angiotensin 1-8) (Angiotensin II) (Ang II); Angiotensin-3 (Angiotensin 2-8) (Angiotensin III) (Ang III) (Des-Asp[1]-angiotensin II); Angiotensin-4 (Angiotensin 3-8) (Angiotensin IV) (Ang IV); Angiotensin 1-9; Angiotensin 1-7; Angiotensin 1-5; Angiotensin 1-4]"
drug.Protein;P02765;AHSG;ENSG00000145192;P02765;"Alpha-2-HS-glycoprotein (Alpha-2-Z-globulin) (Ba-alpha-2-glycoprotein) (Fetuin-A) [Cleaved into: Alpha-2-HS-glycoprotein chain A; Alpha-2-HS-glycoprotein chain B]"
drug.Protein;P02743;APCS;ENSG00000132703;P02743;Serum amyloid P-component (SAP) (9.5S alpha-1-glycoprotein) [Cleaved into: Serum amyloid P-component(1-203)]
drug.Protein;P02647;APOA1;ENSG00000118137;P02647;"Apolipoprotein A-I (Apo-AI) (ApoA-I) (Apolipoprotein A1) [Cleaved into: Proapolipoprotein A-I (ProapoA-I); Truncated apolipoprotein A-I (Apolipoprotein A-I(1-242))]"
drug.Protein;P02652;APOA2;ENSG00000158874;P02652;"Apolipoprotein A-II (Apo-AII) (ApoA-II) (Apolipoprotein A2) [Cleaved into: Proapolipoprotein A-II (ProapoA-II); Truncated apolipoprotein A-II (Apolipoprotein A-II(1-76))]"
drug.Protein;P06727;APOA4;ENSG00000110244;P06727;Apolipoprotein A-IV (Apo-AIV) (ApoA-IV) (Apolipoprotein A4)
drug.Protein;Q0VD83;APOBR;ENSG00000184730;Q0VD83;Apolipoprotein B receptor (Apolipoprotein B-100 receptor) (Apolipoprotein B-48 receptor) (Apolipoprotein B48 receptor) (apoB-48R)
drug.Protein;P02649;APOE;ENSG00000130203;P02649;Apolipoprotein E (Apo-E)
drug.Protein;O14791;APOL1;ENSG00000100342;O14791;Apolipoprotein L1 (Apolipoprotein L) (Apo-L) (ApoL) (Apolipoprotein L-I) (ApoL-I)
drug.Protein;P09871;C1S;ENSG00000182326;P09871;"Complement C1s subcomponent (EC 3.4.21.42) (C1 esterase) (Complement component 1 subcomponent s) [Cleaved into: Complement C1s subcomponent heavy chain; Complement C1s subcomponent light chain]"
drug.Protein;P04003;C4BPA;ENSG00000123838;P04003;C4b-binding protein alpha chain (C4bp) (Proline-rich protein) (PRP)
drug.Protein;P20851;C4BPB;ENSG00000123843;P20851;C4b-binding protein beta chain
drug.Protein;P46736;BRCC3;ENSG00000185515;P46736;Lys-63-specific deubiquitinase BRCC36 (EC 3.4.19.-) (BRCA1-A complex subunit BRCC36) (BRCA1/BRCA2-containing complex subunit 3) (BRCA1/BRCA2-containing complex subunit 36) (BRISC complex subunit BRCC36)
drug.Protein;P07357;C8A;ENSG00000157131;P07357;Complement component C8 alpha chain (Complement component 8 subunit alpha)
drug.Protein;P07358;C8B;ENSG00000021852;P07358;Complement component C8 beta chain (Complement component 8 subunit beta)
drug.Protein;P07360;C8G;ENSG00000176919;P07360;Complement component C8 gamma chain
drug.Protein;P00751;CFB;ENSG00000243649;P00751;"Complement factor B (EC 3.4.21.47) (C3/C5 convertase) (Glycine-rich beta glycoprotein) (GBG) (PBF2) (Properdin factor B) [Cleaved into: Complement factor B Ba fragment; Complement factor B Bb fragment]"
drug.Protein;P08603;CFH;ENSG00000000971;P08603;Complement factor H (H factor 1)
drug.Protein;P05156;CFI;ENSG00000205403;P05156;"Complement factor I (EC 3.4.21.45) (C3B/C4B inactivator) [Cleaved into: Complement factor I heavy chain; Complement factor I light chain]"
drug.Protein;P10909;CLU;ENSG00000120885;P10909;"Clusterin (Aging-associated gene 4 protein) (Apolipoprotein J) (Apo-J) (Complement cytolysis inhibitor) (CLI) (Complement-associated protein SP-40,40) (Ku70-binding protein 1) (NA1/NA2) (Sulfated glycoprotein 2) (SGP-2) (Testosterone-repressed prostate message 2) (TRPM-2) [Cleaved into: Clusterin beta chain (ApoJalpha) (Complement cytolysis inhibitor a chain); Clusterin alpha chain (ApoJbeta) (Complement cytolysis inhibitor b chain)]"
drug.Protein;P15169;CPN1;ENSG00000120054;P15169;Carboxypeptidase N catalytic chain (CPN) (EC 3.4.17.3) (Anaphylatoxin inactivator) (Arginine carboxypeptidase) (Carboxypeptidase N polypeptide 1) (Carboxypeptidase N small subunit) (Kininase-1) (Lysine carboxypeptidase) (Plasma carboxypeptidase B) (Serum carboxypeptidase N) (SCPN)
drug.Protein;P22792;CPN2;ENSG00000178772;P22792;Carboxypeptidase N subunit 2 (Carboxypeptidase N 83 kDa chain) (Carboxypeptidase N large subunit) (Carboxypeptidase N polypeptide 2) (Carboxypeptidase N regulatory subunit)
drug.Protein;P81605;DCD;ENSG00000161634;P81605;"Dermcidin (EC 3.4.-.-) (Preproteolysin) [Cleaved into: Survival-promoting peptide; DCD-1]"
drug.Protein;P15924;DSP;ENSG00000096696;P15924;Desmoplakin (DP) (250/210 kDa paraneoplastic pemphigus antigen)
drug.Protein;P00748;F12;ENSG00000131187;P00748;"Coagulation factor XII (EC 3.4.21.38) (Hageman factor) (HAF) [Cleaved into: Coagulation factor XIIa heavy chain; Beta-factor XIIa part 1; Coagulation factor XIIa light chain (Beta-factor XIIa part 2)]"
drug.Protein;P05160;F13B;ENSG00000143278;P05160;Coagulation factor XIII B chain (Fibrin-stabilizing factor B subunit) (Protein-glutamine gamma-glutamyltransferase B chain) (Transglutaminase B chain)
drug.Protein;O75636;FCN3;ENSG00000142748;O75636;Ficolin-3 (Collagen/fibrinogen domain-containing lectin 3 p35) (Collagen/fibrinogen domain-containing protein 3) (Hakata antigen)
drug.Protein;P02751;FN1;ENSG00000115414;P02751;"Fibronectin (FN) (Cold-insoluble globulin) (CIG) [Cleaved into: Anastellin; Ugl-Y1; Ugl-Y2; Ugl-Y3]"
drug.Protein;P06396;GSN;ENSG00000148180;P06396;Gelsolin (AGEL) (Actin-depolymerizing factor) (ADF) (Brevin)
drug.Protein;P00739;HPR;ENSG00000261701;P00739;Haptoglobin-related protein
drug.Protein;Q86YZ3;HRNR;ENSG00000197915;Q86YZ3;Hornerin
drug.Protein;P01876;IGHA1;ENSG00000211895;P01876;Immunoglobulin heavy constant alpha 1 (Ig alpha-1 chain C region) (Ig alpha-1 chain C region BUR) (Ig alpha-1 chain C region TRO)
drug.Protein;P01871;IGHM;ENSG00000211899;P01871;Immunoglobulin heavy constant mu (Ig mu chain C region) (Ig mu chain C region BOT) (Ig mu chain C region GAL) (Ig mu chain C region OU)
drug.Protein;P01599;IGKV1-17;ENSG00000240382;P01599;Immunoglobulin kappa variable 1-17 (Ig kappa chain V-I region Gal) (Ig kappa chain V-I region WEA)
drug.Protein;P01619;IGKV3-20;ENSG00000239951;P01619;Immunoglobulin kappa variable 3-20 (Ig kappa chain V-III region B6) (Ig kappa chain V-III region GOL) (Ig kappa chain V-III region HAH) (Ig kappa chain V-III region HIC) (Ig kappa chain V-III region IARC/BL41) (Ig kappa chain V-III region NG9) (Ig kappa chain V-III region SIE) (Ig kappa chain V-III region Ti) (Ig kappa chain V-III region WOL)
drug.Protein;P80748;IGLV3-21;ENSG00000211662;P80748;Immunoglobulin lambda variable 3-21 (Ig lambda chain V-III region LOI) (Ig lambda chain V-V region DEL) (Ig lambda chain V-VII region MOT)
drug.Protein;P19827;ITIH1;ENSG00000055957;P19827;Inter-alpha-trypsin inhibitor heavy chain H1 (ITI heavy chain H1) (ITI-HC1) (Inter-alpha-inhibitor heavy chain 1) (Inter-alpha-trypsin inhibitor complex component III) (Serum-derived hyaluronan-associated protein) (SHAP)
drug.Protein;P19823;ITIH2;ENSG00000151655;P19823;Inter-alpha-trypsin inhibitor heavy chain H2 (ITI heavy chain H2) (ITI-HC2) (Inter-alpha-inhibitor heavy chain 2) (Inter-alpha-trypsin inhibitor complex component II) (Serum-derived hyaluronan-associated protein) (SHAP)
drug.Protein;Q06033;ITIH3;ENSG00000162267;Q06033;Inter-alpha-trypsin inhibitor heavy chain H3 (ITI heavy chain H3) (ITI-HC3) (Inter-alpha-inhibitor heavy chain 3) (Serum-derived hyaluronan-associated protein) (SHAP)
drug.Protein;Q14624;ITIH4;ENSG00000055955;Q14624;"Inter-alpha-trypsin inhibitor heavy chain H4 (ITI heavy chain H4) (ITI-HC4) (Inter-alpha-inhibitor heavy chain 4) (Inter-alpha-trypsin inhibitor family heavy chain-related protein) (IHRP) (Plasma kallikrein sensitive glycoprotein 120) (Gp120) (PK-120) [Cleaved into: 70 kDa inter-alpha-trypsin inhibitor heavy chain H4; 35 kDa inter-alpha-trypsin inhibitor heavy chain H4]"
drug.Protein;P01591;JCHAIN;ENSG00000132465;P01591;Immunoglobulin J chain (Joining chain of multimeric IgA and IgM)
drug.Protein;P14923;JUP;ENSG00000173801;P14923;Junction plakoglobin (Catenin gamma) (Desmoplakin III) (Desmoplakin-3)
drug.Protein;P03952;KLKB1;ENSG00000164344;P03952;"Plasma kallikrein (EC 3.4.21.34) (Fletcher factor) (Kininogenin) (Plasma prekallikrein) (PKK) [Cleaved into: Plasma kallikrein heavy chain; Plasma kallikrein light chain]"
drug.Protein;P01042;KNG1;ENSG00000113889;P01042;"Kininogen-1 (Alpha-2-thiol proteinase inhibitor) (Fitzgerald factor) (High molecular weight kininogen) (HMWK) (Williams-Fitzgerald-Flaujeac factor) [Cleaved into: Kininogen-1 heavy chain; T-kinin (Ile-Ser-Bradykinin); Bradykinin (Kallidin I); Lysyl-bradykinin (Kallidin II); Kininogen-1 light chain; Low molecular weight growth-promoting factor]"
drug.Protein;P04264;KRT1;ENSG00000167768;P04264;Keratin, type II cytoskeletal 1 (67 kDa cytokeratin) (Cytokeratin-1) (CK-1) (Hair alpha protein) (Keratin-1) (K1) (Type-II keratin Kb1)
drug.Protein;P13645;KRT10;ENSG00000186395;P13645;Keratin, type I cytoskeletal 10 (Cytokeratin-10) (CK-10) (Keratin-10) (K10)
drug.Protein;P02533;KRT14;ENSG00000186847;P02533;Keratin, type I cytoskeletal 14 (Cytokeratin-14) (CK-14) (Keratin-14) (K14)
drug.Protein;P08779;KRT16;ENSG00000186832;P08779;Keratin, type I cytoskeletal 16 (Cytokeratin-16) (CK-16) (Keratin-16) (K16)
drug.Protein;P35908;KRT2;ENSG00000172867;P35908;Keratin, type II cytoskeletal 2 epidermal (Cytokeratin-2e) (CK-2e) (Epithelial keratin-2e) (Keratin-2 epidermis) (Keratin-2e) (K2e) (Type-II keratin Kb2)
drug.Protein;P13647;KRT5;ENSG00000186081;P13647;Keratin, type II cytoskeletal 5 (58 kDa cytokeratin) (Cytokeratin-5) (CK-5) (Keratin-5) (K5) (Type-II keratin Kb5)
drug.Protein;P02538;KRT6A;ENSG00000205420;P02538;Keratin, type II cytoskeletal 6A (Cytokeratin-6A) (CK-6A) (Cytokeratin-6D) (CK-6D) (Keratin-6A) (K6A) (Type-II keratin Kb6) (allergen Hom s 5)
drug.Protein;P35527;KRT9;ENSG00000171403;P35527;Keratin, type I cytoskeletal 9 (Cytokeratin-9) (CK-9) (Keratin-9) (K9)
drug.Protein;Q96PD5;PGLYRP2;ENSG00000161031;Q96PD5;N-acetylmuramoyl-L-alanine amidase (EC 3.5.1.28) (Peptidoglycan recognition protein 2) (Peptidoglycan recognition protein long) (PGRP-L)
drug.Protein;P20742;PZP;ENSG00000126838;P20742;Pregnancy zone protein (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 6)
drug.Protein;P49908;SELENOP;ENSG00000250722;P49908;Selenoprotein P (SeP)
drug.Protein;P01011;SERPINA3;ENSG00000196136;P01011;Alpha-1-antichymotrypsin (ACT) (Cell growth-inhibiting gene 24/25 protein) (Serpin A3) [Cleaved into: Alpha-1-antichymotrypsin His-Pro-less]
drug.Protein;P29622;SERPINA4;ENSG00000100665;P29622;Kallistatin (Kallikrein inhibitor) (Peptidase inhibitor 4) (PI-4) (Serpin A4)
drug.Protein;P51693;APLP1;ENSG00000105290;P51693;Amyloid beta precursor like protein 1 (Amyloid beta (A4) precursor-like protein 1) (Amyloid-like protein 1) (APLP) (APLP-1) [Cleaved into: C30]
drug.Protein;Q06481;APLP2;ENSG00000084234;Q06481;Amyloid beta precursor like protein 2 (APPH) (Amyloid beta (A4) precursor-like protein 2) (Amyloid protein homolog) (Amyloid-like protein 2) (APLP-2) (CDEI box-binding protein) (CDEBP) (Sperm membrane protein YWK-II)
drug.Protein;P16444;DPEP1;ENSG00000015413;P16444;Dipeptidase 1 (EC 3.4.13.19) (Beta-lactamase) (EC 3.5.2.6) (Dehydropeptidase-I) (Microsomal dipeptidase) (Renal dipeptidase) (hRDP)
drug.Protein;P20594;NPR2;ENSG00000159899;P20594;Atrial natriuretic peptide receptor 2 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type B) (ANP-B) (ANPR-B) (NPR-B) (Guanylate cyclase B) (GC-B)
drug.Protein;P80188;LCN2;ENSG00000148346;P80188;Neutrophil gelatinase-associated lipocalin (NGAL) (25 kDa alpha-2-microglobulin-related subunit of MMP-9) (Lipocalin-2) (Oncogene 24p3) (Siderocalin) (p25)
drug.Protein;P01857;IGHG1;ENSG00000211896;P01857;Immunoglobulin heavy constant gamma 1 (Ig gamma-1 chain C region) (Ig gamma-1 chain C region EU) (Ig gamma-1 chain C region KOL) (Ig gamma-1 chain C region NIE)
drug.Protein;Q9NWZ5;UCKL1;ENSG00000198276;Q9NWZ5;Uridine-cytidine kinase-like 1 (EC 2.7.1.48)
drug.Protein;P23919;DTYMK;ENSG00000168393;P23919;Thymidylate kinase (EC 2.7.4.9) (dTMP kinase)
drug.Protein;Q15788;NCOA1;ENSG00000084676;Q15788;Nuclear receptor coactivator 1 (NCoA-1) (EC 2.3.1.48) (Class E basic helix-loop-helix protein 74) (bHLHe74) (Protein Hin-2) (RIP160) (Renal carcinoma antigen NY-REN-52) (Steroid receptor coactivator 1) (SRC-1)
drug.Protein;Q96C86;DCPS;ENSG00000110063;Q96C86;m7GpppX diphosphatase (EC 3.6.1.59) (DCS-1) (Decapping scavenger enzyme) (Hint-related 7meGMP-directed hydrolase) (Histidine triad nucleotide-binding protein 5) (Histidine triad protein member 5) (HINT-5) (Scavenger mRNA-decapping enzyme DcpS)
drug.Protein;P06730;EIF4E;ENSG00000151247;P06730;Eukaryotic translation initiation factor 4E (eIF-4E) (eIF4E) (eIF-4F 25 kDa subunit) (mRNA cap-binding protein)
drug.Protein;P17538;CTRB1;ENSG00000168925;P17538;"Chymotrypsinogen B (EC 3.4.21.1) [Cleaved into: Chymotrypsin B chain A; Chymotrypsin B chain B; Chymotrypsin B chain C]"
drug.Protein;P07477;PRSS1;ENSG00000204983;P07477;"Serine protease 1 (EC 3.4.21.4) (Anionic trypsin I) (Anionic trypsin-I) (Beta-trypsin) (Cationic trypsinogen) (Pretrypsinogen I) (Trypsin I) (Trypsin-1) [Cleaved into: Alpha-trypsin chain 1; Alpha-trypsin chain 2]"
drug.Protein;P19883;FST;ENSG00000134363;P19883;Follistatin (FS) (Activin-binding protein)
drug.Protein;Q9UKU7;ACAD8;ENSG00000151498;Q9UKU7;Isobutyryl-CoA dehydrogenase, mitochondrial (IBDH) (EC 1.3.8.-) (Activator-recruited cofactor 42 kDa component) (ARC42) (Acyl-CoA dehydrogenase family member 8) (ACAD-8)
drug.Protein;P16930;FAH;ENSG00000103876;P16930;Fumarylacetoacetase (FAA) (EC 3.7.1.2) (Beta-diketonase) (Fumarylacetoacetate hydrolase)
drug.Protein;P15259;PGAM2;ENSG00000164708;P15259;Phosphoglycerate mutase 2 (EC 5.4.2.11) (EC 5.4.2.4) (BPG-dependent PGAM 2) (Muscle-specific phosphoglycerate mutase) (Phosphoglycerate mutase isozyme M) (PGAM-M)
drug.Protein;Q9P2W7;B3GAT1;ENSG00000109956;Q9P2W7;Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1 (EC 2.4.1.135) (Beta-1,3-glucuronyltransferase 1) (Glucuronosyltransferase P) (GlcAT-P) (UDP-GlcUA:glycoprotein beta-1,3-glucuronyltransferase) (GlcUAT-P)
drug.Protein;Q9NP99;TREM1;ENSG00000124731;Q9NP99;Triggering receptor expressed on myeloid cells 1 (TREM-1) (Triggering receptor expressed on monocytes 1) (CD antigen CD354)
drug.Protein;P26196;DDX6;ENSG00000110367;P26196;Probable ATP-dependent RNA helicase DDX6 (EC 3.6.4.13) (ATP-dependent RNA helicase p54) (DEAD box protein 6) (Oncogene RCK)
drug.Protein;Q9NWT6;HIF1AN;ENSG00000166135;Q9NWT6;Hypoxia-inducible factor 1-alpha inhibitor (EC 1.14.11.30) (EC 1.14.11.n4) (Factor inhibiting HIF-1) (FIH-1) (Hypoxia-inducible factor asparagine hydroxylase)
drug.Protein;P21283;ATP6V1C1;ENSG00000155097;P21283;V-type proton ATPase subunit C 1 (V-ATPase subunit C 1) (Vacuolar proton pump subunit C 1)
drug.Protein;O00204;SULT2B1;ENSG00000088002;O00204;Sulfotransferase 2B1 (EC 2.8.2.2) (Alcohol sulfotransferase) (Hydroxysteroid sulfotransferase 2) (Sulfotransferase family 2B member 1) (Sulfotransferase family cytosolic 2B member 1) (ST2B1)
drug.Protein;P13929;ENO3;ENSG00000108515;P13929;Beta-enolase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase) (Enolase 3) (Muscle-specific enolase) (MSE) (Skeletal muscle enolase)
drug.Protein;P02144;MB;ENSG00000198125;P02144;Myoglobin
drug.Protein;Q96MA6;AK8;ENSG00000165695;Q96MA6;Adenylate kinase 8 (AK 8) (EC 2.7.4.3) (EC 2.7.4.6) (ATP-AMP transphosphorylase 8)
drug.Protein;Q99798;ACO2;ENSG00000100412;Q99798;Aconitate hydratase, mitochondrial (Aconitase) (EC 4.2.1.3) (Citrate hydro-lyase)
drug.Protein;P48735;IDH2;ENSG00000182054;P48735;Isocitrate dehydrogenase [NADP], mitochondrial (IDH) (EC 1.1.1.42) (ICD-M) (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase)
drug.Protein;O75874;IDH1;ENSG00000138413;O75874;Isocitrate dehydrogenase [NADP] cytoplasmic (IDH) (IDH1) (EC 1.1.1.42) (Cytosolic NADP-isocitrate dehydrogenase) (IDPc) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase)
drug.Protein;P42768;WAS;ENSG00000015285;P42768;Actin nucleation-promoting factor WAS (Wiskott-Aldrich syndrome protein) (WASp)
drug.Protein;P18031;PTPN1;ENSG00000196396;P18031;Tyrosine-protein phosphatase non-receptor type 1 (EC 3.1.3.48) (Protein-tyrosine phosphatase 1B) (PTP-1B)
drug.Protein;P63208;SKP1;ENSG00000113558;P63208;S-phase kinase-associated protein 1 (Cyclin-A/CDK2-associated protein p19) (p19A) (Organ of Corti protein 2) (OCP-2) (Organ of Corti protein II) (OCP-II) (RNA polymerase II elongation factor-like protein) (SIII) (Transcription elongation factor B polypeptide 1-like) (p19skp1)
drug.Protein;P22061;PCMT1;ENSG00000120265;P22061;Protein-L-isoaspartate(D-aspartate) O-methyltransferase (PIMT) (EC 2.1.1.77) (L-isoaspartyl protein carboxyl methyltransferase) (Protein L-isoaspartyl/D-aspartyl methyltransferase) (Protein-beta-aspartate methyltransferase)
drug.Protein;O60678;PRMT3;ENSG00000185238;O60678;Protein arginine N-methyltransferase 3 (EC 2.1.1.319) (Heterogeneous nuclear ribonucleoprotein methyltransferase-like protein 3)
drug.Protein;Q99873;PRMT1;ENSG00000126457;Q99873;Protein arginine N-methyltransferase 1 (EC 2.1.1.319) (Histone-arginine N-methyltransferase PRMT1) (Interferon receptor 1-bound protein 4)
drug.Protein;Q8WTS6;SETD7;ENSG00000145391;Q8WTS6;Histone-lysine N-methyltransferase SETD7 (EC 2.1.1.364) (Histone H3-K4 methyltransferase SETD7) (H3-K4-HMTase SETD7) (Lysine N-methyltransferase 7) (SET domain-containing protein 7) (SET7/9)
drug.Protein;Q9H2P9;DPH5;ENSG00000117543;Q9H2P9;Diphthine methyl ester synthase (EC 2.1.1.314) (Diphthamide biosynthesis methyltransferase)
drug.Protein;Q86VU5;COMTD1;ENSG00000165644;Q86VU5;Catechol O-methyltransferase domain-containing protein 1 (EC 2.1.1.-)
drug.Protein;P11309;PIM1;ENSG00000137193;P11309;Serine/threonine-protein kinase pim-1 (EC 2.7.11.1)
drug.Protein;P49247;RPIA;ENSG00000153574;P49247;Ribose-5-phosphate isomerase (EC 5.3.1.6) (Phosphoriboisomerase)
drug.Protein;Q8WX39;LCN9;ENSG00000148386;Q8WX39;Epididymal-specific lipocalin-9 (MUP-like lipocalin)
drug.Protein;Q13526;PIN1;ENSG00000127445;Q13526;Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 (EC 5.2.1.8) (Peptidyl-prolyl cis-trans isomerase Pin1) (PPIase Pin1) (Rotamase Pin1)
drug.Protein;Q16613;AANAT;ENSG00000129673;Q16613;Serotonin N-acetyltransferase (Serotonin acetylase) (EC 2.3.1.87) (Aralkylamine N-acetyltransferase) (AA-NAT)
drug.Protein;P62258;YWHAE;ENSG00000108953;P62258;14-3-3 protein epsilon (14-3-3E)
drug.Protein;P53779;MAPK10;ENSG00000109339;P53779;Mitogen-activated protein kinase 10 (MAP kinase 10) (MAPK 10) (EC 2.7.11.24) (MAP kinase p49 3F12) (Stress-activated protein kinase 1b) (SAPK1b) (Stress-activated protein kinase JNK3) (c-Jun N-terminal kinase 3)
drug.Protein;Q9UQF2;MAPK8IP1;ENSG00000121653;Q9UQF2;C-Jun-amino-terminal kinase-interacting protein 1 (JIP-1) (JNK-interacting protein 1) (Islet-brain 1) (IB-1) (JNK MAP kinase scaffold protein 1) (Mitogen-activated protein kinase 8-interacting protein 1)
drug.Protein;P33981;TTK;ENSG00000112742;P33981;Dual specificity protein kinase TTK (EC 2.7.12.1) (Phosphotyrosine picked threonine-protein kinase) (PYT)
drug.Protein;Q13907;IDI1;ENSG00000067064;Q13907;Isopentenyl-diphosphate Delta-isomerase 1 (EC 5.3.3.2) (Isopentenyl pyrophosphate isomerase 1) (IPP isomerase 1) (IPPI1)
drug.Protein;P10644;PRKAR1A;ENSG00000108946;P10644;cAMP-dependent protein kinase type I-alpha regulatory subunit (Tissue-specific extinguisher 1) (TSE1)
drug.Protein;P07478;PRSS2;ENSG00000275896;P07478;Trypsin-2 (EC 3.4.21.4) (Anionic trypsinogen) (Serine protease 2) (Trypsin II)
drug.Protein;P08631;HCK;ENSG00000101336;P08631;Tyrosine-protein kinase HCK (EC 2.7.10.2) (Hematopoietic cell kinase) (Hemopoietic cell kinase) (p59-HCK/p60-HCK) (p59Hck) (p61Hck)
drug.Protein;Q9UBX1;CTSF;ENSG00000174080;Q9UBX1;Cathepsin F (CATSF) (EC 3.4.22.41)
drug.Protein;P02788;LTF;ENSG00000012223;P02788;"Lactotransferrin (Lactoferrin) (EC 3.4.21.-) (Growth-inhibiting protein 12) (Talalactoferrin) [Cleaved into: Lactoferricin-H (Lfcin-H); Kaliocin-1; Lactoferroxin-A; Lactoferroxin-B; Lactoferroxin-C]"
drug.Protein;O14792;HS3ST1;ENSG00000002587;O14792;Heparan sulfate glucosamine 3-O-sulfotransferase 1 (EC 2.8.2.23) (Heparan sulfate D-glucosaminyl 3-O-sulfotransferase 1) (3-OST-1) (Heparan sulfate 3-O-sulfotransferase 1) (h3-OST-1)
drug.Protein;P10153;RNASE2;ENSG00000169385;P10153;Non-secretory ribonuclease (EC 4.6.1.18) (Eosinophil-derived neurotoxin) (RNase UpI-2) (Ribonuclease 2) (RNase 2) (Ribonuclease US)
drug.Protein;Q9Y663;HS3ST3A1;ENSG00000153976;Q9Y663;Heparan sulfate glucosamine 3-O-sulfotransferase 3A1 (EC 2.8.2.30) (Heparan sulfate D-glucosaminyl 3-O-sulfotransferase 3A1) (3-OST-3A) (Heparan sulfate 3-O-sulfotransferase 3A1) (h3-OST-3A)
drug.Protein;P52848;NDST1;ENSG00000070614;P52848;"Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1 (Glucosaminyl N-deacetylase/N-sulfotransferase 1) (NDST-1) (N-heparan sulfate sulfotransferase 1) (N-HSST 1) ([Heparan sulfate]-glucosamine N-sulfotransferase 1) (HSNST 1) [Includes: Heparan sulfate N-deacetylase 1 (EC 3.5.1.-); Heparan sulfate N-sulfotransferase 1 (EC 2.8.2.8)]"
drug.Protein;P11226;MBL2;ENSG00000165471;P11226;Mannose-binding protein C (MBP-C) (Collectin-1) (MBP1) (Mannan-binding protein) (Mannose-binding lectin)
drug.Protein;P35558;PCK1;ENSG00000124253;P35558;Phosphoenolpyruvate carboxykinase, cytosolic [GTP] (PEPCK-C) (EC 4.1.1.32) (Serine-protein kinase PCK1) (EC 2.7.11.-)
drug.Protein;P17931;LGALS3;ENSG00000131981;P17931;Galectin-3 (Gal-3) (35 kDa lectin) (Carbohydrate-binding protein 35) (CBP 35) (Galactose-specific lectin 3) (Galactoside-binding protein) (GALBP) (IgE-binding protein) (L-31) (Laminin-binding protein) (Lectin L-29) (Mac-2 antigen)
drug.Protein;Q9NPH2;ISYNA1;ENSG00000105655;Q9NPH2;Inositol-3-phosphate synthase 1 (IPS 1) (EC 5.5.1.4) (Myo-inositol 1-phosphate synthase) (MI-1-P synthase) (MIP synthase) (hIPS) (Myo-inositol 1-phosphate synthase A1) (hINO1)
drug.Protein;Q9UNI1;CELA1;ENSG00000139610;Q9UNI1;Chymotrypsin-like elastase family member 1 (EC 3.4.21.36) (Elastase-1) (Pancreatic elastase 1)
drug.Protein;P01834;IGKC;ENSG00000211592;P01834;Immunoglobulin kappa constant (Ig kappa chain C region) (Ig kappa chain C region AG) (Ig kappa chain C region CUM) (Ig kappa chain C region EU) (Ig kappa chain C region OU) (Ig kappa chain C region ROY) (Ig kappa chain C region TI)
drug.Protein;Q6NUS8;UGT3A1;ENSG00000145626;Q6NUS8;UDP-glucuronosyltransferase 3A1 (UDPGT 3A1) (EC 2.4.1.17)
drug.Protein;P52961;ART1;ENSG00000129744;P52961;GPI-linked NAD(P)(+)--arginine ADP-ribosyltransferase 1 (EC 2.4.2.31) (ADP-ribosyltransferase C2 and C3 toxin-like 1) (ARTC1) (Mono(ADP-ribosyl)transferase 1) (CD antigen CD296)
drug.Protein;P43235;CTSK;ENSG00000143387;P43235;Cathepsin K (EC 3.4.22.38) (Cathepsin O) (Cathepsin O2) (Cathepsin X)
drug.Protein;P51003;PAPOLA;ENSG00000090060;P51003;Poly(A) polymerase alpha (PAP-alpha) (EC 2.7.7.19) (Polynucleotide adenylyltransferase alpha)
drug.Protein;P46976;GYG1;ENSG00000163754;P46976;Glycogenin-1 (GN-1) (GN1) (EC 2.4.1.186)
drug.Protein;Q14376;GALE;ENSG00000117308;Q14376;UDP-glucose 4-epimerase (EC 5.1.3.2) (Galactowaldenase) (UDP-N-acetylgalactosamine 4-epimerase) (UDP-GalNAc 4-epimerase) (UDP-N-acetylglucosamine 4-epimerase) (UDP-GlcNAc 4-epimerase) (EC 5.1.3.7) (UDP-galactose 4-epimerase)
drug.Protein;Q7Z4J2;GLT6D1;ENSG00000204007;Q7Z4J2;Putative glycosyltransferase 6 domain-containing protein 1 (EC 2.4.1.-) (Galactosyltransferase family 6 domain-containing 1)
drug.Protein;Q9H4M7;PLEKHA4;ENSG00000105559;Q9H4M7;Pleckstrin homology domain-containing family A member 4 (PH domain-containing family A member 4) (Phosphoinositol 3-phosphate-binding protein 1) (PEPP-1)
drug.Protein;Q9UN19;DAPP1;ENSG00000070190;Q9UN19;Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide (hDAPP1) (B lymphocyte adapter protein Bam32) (B-cell adapter molecule of 32 kDa)
drug.Protein;P23677;ITPKA;ENSG00000137825;P23677;Inositol-trisphosphate 3-kinase A (EC 2.7.1.127) (Inositol 1,4,5-trisphosphate 3-kinase A) (IP3 3-kinase A) (IP3K A) (InsP 3-kinase A)
drug.Protein;Q99418;CYTH2;ENSG00000105443;Q99418;Cytohesin-2 (ARF exchange factor) (ARF nucleotide-binding site opener) (Protein ARNO) (PH, SEC7 and coiled-coil domain-containing protein 2)
drug.Protein;O43739;CYTH3;ENSG00000008256;O43739;Cytohesin-3 (ARF nucleotide-binding site opener 3) (Protein ARNO3) (General receptor of phosphoinositides 1) (Grp1) (PH, SEC7 and coiled-coil domain-containing protein 3)
drug.Protein;P62330;ARF6;ENSG00000165527;P62330;ADP-ribosylation factor 6 (EC 3.6.5.2)
drug.Protein;P62491;RAB11A;ENSG00000103769;P62491;Ras-related protein Rab-11A (Rab-11) (EC 3.6.5.2) (YL8)
drug.Protein;P19961;AMY2B;ENSG00000240038;P19961;Alpha-amylase 2B (EC 3.2.1.1) (1,4-alpha-D-glucan glucanohydrolase 2B) (Carcinoid alpha-amylase)
drug.Protein;Q13748;;;;
drug.Protein;P04350;TUBB4A;ENSG00000104833;P04350;Tubulin beta-4A chain (Tubulin 5 beta) (Tubulin beta-4 chain)
drug.Protein;Q13509;TUBB3;ENSG00000258947;Q13509;Tubulin beta-3 chain (Tubulin beta-4 chain) (Tubulin beta-III)
drug.Protein;Q9BQE3;TUBA1C;ENSG00000167553;Q9BQE3;Tubulin alpha-1C chain (Alpha-tubulin 6) (Tubulin alpha-6 chain) [Cleaved into: Detyrosinated tubulin alpha-1C chain]
drug.Protein;Q9NY65;TUBA8;ENSG00000183785;Q9NY65;Tubulin alpha-8 chain (Alpha-tubulin 8) (Tubulin alpha chain-like 2)
drug.Protein;P68363;TUBA1B;ENSG00000123416;P68363;Tubulin alpha-1B chain (Alpha-tubulin ubiquitous) (Tubulin K-alpha-1) (Tubulin alpha-ubiquitous chain) [Cleaved into: Detyrosinated tubulin alpha-1B chain]
drug.Protein;P14174;MIF;ENSG00000240972;P14174;Macrophage migration inhibitory factor (MIF) (EC 5.3.2.1) (Glycosylation-inhibiting factor) (GIF) (L-dopachrome isomerase) (L-dopachrome tautomerase) (EC 5.3.3.12) (Phenylpyruvate tautomerase)
drug.Protein;P24941;CDK2;ENSG00000123374;P24941;Cyclin-dependent kinase 2 (EC 2.7.11.22) (Cell division protein kinase 2) (p33 protein kinase)
drug.Protein;P05019;IGF1;ENSG00000017427;P05019;Insulin-like growth factor I (IGF-I) (Mechano growth factor) (MGF) (Somatomedin-C)
drug.Protein;P46459;NSF;ENSG00000073969;P46459;Vesicle-fusing ATPase (EC 3.6.4.6) (N-ethylmaleimide-sensitive fusion protein) (NEM-sensitive fusion protein) (Vesicular-fusion protein NSF)
drug.Protein;Q86YB8;ERO1B;ENSG00000086619;Q86YB8;ERO1-like protein beta (ERO1-L-beta) (EC 1.8.4.-) (Endoplasmic reticulum oxidoreductase beta) (Endoplasmic reticulum oxidoreductin-1-like protein B) (Oxidoreductin-1-L-beta)
drug.Protein;P19367;HK1;ENSG00000156515;P19367;Hexokinase-1 (EC 2.7.1.1) (Brain form hexokinase) (Hexokinase type I) (HK I) (Hexokinase-A)
drug.Protein;P35557;GCK;ENSG00000106633;P35557;Hexokinase-4 (HK4) (EC 2.7.1.1) (Glucokinase) (Hexokinase type IV) (HK IV) (Hexokinase-D)
drug.Protein;P22732;SLC2A5;ENSG00000142583;P22732;Solute carrier family 2, facilitated glucose transporter member 5 (Fructose transporter) (Glucose transporter type 5, small intestine) (GLUT-5)
drug.Protein;Q9UGQ3;SLC2A6;ENSG00000160326;Q9UGQ3;Solute carrier family 2, facilitated glucose transporter member 6 (Glucose transporter type 6) (GLUT-6)
drug.Protein;Q6PXP3;SLC2A7;ENSG00000197241;Q6PXP3;Solute carrier family 2, facilitated glucose transporter member 7 (Glucose transporter type 7) (GLUT-7) (hGLUT7)
drug.Protein;Q9NY64;SLC2A8;ENSG00000136856;Q9NY64;Solute carrier family 2, facilitated glucose transporter member 8 (Glucose transporter type 8) (GLUT-8) (Glucose transporter type X1)
drug.Protein;O95528;SLC2A10;ENSG00000197496;O95528;Solute carrier family 2, facilitated glucose transporter member 10 (Glucose transporter type 10) (GLUT-10)
drug.Protein;Q9BYW1;SLC2A11;ENSG00000133460;Q9BYW1;Solute carrier family 2, facilitated glucose transporter member 11 (Glucose transporter type 11) (GLUT-11)
drug.Protein;Q8TD20;SLC2A12;ENSG00000146411;Q8TD20;Solute carrier family 2, facilitated glucose transporter member 12 (Glucose transporter type 12) (GLUT-12)
drug.Protein;P31639;SLC5A2;ENSG00000140675;P31639;Sodium/glucose cotransporter 2 (Na(+)/glucose cotransporter 2) (Low affinity sodium-glucose cotransporter) (Solute carrier family 5 member 2)
drug.Protein;Q9BWD1;ACAT2;ENSG00000120437;Q9BWD1;Acetyl-CoA acetyltransferase, cytosolic (EC 2.3.1.9) (Acetyl-CoA transferase-like protein) (Cytosolic acetoacetyl-CoA thiolase)
drug.Protein;P02689;PMP2;ENSG00000147588;P02689;Myelin P2 protein (Peripheral myelin protein 2)
drug.Protein;P17612;PRKACA;ENSG00000072062;P17612;cAMP-dependent protein kinase catalytic subunit alpha (PKA C-alpha) (EC 2.7.11.11)
drug.Protein;Q86XF0;DHFR2;ENSG00000178700;Q86XF0;Dihydrofolate reductase 2, mitochondrial (Dihydrofolate reductase, mitochondrial) (EC 1.5.1.3) (Dihydrofolate reductase-like protein 1)
drug.Protein;Q13363;CTBP1;ENSG00000159692;Q13363;C-terminal-binding protein 1 (CtBP1) (EC 1.1.1.-)
drug.Protein;O14936;CASK;ENSG00000147044;O14936;Peripheral plasma membrane protein CASK (hCASK) (EC 2.7.11.1) (Calcium/calmodulin-dependent serine protein kinase) (Protein lin-2 homolog)
drug.Protein;Q9BVM4;GGACT;ENSG00000134864;Q9BVM4;Gamma-glutamylaminecyclotransferase (GGACT) (EC 4.3.2.8) (AIG2-like domain-containing protein 1) (Gamma-glutamylamine cyclotransferase)
drug.Protein;P20472;PVALB;ENSG00000100362;P20472;Parvalbumin alpha
drug.Protein;P14621;ACYP2;ENSG00000170634;P14621;Acylphosphatase-2 (EC 3.6.1.7) (Acylphosphatase, muscle type isozyme) (Acylphosphate phosphohydrolase 2)
drug.Protein;Q9NQX3;GPHN;ENSG00000171723;Q9NQX3;"Gephyrin [Includes: Molybdopterin adenylyltransferase (MPT adenylyltransferase) (EC 2.7.7.75) (Domain G); Molybdopterin molybdenumtransferase (MPT Mo-transferase) (EC 2.10.1.1) (Domain E)]"
drug.Protein;Q7Z406;MYH14;ENSG00000105357;Q7Z406;Myosin-14 (Myosin heavy chain 14) (Myosin heavy chain, non-muscle IIc) (Non-muscle myosin heavy chain IIc) (NMHC II-C)
drug.Protein;Q09013;DMPK;ENSG00000104936;Q09013;Myotonin-protein kinase (MT-PK) (EC 2.7.11.1) (DM-kinase) (DMK) (DM1 protein kinase) (DMPK) (Myotonic dystrophy protein kinase)
drug.Protein;Q9UKM7;MAN1B1;ENSG00000177239;Q9UKM7;Endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase (EC 3.2.1.113) (ER alpha-1,2-mannosidase) (ER mannosidase 1) (ERMan1) (Man9GlcNAc2-specific-processing alpha-mannosidase) (Mannosidase alpha class 1B member 1)
drug.Protein;P31641;SLC6A6;ENSG00000131389;P31641;Sodium- and chloride-dependent taurine transporter (Solute carrier family 6 member 6)
drug.Protein;P07602;PSAP;ENSG00000197746;P07602;"Prosaposin (Proactivator polypeptide) [Cleaved into: Saposin-A (Protein A); Saposin-B-Val; Saposin-B (Cerebroside sulfate activator) (CSAct) (Dispersin) (Sphingolipid activator protein 1) (SAP-1) (Sulfatide/GM1 activator); Saposin-C (A1 activator) (Co-beta-glucosidase) (Glucosylceramidase activator) (Sphingolipid activator protein 2) (SAP-2); Saposin-D (Component C) (Protein C)]"
drug.Protein;O75390;CS;ENSG00000062485;O75390;Citrate synthase, mitochondrial (EC 2.3.3.1) (Citrate (Si)-synthase)
drug.Protein;P36959;GMPR;ENSG00000137198;P36959;GMP reductase 1 (GMPR 1) (EC 1.7.1.7) (Guanosine 5'-monophosphate oxidoreductase 1) (Guanosine monophosphate reductase 1)
drug.Protein;Q9Y6L7;TLL2;ENSG00000095587;Q9Y6L7;Tolloid-like protein 2 (EC 3.4.24.-)
drug.Protein;P35398;RORA;ENSG00000069667;P35398;Nuclear receptor ROR-alpha (Nuclear receptor RZR-alpha) (Nuclear receptor subfamily 1 group F member 1) (RAR-related orphan receptor A) (Retinoid-related orphan receptor-alpha)
drug.Protein;P07108;DBI;ENSG00000155368;P07108;Acyl-CoA-binding protein (ACBP) (Diazepam-binding inhibitor) (DBI) (Endozepine) (EP)
drug.Protein;Q92993;KAT5;ENSG00000172977;Q92993;Histone acetyltransferase KAT5 (EC 2.3.1.48) (60 kDa Tat-interactive protein) (Tip60) (Histone acetyltransferase HTATIP) (HIV-1 Tat interactive protein) (Lysine acetyltransferase 5) (Protein 2-hydroxyisobutyryltransferase KAT5) (EC 2.3.1.-) (Protein acetyltransferase KAT5) (EC 2.3.1.-) (Protein crotonyltransferase KAT5) (EC 2.3.1.-) (cPLA(2)-interacting protein)
drug.Protein;Q92830;KAT2A;ENSG00000108773;Q92830;Histone acetyltransferase KAT2A (EC 2.3.1.48) (General control of amino acid synthesis protein 5-like 2) (Histone acetyltransferase GCN5) (hGCN5) (Histone glutaryltransferase KAT2A) (EC 2.3.1.-) (Histone succinyltransferase KAT2A) (EC 2.3.1.-) (Lysine acetyltransferase 2A) (STAF97)
drug.Protein;Q92831;KAT2B;ENSG00000114166;Q92831;Histone acetyltransferase KAT2B (EC 2.3.1.48) (Histone acetyltransferase PCAF) (Histone acetylase PCAF) (Lysine acetyltransferase 2B) (P300/CBP-associated factor) (P/CAF) (Spermidine acetyltransferase KAT2B) (EC 2.3.1.57)
drug.Protein;P06744;GPI;ENSG00000105220;P06744;Glucose-6-phosphate isomerase (GPI) (EC 5.3.1.9) (Autocrine motility factor) (AMF) (Neuroleukin) (NLK) (Phosphoglucose isomerase) (PGI) (Phosphohexose isomerase) (PHI) (Sperm antigen 36) (SA-36)
drug.Protein;Q08881;ITK;ENSG00000113263;Q08881;Tyrosine-protein kinase ITK/TSK (EC 2.7.10.2) (Interleukin-2-inducible T-cell kinase) (IL-2-inducible T-cell kinase) (Kinase EMT) (T-cell-specific kinase) (Tyrosine-protein kinase Lyk)
drug.Protein;P43405;SYK;ENSG00000165025;P43405;Tyrosine-protein kinase SYK (EC 2.7.10.2) (Spleen tyrosine kinase) (p72-Syk)
drug.Protein;P49137;MAPKAPK2;ENSG00000162889;P49137;MAP kinase-activated protein kinase 2 (MAPK-activated protein kinase 2) (MAPKAP kinase 2) (MAPKAP-K2) (MAPKAPK-2) (MK-2) (MK2) (EC 2.7.11.1)
drug.Protein;P48736;PIK3CG;ENSG00000105851;P48736;Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform (PI3-kinase subunit gamma) (PI3K-gamma) (PI3Kgamma) (PtdIns-3-kinase subunit gamma) (EC 2.7.1.137) (EC 2.7.1.153) (EC 2.7.1.154) (Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit gamma) (PtdIns-3-kinase subunit p110-gamma) (p110gamma) (Phosphoinositide-3-kinase catalytic gamma polypeptide) (Serine/threonine protein kinase PIK3CG) (EC 2.7.11.1) (p120-PI3K)
drug.Protein;Q04759;PRKCQ;ENSG00000065675;Q04759;Protein kinase C theta type (EC 2.7.11.13) (nPKC-theta)
drug.Protein;P43403;ZAP70;ENSG00000115085;P43403;Tyrosine-protein kinase ZAP-70 (EC 2.7.10.2) (70 kDa zeta-chain associated protein) (Syk-related tyrosine kinase)
drug.Protein;P48449;LSS;ENSG00000160285;P48449;Lanosterol synthase (EC 5.4.99.7) (2,3-epoxysqualene--lanosterol cyclase) (Oxidosqualene--lanosterol cyclase) (OSC) (hOSC)
drug.Protein;P20231;TPSB2;ENSG00000197253;P20231;Tryptase beta-2 (Tryptase-2) (EC 3.4.21.59) (Tryptase II)
drug.Protein;P50607;TUB;ENSG00000166402;P50607;Tubby protein homolog
drug.Protein;P34913;EPHX2;ENSG00000120915;P34913;"Bifunctional epoxide hydrolase 2 [Includes: Cytosolic epoxide hydrolase 2 (CEH) (EC 3.3.2.10) (Epoxide hydratase) (Soluble epoxide hydrolase) (SEH); Lipid-phosphate phosphatase (EC 3.1.3.76)]"
drug.Protein;Q16706;MAN2A1;ENSG00000112893;Q16706;Alpha-mannosidase 2 (EC 3.2.1.114) (Golgi alpha-mannosidase II) (AMan II) (Man II) (Mannosidase alpha class 2A member 1) (Mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase)
drug.Protein;P50897;PPT1;ENSG00000131238;P50897;Palmitoyl-protein thioesterase 1 (PPT-1) (EC 3.1.2.22) (Palmitoyl-protein hydrolase 1)
drug.Protein;Q9UKQ2;ADAM28;ENSG00000042980;Q9UKQ2;Disintegrin and metalloproteinase domain-containing protein 28 (ADAM 28) (EC 3.4.24.-) (Epididymal metalloproteinase-like, disintegrin-like, and cysteine-rich protein II) (eMDC II) (Metalloproteinase-like, disintegrin-like, and cysteine-rich protein L) (MDC-L)
drug.Protein;Q00535;CDK5;ENSG00000164885;Q00535;Cyclin-dependent kinase 5 (EC 2.7.11.1) (Cell division protein kinase 5) (Cyclin-dependent-like kinase 5) (Serine/threonine-protein kinase PSSALRE) (Tau protein kinase II catalytic subunit) (TPKII catalytic subunit)
drug.Protein;P06493;CDK1;ENSG00000170312;P06493;Cyclin-dependent kinase 1 (CDK1) (EC 2.7.11.22) (EC 2.7.11.23) (Cell division control protein 2 homolog) (Cell division protein kinase 1) (p34 protein kinase)
drug.Protein;Q15078;CDK5R1;ENSG00000176749;Q15078;"Cyclin-dependent kinase 5 activator 1 (CDK5 activator 1) (Cyclin-dependent kinase 5 regulatory subunit 1) (TPKII regulatory subunit) [Cleaved into: Cyclin-dependent kinase 5 activator 1, p35 (p35); Cyclin-dependent kinase 5 activator 1, p25 (p25) (Tau protein kinase II 23 kDa subunit) (p23)]"
drug.Protein;P13639;EEF2;ENSG00000167658;P13639;Elongation factor 2 (EF-2)
drug.Protein;Q9NXA8;SIRT5;ENSG00000124523;Q9NXA8;NAD-dependent protein deacylase sirtuin-5, mitochondrial (EC 2.3.1.-) (Regulatory protein SIR2 homolog 5) (SIR2-like protein 5)
drug.Protein;Q9NTG7;SIRT3;ENSG00000142082;Q9NTG7;NAD-dependent protein deacetylase sirtuin-3, mitochondrial (hSIRT3) (EC 2.3.1.286) (Regulatory protein SIR2 homolog 3) (SIR2-like protein 3)
drug.Protein;P07148;FABP1;ENSG00000163586;P07148;Fatty acid-binding protein, liver (Fatty acid-binding protein 1) (Liver-type fatty acid-binding protein) (L-FABP)
drug.Protein;P35080;PFN2;ENSG00000070087;P35080;Profilin-2 (Profilin II)
drug.Protein;Q92930;RAB8B;ENSG00000166128;Q92930;Ras-related protein Rab-8B
drug.Protein;P20248;CCNA2;ENSG00000145386;P20248;Cyclin-A2 (Cyclin-A) (Cyclin A)
drug.Protein;Q9BZX2;UCK2;ENSG00000143179;Q9BZX2;Uridine-cytidine kinase 2 (UCK 2) (EC 2.7.1.48) (Cytidine monophosphokinase 2) (Testis-specific protein TSA903) (Uridine monophosphokinase 2)
drug.Protein;Q6UWN8;SPINK6;ENSG00000178172;Q6UWN8;Serine protease inhibitor Kazal-type 6 (Kallikrein inhibitor)
drug.Protein;P07858;CTSB;ENSG00000164733;P07858;"Cathepsin B (EC 3.4.22.1) (APP secretase) (APPS) (Cathepsin B1) [Cleaved into: Cathepsin B light chain; Cathepsin B heavy chain]"
drug.Protein;Q8N142;ADSS1;ENSG00000185100;Q8N142;Adenylosuccinate synthetase isozyme 1 (AMPSase 1) (AdSS 1) (EC 6.3.4.4) (Adenylosuccinate synthetase, basic isozyme) (Adenylosuccinate synthetase, muscle isozyme) (M-type adenylosuccinate synthetase) (Adenylosuccinate synthetase-like 1) (AdSSL1) (IMP--aspartate ligase 1)
drug.Protein;P09668;CTSH;ENSG00000103811;P09668;"Pro-cathepsin H [Cleaved into: Cathepsin H mini chain; Cathepsin H (EC 3.4.22.16); Cathepsin H heavy chain; Cathepsin H light chain]"
drug.Protein;Q00169;PITPNA;ENSG00000174238;Q00169;Phosphatidylinositol transfer protein alpha isoform (PI-TP-alpha) (PtdIns transfer protein alpha) (PtdInsTP alpha)
drug.Protein;P08581;MET;ENSG00000105976;P08581;Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met)
drug.Protein;Q02750;MAP2K1;ENSG00000169032;Q02750;Dual specificity mitogen-activated protein kinase kinase 1 (MAP kinase kinase 1) (MAPKK 1) (MKK1) (EC 2.7.12.2) (ERK activator kinase 1) (MAPK/ERK kinase 1) (MEK 1)
drug.Protein;P32119;PRDX2;ENSG00000167815;P32119;Peroxiredoxin-2 (EC 1.11.1.24) (Natural killer cell-enhancing factor B) (NKEF-B) (PRP) (Thiol-specific antioxidant protein) (TSA) (Thioredoxin peroxidase 1) (Thioredoxin-dependent peroxide reductase 1) (Thioredoxin-dependent peroxiredoxin 2)
drug.Protein;P15090;FABP4;ENSG00000170323;P15090;Fatty acid-binding protein, adipocyte (Adipocyte lipid-binding protein) (ALBP) (Adipocyte-type fatty acid-binding protein) (A-FABP) (AFABP) (Fatty acid-binding protein 4)
drug.Protein;Q9UJM8;HAO1;ENSG00000101323;Q9UJM8;2-Hydroxyacid oxidase 1 (HAOX1) (EC 1.1.3.15) (Glycolate oxidase) (GO) (GOX) (Glyoxylate oxidase) (EC 1.2.3.5)
drug.Protein;P36873;PPP1CC;ENSG00000186298;P36873;Serine/threonine-protein phosphatase PP1-gamma catalytic subunit (PP-1G) (EC 3.1.3.16) (Protein phosphatase 1C catalytic subunit)
drug.Protein;P09012;SNRPA;ENSG00000077312;P09012;U1 small nuclear ribonucleoprotein A (U1 snRNP A) (U1-A) (U1A)
drug.Protein;O60551;NMT2;ENSG00000152465;O60551;Glycylpeptide N-tetradecanoyltransferase 2 (EC 2.3.1.97) (Myristoyl-CoA:protein N-myristoyltransferase 2) (NMT 2) (Peptide N-myristoyltransferase 2) (Protein-lysine myristoyltransferase NMT2) (EC 2.3.1.-) (Type II N-myristoyltransferase)
drug.Protein;Q6UWM7;LCTL;ENSG00000188501;Q6UWM7;Lactase-like protein (Klotho/lactase-phlorizin hydrolase-related protein)
drug.Protein;P04053;DNTT;ENSG00000107447;P04053;DNA nucleotidylexotransferase (EC 2.7.7.31) (Terminal addition enzyme) (Terminal deoxynucleotidyltransferase) (Terminal transferase)
drug.Protein;Q9UBQ6;EXTL2;ENSG00000162694;Q9UBQ6;Exostosin-like 2 (EC 2.4.1.223) (Alpha-1,4-N-acetylhexosaminyltransferase EXTL2) (Alpha-GalNAcT EXTL2) (EXT-related protein 2) (Glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase) [Cleaved into: Processed exostosin-like 2]
drug.Protein;Q16222;UAP1;ENSG00000117143;Q16222;"UDP-N-acetylhexosamine pyrophosphorylase (Antigen X) (AGX) (Sperm-associated antigen 2) [Includes: UDP-N-acetylgalactosamine pyrophosphorylase (EC 2.7.7.83) (AGX-1); UDP-N-acetylglucosamine pyrophosphorylase (EC 2.7.7.23) (AGX-2)]"
drug.Protein;P16442;ABO;ENSG00000175164;P16442;Histo-blood group ABO system transferase (Fucosylglycoprotein 3-alpha-galactosyltransferase) (Fucosylglycoprotein alpha-N-acetylgalactosaminyltransferase) (Glycoprotein-fucosylgalactoside alpha-N-acetylgalactosaminyltransferase) (EC 2.4.1.40) (Glycoprotein-fucosylgalactoside alpha-galactosyltransferase) (EC 2.4.1.37) (Histo-blood group A transferase) (A transferase) (Histo-blood group B transferase) (B transferase) (NAGAT) [Cleaved into: Fucosylglycoprotein alpha-N-acetylgalactosaminyltransferase soluble form]
drug.Protein;Q99470;SDF2;ENSG00000132581;Q99470;Stromal cell-derived factor 2 (SDF-2)
drug.Protein;P01112;HRAS;ENSG00000174775;P01112;GTPase HRas (EC 3.6.5.2) (H-Ras-1) (Ha-Ras) (Transforming protein p21) (c-H-ras) (p21ras) [Cleaved into: GTPase HRas, N-terminally processed]
drug.Protein;P07339;CTSD;ENSG00000117984;P07339;"Cathepsin D (EC 3.4.23.5) [Cleaved into: Cathepsin D light chain; Cathepsin D heavy chain]"
drug.Protein;Q9NPB1;NT5M;ENSG00000205309;Q9NPB1;5'(3')-deoxyribonucleotidase, mitochondrial (5',3'-nucleotidase, mitochondrial) (EC 3.1.3.-) (Deoxy-5'-nucleotidase 2) (dNT-2)
drug.Protein;P16112;ACAN;ENSG00000157766;P16112;Aggrecan core protein (Cartilage-specific proteoglycan core protein) (CSPCP) (Chondroitin sulfate proteoglycan core protein 1) (Chondroitin sulfate proteoglycan 1) [Cleaved into: Aggrecan core protein 2]
drug.Protein;P17900;GM2A;ENSG00000196743;P17900;Ganglioside GM2 activator (Cerebroside sulfate activator protein) (GM2-AP) (Sphingolipid activator protein 3) (SAP-3) [Cleaved into: Ganglioside GM2 activator isoform short]
drug.Protein;P25105;PTAFR;ENSG00000169403;P25105;Platelet-activating factor receptor (PAF-R) (PAFr)
drug.Protein;P08842;STS;ENSG00000101846;P08842;Steryl-sulfatase (EC 3.1.6.2) (Arylsulfatase C) (ASC) (Estrone sulfatase) (Steroid sulfatase) (Steryl-sulfate sulfohydrolase)
drug.Protein;P22459;KCNA4;ENSG00000182255;P22459;Potassium voltage-gated channel subfamily A member 4 (HPCN2) (Voltage-gated K(+) channel HuKII) (Voltage-gated potassium channel HBK4) (Voltage-gated potassium channel HK1) (Voltage-gated potassium channel subunit Kv1.4)
drug.Protein;Q9UKL6;PCTP;ENSG00000141179;Q9UKL6;Phosphatidylcholine transfer protein (PC-TP) (START domain-containing protein 2) (StARD2) (StAR-related lipid transfer protein 2)
drug.Protein;P35030;PRSS3;ENSG00000010438;P35030;Trypsin-3 (EC 3.4.21.4) (Brain trypsinogen) (Mesotrypsin) (Mesotrypsinogen) (Serine protease 3) (Serine protease 4) (Trypsin III) (Trypsin IV)
drug.Protein;O00408;PDE2A;ENSG00000186642;O00408;cGMP-dependent 3',5'-cyclic phosphodiesterase (EC 3.1.4.17) (Cyclic GMP-stimulated phosphodiesterase) (CGS-PDE) (cGSPDE)
drug.Protein;Q9UL51;HCN2;ENSG00000099822;Q9UL51;Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2 (Brain cyclic nucleotide-gated channel 2) (BCNG-2)
drug.Protein;P13501;CCL5;ENSG00000271503;P13501;"C-C motif chemokine 5 (EoCP) (Eosinophil chemotactic cytokine) (SIS-delta) (Small-inducible cytokine A5) (T cell-specific protein P228) (TCP228) (T-cell-specific protein RANTES) [Cleaved into: RANTES(3-68); RANTES(4-68)]"
drug.Protein;P49913;CAMP;ENSG00000164047;P49913;"Cathelicidin antimicrobial peptide (18 kDa cationic antimicrobial protein) (CAP-18) (hCAP-18) [Cleaved into: Antibacterial peptide FALL-39 (FALL-39 peptide antibiotic); Antibacterial peptide LL-37]"
drug.Protein;P08311;CTSG;ENSG00000100448;P08311;Cathepsin G (CG) (EC 3.4.21.20) [Cleaved into: Cathepsin G, C-terminal truncated form]
drug.Protein;P49789;FHIT;ENSG00000189283;P49789;Bis(5'-adenosyl)-triphosphatase (EC 3.6.1.29) (AP3A hydrolase) (AP3Aase) (Adenosine 5'-monophosphoramidase FHIT) (EC 3.9.1.-) (Adenylylsulfatase) (EC 3.6.2.1) (Adenylylsulfate-ammonia adenylyltransferase) (EC 2.7.7.51) (Diadenosine 5',5'''-P1,P3-triphosphate hydrolase) (Dinucleosidetriphosphatase) (Fragile histidine triad protein)
drug.Protein;P23458;JAK1;ENSG00000162434;P23458;Tyrosine-protein kinase JAK1 (EC 2.7.10.2) (Janus kinase 1) (JAK-1)
drug.Protein;P09848;LCT;ENSG00000115850;P09848;"Lactase/phlorizin hydrolase (Lactase/glycosylceramidase) [Includes: Lactase (EC 3.2.1.108); Glycosylceramidase (EC 3.2.1.62) (Phlorizin hydrolase)]"
drug.Protein;P30793;GCH1;ENSG00000131979;P30793;GTP cyclohydrolase 1 (EC 3.5.4.16) (GTP cyclohydrolase I) (GTP-CH-I)
drug.Protein;P56817;BACE1;ENSG00000186318;P56817;Beta-secretase 1 (EC 3.4.23.46) (Aspartyl protease 2) (ASP2) (Asp 2) (Beta-site amyloid precursor protein cleaving enzyme 1) (Beta-site APP cleaving enzyme 1) (Memapsin-2) (Membrane-associated aspartic protease 2)
drug.Protein;P46926;GNPDA1;ENSG00000113552;P46926;Glucosamine-6-phosphate isomerase 1 (EC 3.5.99.6) (Glucosamine-6-phosphate deaminase 1) (GNPDA 1) (GlcN6P deaminase 1) (Oscillin)
drug.Protein;Q9BW91;NUDT9;ENSG00000170502;Q9BW91;ADP-ribose pyrophosphatase, mitochondrial (EC 3.6.1.13) (ADP-ribose diphosphatase) (ADP-ribose phosphohydrolase) (Adenosine diphosphoribose pyrophosphatase) (ADPR-PPase) (Nucleoside diphosphate-linked moiety X motif 9) (Nudix motif 9)
drug.Protein;O60264;SMARCA5;ENSG00000153147;O60264;SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5 (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin A5) (EC 3.6.4.-) (Sucrose nonfermenting protein 2 homolog) (hSNF2H)
drug.Protein;P04745;;;;
drug.Protein;O14594;NCAN;ENSG00000130287;O14594;Neurocan core protein (Chondroitin sulfate proteoglycan 3)
drug.Protein;Q701N4;KRTAP5-2;ENSG00000205867;Q701N4;Keratin-associated protein 5-2 (Keratin-associated protein 5-8) (Keratin-associated protein 5.2) (Keratin-associated protein 5.8) (Ultrahigh sulfur keratin-associated protein 5.2)
drug.Protein;Q9BZZ2;SIGLEC1;ENSG00000088827;Q9BZZ2;Sialoadhesin (Sialic acid-binding Ig-like lectin 1) (Siglec-1) (CD antigen CD169)
drug.Protein;P05162;LGALS2;ENSG00000100079;P05162;Galectin-2 (Gal-2) (Beta-galactoside-binding lectin L-14-II) (HL14) (Lactose-binding lectin 2) (S-Lac lectin 2)
drug.Protein;P47929;"LGALS7; LGALS7B";ENSG00000205076;P47929;Galectin-7 (Gal-7) (HKL-14) (PI7) (p53-induced gene 1 protein)
drug.Protein;Q6L8H2;KRTAP5-3;ENSG00000196224;Q6L8H2;Keratin-associated protein 5-3 (Keratin-associated protein 5-9) (Keratin-associated protein 5.3) (Keratin-associated protein 5.9) (UHS KerB-like) (Ultrahigh sulfur keratin-associated protein 5.3)
drug.Protein;P35247;SFTPD;ENSG00000133661;P35247;Pulmonary surfactant-associated protein D (PSP-D) (SP-D) (Collectin-7) (Lung surfactant protein D)
drug.Protein;P01574;IFNB1;ENSG00000171855;P01574;Interferon beta (IFN-beta) (Fibroblast interferon)
drug.Protein;P28838;LAP3;ENSG00000002549;P28838;Cytosol aminopeptidase (EC 3.4.11.1) (Cysteinylglycine-S-conjugate dipeptidase) (EC 3.4.13.23) (Leucine aminopeptidase 3) (LAP-3) (Leucyl aminopeptidase) (Peptidase S) (Proline aminopeptidase) (EC 3.4.11.5) (Prolyl aminopeptidase)
drug.Protein;P16118;PFKFB1;ENSG00000158571;P16118;"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1 (6PF-2-K/Fru-2,6-P2ase 1) (PFK/FBPase 1) (6PF-2-K/Fru-2,6-P2ase liver isozyme) [Includes: 6-phosphofructo-2-kinase (EC 2.7.1.105); Fructose-2,6-bisphosphatase (EC 3.1.3.46)]"
drug.Protein;P09466;PAEP;ENSG00000122133;P09466;Glycodelin (GD) (Placental protein 14) (PP14) (Pregnancy-associated endometrial alpha-2 globulin) (PAEG) (PEG) (Progestagen-associated endometrial protein) (Progesterone-associated endometrial protein) (Zona-binding inhibitory factor-1) (ZIF-1)
drug.Protein;P62837;UBE2D2;ENSG00000131508;P62837;Ubiquitin-conjugating enzyme E2 D2 (EC 2.3.2.23) ((E3-independent) E2 ubiquitin-conjugating enzyme D2) (EC 2.3.2.24) (E2 ubiquitin-conjugating enzyme D2) (Ubiquitin carrier protein D2) (Ubiquitin-conjugating enzyme E2(17)KB 2) (Ubiquitin-conjugating enzyme E2-17 kDa 2) (Ubiquitin-protein ligase D2) (p53-regulated ubiquitin-conjugating enzyme 1)
drug.Protein;P08238;HSP90AB1;ENSG00000096384;P08238;Heat shock protein HSP 90-beta (HSP 90) (Heat shock 84 kDa) (HSP 84) (HSP84)
drug.Protein;P04118;CLPS;ENSG00000137392;P04118;Colipase
drug.Protein;P30301;MIP;ENSG00000135517;P30301;Lens fiber major intrinsic protein (Aquaporin-0) (MIP26) (MP26)
drug.Protein;P20339;RAB5A;ENSG00000144566;P20339;Ras-related protein Rab-5A (EC 3.6.5.2)
drug.Protein;P22694;PRKACB;ENSG00000142875;P22694;cAMP-dependent protein kinase catalytic subunit beta (PKA C-beta) (EC 2.7.11.11)
drug.Protein;P50613;CDK7;ENSG00000134058;P50613;Cyclin-dependent kinase 7 (EC 2.7.11.22) (EC 2.7.11.23) (39 kDa protein kinase) (p39 Mo15) (CDK-activating kinase 1) (Cell division protein kinase 7) (Serine/threonine-protein kinase 1) (TFIIH basal transcription factor complex kinase subunit)
drug.Protein;P31949;S100A11;ENSG00000163191;P31949;Protein S100-A11 (Calgizzarin) (Metastatic lymph node gene 70 protein) (MLN 70) (Protein S100-C) (S100 calcium-binding protein A11) [Cleaved into: Protein S100-A11, N-terminally processed]
drug.Protein;P53778;MAPK12;ENSG00000188130;P53778;Mitogen-activated protein kinase 12 (MAP kinase 12) (MAPK 12) (EC 2.7.11.24) (Extracellular signal-regulated kinase 6) (ERK-6) (Mitogen-activated protein kinase p38 gamma) (MAP kinase p38 gamma) (Stress-activated protein kinase 3)
drug.Protein;O14965;AURKA;ENSG00000087586;O14965;Aurora kinase A (EC 2.7.11.1) (Aurora 2) (Aurora/IPL1-related kinase 1) (ARK-1) (Aurora-related kinase 1) (hARK1) (Breast tumor-amplified kinase) (Serine/threonine-protein kinase 15) (Serine/threonine-protein kinase 6) (Serine/threonine-protein kinase aurora-A)
drug.Protein;Q10588;BST1;ENSG00000109743;Q10588;ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2 (EC 3.2.2.6) (ADP-ribosyl cyclase 2) (Bone marrow stromal antigen 1) (BST-1) (Cyclic ADP-ribose hydrolase 2) (cADPr hydrolase 2) (CD antigen CD157)
drug.Protein;Q8NFW8;CMAS;ENSG00000111726;Q8NFW8;N-acylneuraminate cytidylyltransferase (EC 2.7.7.43) (CMP-N-acetylneuraminic acid synthase) (CMP-NeuNAc synthase)
drug.Protein;Q96L21;RPL10L;ENSG00000165496;Q96L21;60S ribosomal protein L10-like (Large ribosomal subunit protein uL16-like)
drug.Protein;P40429;RPL13A;ENSG00000142541;P40429;60S ribosomal protein L13a (23 kDa highly basic protein) (Large ribosomal subunit protein uL13)
drug.Protein;P62829;RPL23;ENSG00000125691;P62829;60S ribosomal protein L23 (60S ribosomal protein L17) (Large ribosomal subunit protein uL14)
drug.Protein;P61313;RPL15;ENSG00000174748;P61313;60S ribosomal protein L15 (Large ribosomal subunit protein eL15)
drug.Protein;P84098;RPL19;ENSG00000108298;P84098;60S ribosomal protein L19 (Large ribosomal subunit protein eL19)
drug.Protein;P62750;RPL23A;ENSG00000198242;P62750;60S ribosomal protein L23a (Large ribosomal subunit protein uL23)
drug.Protein;Q9UHA3;RSL24D1;ENSG00000137876;Q9UHA3;Probable ribosome biogenesis protein RLP24 (Ribosomal L24 domain-containing protein 1) (Ribosomal protein L24-like)
drug.Protein;Q9UNX3;RPL26L1;ENSG00000037241;Q9UNX3;60S ribosomal protein L26-like 1 (Large ribosomal subunit protein uL24-like 1)
drug.Protein;P62917;RPL8;ENSG00000161016;P62917;60S ribosomal protein L8 (Large ribosomal subunit protein uL2)
drug.Protein;P61927;RPL37;ENSG00000145592;P61927;60S ribosomal protein L37 (G1.16) (Large ribosomal subunit protein eL37)
drug.Protein;P39023;RPL3;ENSG00000100316;P39023;60S ribosomal protein L3 (HIV-1 TAR RNA-binding protein B) (TARBP-B) (Large ribosomal subunit protein uL3)
drug.Protein;P62913;RPL11;ENSG00000142676;P62913;60S ribosomal protein L11 (CLL-associated antigen KW-12) (Large ribosomal subunit protein uL5)
drug.Protein;P55769;SNU13;ENSG00000100138;P55769;NHP2-like protein 1 (High mobility group-like nuclear protein 2 homolog 1) (OTK27) (SNU13 homolog) (hSNU13) (U4/U6.U5 small nuclear ribonucleoprotein SNU13) (U4/U6.U5 tri-snRNP 15.5 kDa protein) [Cleaved into: NHP2-like protein 1, N-terminally processed]
drug.Protein;P15085;CPA1;ENSG00000091704;P15085;Carboxypeptidase A1 (EC 3.4.17.1)
drug.Protein;P62136;PPP1CA;ENSG00000172531;P62136;Serine/threonine-protein phosphatase PP1-alpha catalytic subunit (PP-1A) (EC 3.1.3.16)
drug.Protein;P30153;PPP2R1A;ENSG00000105568;P30153;Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform (Medium tumor antigen-associated 61 kDa protein) (PP2A subunit A isoform PR65-alpha) (PP2A subunit A isoform R1-alpha)
drug.Protein;Q13362;PPP2R5C;ENSG00000078304;Q13362;Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform (PP2A B subunit isoform B'-gamma) (PP2A B subunit isoform B56-gamma) (PP2A B subunit isoform PR61-gamma) (PP2A B subunit isoform R5-gamma) (Renal carcinoma antigen NY-REN-29)
drug.Protein;P63151;PPP2R2A;ENSG00000221914;P63151;Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform (PP2A subunit B isoform B55-alpha) (PP2A subunit B isoform PR55-alpha) (PP2A subunit B isoform R2-alpha) (PP2A subunit B isoform alpha)
drug.Protein;P05062;ALDOB;ENSG00000136872;P05062;Fructose-bisphosphate aldolase B (EC 4.1.2.13) (Liver-type aldolase)
drug.Protein;P31323;PRKAR2B;ENSG00000005249;P31323;cAMP-dependent protein kinase type II-beta regulatory subunit
drug.Protein;P0CG22;DHRS4L1;ENSG00000225766;P0CG22;Putative dehydrogenase/reductase SDR family member 4-like 1 (EC 1.1.-.-) (Short chain dehydrogenase/reductase family 25C member 4) (Protein SDR25C4)
drug.Protein;P0CG47;UBB;ENSG00000170315;P0CG47;Polyubiquitin-B [Cleaved into: Ubiquitin]
drug.Protein;O15379;HDAC3;ENSG00000171720;O15379;Histone deacetylase 3 (HD3) (EC 3.5.1.98) (Protein deacetylase HDAC3) (EC 3.5.1.-) (Protein deacylase HDAC3) (EC 3.5.1.-) (RPD3-2) (SMAP45)
drug.Protein;Q9UBN7;HDAC6;ENSG00000094631;Q9UBN7;Histone deacetylase 6 (HD6) (EC 3.5.1.98) (Tubulin-lysine deacetylase HDAC6) (EC 3.5.1.-)
drug.Protein;O60547;GMDS;ENSG00000112699;O60547;GDP-mannose 4,6 dehydratase (EC 4.2.1.47) (GDP-D-mannose dehydratase) (GMD)
drug.Protein;P23276;KEL;ENSG00000197993;P23276;Kell blood group glycoprotein (EC 3.4.24.-) (CD antigen CD238)
drug.Protein;P30084;ECHS1;ENSG00000127884;P30084;Enoyl-CoA hydratase, mitochondrial (mECH) (mECH1) (EC 4.2.1.17) (EC 5.3.3.8) (Enoyl-CoA hydratase 1) (ECHS1) (Short-chain enoyl-CoA hydratase) (SCEH)
drug.Protein;P04632;CAPNS1;ENSG00000126247;P04632;Calpain small subunit 1 (CSS1) (Calcium-activated neutral proteinase small subunit) (CANP small subunit) (Calcium-dependent protease small subunit) (CDPS) (Calcium-dependent protease small subunit 1) (Calpain regulatory subunit)
drug.Protein;Q08462;ADCY2;ENSG00000078295;Q08462;Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2)
drug.Protein;P63092;GNAS;ENSG00000087460;P63092;Guanine nucleotide-binding protein G(s) subunit alpha isoforms short (Adenylate cyclase-stimulating G alpha protein)
drug.Protein;O95622;ADCY5;ENSG00000173175;O95622;Adenylate cyclase type 5 (EC 4.6.1.1) (ATP pyrophosphate-lyase 5) (Adenylate cyclase type V) (Adenylyl cyclase 5) (AC5)
drug.Protein;Q96T66;NMNAT3;ENSG00000163864;Q96T66;Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 3 (NMN/NaMN adenylyltransferase 3) (Nicotinamide-nucleotide adenylyltransferase 3) (NMN adenylyltransferase 3) (Nicotinate-nucleotide adenylyltransferase 3) (NaMN adenylyltransferase 3) (EC 2.7.7.18) (Pyridine nucleotide adenylyltransferase 3) (PNAT-3) (EC 2.7.7.1)
drug.Protein;P54317;PNLIPRP2;ENSG00000266200;P54317;Pancreatic lipase-related protein 2 (PL-RP2) (Cytotoxic T lymphocyte lipase) (Galactolipase) (EC 3.1.1.26) (Triacylglycerol lipase) (EC 3.1.1.3)
drug.Protein;P68133;ACTA1;ENSG00000143632;P68133;Actin, alpha skeletal muscle (Alpha-actin-1) [Cleaved into: Actin, alpha skeletal muscle, intermediate form]
drug.Protein;P60953;CDC42;ENSG00000070831;P60953;Cell division control protein 42 homolog (EC 3.6.5.2) (G25K GTP-binding protein)
drug.Protein;P98170;XIAP;ENSG00000101966;P98170;E3 ubiquitin-protein ligase XIAP (EC 2.3.2.27) (Baculoviral IAP repeat-containing protein 4) (IAP-like protein) (ILP) (hILP) (Inhibitor of apoptosis protein 3) (IAP-3) (hIAP-3) (hIAP3) (RING-type E3 ubiquitin transferase XIAP) (X-linked inhibitor of apoptosis protein) (X-linked IAP)
drug.Protein;P35270;SPR;ENSG00000116096;P35270;Sepiapterin reductase (SPR) (EC 1.1.1.153)
drug.Protein;P22830;FECH;ENSG00000066926;P22830;Ferrochelatase, mitochondrial (EC 4.99.1.1) (Heme synthase) (Protoheme ferro-lyase)
drug.Protein;P51161;FABP6;ENSG00000170231;P51161;Gastrotropin (GT) (Fatty acid-binding protein 6) (Ileal lipid-binding protein) (ILBP) (Intestinal 15 kDa protein) (I-15P) (Intestinal bile acid-binding protein) (I-BABP)
drug.Protein;P13073;COX4I1;ENSG00000131143;P13073;Cytochrome c oxidase subunit 4 isoform 1, mitochondrial (Cytochrome c oxidase polypeptide IV) (Cytochrome c oxidase subunit IV isoform 1) (COX IV-1)
drug.Protein;P00395;MT-CO1;ENSG00000198804;P00395;Cytochrome c oxidase subunit 1 (EC 7.1.1.9) (Cytochrome c oxidase polypeptide I)
drug.Protein;P00403;MT-CO2;ENSG00000198712;P00403;Cytochrome c oxidase subunit 2 (EC 7.1.1.9) (Cytochrome c oxidase polypeptide II)
drug.Protein;P00414;MT-CO3;ENSG00000198938;P00414;Cytochrome c oxidase subunit 3 (EC 7.1.1.9) (Cytochrome c oxidase polypeptide III)
drug.Protein;P20674;COX5A;ENSG00000178741;P20674;Cytochrome c oxidase subunit 5A, mitochondrial (Cytochrome c oxidase polypeptide Va)
drug.Protein;P10606;COX5B;ENSG00000135940;P10606;Cytochrome c oxidase subunit 5B, mitochondrial (Cytochrome c oxidase polypeptide Vb)
drug.Protein;P09669;COX6C;ENSG00000164919;P09669;Cytochrome c oxidase subunit 6C (Cytochrome c oxidase polypeptide VIc)
drug.Protein;P24311;COX7B;ENSG00000131174;P24311;Cytochrome c oxidase subunit 7B, mitochondrial (Cytochrome c oxidase polypeptide VIIb)
drug.Protein;P15954;COX7C;ENSG00000127184;P15954;Cytochrome c oxidase subunit 7C, mitochondrial (Cytochrome c oxidase polypeptide VIIc)
drug.Protein;P10176;COX8A;ENSG00000176340;P10176;Cytochrome c oxidase subunit 8A, mitochondrial (Cytochrome c oxidase polypeptide VIII-liver/heart) (Cytochrome c oxidase subunit 8-2)
drug.Protein;Q02221;COX6A2;ENSG00000156885;Q02221;Cytochrome c oxidase subunit 6A2, mitochondrial (Cytochrome c oxidase polypeptide VIa-heart) (COXVIAH) (Cytochrome c oxidase subunit VIA-muscle) (COX VIa-M)
drug.Protein;P14854;COX6B1;ENSG00000126267;P14854;Cytochrome c oxidase subunit 6B1 (Cytochrome c oxidase subunit VIb isoform 1) (COX VIb-1)
drug.Protein;P24310;COX7A1;ENSG00000161281;P24310;Cytochrome c oxidase subunit 7A1, mitochondrial (Cytochrome c oxidase subunit VIIa-heart) (Cytochrome c oxidase subunit VIIa-H) (Cytochrome c oxidase subunit VIIa-muscle) (Cytochrome c oxidase subunit VIIa-M)
drug.Protein;Q7KZA3;;;;
drug.Protein;Q8TDU6;GPBAR1;ENSG00000179921;Q8TDU6;G-protein coupled bile acid receptor 1 (G-protein coupled receptor GPCR19) (hGPCR19) (Membrane-type receptor for bile acids) (M-BAR) (hBG37) (BG37)
drug.Protein;O43252;PAPSS1;ENSG00000138801;O43252;"Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 1 (PAPS synthase 1) (PAPSS 1) (Sulfurylase kinase 1) (SK 1) (SK1) [Includes: Sulfate adenylyltransferase (EC 2.7.7.4) (ATP-sulfurylase) (Sulfate adenylate transferase) (SAT); Adenylyl-sulfate kinase (EC 2.7.1.25) (3'-phosphoadenosine-5'-phosphosulfate synthase) (APS kinase) (Adenosine-5'-phosphosulfate 3'-phosphotransferase) (Adenylylsulfate 3'-phosphotransferase)]"
drug.Protein;P16050;ALOX15;ENSG00000161905;P16050;Polyunsaturated fatty acid lipoxygenase ALOX15 (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate 15-lipoxygenase) (15-LOX) (15-LOX-1) (EC 1.13.11.33) (Arachidonate omega-6 lipoxygenase) (Hepoxilin A3 synthase Alox15) (EC 1.13.11.-) (Linoleate 13S-lipoxygenase) (EC 1.13.11.12)
drug.Protein;Q8TCG2;PI4K2B;ENSG00000038210;Q8TCG2;Phosphatidylinositol 4-kinase type 2-beta (EC 2.7.1.67) (Phosphatidylinositol 4-kinase type II-beta) (PI4KII-BETA)
drug.Protein;P08648;ITGA5;ENSG00000161638;P08648;"Integrin alpha-5 (CD49 antigen-like family member E) (Fibronectin receptor subunit alpha) (Integrin alpha-F) (VLA-5) (CD antigen CD49e) [Cleaved into: Integrin alpha-5 heavy chain; Integrin alpha-5 light chain]"
drug.Protein;P37840;SNCA;ENSG00000145335;P37840;Alpha-synuclein (Non-A beta component of AD amyloid) (Non-A4 component of amyloid precursor) (NACP)
drug.Protein;Q96EB6;SIRT1;ENSG00000096717;Q96EB6;NAD-dependent protein deacetylase sirtuin-1 (hSIRT1) (EC 2.3.1.286) (NAD-dependent protein deacylase sirtuin-1) (EC 2.3.1.-) (Regulatory protein SIR2 homolog 1) (SIR2-like protein 1) (hSIR2) [Cleaved into: SirtT1 75 kDa fragment (75SirT1)]
drug.Protein;Q86T13;CLEC14A;ENSG00000176435;Q86T13;C-type lectin domain family 14 member A (Epidermal growth factor receptor 5) (EGFR-5)
drug.Protein;Q92945;KHSRP;ENSG00000088247;Q92945;Far upstream element-binding protein 2 (FUSE-binding protein 2) (KH type-splicing regulatory protein) (KSRP) (p75)
drug.Protein;P09104;ENO2;ENSG00000111674;P09104;Gamma-enolase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase) (Enolase 2) (Neural enolase) (Neuron-specific enolase) (NSE)
drug.Protein;P11802;CDK4;ENSG00000135446;P11802;Cyclin-dependent kinase 4 (EC 2.7.11.22) (Cell division protein kinase 4) (PSK-J3)
drug.Protein;P61769;B2M;ENSG00000166710;P61769;Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]
drug.Protein;P01848;TRAC;ENSG00000277734;P01848;T cell receptor alpha chain constant
drug.Protein;P01850;TRBC1;ENSG00000211751;P01850;T cell receptor beta constant 1
drug.Protein;P04439;HLA-A;ENSG00000206503;P04439;HLA class I histocompatibility antigen, A alpha chain (Human leukocyte antigen A) (HLA-A)
drug.Protein;P62312;LSM6;ENSG00000164167;P62312;U6 snRNA-associated Sm-like protein LSm6
drug.Protein;Q7Z2Z2;EFL1;ENSG00000140598;Q7Z2Z2;Elongation factor-like GTPase 1 (Elongation factor Tu GTP-binding domain-containing protein 1) (Elongation factor-like 1) (Protein FAM42A)
drug.Protein;Q16762;TST;ENSG00000128311;Q16762;Thiosulfate sulfurtransferase (EC 2.8.1.1) (Rhodanese)
drug.Protein;P29460;IL12B;ENSG00000113302;P29460;Interleukin-12 subunit beta (IL-12B) (Cytotoxic lymphocyte maturation factor 40 kDa subunit) (CLMF p40) (IL-12 subunit p40) (NK cell stimulatory factor chain 2) (NKSF2)
drug.Protein;Q9Y3I0;RTCB;ENSG00000100220;Q9Y3I0;RNA-splicing ligase RtcB homolog (EC 6.5.1.8) (3'-phosphate/5'-hydroxy nucleic acid ligase)
drug.Protein;P84077;ARF1;ENSG00000143761;P84077;ADP-ribosylation factor 1
drug.Protein;Q06124;PTPN11;ENSG00000179295;Q06124;Tyrosine-protein phosphatase non-receptor type 11 (EC 3.1.3.48) (Protein-tyrosine phosphatase 1D) (PTP-1D) (Protein-tyrosine phosphatase 2C) (PTP-2C) (SH-PTP2) (SHP-2) (Shp2) (SH-PTP3)
drug.Protein;Q3KNW5;SLC10A6;ENSG00000145283;Q3KNW5;Sodium-dependent organic anion transporter (SOAT) (Solute carrier family 10 member 6) (SLC10A6)
drug.Protein;Q7Z4W1;DCXR;ENSG00000169738;Q7Z4W1;L-xylulose reductase (XR) (EC 1.1.1.10) (Carbonyl reductase II) (Dicarbonyl/L-xylulose reductase) (Kidney dicarbonyl reductase) (kiDCR) (Short chain dehydrogenase/reductase family 20C member 1) (Sperm surface protein P34H)
drug.Protein;P36871;PGM1;ENSG00000079739;P36871;Phosphoglucomutase-1 (PGM 1) (EC 5.4.2.2) (Glucose phosphomutase 1)
drug.Protein;P14920;DAO;ENSG00000110887;P14920;D-amino-acid oxidase (DAAO) (DAMOX) (DAO) (EC 1.4.3.3)
drug.Protein;Q8NBQ5;HSD17B11;ENSG00000198189;Q8NBQ5;Estradiol 17-beta-dehydrogenase 11 (EC 1.1.1.62) (17-beta-hydroxysteroid dehydrogenase 11) (17-beta-HSD 11) (17bHSD11) (17betaHSD11) (17-beta-hydroxysteroid dehydrogenase XI) (17-beta-HSD XI) (17betaHSDXI) (Cutaneous T-cell lymphoma-associated antigen HD-CL-03) (CTCL-associated antigen HD-CL-03) (Dehydrogenase/reductase SDR family member 8) (Retinal short-chain dehydrogenase/reductase 2) (retSDR2) (Short chain dehydrogenase/reductase family 16C member 2)
drug.Protein;P01859;IGHG2;ENSG00000211893;P01859;Immunoglobulin heavy constant gamma 2 (Ig gamma-2 chain C region) (Ig gamma-2 chain C region DOT) (Ig gamma-2 chain C region TIL) (Ig gamma-2 chain C region ZIE)
drug.Protein;O60911;CTSV;ENSG00000136943;O60911;Cathepsin L2 (EC 3.4.22.43) (Cathepsin U) (Cathepsin V)
drug.Protein;P08048;ZFY;ENSG00000067646;P08048;Zinc finger Y-chromosomal protein
drug.Protein;P42126;ECI1;ENSG00000167969;P42126;Enoyl-CoA delta isomerase 1, mitochondrial (EC 5.3.3.8) (3,2-trans-enoyl-CoA isomerase) (Delta(3),Delta(2)-enoyl-CoA isomerase) (D3,D2-enoyl-CoA isomerase) (Dodecenoyl-CoA isomerase)
drug.Protein;P11310;ACADM;ENSG00000117054;P11310;Medium-chain specific acyl-CoA dehydrogenase, mitochondrial (MCAD) (EC 1.3.8.7) (Medium chain acyl-CoA dehydrogenase) (MCADH)
drug.Protein;P17600;SYN1;ENSG00000008056;P17600;Synapsin-1 (Brain protein 4.1) (Synapsin I)
drug.Protein;O14874;BCKDK;ENSG00000103507;O14874;[3-methyl-2-oxobutanoate dehydrogenase [lipoamide]] kinase, mitochondrial (EC 2.7.11.4) (Branched-chain alpha-ketoacid dehydrogenase kinase) (BCKD-kinase) (BCKDHKIN)
drug.Protein;P54278;PMS2;ENSG00000122512;P54278;Mismatch repair endonuclease PMS2 (EC 3.1.-.-) (DNA mismatch repair protein PMS2) (PMS1 protein homolog 2)
drug.Protein;Q15075;EEA1;ENSG00000102189;Q15075;Early endosome antigen 1 (Endosome-associated protein p162) (Zinc finger FYVE domain-containing protein 2)
drug.Protein;Q05315;CLC;ENSG00000105205;Q05315;Galectin-10 (Gal-10) (Charcot-Leyden crystal protein) (CLC) (Eosinophil lysophospholipase) (Lysolecithin acylhydrolase)
drug.Protein;P00973;OAS1;ENSG00000089127;P00973;2'-5'-oligoadenylate synthase 1 ((2-5')oligo(A) synthase 1) (2-5A synthase 1) (EC 2.7.7.84) (E18/E16) (p46/p42 OAS)
drug.Protein;P11488;GNAT1;ENSG00000114349;P11488;Guanine nucleotide-binding protein G(t) subunit alpha-1 (Transducin alpha-1 chain)
drug.Protein;P41235;HNF4A;ENSG00000101076;P41235;Hepatocyte nuclear factor 4-alpha (HNF-4-alpha) (Nuclear receptor subfamily 2 group A member 1) (Transcription factor 14) (TCF-14) (Transcription factor HNF-4)
drug.Protein;P98155;VLDLR;ENSG00000147852;P98155;Very low-density lipoprotein receptor (VLDL receptor) (VLDL-R)
drug.Protein;Q9NZD2;GLTP;ENSG00000139433;Q9NZD2;Glycolipid transfer protein (GLTP)
drug.Protein;Q9UNK4;PLA2G2D;ENSG00000117215;Q9UNK4;Group IID secretory phospholipase A2 (GIID sPLA2) (sPLA2-IID) (EC 3.1.1.4) (PLA2IID) (Phosphatidylcholine 2-acylhydrolase 2D) (Secretory-type PLA, stroma-associated homolog)
drug.Protein;O94766;B3GAT3;ENSG00000149541;O94766;Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3 (EC 2.4.1.135) (Beta-1,3-glucuronyltransferase 3) (Glucuronosyltransferase I) (GlcAT-I) (UDP-GlcUA:Gal beta-1,3-Gal-R glucuronyltransferase) (GlcUAT-I)
drug.Protein;P00746;CFD;ENSG00000197766;P00746;Complement factor D (EC 3.4.21.46) (Adipsin) (C3 convertase activator) (Properdin factor D)
drug.Protein;P30419;NMT1;ENSG00000136448;P30419;Glycylpeptide N-tetradecanoyltransferase 1 (EC 2.3.1.97) (Myristoyl-CoA:protein N-myristoyltransferase 1) (HsNMT1) (NMT 1) (Type I N-myristoyltransferase) (Peptide N-myristoyltransferase 1) (Protein-lysine myristoyltransferase NMT1) (EC 2.3.1.-)
drug.Protein;P78368;CSNK1G2;ENSG00000133275;P78368;Casein kinase I isoform gamma-2 (CKI-gamma 2) (EC 2.7.11.1)
drug.Protein;P11413;G6PD;ENSG00000160211;P11413;Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)
drug.Protein;P0CG04;IGLC1;ENSG00000211675;P0CG04;Immunoglobulin lambda constant 1 (Ig lambda chain C region MGC) (Ig lambda-1 chain C region)
drug.Protein;P01709;IGLV2-8;ENSG00000278196;P01709;Immunoglobulin lambda variable 2-8 (Ig lambda chain V-II region BO) (Ig lambda chain V-II region MGC)
drug.Protein;Q03403;TFF2;ENSG00000160181;Q03403;Trefoil factor 2 (Spasmolysin) (Spasmolytic polypeptide) (SP)
drug.Protein;O43612;HCRT;ENSG00000161610;O43612;"Orexin (Hypocretin) (Hcrt) [Cleaved into: Orexin-A (Hypocretin-1) (Hcrt1); Orexin-B (Hypocretin-2) (Hcrt2)]"
drug.Protein;P80075;CCL8;ENSG00000108700;P80075;C-C motif chemokine 8 (HC14) (Monocyte chemoattractant protein 2) (Monocyte chemotactic protein 2) (MCP-2) (Small-inducible cytokine A8) [Cleaved into: MCP-2(6-76)]
drug.Protein;P04062;GBA;ENSG00000177628;P04062;Lysosomal acid glucosylceramidase (Lysosomal acid GCase) (EC 3.2.1.45) (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase) (Beta-GC) (Cholesterol glucosyltransferase) (SGTase) (EC 2.4.1.-) (Cholesteryl-beta-glucosidase) (EC 3.2.1.-) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase) (Lysosomal cholesterol glycosyltransferase) (Lysosomal galactosylceramidase) (EC 3.2.1.46) (Lysosomal glycosylceramidase)
drug.Protein;O14735;CDIPT;ENSG00000103502;O14735;CDP-diacylglycerol--inositol 3-phosphatidyltransferase (EC 2.7.8.11) (Phosphatidylinositol synthase) (PI synthase) (PtdIns synthase)
drug.Protein;Q13231;CHIT1;ENSG00000133063;Q13231;Chitotriosidase-1 (EC 3.2.1.14) (Chitinase-1)
drug.Protein;Q92876;KLK6;ENSG00000167755;Q92876;Kallikrein-6 (EC 3.4.21.-) (Neurosin) (Protease M) (SP59) (Serine protease 18) (Serine protease 9) (Zyme)
drug.Protein;Q92947;GCDH;ENSG00000105607;Q92947;Glutaryl-CoA dehydrogenase, mitochondrial (GCD) (EC 1.3.8.6)
drug.Protein;Q96RQ9;IL4I1;ENSG00000104951;Q96RQ9;L-amino-acid oxidase (LAAO) (LAO) (EC 1.4.3.2) (EC 1.4.3.25) (Interleukin-4-induced protein 1) (IL4-induced protein 1) (hIL4I1) (Protein Fig-1) (hFIG1)
drug.Protein;P26440;IVD;ENSG00000128928;P26440;Isovaleryl-CoA dehydrogenase, mitochondrial (IVD) (EC 1.3.8.4) (Butyryl-CoA dehydrogenase) (EC 1.3.8.1)
drug.Protein;O95831;AIFM1;ENSG00000156709;O95831;Apoptosis-inducing factor 1, mitochondrial (EC 1.6.99.-) (Programmed cell death protein 8)
drug.Protein;Q9UHQ9;CYB5R1;ENSG00000159348;Q9UHQ9;NADH-cytochrome b5 reductase 1 (b5R.1) (EC 1.6.2.2) (Humb5R2) (NAD(P)H:quinone oxidoreductase type 3 polypeptide A2)
drug.Protein;P22570;FDXR;ENSG00000161513;P22570;NADPH:adrenodoxin oxidoreductase, mitochondrial (AR) (Adrenodoxin reductase) (EC 1.18.1.6) (Ferredoxin--NADP(+) reductase) (Ferredoxin reductase)
drug.Protein;Q15067;ACOX1;ENSG00000161533;Q15067;"Peroxisomal acyl-coenzyme A oxidase 1 (AOX) (EC 1.3.3.6) (Palmitoyl-CoA oxidase) (Peroxisomal fatty acyl-CoA oxidase) (Straight-chain acyl-CoA oxidase) (SCOX) [Cleaved into: Peroxisomal acyl-CoA oxidase 1, A chain; Peroxisomal acyl-CoA oxidase 1, B chain; Peroxisomal acyl-CoA oxidase 1, C chain]"
drug.Protein;P55789;GFER;ENSG00000127554;P55789;FAD-linked sulfhydryl oxidase ALR (EC 1.8.3.2) (Augmenter of liver regeneration) (hERV1) (Hepatopoietin)
drug.Protein;P32019;INPP5B;ENSG00000204084;P32019;Type II inositol 1,4,5-trisphosphate 5-phosphatase (EC 3.1.3.36) (75 kDa inositol polyphosphate-5-phosphatase) (Phosphoinositide 5-phosphatase) (5PTase)
drug.Protein;P05413;FABP3;ENSG00000121769;P05413;Fatty acid-binding protein, heart (Fatty acid-binding protein 3) (Heart-type fatty acid-binding protein) (H-FABP) (Mammary-derived growth inhibitor) (MDGI) (Muscle fatty acid-binding protein) (M-FABP)
drug.Protein;P15151;PVR;ENSG00000073008;P15151;Poliovirus receptor (Nectin-like protein 5) (NECL-5) (CD antigen CD155)
drug.Protein;Q96QU6;ACCS;ENSG00000110455;Q96QU6;1-aminocyclopropane-1-carboxylate synthase-like protein 1 (ACC synthase-like protein 1)
drug.Protein;P23526;AHCY;ENSG00000101444;P23526;Adenosylhomocysteinase (AdoHcyase) (EC 3.3.1.1) (S-adenosyl-L-homocysteine hydrolase)
drug.Protein;Q9HAN9;NMNAT1;ENSG00000173614;Q9HAN9;Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1 (NMN/NaMN adenylyltransferase 1) (EC 2.7.7.1) (EC 2.7.7.18) (Nicotinamide-nucleotide adenylyltransferase 1) (NMN adenylyltransferase 1) (Nicotinate-nucleotide adenylyltransferase 1) (NaMN adenylyltransferase 1)
drug.Protein;O75676;RPS6KA4;ENSG00000162302;O75676;Ribosomal protein S6 kinase alpha-4 (S6K-alpha-4) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 4) (Nuclear mitogen- and stress-activated protein kinase 2) (Ribosomal protein kinase B) (RSKB)
drug.Protein;Q9NYQ3;HAO2;ENSG00000116882;Q9NYQ3;2-Hydroxyacid oxidase 2 (HAOX2) (EC 1.1.3.15) ((S)-2-hydroxy-acid oxidase, peroxisomal) (Cell growth-inhibiting gene 16 protein) (Long chain alpha-hydroxy acid oxidase) (Long-chain L-2-hydroxy acid oxidase)
drug.Protein;Q96CD2;PPCDC;ENSG00000138621;Q96CD2;Phosphopantothenoylcysteine decarboxylase (PPC-DC) (EC 4.1.1.36) (CoaC)
drug.Protein;O00141;SGK1;ENSG00000118515;O00141;Serine/threonine-protein kinase Sgk1 (EC 2.7.11.1) (Serum/glucocorticoid-regulated kinase 1)
drug.Protein;P04179;SOD2;ENSG00000112096;P04179;Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1)
drug.Protein;P23946;CMA1;ENSG00000092009;P23946;Chymase (EC 3.4.21.39) (Alpha-chymase) (Mast cell protease I)
drug.Protein;P19622;EN2;ENSG00000164778;P19622;Homeobox protein engrailed-2 (Homeobox protein en-2) (Hu-En-2)
drug.Protein;Q9Y275;TNFSF13B;ENSG00000102524;Q9Y275;"Tumor necrosis factor ligand superfamily member 13B (B lymphocyte stimulator) (BLyS) (B-cell-activating factor) (BAFF) (Dendritic cell-derived TNF-like molecule) (TNF- and APOL-related leukocyte expressed ligand 1) (TALL-1) (CD antigen CD257) [Cleaved into: Tumor necrosis factor ligand superfamily member 13b, membrane form; Tumor necrosis factor ligand superfamily member 13b, soluble form]"
drug.Protein;Q9Y6I3;EPN1;ENSG00000063245;Q9Y6I3;Epsin-1 (EH domain-binding mitotic phosphoprotein) (EPS-15-interacting protein 1)
drug.Protein;P10600;TGFB3;ENSG00000119699;P10600;"Transforming growth factor beta-3 proprotein [Cleaved into: Latency-associated peptide (LAP); Transforming growth factor beta-3 (TGF-beta-3)]"
drug.Protein;P09382;LGALS1;ENSG00000100097;P09382;Galectin-1 (Gal-1) (14 kDa laminin-binding protein) (HLBP14) (14 kDa lectin) (Beta-galactoside-binding lectin L-14-I) (Galaptin) (HBL) (HPL) (Lactose-binding lectin 1) (Lectin galactoside-binding soluble 1) (Putative MAPK-activating protein PM12) (S-Lac lectin 1)
drug.Protein;Q96GD3;SCMH1;ENSG00000010803;Q96GD3;Polycomb protein SCMH1 (Sex comb on midleg homolog 1)
drug.Protein;Q12965;MYO1E;ENSG00000157483;Q12965;Unconventional myosin-Ie (Myosin-Ic) (Unconventional myosin 1E)
drug.Protein;Q14565;DMC1;ENSG00000100206;Q14565;Meiotic recombination protein DMC1/LIM15 homolog
drug.Protein;P61925;PKIA;ENSG00000171033;P61925;cAMP-dependent protein kinase inhibitor alpha (PKI-alpha) (cAMP-dependent protein kinase inhibitor, muscle/brain isoform)
drug.Protein;Q6PHW0;IYD;ENSG00000009765;Q6PHW0;Iodotyrosine deiodinase 1 (IYD-1) (EC 1.21.1.1) (Iodotyrosine dehalogenase 1)
drug.Protein;Q86WA6;BPHL;ENSG00000137274;Q86WA6;Valacyclovir hydrolase (VACVase) (Valacyclovirase) (EC 3.1.-.-) (Biphenyl hydrolase-like protein) (Biphenyl hydrolase-related protein) (Bph-rp) (Breast epithelial mucin-associated antigen) (MCNAA)
drug.Protein;P55210;CASP7;ENSG00000165806;P55210;"Caspase-7 (CASP-7) (EC 3.4.22.60) (Apoptotic protease Mch-3) (CMH-1) (ICE-like apoptotic protease 3) (ICE-LAP3) [Cleaved into: Caspase-7 subunit p20; Caspase-7 subunit p11]"
drug.Protein;P15309;ACP3;ENSG00000014257;P15309;Prostatic acid phosphatase (PAP) (EC 3.1.3.2) (5'-nucleotidase) (5'-NT) (EC 3.1.3.5) (Acid phosphatase 3) (Ecto-5'-nucleotidase) (Protein tyrosine phosphatase ACP3) (EC 3.1.3.48) (Thiamine monophosphatase) (TMPase) [Cleaved into: PAPf39]
drug.Protein;P26572;MGAT1;ENSG00000131446;P26572;Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase (EC 2.4.1.101) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase I) (GNT-I) (GlcNAc-T I)
drug.Protein;P51178;PLCD1;ENSG00000187091;P51178;1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-1 (EC 3.1.4.11) (Phosphoinositide phospholipase C-delta-1) (Phospholipase C-III) (PLC-III) (Phospholipase C-delta-1) (PLC-delta-1)
drug.Protein;P35241;RDX;ENSG00000137710;P35241;Radixin
drug.Protein;Q14643;ITPR1;ENSG00000150995;Q14643;Inositol 1,4,5-trisphosphate receptor type 1 (IP3 receptor isoform 1) (IP3R 1) (InsP3R1) (Type 1 inositol 1,4,5-trisphosphate receptor) (Type 1 InsP3 receptor)
drug.Protein;P33316;DUT;ENSG00000128951;P33316;Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial (dUTPase) (EC 3.6.1.23) (dUTP pyrophosphatase)
drug.Protein;P22749;GNLY;ENSG00000115523;P22749;Granulysin (Lymphokine LAG-2) (Protein NKG5) (T-cell activation protein 519)
drug.Protein;P34096;RNASE4;ENSG00000258818;P34096;Ribonuclease 4 (RNase 4) (EC 3.1.27.-)
drug.Protein;Q6UWP2;DHRS11;ENSG00000278535;Q6UWP2;Dehydrogenase/reductase SDR family member 11 (17-beta-hydroxysteroid dehydrogenase) (3-beta-hydroxysteroid 3-dehydrogenase) (EC 1.1.1.270) (Estradiol 17-beta-dehydrogenase) (EC 1.1.1.62) (Short-chain dehydrogenase/reductase family 24C member 1)
drug.Protein;Q16698;DECR1;ENSG00000104325;Q16698;2,4-dienoyl-CoA reductase [(3E)-enoyl-CoA-producing], mitochondrial (EC 1.3.1.124) (2,4-dienoyl-CoA reductase [NADPH]) (4-enoyl-CoA reductase [NADPH]) (Short chain dehydrogenase/reductase family 18C member 1)
drug.Protein;Q14914;PTGR1;ENSG00000106853;Q14914;Prostaglandin reductase 1 (PRG-1) (15-oxoprostaglandin 13-reductase) (EC 1.3.1.48) (Dithiolethione-inducible gene 1 protein) (D3T-inducible gene 1 protein) (DIG-1) (Leukotriene B4 12-hydroxydehydrogenase) (NAD(P)H-dependent alkenal/one oxidoreductase) (EC 1.3.1.74)
drug.Protein;Q9P2N6;KANSL3;ENSG00000114982;Q9P2N6;KAT8 regulatory NSL complex subunit 3 (NSL complex protein NSL3) (Non-specific lethal 3 homolog) (Serum inhibited-related protein) (Testis development protein PRTD)
drug.Protein;Q8WVQ1;CANT1;ENSG00000171302;Q8WVQ1;Soluble calcium-activated nucleotidase 1 (SCAN-1) (EC 3.6.1.6) (Apyrase homolog) (Putative MAPK-activating protein PM09) (Putative NF-kappa-B-activating protein 107)
drug.Protein;P50750;CDK9;ENSG00000136807;P50750;Cyclin-dependent kinase 9 (EC 2.7.11.22) (EC 2.7.11.23) (C-2K) (Cell division cycle 2-like protein kinase 4) (Cell division protein kinase 9) (Serine/threonine-protein kinase PITALRE) (Tat-associated kinase complex catalytic subunit)
drug.Protein;Q00534;CDK6;ENSG00000105810;Q00534;Cyclin-dependent kinase 6 (EC 2.7.11.22) (Cell division protein kinase 6) (Serine/threonine-protein kinase PLSTIRE)
drug.Protein;P49336;CDK8;ENSG00000132964;P49336;Cyclin-dependent kinase 8 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 8) (Mediator complex subunit CDK8) (Mediator of RNA polymerase II transcription subunit CDK8) (Protein kinase K35)
drug.Protein;P19438;TNFRSF1A;ENSG00000067182;P19438;"Tumor necrosis factor receptor superfamily member 1A (Tumor necrosis factor receptor 1) (TNF-R1) (Tumor necrosis factor receptor type I) (TNF-RI) (TNFR-I) (p55) (p60) (CD antigen CD120a) [Cleaved into: Tumor necrosis factor receptor superfamily member 1A, membrane form; Tumor necrosis factor-binding protein 1 (TBPI)]"
drug.Protein;O76083;PDE9A;ENSG00000160191;O76083;High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (EC 3.1.4.35)
drug.Protein;P09958;FURIN;ENSG00000140564;P09958;Furin (EC 3.4.21.75) (Dibasic-processing enzyme) (Paired basic amino acid residue-cleaving enzyme) (PACE)
drug.Protein;P02775;PPBP;ENSG00000163736;P02775;"Platelet basic protein (PBP) (C-X-C motif chemokine 7) (Leukocyte-derived growth factor) (LDGF) (Macrophage-derived growth factor) (MDGF) (Small-inducible cytokine B7) [Cleaved into: Connective tissue-activating peptide III (CTAP-III) (LA-PF4) (Low-affinity platelet factor IV); TC-2; Connective tissue-activating peptide III(1-81) (CTAP-III(1-81)); Beta-thromboglobulin (Beta-TG); Neutrophil-activating peptide 2(74) (NAP-2(74)); Neutrophil-activating peptide 2(73) (NAP-2(73)); Neutrophil-activating peptide 2 (NAP-2); TC-1; Neutrophil-activating peptide 2(1-66) (NAP-2(1-66)); Neutrophil-activating peptide 2(1-63) (NAP-2(1-63))]"
drug.Protein;P49366;DHPS;ENSG00000095059;P49366;Deoxyhypusine synthase (DHS) (EC 2.5.1.46)
drug.Protein;P07711;CTSL;ENSG00000135047;P07711;"Procathepsin L (EC 3.4.22.15) (Cathepsin L1) (Major excreted protein) (MEP) [Cleaved into: Cathepsin L; Cathepsin L heavy chain; Cathepsin L light chain]"
drug.Protein;Q9H4G4;GLIPR2;ENSG00000122694;Q9H4G4;Golgi-associated plant pathogenesis-related protein 1 (GAPR-1) (Golgi-associated PR-1 protein) (Glioma pathogenesis-related protein 2) (GliPR 2)
drug.Protein;P30305;CDC25B;ENSG00000101224;P30305;M-phase inducer phosphatase 2 (EC 3.1.3.48) (Dual specificity phosphatase Cdc25B)
drug.Protein;Q96AZ6;ISG20;ENSG00000172183;Q96AZ6;Interferon-stimulated gene 20 kDa protein (EC 3.1.13.1) (Estrogen-regulated transcript 45 protein) (Promyelocytic leukemia nuclear body-associated protein ISG20)
drug.Protein;P25311;AZGP1;ENSG00000160862;P25311;Zinc-alpha-2-glycoprotein (Zn-alpha-2-GP) (Zn-alpha-2-glycoprotein)
drug.Protein;P05451;REG1A;ENSG00000115386;P05451;Lithostathine-1-alpha (Islet cells regeneration factor) (ICRF) (Islet of Langerhans regenerating protein) (REG) (Pancreatic stone protein) (PSP) (Pancreatic thread protein) (PTP) (Regenerating islet-derived protein 1-alpha) (REG-1-alpha) (Regenerating protein I alpha)
drug.Protein;P06132;UROD;ENSG00000126088;P06132;Uroporphyrinogen decarboxylase (UPD) (URO-D) (EC 4.1.1.37)
drug.Protein;Q9Y286;SIGLEC7;ENSG00000168995;Q9Y286;Sialic acid-binding Ig-like lectin 7 (Siglec-7) (Adhesion inhibitory receptor molecule 1) (AIRM-1) (CDw328) (D-siglec) (QA79 membrane protein) (p75) (CD antigen CD328)
drug.Protein;P36956;SREBF1;ENSG00000072310;P36956;Sterol regulatory element-binding protein 1 (SREBP-1) (Class D basic helix-loop-helix protein 1) (bHLHd1) (Sterol regulatory element-binding transcription factor 1) [Cleaved into: Processed sterol regulatory element-binding protein 1 (Transcription factor SREBF1)]
drug.Protein;Q15120;PDK3;ENSG00000067992;Q15120;[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrial (EC 2.7.11.2) (Pyruvate dehydrogenase kinase isoform 3)
drug.Protein;P25774;CTSS;ENSG00000163131;P25774;Cathepsin S (EC 3.4.22.27)
drug.Protein;P41743;PRKCI;ENSG00000163558;P41743;Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (PRKC-lambda/iota) (aPKC-lambda/iota) (nPKC-iota)
drug.Protein;P55055;NR1H2;ENSG00000131408;P55055;Oxysterols receptor LXR-beta (Liver X receptor beta) (Nuclear receptor NER) (Nuclear receptor subfamily 1 group H member 2) (Ubiquitously-expressed nuclear receptor)
drug.Protein;Q14541;HNF4G;ENSG00000164749;Q14541;Hepatocyte nuclear factor 4-gamma (HNF-4-gamma) (Nuclear receptor subfamily 2 group A member 2)
drug.Protein;O43617;TRAPPC3;ENSG00000054116;O43617;Trafficking protein particle complex subunit 3 (BET3 homolog)
drug.Protein;P00709;LALBA;ENSG00000167531;P00709;Alpha-lactalbumin (Lactose synthase B protein) (Lysozyme-like protein 7)
drug.Protein;Q01469;FABP5;ENSG00000164687;Q01469;Fatty acid-binding protein 5 (Epidermal-type fatty acid-binding protein) (E-FABP) (Fatty acid-binding protein, epidermal) (Psoriasis-associated fatty acid-binding protein homolog) (PA-FABP)
drug.Protein;P36405;ARL3;ENSG00000138175;P36405;ADP-ribosylation factor-like protein 3
drug.Protein;Q9Y468;L3MBTL1;ENSG00000185513;Q9Y468;Lethal(3)malignant brain tumor-like protein 1 (H-l(3)mbt) (H-l(3)mbt protein) (L(3)mbt-like) (L(3)mbt protein homolog) (L3MBTL1)
drug.Protein;P30041;PRDX6;ENSG00000117592;P30041;Peroxiredoxin-6 (EC 1.11.1.27) (1-Cys peroxiredoxin) (1-Cys PRX) (24 kDa protein) (Acidic calcium-independent phospholipase A2) (aiPLA2) (EC 3.1.1.4) (Antioxidant protein 2) (Glutathione-dependent peroxiredoxin) (Liver 2D page spot 40) (Lysophosphatidylcholine acyltransferase 5) (LPC acyltransferase 5) (LPCAT-5) (Lyso-PC acyltransferase 5) (EC 2.3.1.23) (Non-selenium glutathione peroxidase) (NSGPx) (Red blood cells page spot 12)
drug.Protein;Q8IWL2;SFTPA1;ENSG00000122852;Q8IWL2;Pulmonary surfactant-associated protein A1 (PSP-A) (PSPA) (SP-A) (SP-A1) (35 kDa pulmonary surfactant-associated protein) (Alveolar proteinosis protein) (Collectin-4)
drug.Protein;Q6NXR0;IRGC;ENSG00000124449;Q6NXR0;Interferon-inducible GTPase 5 (EC 3.6.5.-) (Immunity-related GTPase cinema 1)
drug.Protein;Q9Y691;KCNMB2;ENSG00000197584;Q9Y691;Calcium-activated potassium channel subunit beta-2 (BK channel subunit beta-2) (BKbeta2) (Hbeta2) (Calcium-activated potassium channel, subfamily M subunit beta-2) (Charybdotoxin receptor subunit beta-2) (Hbeta3) (K(VCA)beta-2) (Maxi K channel subunit beta-2) (Slo-beta-2)
drug.Protein;Q9UNA0;ADAMTS5;ENSG00000154736;Q9UNA0;A disintegrin and metalloproteinase with thrombospondin motifs 5 (ADAM-TS 5) (ADAM-TS5) (ADAMTS-5) (EC 3.4.24.-) (A disintegrin and metalloproteinase with thrombospondin motifs 11) (ADAM-TS 11) (ADAMTS-11) (ADMP-2) (Aggrecanase-2)
drug.Protein;P35222;CTNNB1;ENSG00000168036;P35222;Catenin beta-1 (Beta-catenin)
drug.Protein;Q15849;SLC14A2;ENSG00000132874;Q15849;Urea transporter 2 (Solute carrier family 14 member 2) (Urea transporter, kidney)
drug.Protein;Q13336;SLC14A1;ENSG00000141469;Q13336;Urea transporter 1 (Solute carrier family 14 member 1) (Urea transporter, erythrocyte)
drug.Protein;Q12756;KIF1A;ENSG00000130294;Q12756;Kinesin-like protein KIF1A (Axonal transporter of synaptic vesicles) (Microtubule-based motor KIF1A) (Unc-104- and KIF1A-related protein) (hUnc-104)
drug.Protein;P36897;TGFBR1;ENSG00000106799;P36897;TGF-beta receptor type-1 (TGFR-1) (EC 2.7.11.30) (Activin A receptor type II-like protein kinase of 53kD) (Activin receptor-like kinase 5) (ALK-5) (ALK5) (Serine/threonine-protein kinase receptor R4) (SKR4) (TGF-beta type I receptor) (Transforming growth factor-beta receptor type I) (TGF-beta receptor type I) (TbetaR-I)
drug.Protein;P29508;SERPINB3;ENSG00000057149;P29508;Serpin B3 (Protein T4-A) (Squamous cell carcinoma antigen 1) (SCCA-1)
drug.Protein;P02741;CRP;ENSG00000132693;P02741;C-reactive protein [Cleaved into: C-reactive protein(1-205)]
drug.Protein;Q96BH3;ELSPBP1;ENSG00000169393;Q96BH3;Epididymal sperm-binding protein 1 (Epididymal secretory protein 12) (hE12)
drug.Protein;Q9Y678;COPG1;ENSG00000181789;Q9Y678;Coatomer subunit gamma-1 (Gamma-1-coat protein) (Gamma-1-COP)
drug.Protein;Q13426;XRCC4;ENSG00000152422;Q13426;DNA repair protein XRCC4 (hXRCC4) (X-ray repair cross-complementing protein 4) [Cleaved into: Protein XRCC4, C-terminus (XRCC4/C)]
drug.Protein;P51687;SUOX;ENSG00000139531;P51687;Sulfite oxidase, mitochondrial (EC 1.8.3.1)
drug.Protein;P18509;ADCYAP1;ENSG00000141433;P18509;"Pituitary adenylate cyclase-activating polypeptide (PACAP) [Cleaved into: PACAP-related peptide (PRP-48); Pituitary adenylate cyclase-activating polypeptide 27 (PACAP-27) (PACAP27); Pituitary adenylate cyclase-activating polypeptide 38 (PACAP-38) (PACAP38)]"
drug.Protein;P52732;KIF11;ENSG00000138160;P52732;Kinesin-like protein KIF11 (Kinesin-like protein 1) (Kinesin-like spindle protein HKSP) (Kinesin-related motor protein Eg5) (Thyroid receptor-interacting protein 5) (TR-interacting protein 5) (TRIP-5)
drug.Protein;P00167;CYB5A;ENSG00000166347;P00167;Cytochrome b5 (Microsomal cytochrome b5 type A) (MCB5)
drug.Protein;P53355;DAPK1;ENSG00000196730;P53355;Death-associated protein kinase 1 (DAP kinase 1) (EC 2.7.11.1)
drug.Protein;Q9UQM7;CAMK2A;ENSG00000070808;Q9UQM7;Calcium/calmodulin-dependent protein kinase type II subunit alpha (CaM kinase II subunit alpha) (CaMK-II subunit alpha) (EC 2.7.11.17)
drug.Protein;P22314;UBA1;ENSG00000130985;P22314;Ubiquitin-like modifier-activating enzyme 1 (EC 6.2.1.45) (Protein A1S9) (Ubiquitin-activating enzyme E1)
drug.Protein;P0CG29;GSTT2;ENSG00000099984;P0CG29;Glutathione S-transferase theta-2 (EC 2.5.1.18) (GST class-theta-2)
drug.Protein;P61587;RND3;ENSG00000115963;P61587;Rho-related GTP-binding protein RhoE (Protein MemB) (Rho family GTPase 3) (Rho-related GTP-binding protein Rho8) (Rnd3)
drug.Protein;Q15382;RHEB;ENSG00000106615;Q15382;GTP-binding protein Rheb (Ras homolog enriched in brain)
drug.Protein;P10114;RAP2A;ENSG00000125249;P10114;Ras-related protein Rap-2a (EC 3.6.5.2) (RbBP-30)
drug.Protein;P08574;CYC1;ENSG00000179091;P08574;Cytochrome c1, heme protein, mitochondrial (EC 7.1.1.8) (Complex III subunit 4) (Complex III subunit IV) (Cytochrome b-c1 complex subunit 4) (Ubiquinol-cytochrome-c reductase complex cytochrome c1 subunit) (Cytochrome c-1)
drug.Protein;P00156;MT-CYB;ENSG00000198727;P00156;Cytochrome b (Complex III subunit 3) (Complex III subunit III) (Cytochrome b-c1 complex subunit 3) (Ubiquinol-cytochrome-c reductase complex cytochrome b subunit)
drug.Protein;P31930;UQCRC1;ENSG00000010256;P31930;Cytochrome b-c1 complex subunit 1, mitochondrial (Complex III subunit 1) (Core protein I) (Ubiquinol-cytochrome-c reductase complex core protein 1)
drug.Protein;P22695;UQCRC2;ENSG00000140740;P22695;Cytochrome b-c1 complex subunit 2, mitochondrial (Complex III subunit 2) (Core protein II) (Ubiquinol-cytochrome-c reductase complex core protein 2)
drug.Protein;P07919;UQCRH;ENSG00000173660;P07919;Cytochrome b-c1 complex subunit 6, mitochondrial (Complex III subunit 6) (Complex III subunit VIII) (Cytochrome c1 non-heme 11 kDa protein) (Mitochondrial hinge protein) (Ubiquinol-cytochrome c reductase complex 11 kDa protein)
drug.Protein;O14949;UQCRQ;ENSG00000164405;O14949;Cytochrome b-c1 complex subunit 8 (Complex III subunit 8) (Complex III subunit VIII) (Ubiquinol-cytochrome c reductase complex 9.5 kDa protein) (Ubiquinol-cytochrome c reductase complex ubiquinone-binding protein QP-C)
drug.Protein;P47985;UQCRFS1;ENSG00000169021;P47985;Cytochrome b-c1 complex subunit Rieske, mitochondrial (EC 7.1.1.8) (Complex III subunit 5) (Cytochrome b-c1 complex subunit 5) (Rieske iron-sulfur protein) (RISP) (Rieske protein UQCRFS1) (Ubiquinol-cytochrome c reductase iron-sulfur subunit) [Cleaved into: Cytochrome b-c1 complex subunit 9 (Su9) (Subunit 9) (8 kDa subunit 9) (Complex III subunit IX) (Cytochrome b-c1 complex subunit 11) (UQCRFS1 mitochondrial targeting sequence) (UQCRFS1 MTS) (Ubiquinol-cytochrome c reductase 8 kDa protein)]
drug.Protein;P14927;UQCRB;ENSG00000156467;P14927;Cytochrome b-c1 complex subunit 7 (Complex III subunit 7) (Complex III subunit VII) (QP-C) (Ubiquinol-cytochrome c reductase complex 14 kDa protein)
drug.Protein;Q9UDW1;UQCR10;ENSG00000184076;Q9UDW1;Cytochrome b-c1 complex subunit 9 (Complex III subunit 9) (Complex III subunit X) (Cytochrome c1 non-heme 7 kDa protein) (Ubiquinol-cytochrome c reductase complex 7.2 kDa protein)
drug.Protein;P21912;SDHB;ENSG00000117118;P21912;Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial (EC 1.3.5.1) (Iron-sulfur subunit of complex II) (Ip)
drug.Protein;P01593;IGKV1D-33;ENSG00000239975;P01593;Immunoglobulin kappa variable 1D-33 (Ig kappa chain V-I region AG) (Ig kappa chain V-I region Bi) (Ig kappa chain V-I region Lay) (Ig kappa chain V-I region Ni) (Ig kappa chain V-I region Rei) (Ig kappa chain V-I region Roy) (Ig kappa chain V-I region Scw) (Ig kappa chain V-I region WAT)
drug.Protein;P01764;IGHV3-23;ENSG00000211949;P01764;Immunoglobulin heavy variable 3-23 (Ig heavy chain V-III region LAY) (Ig heavy chain V-III region POM) (Ig heavy chain V-III region TEI) (Ig heavy chain V-III region TIL) (Ig heavy chain V-III region TUR) (Ig heavy chain V-III region VH26) (Ig heavy chain V-III region WAS) (Ig heavy chain V-III region ZAP)
drug.Protein;P60981;DSTN;ENSG00000125868;P60981;Destrin (Actin-depolymerizing factor) (ADF)
drug.Protein;Q14494;NFE2L1;ENSG00000082641;Q14494;Endoplasmic reticulum membrane sensor NFE2L1 (Locus control region-factor 1) (LCR-F1) (Nuclear factor erythroid 2-related factor 1) (NF-E2-related factor 1) (NFE2-related factor 1) (Nuclear factor, erythroid derived 2, like 1) (Protein NRF1, p120 form) (Transcription factor 11) (TCF-11) [Cleaved into: Transcription factor NRF1 (Protein NRF1, p110 form)]
drug.Protein;P23528;CFL1;ENSG00000172757;P23528;Cofilin-1 (18 kDa phosphoprotein) (p18) (Cofilin, non-muscle isoform)
drug.Protein;Q9GZU7;CTDSP1;ENSG00000144579;Q9GZU7;Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 (EC 3.1.3.16) (Nuclear LIM interactor-interacting factor 3) (NLI-IF) (NLI-interacting factor 3) (Small C-terminal domain phosphatase 1) (SCP1) (Small CTD phosphatase 1)
drug.Protein;P17213;BPI;ENSG00000101425;P17213;Bactericidal permeability-increasing protein (BPI) (CAP 57)
drug.Protein;Q6PKH6;DHRS4L2;ENSG00000187630;Q6PKH6;Dehydrogenase/reductase SDR family member 4-like 2 (EC 1.1.-.-) (Short chain dehydrogenase/reductase family 25C member 3) (Protein SDR25C3)
drug.Protein;P29973;CNGA1;ENSG00000198515;P29973;cGMP-gated cation channel alpha-1 (Cyclic nucleotide-gated cation channel 1) (Cyclic nucleotide-gated channel alpha-1) (CNG channel alpha-1) (CNG-1) (CNG1) (Cyclic nucleotide-gated channel, photoreceptor) (Rod photoreceptor cGMP-gated channel subunit alpha)
drug.Protein;Q9BVJ7;DUSP23;ENSG00000158716;Q9BVJ7;Dual specificity protein phosphatase 23 (EC 3.1.3.16) (EC 3.1.3.48) (Low molecular mass dual specificity phosphatase 3) (LDP-3) (VH1-like phosphatase Z)
drug.Protein;P25705;ATP5F1A;ENSG00000152234;P25705;ATP synthase subunit alpha, mitochondrial (ATP synthase F1 subunit alpha)
drug.Protein;P06576;ATP5F1B;ENSG00000110955;P06576;ATP synthase subunit beta, mitochondrial (EC 7.1.2.2) (ATP synthase F1 subunit beta)
drug.Protein;P36542;ATP5F1C;ENSG00000165629;P36542;ATP synthase subunit gamma, mitochondrial (ATP synthase F1 subunit gamma) (F-ATPase gamma subunit)
drug.Protein;Q6NVY1;HIBCH;ENSG00000198130;Q6NVY1;3-hydroxyisobutyryl-CoA hydrolase, mitochondrial (EC 3.1.2.4) (3-hydroxyisobutyryl-coenzyme A hydrolase) (HIB-CoA hydrolase) (HIBYL-CoA-H)
drug.Protein;O94768;STK17B;ENSG00000081320;O94768;Serine/threonine-protein kinase 17B (EC 2.7.11.1) (DAP kinase-related apoptosis-inducing protein kinase 2)
drug.Protein;P60709;ACTB;ENSG00000075624;P60709;Actin, cytoplasmic 1 (Beta-actin) [Cleaved into: Actin, cytoplasmic 1, N-terminally processed]
drug.Protein;O00303;EIF3F;ENSG00000175390;O00303;Eukaryotic translation initiation factor 3 subunit F (eIF3f) (Deubiquitinating enzyme eIF3f) (EC 3.4.19.12) (Eukaryotic translation initiation factor 3 subunit 5) (eIF-3-epsilon) (eIF3 p47)
drug.Protein;P54652;HSPA2;ENSG00000126803;P54652;Heat shock-related 70 kDa protein 2 (Heat shock 70 kDa protein 2)
drug.Protein;Q9Y230;RUVBL2;ENSG00000183207;Q9Y230;RuvB-like 2 (EC 3.6.4.12) (48 kDa TATA box-binding protein-interacting protein) (48 kDa TBP-interacting protein) (51 kDa erythrocyte cytosolic protein) (ECP-51) (INO80 complex subunit J) (Repressing pontin 52) (Reptin 52) (TIP49b) (TIP60-associated protein 54-beta) (TAP54-beta)
drug.Protein;Q15393;SF3B3;ENSG00000189091;Q15393;Splicing factor 3B subunit 3 (Pre-mRNA-splicing factor SF3b 130 kDa subunit) (SF3b130) (STAF130) (Spliceosome-associated protein 130) (SAP 130)
drug.Protein;P17676;CEBPB;ENSG00000172216;P17676;CCAAT/enhancer-binding protein beta (C/EBP beta) (Liver activator protein) (LAP) (Liver-enriched inhibitory protein) (LIP) (Nuclear factor NF-IL6) (Transcription factor 5) (TCF-5)
drug.Protein;O14964;HGS;ENSG00000185359;O14964;Hepatocyte growth factor-regulated tyrosine kinase substrate (Hrs) (Protein pp110)
drug.Protein;P15086;CPB1;ENSG00000153002;P15086;Carboxypeptidase B (EC 3.4.17.2) (Pancreas-specific protein) (PASP)
drug.Protein;Q9HB21;PLEKHA1;ENSG00000107679;Q9HB21;Pleckstrin homology domain-containing family A member 1 (PH domain-containing family A member 1) (Tandem PH domain-containing protein 1) (TAPP-1)
drug.Protein;P07384;CAPN1;ENSG00000014216;P07384;Calpain-1 catalytic subunit (EC 3.4.22.52) (Calcium-activated neutral proteinase 1) (CANP 1) (Calpain mu-type) (Calpain-1 large subunit) (Cell proliferation-inducing gene 30 protein) (Micromolar-calpain) (muCANP)
drug.Protein;Q8WUI4;HDAC7;ENSG00000061273;Q8WUI4;Histone deacetylase 7 (HD7) (EC 3.5.1.98) (Histone deacetylase 7A) (HD7a)
drug.Protein;Q9HBH1;PDF;ENSG00000258429;Q9HBH1;Peptide deformylase, mitochondrial (EC 3.5.1.88) (Polypeptide deformylase)
drug.Protein;P41091;EIF2S3;ENSG00000130741;P41091;Eukaryotic translation initiation factor 2 subunit 3 (EC 3.6.5.3) (Eukaryotic translation initiation factor 2 subunit gamma X) (eIF-2-gamma X) (eIF-2gX)
drug.Protein;P63096;GNAI1;ENSG00000127955;P63096;Guanine nucleotide-binding protein G(i) subunit alpha-1 (Adenylate cyclase-inhibiting G alpha protein)
drug.Protein;P51151;RAB9A;ENSG00000123595;P51151;Ras-related protein Rab-9A
drug.Protein;P40616;ARL1;ENSG00000120805;P40616;ADP-ribosylation factor-like protein 1
drug.Protein;P62826;RAN;ENSG00000132341;P62826;GTP-binding nuclear protein Ran (EC 3.6.5.-) (Androgen receptor-associated protein 24) (GTPase Ran) (Ras-like protein TC4) (Ras-related nuclear protein)
drug.Protein;P51149;RAB7A;ENSG00000075785;P51149;Ras-related protein Rab-7a (EC 3.6.5.2)
drug.Protein;P15170;GSPT1;ENSG00000103342;P15170;Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (Eukaryotic peptide chain release factor subunit 3a) (eRF3a) (G1 to S phase transition protein 1 homolog)
drug.Protein;P61586;RHOA;ENSG00000067560;P61586;Transforming protein RhoA (EC 3.6.5.2) (Rho cDNA clone 12) (h12)
drug.Protein;P18085;ARF4;ENSG00000168374;P18085;ADP-ribosylation factor 4
drug.Protein;P11233;RALA;ENSG00000006451;P11233;Ras-related protein Ral-A (EC 3.6.5.2)
drug.Protein;Q96KC2;ARL5B;ENSG00000165997;Q96KC2;ADP-ribosylation factor-like protein 5B (ADP-ribosylation factor-like protein 8)
drug.Protein;Q9Y6B6;SAR1B;ENSG00000152700;Q9Y6B6;GTP-binding protein SAR1b (GTP-binding protein B) (GTBPB)
drug.Protein;Q9Y689;ARL5A;ENSG00000162980;Q9Y689;ADP-ribosylation factor-like protein 5A
drug.Protein;P53582;METAP1;ENSG00000164024;P53582;Methionine aminopeptidase 1 (MAP 1) (MetAP 1) (EC 3.4.11.18) (Peptidase M 1)
drug.Protein;P60484;PTEN;ENSG00000171862;P60484;Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67) (Mutated in multiple advanced cancers 1) (Phosphatase and tensin homolog)
drug.Protein;Q63HM9;PLCXD3;ENSG00000182836;Q63HM9;PI-PLC X domain-containing protein 3
drug.Protein;Q9UNP4;ST3GAL5;ENSG00000115525;Q9UNP4;Lactosylceramide alpha-2,3-sialyltransferase (EC 2.4.99.9) (CMP-NeuAc:lactosylceramide alpha-2,3-sialyltransferase) (GM3 synthase) (Ganglioside GM3 synthase) (ST3Gal V) (ST3GalV) (Sialyltransferase 9)
drug.Protein;P19835;CEL;ENSG00000170835;P19835;Bile salt-activated lipase (BAL) (EC 3.1.1.13) (EC 3.1.1.3) (EC 3.1.1.6) (Bile salt-stimulated lipase) (BSSL) (Bucelipase) (Carboxyl ester lipase) (Cholesterol esterase) (Pancreatic lysophospholipase) (Sterol esterase)
drug.Protein;P49759;CLK1;ENSG00000013441;P49759;Dual specificity protein kinase CLK1 (EC 2.7.12.1) (CDC-like kinase 1)
drug.Protein;Q05655;PRKCD;ENSG00000163932;Q05655;"Protein kinase C delta type (EC 2.7.11.13) (Tyrosine-protein kinase PRKCD) (EC 2.7.10.2) (nPKC-delta) [Cleaved into: Protein kinase C delta type regulatory subunit; Protein kinase C delta type catalytic subunit (Sphingosine-dependent protein kinase-1) (SDK1)]"
drug.Protein;P29323;EPHB2;ENSG00000133216;P29323;"Ephrin type-B receptor 2 (EC 2.7.10.1) (Developmentally-regulated Eph-related tyrosine kinase) (ELK-related tyrosine kinase) (EPH tyrosine kinase 3) (EPH-like kinase 5) (EK5) (hEK5) (Renal carcinoma antigen NY-REN-47) (Tyrosine-protein kinase TYRO5) (Tyrosine-protein kinase receptor EPH-3) [Cleaved into: EphB2/CTF1; EphB2/CTF2]"
drug.Protein;P55072;VCP;ENSG00000165280;P55072;Transitional endoplasmic reticulum ATPase (TER ATPase) (EC 3.6.4.6) (15S Mg(2+)-ATPase p97 subunit) (Valosin-containing protein) (VCP)
drug.Protein;Q96QT4;TRPM7;ENSG00000092439;Q96QT4;Transient receptor potential cation channel subfamily M member 7 (EC 2.7.11.1) (Channel-kinase 1) (Long transient receptor potential channel 7) (LTrpC-7) (LTrpC7)
drug.Protein;P49368;CCT3;ENSG00000163468;P49368;T-complex protein 1 subunit gamma (TCP-1-gamma) (CCT-gamma) (hTRiC5)
drug.Protein;P51570;GALK1;ENSG00000108479;P51570;Galactokinase (EC 2.7.1.6) (Galactose kinase)
drug.Protein;Q06609;RAD51;ENSG00000051180;Q06609;DNA repair protein RAD51 homolog 1 (HsRAD51) (hRAD51) (RAD51 homolog A)
drug.Protein;Q99661;KIF2C;ENSG00000142945;Q99661;Kinesin-like protein KIF2C (Kinesin-like protein 6) (Mitotic centromere-associated kinesin) (MCAK)
drug.Protein;Q16877;PFKFB4;ENSG00000114268;Q16877;"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4 (6PF-2-K/Fru-2,6-P2ase 4) (PFK/FBPase 4) (6PF-2-K/Fru-2,6-P2ase testis-type isozyme) [Includes: 6-phosphofructo-2-kinase (EC 2.7.1.105); Fructose-2,6-bisphosphatase (EC 3.1.3.46)]"
drug.Protein;P61457;PCBD1;ENSG00000166228;P61457;Pterin-4-alpha-carbinolamine dehydratase (PHS) (EC 4.2.1.96) (4-alpha-hydroxy-tetrahydropterin dehydratase) (Dimerization cofactor of hepatocyte nuclear factor 1-alpha) (DCoH) (Dimerization cofactor of HNF1) (Phenylalanine hydroxylase-stimulating protein) (Pterin carbinolamine dehydratase) (PCD)
drug.Protein;P01270;PTH;ENSG00000152266;P01270;Parathyroid hormone (PTH) (Parathormone) (Parathyrin)
drug.Protein;P20823;HNF1A;ENSG00000135100;P20823;Hepatocyte nuclear factor 1-alpha (HNF-1-alpha) (HNF-1A) (Liver-specific transcription factor LF-B1) (LFB1) (Transcription factor 1) (TCF-1)
drug.Protein;P35749;MYH11;ENSG00000133392;P35749;Myosin-11 (Myosin heavy chain 11) (Myosin heavy chain, smooth muscle isoform) (SMMHC)
drug.Protein;O15169;AXIN1;ENSG00000103126;O15169;Axin-1 (Axis inhibition protein 1) (hAxin)
drug.Protein;Q16740;CLPP;ENSG00000125656;Q16740;ATP-dependent Clp protease proteolytic subunit, mitochondrial (EC 3.4.21.92) (Endopeptidase Clp)
drug.Protein;Q92696;RABGGTA;ENSG00000100949;Q92696;Geranylgeranyl transferase type-2 subunit alpha (EC 2.5.1.60) (Geranylgeranyl transferase type II subunit alpha) (Rab geranyl-geranyltransferase subunit alpha) (Rab GG transferase alpha) (Rab GGTase alpha) (Rab geranylgeranyltransferase subunit alpha)
drug.Protein;P53611;RABGGTB;ENSG00000137955;P53611;Geranylgeranyl transferase type-2 subunit beta (EC 2.5.1.60) (Geranylgeranyl transferase type II subunit beta) (GGTase-II-beta) (Rab geranyl-geranyltransferase subunit beta) (Rab GG transferase beta) (Rab GGTase beta) (Rab geranylgeranyltransferase subunit beta) (Type II protein geranyl-geranyltransferase subunit beta)
drug.Protein;P29377;S100G;ENSG00000169906;P29377;Protein S100-G (Calbindin-D9k) (S100 calcium-binding protein G) (Vitamin D-dependent calcium-binding protein, intestinal) (CABP)
drug.Protein;P0CG48;UBC;ENSG00000150991;P0CG48;Polyubiquitin-C [Cleaved into: Ubiquitin]
drug.Protein;P16278;GLB1;ENSG00000170266;P16278;Beta-galactosidase (EC 3.2.1.23) (Acid beta-galactosidase) (Lactase) (Elastin receptor 1)
drug.Protein;O00182;LGALS9;ENSG00000168961;O00182;Galectin-9 (Gal-9) (Ecalectin) (Tumor antigen HOM-HD-21)
drug.Protein;P02778;CXCL10;ENSG00000169245;P02778;C-X-C motif chemokine 10 (10 kDa interferon gamma-induced protein) (Gamma-IP10) (IP-10) (Small-inducible cytokine B10) [Cleaved into: CXCL10(1-73)]
drug.Protein;O75976;CPD;ENSG00000108582;O75976;Carboxypeptidase D (EC 3.4.17.22) (Metallocarboxypeptidase D) (gp180)
drug.Protein;P19429;TNNI3;ENSG00000129991;P19429;Troponin I, cardiac muscle (Cardiac troponin I)
drug.Protein;Q9UL54;TAOK2;ENSG00000149930;Q9UL54;Serine/threonine-protein kinase TAO2 (EC 2.7.11.1) (Kinase from chicken homolog C) (hKFC-C) (Prostate-derived sterile 20-like kinase 1) (PSK-1) (PSK1) (Prostate-derived STE20-like kinase 1) (Thousand and one amino acid protein kinase 2)
drug.Protein;Q03721;KCNC4;ENSG00000116396;Q03721;Potassium voltage-gated channel subfamily C member 4 (KSHIIIC) (Voltage-gated potassium channel subunit Kv3.4)
drug.Protein;Q15796;SMAD2;ENSG00000175387;Q15796;Mothers against decapentaplegic homolog 2 (MAD homolog 2) (Mothers against DPP homolog 2) (JV18-1) (Mad-related protein 2) (hMAD-2) (SMAD family member 2) (SMAD 2) (Smad2) (hSMAD2)
drug.Protein;O00187;MASP2;ENSG00000009724;O00187;"Mannan-binding lectin serine protease 2 (EC 3.4.21.104) (MBL-associated serine protease 2) (Mannose-binding protein-associated serine protease 2) (MASP-2) [Cleaved into: Mannan-binding lectin serine protease 2 A chain; Mannan-binding lectin serine protease 2 B chain]"
drug.Protein;P36952;SERPINB5;ENSG00000206075;P36952;Serpin B5 (Maspin) (Peptidase inhibitor 5) (PI-5)
drug.Protein;O60493;SNX3;ENSG00000112335;O60493;Sorting nexin-3 (Protein SDP3)
drug.Protein;Q9ULY5;CLEC4E;ENSG00000166523;Q9ULY5;C-type lectin domain family 4 member E (C-type lectin superfamily member 9) (Macrophage-inducible C-type lectin) (MINCLE)
drug.Protein;P51800;CLCNKA;ENSG00000186510;P51800;Chloride channel protein ClC-Ka (Chloride channel Ka) (ClC-K1)
drug.Protein;Q16769;QPCT;ENSG00000115828;Q16769;Glutaminyl-peptide cyclotransferase (EC 2.3.2.5) (Glutaminyl cyclase) (QC) (sQC) (Glutaminyl-tRNA cyclotransferase) (Glutamyl cyclase) (EC)
drug.Protein;P35914;HMGCL;ENSG00000117305;P35914;Hydroxymethylglutaryl-CoA lyase, mitochondrial (HL) (HMG-CoA lyase) (EC 4.1.3.4) (3-hydroxy-3-methylglutarate-CoA lyase)
drug.Protein;Q8TF76;HASPIN;ENSG00000177602;Q8TF76;Serine/threonine-protein kinase haspin (EC 2.7.11.1) (Germ cell-specific gene 2 protein) (H-haspin) (Haploid germ cell-specific nuclear protein kinase)
drug.Protein;P30291;WEE1;ENSG00000166483;P30291;Wee1-like protein kinase (WEE1hu) (EC 2.7.10.2) (Wee1A kinase)
drug.Protein;P15813;CD1D;ENSG00000158473;P15813;Antigen-presenting glycoprotein CD1d (R3G1) (CD antigen CD1d)
drug.Protein;P01877;IGHA2;ENSG00000211890;P01877;Immunoglobulin heavy constant alpha 2 (Ig alpha-2 chain C region) (Ig alpha-2 chain C region BUT) (Ig alpha-2 chain C region LAN)
drug.Protein;Q13285;NR5A1;ENSG00000136931;Q13285;Steroidogenic factor 1 (SF-1) (STF-1) (hSF-1) (Adrenal 4-binding protein) (Fushi tarazu factor homolog 1) (Nuclear receptor subfamily 5 group A member 1) (Steroid hormone receptor Ad4BP)
drug.Protein;Q03426;MVK;ENSG00000110921;Q03426;Mevalonate kinase (MK) (EC 2.7.1.36)
drug.Protein;Q96GD4;AURKB;ENSG00000178999;Q96GD4;Aurora kinase B (EC 2.7.11.1) (Aurora 1) (Aurora- and IPL1-like midbody-associated protein 1) (AIM-1) (Aurora/IPL1-related kinase 2) (ARK-2) (Aurora-related kinase 2) (STK-1) (Serine/threonine-protein kinase 12) (Serine/threonine-protein kinase 5) (Serine/threonine-protein kinase aurora-B)
drug.Protein;Q13464;ROCK1;ENSG00000067900;Q13464;Rho-associated protein kinase 1 (EC 2.7.11.1) (Renal carcinoma antigen NY-REN-35) (Rho-associated, coiled-coil-containing protein kinase 1) (Rho-associated, coiled-coil-containing protein kinase I) (ROCK-I) (p160 ROCK-1) (p160ROCK)
drug.Protein;O60674;JAK2;ENSG00000096968;O60674;Tyrosine-protein kinase JAK2 (EC 2.7.10.2) (Janus kinase 2) (JAK-2)
drug.Protein;O43293;DAPK3;ENSG00000167657;O43293;Death-associated protein kinase 3 (DAP kinase 3) (EC 2.7.11.1) (DAP-like kinase) (Dlk) (MYPT1 kinase) (Zipper-interacting protein kinase) (ZIP-kinase)
drug.Protein;P52333;JAK3;ENSG00000105639;P52333;Tyrosine-protein kinase JAK3 (EC 2.7.10.2) (Janus kinase 3) (JAK-3) (Leukocyte janus kinase) (L-JAK)
drug.Protein;P29597;TYK2;ENSG00000105397;P29597;Non-receptor tyrosine-protein kinase TYK2 (EC 2.7.10.2)
drug.Protein;Q96LB9;PGLYRP3;ENSG00000159527;Q96LB9;Peptidoglycan recognition protein 3 (Peptidoglycan recognition protein I-alpha) (PGLYRPIalpha) (PGRP-I-alpha) (Peptidoglycan recognition protein intermediate alpha)
drug.Protein;Q9Y6M4;CSNK1G3;ENSG00000151292;Q9Y6M4;Casein kinase I isoform gamma-3 (CKI-gamma 3) (EC 2.7.11.1)
drug.Protein;Q15418;RPS6KA1;ENSG00000117676;Q15418;Ribosomal protein S6 kinase alpha-1 (S6K-alpha-1) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 1) (p90-RSK 1) (p90RSK1) (p90S6K) (MAP kinase-activated protein kinase 1a) (MAPK-activated protein kinase 1a) (MAPKAP kinase 1a) (MAPKAPK-1a) (Ribosomal S6 kinase 1) (RSK-1)
drug.Protein;P41231;P2RY2;ENSG00000175591;P41231;P2Y purinoceptor 2 (P2Y2) (ATP receptor) (P2U purinoceptor 1) (P2U1) (P2U receptor 1) (Purinergic receptor)
drug.Protein;O14957;UQCR11;ENSG00000127540;O14957;Cytochrome b-c1 complex subunit 10 (Complex III subunit 10) (Complex III subunit XI) (Ubiquinol-cytochrome c reductase complex 6.4 kDa protein)
drug.Protein;Q9H1R3;MYLK2;ENSG00000101306;Q9H1R3;Myosin light chain kinase 2, skeletal/cardiac muscle (MLCK2) (EC 2.7.11.18)
drug.Protein;P51681;CCR5;ENSG00000160791;P51681;C-C chemokine receptor type 5 (C-C CKR-5) (CC-CKR-5) (CCR-5) (CCR5) (CHEMR13) (HIV-1 fusion coreceptor) (CD antigen CD195)
drug.Protein;P06881;CALCA;ENSG00000110680;P06881;Calcitonin gene-related peptide 1 (Alpha-type CGRP) (Calcitonin gene-related peptide I) (CGRP-I)
drug.Protein;Q16602;CALCRL;ENSG00000064989;Q16602;Calcitonin gene-related peptide type 1 receptor (CGRP type 1 receptor) (Calcitonin receptor-like receptor)
drug.Protein;P29371;TACR3;ENSG00000169836;P29371;Neuromedin-K receptor (NKR) (NK-3 receptor) (NK-3R) (Neurokinin B receptor) (Tachykinin receptor 3)
drug.Protein;Q15648;MED1;ENSG00000125686;Q15648;Mediator of RNA polymerase II transcription subunit 1 (Activator-recruited cofactor 205 kDa component) (ARC205) (Mediator complex subunit 1) (Peroxisome proliferator-activated receptor-binding protein) (PBP) (PPAR-binding protein) (Thyroid hormone receptor-associated protein complex 220 kDa component) (Trap220) (Thyroid receptor-interacting protein 2) (TR-interacting protein 2) (TRIP-2) (Vitamin D receptor-interacting protein complex component DRIP205) (p53 regulatory protein RB18A)
drug.Protein;P49356;FNTB;ENSG00000257365;P49356;Protein farnesyltransferase subunit beta (FTase-beta) (EC 2.5.1.58) (CAAX farnesyltransferase subunit beta) (Ras proteins prenyltransferase subunit beta)
drug.Protein;P49354;FNTA;ENSG00000168522;P49354;Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha (EC 2.5.1.58) (EC 2.5.1.59) (CAAX farnesyltransferase subunit alpha) (FTase-alpha) (Ras proteins prenyltransferase subunit alpha) (Type I protein geranyl-geranyltransferase subunit alpha) (GGTase-I-alpha)
drug.Protein;P30874;SSTR2;ENSG00000180616;P30874;Somatostatin receptor type 2 (SS-2-R) (SS2-R) (SS2R) (SST2) (SRIF-1)
drug.Protein;P35346;SSTR5;ENSG00000162009;P35346;Somatostatin receptor type 5 (SS-5-R) (SS5-R) (SS5R) (SST5)
drug.Protein;P17342;NPR3;ENSG00000113389;P17342;Atrial natriuretic peptide receptor 3 (Atrial natriuretic peptide clearance receptor) (Atrial natriuretic peptide receptor type C) (ANP-C) (ANPR-C) (NPR-C)
drug.Protein;Q16206;ENOX2;ENSG00000165675;Q16206;"Ecto-NOX disulfide-thiol exchanger 2 (APK1 antigen) (Cytosolic ovarian carcinoma antigen 1) (Tumor-associated hydroquinone oxidase) (tNOX) [Includes: Hydroquinone [NADH] oxidase (EC 1.-.-.-); Protein disulfide-thiol oxidoreductase (EC 1.-.-.-)]"
drug.Protein;P02675;FGB;ENSG00000171564;P02675;"Fibrinogen beta chain [Cleaved into: Fibrinopeptide B; Fibrinogen beta chain]"
drug.Protein;P20292;ALOX5AP;ENSG00000132965;P20292;Arachidonate 5-lipoxygenase-activating protein (FLAP) (MK-886-binding protein)
drug.Protein;Q01726;MC1R;ENSG00000258839;Q01726;Melanocyte-stimulating hormone receptor (MSH-R) (Melanocortin receptor 1) (MC1-R)
drug.Protein;Q5XXA6;ANO1;ENSG00000131620;Q5XXA6;Anoctamin-1 (Discovered on gastrointestinal stromal tumors protein 1) (Oral cancer overexpressed protein 2) (Transmembrane protein 16A) (Tumor-amplified and overexpressed sequence 2)
drug.Protein;P56696;KCNQ4;ENSG00000117013;P56696;Potassium voltage-gated channel subfamily KQT member 4 (KQT-like 4) (Potassium channel subunit alpha KvLQT4) (Voltage-gated potassium channel subunit Kv7.4)
drug.Protein;P15382;KCNE1;ENSG00000180509;P15382;Potassium voltage-gated channel subfamily E member 1 (Delayed rectifier potassium channel subunit IsK) (IKs producing slow voltage-gated potassium channel subunit beta Mink) (Minimal potassium channel)
drug.Protein;P20273;CD22;ENSG00000012124;P20273;B-cell receptor CD22 (B-lymphocyte cell adhesion molecule) (BL-CAM) (Sialic acid-binding Ig-like lectin 2) (Siglec-2) (T-cell surface antigen Leu-14) (CD antigen CD22)
drug.Protein;Q5T4S7;UBR4;ENSG00000127481;Q5T4S7;E3 ubiquitin-protein ligase UBR4 (EC 2.3.2.27) (600 kDa retinoblastoma protein-associated factor) (N-recognin-4) (RING-type E3 ubiquitin transferase UBR4) (Retinoblastoma-associated factor of 600 kDa) (RBAF600) (p600) (Zinc finger UBR1-type protein 1)
drug.Protein;Q8WXI7;MUC16;ENSG00000181143;Q8WXI7;Mucin-16 (MUC-16) (Ovarian cancer-related tumor marker CA125) (CA-125) (Ovarian carcinoma antigen CA125)
drug.Protein;P27695;APEX1;ENSG00000100823;P27695;DNA-(apurinic or apyrimidinic site) endonuclease (EC 3.1.11.2) (APEX nuclease) (APEN) (Apurinic-apyrimidinic endonuclease 1) (AP endonuclease 1) (APE-1) (REF-1) (Redox factor-1) [Cleaved into: DNA-(apurinic or apyrimidinic site) endonuclease, mitochondrial]
drug.Protein;P08865;RPSA;ENSG00000168028;P08865;40S ribosomal protein SA (37 kDa laminin receptor precursor) (37LRP) (37/67 kDa laminin receptor) (LRP/LR) (67 kDa laminin receptor) (67LR) (Colon carcinoma laminin-binding protein) (Laminin receptor 1) (LamR) (Laminin-binding protein precursor p40) (LBP/p40) (Multidrug resistance-associated protein MGr1-Ag) (NEM/1CHD4) (Small ribosomal subunit protein uS2)
drug.Protein;O14672;ADAM10;ENSG00000137845;O14672;Disintegrin and metalloproteinase domain-containing protein 10 (ADAM 10) (EC 3.4.24.81) (CDw156) (Kuzbanian protein homolog) (Mammalian disintegrin-metalloprotease) (CD antigen CD156c)
drug.Protein;Q9Y6K9;IKBKG;ENSG00000269335;Q9Y6K9;NF-kappa-B essential modulator (NEMO) (FIP-3) (IkB kinase-associated protein 1) (IKKAP1) (Inhibitor of nuclear factor kappa-B kinase subunit gamma) (I-kappa-B kinase subunit gamma) (IKK-gamma) (IKKG) (IkB kinase subunit gamma) (NF-kappa-B essential modifier)
drug.Protein;P25929;NPY1R;ENSG00000164128;P25929;Neuropeptide Y receptor type 1 (NPY1-R)
drug.Protein;Q15761;NPY5R;ENSG00000164129;Q15761;Neuropeptide Y receptor type 5 (NPY5-R) (NPY-Y5 receptor) (NPYY5-R) (Y5 receptor)
drug.Protein;P50391;NPY4R;ENSG00000204174;P50391;Neuropeptide Y receptor type 4 (NPY4-R) (Pancreatic polypeptide receptor 1) (PP1)
drug.Protein;P22607;FGFR3;ENSG00000068078;P22607;Fibroblast growth factor receptor 3 (FGFR-3) (EC 2.7.10.1) (CD antigen CD333)
drug.Protein;P06280;GLA;ENSG00000102393;P06280;Alpha-galactosidase A (EC 3.2.1.22) (Alpha-D-galactosidase A) (Alpha-D-galactoside galactohydrolase) (Galactosylgalactosylglucosylceramidase GLA) (Melibiase) (Agalsidase)
drug.Protein;Q13443;ADAM9;ENSG00000168615;Q13443;Disintegrin and metalloproteinase domain-containing protein 9 (ADAM 9) (EC 3.4.24.-) (Cellular disintegrin-related protein) (Meltrin-gamma) (Metalloprotease/disintegrin/cysteine-rich protein 9) (Myeloma cell metalloproteinase)
drug.Protein;Q86US8;SMG6;ENSG00000070366;Q86US8;Telomerase-binding protein EST1A (EC 3.1.-.-) (Ever shorter telomeres 1A) (hEST1A) (Nonsense mediated mRNA decay factor SMG6) (Smg-6 homolog) (hSmg5/7a)
drug.Protein;Q96KG9;SCYL1;ENSG00000142186;Q96KG9;N-terminal kinase-like protein (Coated vesicle-associated kinase of 90 kDa) (SCY1-like protein 1) (Telomerase regulation-associated protein) (Telomerase transcriptional element-interacting factor) (Teratoma-associated tyrosine kinase)
drug.Protein;P30411;BDKRB2;ENSG00000168398;P30411;B2 bradykinin receptor (B2R) (BK-2 receptor)
drug.Protein;P23560;BDNF;ENSG00000176697;P23560;Brain-derived neurotrophic factor (BDNF) (Abrineurin) [Cleaved into: BDNF precursor form (ProBDNF)]
drug.Protein;P24394;IL4R;ENSG00000077238;P24394;Interleukin-4 receptor subunit alpha (IL-4 receptor subunit alpha) (IL-4R subunit alpha) (IL-4R-alpha) (IL-4RA) (CD antigen CD124) [Cleaved into: Soluble interleukin-4 receptor subunit alpha (Soluble IL-4 receptor subunit alpha) (Soluble IL-4R-alpha) (sIL4Ralpha/prot) (IL-4-binding protein) (IL4-BP)]
drug.Protein;Q14627;IL13RA2;ENSG00000123496;Q14627;Interleukin-13 receptor subunit alpha-2 (IL-13 receptor subunit alpha-2) (IL-13R subunit alpha-2) (IL-13R-alpha-2) (IL-13RA2) (Interleukin-13-binding protein) (CD antigen CD213a2)
drug.Protein;Q03431;PTH1R;ENSG00000160801;Q03431;Parathyroid hormone/parathyroid hormone-related peptide receptor (PTH/PTHrP type I receptor) (PTH/PTHr receptor) (Parathyroid hormone 1 receptor) (PTH1 receptor)
drug.Protein;Q14416;GRM2;ENSG00000164082;Q14416;Metabotropic glutamate receptor 2 (mGluR2)
drug.Protein;Q14832;GRM3;ENSG00000198822;Q14832;Metabotropic glutamate receptor 3 (mGluR3)
drug.Protein;P06731;CEACAM5;ENSG00000105388;P06731;Carcinoembryonic antigen-related cell adhesion molecule 5 (Carcinoembryonic antigen) (CEA) (Meconium antigen 100) (CD antigen CD66e)
drug.Protein;P48357;LEPR;ENSG00000116678;P48357;Leptin receptor (LEP-R) (HuB219) (OB receptor) (OB-R) (CD antigen CD295)
drug.Protein;Q13093;PLA2G7;ENSG00000146070;Q13093;Platelet-activating factor acetylhydrolase (PAF acetylhydrolase) (EC 3.1.1.47) (1-alkyl-2-acetylglycerophosphocholine esterase) (2-acetyl-1-alkylglycerophosphocholine esterase) (Group-VIIA phospholipase A2) (gVIIA-PLA2) (LDL-associated phospholipase A2) (LDL-PLA(2)) (PAF 2-acylhydrolase)
drug.Protein;P16144;ITGB4;ENSG00000132470;P16144;Integrin beta-4 (GP150) (CD antigen CD104)
drug.Protein;P26010;ITGB7;ENSG00000139626;P26010;Integrin beta-7 (Gut homing receptor beta subunit)
drug.Protein;P41597;CCR2;ENSG00000121807;P41597;C-C chemokine receptor type 2 (C-C CKR-2) (CC-CKR-2) (CCR-2) (CCR2) (Monocyte chemoattractant protein 1 receptor) (MCP-1-R) (CD antigen CD192)
drug.Protein;Q9GZP0;PDGFD;ENSG00000170962;Q9GZP0;"Platelet-derived growth factor D (PDGF-D) (Iris-expressed growth factor) (Spinal cord-derived growth factor B) (SCDGF-B) [Cleaved into: Platelet-derived growth factor D, latent form (PDGFD latent form); Platelet-derived growth factor D, receptor-binding form (PDGFD receptor-binding form)]"
drug.Protein;Q8IW54;;;;
drug.Protein;Q6PEY2;TUBA3E;ENSG00000152086;Q6PEY2;Tubulin alpha-3E chain (Alpha-tubulin 3E) [Cleaved into: Detyrosinated tubulin alpha-3E chain]
drug.Protein;Q9H853;TUBA4B;ENSG00000243910;Q9H853;Putative tubulin-like protein alpha-4B (Alpha-tubulin 4B)
drug.Protein;Q13885;TUBB2A;ENSG00000137267;Q13885;Tubulin beta-2A chain (Tubulin beta class IIa)
drug.Protein;Q9BVA1;TUBB2B;ENSG00000137285;Q9BVA1;Tubulin beta-2B chain
drug.Protein;Q9BUF5;TUBB6;ENSG00000176014;Q9BUF5;Tubulin beta-6 chain (Tubulin beta class V)
drug.Protein;O96017;CHEK2;ENSG00000183765;O96017;Serine/threonine-protein kinase Chk2 (EC 2.7.11.1) (CHK2 checkpoint homolog) (Cds1 homolog) (Hucds1) (hCds1) (Checkpoint kinase 2)
drug.Protein;O14757;CHEK1;ENSG00000149554;O14757;Serine/threonine-protein kinase Chk1 (EC 2.7.11.1) (CHK1 checkpoint homolog) (Cell cycle checkpoint kinase) (Checkpoint kinase-1)
drug.Protein;Q15759;MAPK11;ENSG00000185386;Q15759;Mitogen-activated protein kinase 11 (MAP kinase 11) (MAPK 11) (EC 2.7.11.24) (Mitogen-activated protein kinase p38 beta) (MAP kinase p38 beta) (p38b) (Stress-activated protein kinase 2b) (SAPK2b) (p38-2)
drug.Protein;O15264;MAPK13;ENSG00000156711;O15264;Mitogen-activated protein kinase 13 (MAP kinase 13) (MAPK 13) (EC 2.7.11.24) (Mitogen-activated protein kinase p38 delta) (MAP kinase p38 delta) (Stress-activated protein kinase 4)
drug.Protein;P24158;PRTN3;ENSG00000196415;P24158;Myeloblastin (EC 3.4.21.76) (AGP7) (C-ANCA antigen) (Leukocyte proteinase 3) (PR-3) (PR3) (Neutrophil proteinase 4) (NP-4) (P29) (Wegener autoantigen)
drug.Protein;A1Z199;;;;
drug.Protein;Q8TDV5;GPR119;ENSG00000147262;Q8TDV5;Glucose-dependent insulinotropic receptor (G-protein coupled receptor 119)
drug.Protein;Q96BI3;APH1A;ENSG00000117362;Q96BI3;Gamma-secretase subunit APH-1A (APH-1a) (Aph-1alpha) (Presenilin-stabilization factor)
drug.Protein;Q9NZ42;PSENEN;ENSG00000205155;Q9NZ42;Gamma-secretase subunit PEN-2 (Presenilin enhancer protein 2)
drug.Protein;P04141;CSF2;ENSG00000164400;P04141;Granulocyte-macrophage colony-stimulating factor (GM-CSF) (Colony-stimulating factor) (CSF) (Molgramostin) (Sargramostim)
drug.Protein;Q16498;;;;
drug.Protein;A6PZ59;;;;
drug.Protein;P27986;PIK3R1;ENSG00000145675;P27986;Phosphatidylinositol 3-kinase regulatory subunit alpha (PI3-kinase regulatory subunit alpha) (PI3K regulatory subunit alpha) (PtdIns-3-kinase regulatory subunit alpha) (Phosphatidylinositol 3-kinase 85 kDa regulatory subunit alpha) (PI3-kinase subunit p85-alpha) (PtdIns-3-kinase regulatory subunit p85-alpha)
drug.Protein;O00459;PIK3R2;ENSG00000105647;O00459;Phosphatidylinositol 3-kinase regulatory subunit beta (PI3-kinase regulatory subunit beta) (PI3K regulatory subunit beta) (PtdIns-3-kinase regulatory subunit beta) (Phosphatidylinositol 3-kinase 85 kDa regulatory subunit beta) (PI3-kinase subunit p85-beta) (PtdIns-3-kinase regulatory subunit p85-beta)
drug.Protein;Q92569;PIK3R3;ENSG00000117461;Q92569;Phosphatidylinositol 3-kinase regulatory subunit gamma (PI3-kinase regulatory subunit gamma) (PI3K regulatory subunit gamma) (PtdIns-3-kinase regulatory subunit gamma) (Phosphatidylinositol 3-kinase 55 kDa regulatory subunit gamma) (PI3-kinase subunit p55-gamma) (PtdIns-3-kinase regulatory subunit p55-gamma) (p55PIK)
drug.Protein;Q00653;NFKB2;ENSG00000077150;Q00653;Nuclear factor NF-kappa-B p100 subunit (DNA-binding factor KBF2) (H2TF1) (Lymphocyte translocation chromosome 10 protein) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 2) (Oncogene Lyt-10) (Lyt10) [Cleaved into: Nuclear factor NF-kappa-B p52 subunit]
drug.Protein;P43490;NAMPT;ENSG00000105835;P43490;Nicotinamide phosphoribosyltransferase (NAmPRTase) (Nampt) (EC 2.4.2.12) (Pre-B-cell colony-enhancing factor 1) (Pre-B cell-enhancing factor) (Visfatin)
drug.Protein;Q14894;CRYM;ENSG00000103316;Q14894;Ketimine reductase mu-crystallin (EC 1.5.1.25) (NADP-regulated thyroid-hormone-binding protein)
drug.Protein;P01911;HLA-DRB1;ENSG00000196126;P01911;HLA class II histocompatibility antigen, DRB1 beta chain (Human leukocyte antigen DRB1) (HLA-DRB1)
drug.Protein;P21281;ATP6V1B2;ENSG00000147416;P21281;V-type proton ATPase subunit B, brain isoform (V-ATPase subunit B 2) (Endomembrane proton pump 58 kDa subunit) (HO57) (Vacuolar proton pump subunit B 2)
drug.Protein;Q8NFA2;NOXO1;ENSG00000196408;Q8NFA2;NADPH oxidase organizer 1 (NADPH oxidase regulatory protein) (Nox organizer 1) (Nox-organizing protein 1) (SH3 and PX domain-containing protein 5)
drug.Protein;Q13882;PTK6;ENSG00000101213;Q13882;Protein-tyrosine kinase 6 (EC 2.7.10.2) (Breast tumor kinase) (Tyrosine-protein kinase BRK)
drug.Protein;P35225;IL13;ENSG00000169194;P35225;Interleukin-13 (IL-13)
drug.Protein;P37268;FDFT1;ENSG00000079459;P37268;Squalene synthase (SQS) (SS) (EC 2.5.1.21) (FPP:FPP farnesyltransferase) (Farnesyl-diphosphate farnesyltransferase) (Farnesyl-diphosphate farnesyltransferase 1)
drug.Protein;P16422;EPCAM;ENSG00000119888;P16422;Epithelial cell adhesion molecule (Ep-CAM) (Adenocarcinoma-associated antigen) (Cell surface glycoprotein Trop-1) (Epithelial cell surface antigen) (Epithelial glycoprotein) (EGP) (Epithelial glycoprotein 314) (EGP314) (hEGP314) (KS 1/4 antigen) (KSA) (Major gastrointestinal tumor-associated protein GA733-2) (Tumor-associated calcium signal transducer 1) (CD antigen CD326)
drug.Protein;P40238;MPL;ENSG00000117400;P40238;Thrombopoietin receptor (TPO-R) (Myeloproliferative leukemia protein) (Proto-oncogene c-Mpl) (CD antigen CD110)
drug.Protein;P48060;GLIPR1;ENSG00000139278;P48060;Glioma pathogenesis-related protein 1 (GliPR 1) (Protein RTVP-1)
drug.Protein;P51164;ATP4B;ENSG00000186009;P51164;Potassium-transporting ATPase subunit beta (Gastric H(+)/K(+) ATPase subunit beta) (Proton pump beta chain)
drug.Protein;P10147;CCL3;ENSG00000277632;P10147;C-C motif chemokine 3 (G0/G1 switch regulatory protein 19-1) (Macrophage inflammatory protein 1-alpha) (MIP-1-alpha) (PAT 464.1) (SIS-beta) (Small-inducible cytokine A3) (Tonsillar lymphocyte LD78 alpha protein) [Cleaved into: MIP-1-alpha(4-69) (LD78-alpha(4-69))]
drug.Protein;Q92911;SLC5A5;ENSG00000105641;Q92911;Sodium/iodide cotransporter (Na(+)/I(-) cotransporter) (Sodium-iodide symporter) (Na(+)/I(-) symporter) (Solute carrier family 5 member 5)
drug.Protein;P01266;TG;ENSG00000042832;P01266;Thyroglobulin (Tg)
drug.Protein;O43511;SLC26A4;ENSG00000091137;O43511;Pendrin (Sodium-independent chloride/iodide transporter) (Solute carrier family 26 member 4)
drug.Protein;P35625;TIMP3;ENSG00000100234;P35625;Metalloproteinase inhibitor 3 (Protein MIG-5) (Tissue inhibitor of metalloproteinases 3) (TIMP-3)
drug.Protein;Q7L5Y9;MAEA;ENSG00000090316;Q7L5Y9;E3 ubiquitin-protein transferase MAEA (EC 2.3.2.27) (Cell proliferation-inducing gene 5 protein) (Erythroblast macrophage protein) (Human lung cancer oncogene 10 protein) (HLC-10) (Macrophage erythroblast attacher) (P44EMLP)
drug.Protein;Q86VB7;CD163;ENSG00000177575;Q86VB7;Scavenger receptor cysteine-rich type 1 protein M130 (Hemoglobin scavenger receptor) (CD antigen CD163) [Cleaved into: Soluble CD163 (sCD163)]
drug.Protein;P21926;CD9;ENSG00000010278;P21926;CD9 antigen (5H9 antigen) (Cell growth-inhibiting gene 2 protein) (Leukocyte antigen MIC3) (Motility-related protein) (MRP-1) (Tetraspanin-29) (Tspan-29) (p24) (CD antigen CD9)
drug.Protein;P05305;EDN1;ENSG00000078401;P05305;"Endothelin-1 (Preproendothelin-1) (PPET1) [Cleaved into: Endothelin-1 (ET-1); Big endothelin-1]"
drug.Protein;Q9NNW7;TXNRD2;ENSG00000184470;Q9NNW7;Thioredoxin reductase 2, mitochondrial (EC 1.8.1.9) (Selenoprotein Z) (SelZ) (TR-beta) (Thioredoxin reductase TR3)
drug.Protein;P51671;CCL11;ENSG00000172156;P51671;Eotaxin (C-C motif chemokine 11) (Eosinophil chemotactic protein) (Small-inducible cytokine A11)
drug.Protein;P10145;CXCL8;ENSG00000169429;P10145;"Interleukin-8 (IL-8) (C-X-C motif chemokine 8) (Chemokine (C-X-C motif) ligand 8) (Emoctakin) (Granulocyte chemotactic protein 1) (GCP-1) (Monocyte-derived neutrophil chemotactic factor) (MDNCF) (Monocyte-derived neutrophil-activating peptide) (MONAP) (Neutrophil-activating protein 1) (NAP-1) (Protein 3-10C) (T-cell chemotactic factor) [Cleaved into: MDNCF-a (GCP/IL-8 protein IV) (IL8/NAP1 form I); Interleukin-8 ((Ala-IL-8)77) (GCP/IL-8 protein II) (IL-8(1-77)) (IL8/NAP1 form II) (MDNCF-b); IL-8(5-77); IL-8(6-77) ((Ser-IL-8)72) (GCP/IL-8 protein I) (IL8/NAP1 form III) (Lymphocyte-derived neutrophil-activating factor) (LYNAP) (MDNCF-c) (Neutrophil-activating factor) (NAF); IL-8(7-77) (GCP/IL-8 protein V) (IL8/NAP1 form IV); IL-8(8-77) (GCP/IL-8 protein VI) (IL8/NAP1 form V); IL-8(9-77) (GCP/IL-8 protein III) (IL8/NAP1 form VI)]"
drug.Protein;P02749;APOH;ENSG00000091583;P02749;Beta-2-glycoprotein 1 (APC inhibitor) (Activated protein C-binding protein) (Anticardiolipin cofactor) (Apolipoprotein H) (Apo-H) (Beta-2-glycoprotein I) (B2GPI) (Beta(2)GPI)
drug.Protein;Q9NPF7;IL23A;ENSG00000110944;Q9NPF7;Interleukin-23 subunit alpha (IL-23 subunit alpha) (IL-23-A) (Interleukin-23 subunit p19) (IL-23p19)
drug.Protein;Q5NUL3;FFAR4;ENSG00000186188;Q5NUL3;Free fatty acid receptor 4 (G-protein coupled receptor 120) (G-protein coupled receptor 129) (G-protein coupled receptor GT01) (G-protein coupled receptor PGR4) (Omega-3 fatty acid receptor 1)
drug.Protein;Q86V67;;;;
drug.Protein;P61812;TGFB2;ENSG00000092969;P61812;"Transforming growth factor beta-2 proprotein (Cetermin) (Glioblastoma-derived T-cell suppressor factor) (G-TSF) [Cleaved into: Latency-associated peptide (LAP); Transforming growth factor beta-2 (TGF-beta-2)]"
drug.Protein;Q96IY4;CPB2;ENSG00000080618;Q96IY4;Carboxypeptidase B2 (EC 3.4.17.20) (Carboxypeptidase U) (CPU) (Plasma carboxypeptidase B) (pCPB) (Thrombin-activable fibrinolysis inhibitor) (TAFI)
drug.Protein;O15496;PLA2G10;ENSG00000069764;O15496;Group 10 secretory phospholipase A2 (EC 3.1.1.4) (Group X secretory phospholipase A2) (GX sPLA2) (sPLA2-X) (Phosphatidylcholine 2-acylhydrolase 10)
drug.Protein;P22301;IL10;ENSG00000136634;P22301;Interleukin-10 (IL-10) (Cytokine synthesis inhibitory factor) (CSIF)
drug.Protein;Q96AE4;FUBP1;ENSG00000162613;Q96AE4;Far upstream element-binding protein 1 (FBP) (FUSE-binding protein 1) (DNA helicase V) (hDH V)
drug.Protein;P13861;PRKAR2A;ENSG00000114302;P13861;cAMP-dependent protein kinase type II-alpha regulatory subunit
drug.Protein;P49190;PTH2R;ENSG00000144407;P49190;Parathyroid hormone 2 receptor (PTH2 receptor)
drug.Protein;O14763;TNFRSF10B;ENSG00000120889;O14763;Tumor necrosis factor receptor superfamily member 10B (Death receptor 5) (TNF-related apoptosis-inducing ligand receptor 2) (TRAIL receptor 2) (TRAIL-R2) (CD antigen CD262)
drug.Protein;O14793;MSTN;ENSG00000138379;O14793;Growth/differentiation factor 8 (GDF-8) (Myostatin)
drug.Protein;Q15116;PDCD1;ENSG00000188389;Q15116;Programmed cell death protein 1 (Protein PD-1) (hPD-1) (CD antigen CD279)
drug.Protein;P48061;CXCL12;ENSG00000107562;P48061;"Stromal cell-derived factor 1 (SDF-1) (hSDF-1) (C-X-C motif chemokine 12) (Intercrine reduced in hepatomas) (IRH) (hIRH) (Pre-B cell growth-stimulating factor) (PBSF) [Cleaved into: SDF-1-beta(3-72); SDF-1-alpha(3-67)]"
drug.Protein;P58335;ANTXR2;ENSG00000163297;P58335;Anthrax toxin receptor 2 (Capillary morphogenesis gene 2 protein) (CMG-2)
drug.Protein;Q9H6X2;ANTXR1;ENSG00000169604;Q9H6X2;Anthrax toxin receptor 1 (Tumor endothelial marker 8)
drug.Protein;Q9Y6Q6;TNFRSF11A;ENSG00000141655;Q9Y6Q6;Tumor necrosis factor receptor superfamily member 11A (Osteoclast differentiation factor receptor) (ODFR) (Receptor activator of NF-KB) (CD antigen CD265)
drug.Protein;P40763;STAT3;ENSG00000168610;P40763;Signal transducer and activator of transcription 3 (Acute-phase response factor)
drug.Protein;P05155;SERPING1;ENSG00000149131;P05155;Plasma protease C1 inhibitor (C1 Inh) (C1Inh) (C1 esterase inhibitor) (C1-inhibiting factor) (Serpin G1)
drug.Protein;Q969F8;KISS1R;ENSG00000116014;Q969F8;KiSS-1 receptor (KiSS-1R) (G-protein coupled receptor 54) (G-protein coupled receptor OT7T175) (hOT7T175) (Hypogonadotropin-1) (Kisspeptins receptor) (Metastin receptor)
drug.Protein;Q14956;GPNMB;ENSG00000136235;Q14956;Transmembrane glycoprotein NMB (Hematopoietic growth factor inducible neurokinin-1 type)
drug.Protein;Q13233;MAP3K1;ENSG00000095015;Q13233;Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1)
drug.Protein;Q02156;PRKCE;ENSG00000171132;Q02156;Protein kinase C epsilon type (EC 2.7.11.13) (nPKC-epsilon)
drug.Protein;P04792;HSPB1;ENSG00000106211;P04792;Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)
drug.Protein;Q02224;CENPE;ENSG00000138778;Q02224;Centromere-associated protein E (Centromere protein E) (CENP-E) (Kinesin-7) (Kinesin-related protein CENPE)
drug.Protein;P20807;CAPN3;ENSG00000092529;P20807;Calpain-3 (EC 3.4.22.54) (Calcium-activated neutral proteinase 3) (CANP 3) (Calpain L3) (Calpain p94) (Muscle-specific calcium-activated neutral protease 3) (New calpain 1) (nCL-1)
drug.Protein;Q9UQB9;AURKC;ENSG00000105146;Q9UQB9;Aurora kinase C (EC 2.7.11.1) (Aurora 3) (Aurora/IPL1-related kinase 3) (ARK-3) (Aurora-related kinase 3) (Aurora/IPL1/Eg2 protein 2) (Serine/threonine-protein kinase 13) (Serine/threonine-protein kinase aurora-C)
drug.Protein;Q9Y2T6;GPR55;ENSG00000135898;Q9Y2T6;G-protein coupled receptor 55
drug.Protein;P16615;ATP2A2;ENSG00000174437;P16615;Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) (SR Ca(2+)-ATPase 2) (EC 7.2.2.10) (Calcium pump 2) (Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal muscle isoform) (Endoplasmic reticulum class 1/2 Ca(2+) ATPase)
drug.Protein;P06734;FCER2;ENSG00000104921;P06734;"Low affinity immunoglobulin epsilon Fc receptor (BLAST-2) (C-type lectin domain family 4 member J) (Fc-epsilon-RII) (Immunoglobulin E-binding factor) (Lymphocyte IgE receptor) (CD antigen CD23) [Cleaved into: Low affinity immunoglobulin epsilon Fc receptor membrane-bound form; Low affinity immunoglobulin epsilon Fc receptor soluble form]"
drug.Protein;P16410;CTLA4;ENSG00000163599;P16410;Cytotoxic T-lymphocyte protein 4 (Cytotoxic T-lymphocyte-associated antigen 4) (CTLA-4) (CD antigen CD152)
drug.Protein;P49674;CSNK1E;ENSG00000213923;P49674;Casein kinase I isoform epsilon (CKI-epsilon) (CKIe) (EC 2.7.11.1)
drug.Protein;P21439;ABCB4;ENSG00000005471;P21439;Phosphatidylcholine translocator ABCB4 (EC 7.6.2.1) (ATP-binding cassette sub-family B member 4) (Multidrug resistance protein 3) (P-glycoprotein 3)
drug.Protein;P22460;KCNA5;ENSG00000130037;P22460;Potassium voltage-gated channel subfamily A member 5 (HPCN1) (Voltage-gated potassium channel HK2) (Voltage-gated potassium channel subunit Kv1.5)
drug.Protein;O15230;LAMA5;ENSG00000130702;O15230;Laminin subunit alpha-5 (Laminin-10 subunit alpha) (Laminin-11 subunit alpha) (Laminin-15 subunit alpha)
drug.Protein;P07942;LAMB1;ENSG00000091136;P07942;Laminin subunit beta-1 (Laminin B1 chain) (Laminin-1 subunit beta) (Laminin-10 subunit beta) (Laminin-12 subunit beta) (Laminin-2 subunit beta) (Laminin-6 subunit beta) (Laminin-8 subunit beta)
drug.Protein;P11047;LAMC1;ENSG00000135862;P11047;Laminin subunit gamma-1 (Laminin B2 chain) (Laminin-1 subunit gamma) (Laminin-10 subunit gamma) (Laminin-11 subunit gamma) (Laminin-2 subunit gamma) (Laminin-3 subunit gamma) (Laminin-4 subunit gamma) (Laminin-6 subunit gamma) (Laminin-7 subunit gamma) (Laminin-8 subunit gamma) (Laminin-9 subunit gamma) (S-laminin subunit gamma) (S-LAM gamma)
drug.Protein;P25391;LAMA1;ENSG00000101680;P25391;Laminin subunit alpha-1 (Laminin A chain) (Laminin-1 subunit alpha) (Laminin-3 subunit alpha) (S-laminin subunit alpha) (S-LAM alpha)
drug.Protein;Q16787;LAMA3;ENSG00000053747;Q16787;Laminin subunit alpha-3 (Epiligrin 170 kDa subunit) (E170) (Epiligrin subunit alpha) (Kalinin subunit alpha) (Laminin-5 subunit alpha) (Laminin-6 subunit alpha) (Laminin-7 subunit alpha) (Nicein subunit alpha)
drug.Protein;Q9NPC1;LTB4R2;ENSG00000213906;Q9NPC1;Leukotriene B4 receptor 2 (LTB4-R 2) (LTB4-R2) (LTB4 receptor JULF2) (Leukotriene B4 receptor BLT2) (Seven transmembrane receptor BLTR2)
drug.Protein;Q15722;LTB4R;ENSG00000213903;Q15722;Leukotriene B4 receptor 1 (LTB4-R 1) (LTB4-R1) (Chemoattractant receptor-like 1) (G-protein coupled receptor 16) (P2Y purinoceptor 7) (P2Y7)
drug.Protein;P49662;CASP4;ENSG00000196954;P49662;"Caspase-4 (CASP-4) (EC 3.4.22.57) (ICE and Ced-3 homolog 2) (ICH-2) (ICE(rel)-II) (Mih1) (Protease TX) [Cleaved into: Caspase-4 subunit p10; Caspase-4 subunit p20]"
drug.Protein;Q00613;HSF1;ENSG00000185122;Q00613;Heat shock factor protein 1 (HSF 1) (Heat shock transcription factor 1) (HSTF 1)
drug.Protein;P08887;IL6R;ENSG00000160712;P08887;Interleukin-6 receptor subunit alpha (IL-6 receptor subunit alpha) (IL-6R subunit alpha) (IL-6R-alpha) (IL-6RA) (IL-6R 1) (Membrane glycoprotein 80) (gp80) (CD antigen CD126) [Cleaved into: Soluble interleukin-6 receptor subunit alpha (sIL6R)]
drug.Protein;P11597;CETP;ENSG00000087237;P11597;Cholesteryl ester transfer protein (Lipid transfer protein I)
drug.Protein;Q9NQ25;SLAMF7;ENSG00000026751;Q9NQ25;SLAM family member 7 (CD2 subset 1) (CD2-like receptor-activating cytotoxic cells) (CRACC) (Membrane protein FOAP-12) (Novel Ly9) (Protein 19A) (CD antigen CD319)
drug.Protein;P17813;ENG;ENSG00000106991;P17813;Endoglin (CD antigen CD105)
drug.Protein;P28908;TNFRSF8;ENSG00000120949;P28908;Tumor necrosis factor receptor superfamily member 8 (CD30L receptor) (Ki-1 antigen) (Lymphocyte activation antigen CD30) (CD antigen CD30)
drug.Protein;P01127;PDGFB;ENSG00000100311;P01127;Platelet-derived growth factor subunit B (PDGF subunit B) (PDGF-2) (Platelet-derived growth factor B chain) (Platelet-derived growth factor beta polypeptide) (Proto-oncogene c-Sis) (Becaplermin)
drug.Protein;P15391;CD19;ENSG00000177455;P15391;B-lymphocyte antigen CD19 (B-lymphocyte surface antigen B4) (Differentiation antigen CD19) (T-cell surface antigen Leu-12) (CD antigen CD19)
drug.Protein;P53420;COL4A4;ENSG00000081052;P53420;Collagen alpha-4(IV) chain
drug.Protein;P25942;CD40;ENSG00000101017;P25942;Tumor necrosis factor receptor superfamily member 5 (B-cell surface antigen CD40) (Bp50) (CD40L receptor) (CDw40) (CD antigen CD40)
drug.Protein;P01583;IL1A;ENSG00000115008;P01583;Interleukin-1 alpha (IL-1 alpha) (Hematopoietin-1)
drug.Protein;P18510;IL1RN;ENSG00000136689;P18510;Interleukin-1 receptor antagonist protein (IL-1RN) (IL-1ra) (IRAP) (ICIL-1RA) (IL1 inhibitor) (Anakinra)
drug.Protein;P22413;ENPP1;ENSG00000197594;P22413;"Ectonucleotide pyrophosphatase/phosphodiesterase family member 1 (E-NPP 1) (Membrane component chromosome 6 surface marker 1) (Phosphodiesterase I/nucleotide pyrophosphatase 1) (Plasma-cell membrane glycoprotein PC-1) [Cleaved into: Ectonucleotide pyrophosphatase/phosphodiesterase family member 1, secreted form] [Includes: Alkaline phosphodiesterase I (EC 3.1.4.1); Nucleotide pyrophosphatase (NPPase) (EC 3.6.1.9) (Nucleotide diphosphatase)]"
drug.Protein;Q05397;PTK2;ENSG00000169398;Q05397;Focal adhesion kinase 1 (FADK 1) (EC 2.7.10.2) (Focal adhesion kinase-related nonkinase) (FRNK) (Protein phosphatase 1 regulatory subunit 71) (PPP1R71) (Protein-tyrosine kinase 2) (p125FAK) (pp125FAK)
drug.Protein;P06858;LPL;ENSG00000175445;P06858;Lipoprotein lipase (LPL) (EC 3.1.1.34) (Phospholipase A1) (EC 3.1.1.32)
drug.Protein;Q12884;FAP;ENSG00000078098;Q12884;Prolyl endopeptidase FAP (EC 3.4.21.26) (170 kDa melanoma membrane-bound gelatinase) (Dipeptidyl peptidase FAP) (EC 3.4.14.5) (Fibroblast activation protein alpha) (FAPalpha) (Gelatine degradation protease FAP) (EC 3.4.21.-) (Integral membrane serine protease) (Post-proline cleaving enzyme) (Serine integral membrane protease) (SIMP) (Surface-expressed protease) (Seprase) [Cleaved into: Antiplasmin-cleaving enzyme FAP, soluble form (APCE) (EC 3.4.14.5) (EC 3.4.21.-) (EC 3.4.21.26)]
drug.Protein;P29965;CD40LG;ENSG00000102245;P29965;"CD40 ligand (CD40-L) (T-cell antigen Gp39) (TNF-related activation protein) (TRAP) (Tumor necrosis factor ligand superfamily member 5) (CD antigen CD154) [Cleaved into: CD40 ligand, membrane form; CD40 ligand, soluble form (sCD40L)]"
drug.Protein;P08571;CD14;ENSG00000170458;P08571;"Monocyte differentiation antigen CD14 (Myeloid cell-specific leucine-rich glycoprotein) (CD antigen CD14) [Cleaved into: Monocyte differentiation antigen CD14, urinary form; Monocyte differentiation antigen CD14, membrane-bound form]"
drug.Protein;P16070;CD44;ENSG00000026508;P16070;CD44 antigen (CDw44) (Epican) (Extracellular matrix receptor III) (ECMR-III) (GP90 lymphocyte homing/adhesion receptor) (HUTCH-I) (Heparan sulfate proteoglycan) (Hermes antigen) (Hyaluronate receptor) (Phagocytic glycoprotein 1) (PGP-1) (Phagocytic glycoprotein I) (PGP-I) (CD antigen CD44)
drug.Protein;P05112;IL4;ENSG00000113520;P05112;Interleukin-4 (IL-4) (B-cell stimulatory factor 1) (BSF-1) (Binetrakin) (Lymphocyte stimulatory factor 1) (Pitrakinra)
drug.Protein;P15941;MUC1;ENSG00000185499;P15941;"Mucin-1 (MUC-1) (Breast carcinoma-associated antigen DF3) (Cancer antigen 15-3) (CA 15-3) (Carcinoma-associated mucin) (Episialin) (H23AG) (Krebs von den Lungen-6) (KL-6) (PEMT) (Peanut-reactive urinary mucin) (PUM) (Polymorphic epithelial mucin) (PEM) (Tumor-associated epithelial membrane antigen) (EMA) (Tumor-associated mucin) (CD antigen CD227) [Cleaved into: Mucin-1 subunit alpha (MUC1-NT) (MUC1-alpha); Mucin-1 subunit beta (MUC1-beta) (MUC1-CT)]"
drug.Protein;Q9UQQ2;SH2B3;ENSG00000111252;Q9UQQ2;SH2B adapter protein 3 (Lymphocyte adapter protein) (Lymphocyte-specific adapter protein Lnk) (Signal transduction protein Lnk)
drug.Protein;P36507;MAP2K2;ENSG00000126934;P36507;Dual specificity mitogen-activated protein kinase kinase 2 (MAP kinase kinase 2) (MAPKK 2) (EC 2.7.12.2) (ERK activator kinase 2) (MAPK/ERK kinase 2) (MEK 2)
drug.Protein;Q9Y2U5;MAP3K2;ENSG00000169967;Q9Y2U5;Mitogen-activated protein kinase kinase kinase 2 (EC 2.7.11.25) (MAPK/ERK kinase kinase 2) (MEK kinase 2) (MEKK 2)
drug.Protein;Q13555;CAMK2G;ENSG00000148660;Q13555;Calcium/calmodulin-dependent protein kinase type II subunit gamma (CaM kinase II subunit gamma) (CaMK-II subunit gamma) (EC 2.7.11.17)
drug.Protein;P16389;KCNA2;ENSG00000177301;P16389;Potassium voltage-gated channel subfamily A member 2 (NGK1) (Voltage-gated K(+) channel HuKIV) (Voltage-gated potassium channel HBK5) (Voltage-gated potassium channel subunit Kv1.2)
drug.Protein;P17658;KCNA6;ENSG00000151079;P17658;Potassium voltage-gated channel subfamily A member 6 (Voltage-gated potassium channel HBK2) (Voltage-gated potassium channel subunit Kv1.6)
drug.Protein;Q96RP8;KCNA7;ENSG00000104848;Q96RP8;Potassium voltage-gated channel subfamily A member 7 (Voltage-gated potassium channel subunit Kv1.7)
drug.Protein;Q16322;KCNA10;ENSG00000143105;Q16322;Potassium voltage-gated channel subfamily A member 10 (Voltage-gated potassium channel subunit Kv1.8)
drug.Protein;Q14721;KCNB1;ENSG00000158445;Q14721;Potassium voltage-gated channel subfamily B member 1 (Delayed rectifier potassium channel 1) (DRK1) (h-DRK1) (Voltage-gated potassium channel subunit Kv2.1)
drug.Protein;Q92953;KCNB2;ENSG00000182674;Q92953;Potassium voltage-gated channel subfamily B member 2 (Voltage-gated potassium channel subunit Kv2.2)
drug.Protein;P48547;KCNC1;ENSG00000129159;P48547;Potassium voltage-gated channel subfamily C member 1 (NGK2) (Voltage-gated potassium channel subunit Kv3.1) (Voltage-gated potassium channel subunit Kv4)
drug.Protein;Q96PR1;KCNC2;ENSG00000166006;Q96PR1;Potassium voltage-gated channel subfamily C member 2 (Shaw-like potassium channel) (Voltage-gated potassium channel Kv3.2)
drug.Protein;Q14003;KCNC3;ENSG00000131398;Q14003;Potassium voltage-gated channel subfamily C member 3 (KSHIIID) (Voltage-gated potassium channel subunit Kv3.3)
drug.Protein;Q9NSA2;KCND1;ENSG00000102057;Q9NSA2;Potassium voltage-gated channel subfamily D member 1 (Voltage-gated potassium channel subunit Kv4.1)
drug.Protein;P21452;TACR2;ENSG00000075073;P21452;Substance-K receptor (SKR) (NK-2 receptor) (NK-2R) (Neurokinin A receptor) (Tachykinin receptor 2)
drug.Protein;P30872;SSTR1;ENSG00000139874;P30872;Somatostatin receptor type 1 (SS-1-R) (SS1-R) (SS1R) (SST1) (SRIF-2)
drug.Protein;P32745;SSTR3;ENSG00000278195;P32745;Somatostatin receptor type 3 (SS-3-R) (SS3-R) (SS3R) (SST3) (SSR-28)
drug.Protein;P10589;NR2F1;ENSG00000175745;P10589;COUP transcription factor 1 (COUP-TF1) (COUP transcription factor I) (COUP-TF I) (Nuclear receptor subfamily 2 group F member 1) (V-erbA-related protein 3) (EAR-3)
drug.Protein;Q9HAY6;BCO1;ENSG00000135697;Q9HAY6;Beta,beta-carotene 15,15'-dioxygenase (EC 1.13.11.63) (Beta-carotene dioxygenase 1) (Beta-carotene oxygenase 1)
drug.Protein;Q15750;TAB1;ENSG00000100324;Q15750;TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 (Mitogen-activated protein kinase kinase kinase 7-interacting protein 1) (TGF-beta-activated kinase 1-binding protein 1) (TAK1-binding protein 1)
drug.Protein;P21399;ACO1;ENSG00000122729;P21399;Cytoplasmic aconitate hydratase (Aconitase) (EC 4.2.1.3) (Citrate hydro-lyase) (Ferritin repressor protein) (Iron regulatory protein 1) (IRP1) (Iron-responsive element-binding protein 1) (IRE-BP 1)
drug.Protein;P12814;ACTN1;ENSG00000072110;P12814;Alpha-actinin-1 (Alpha-actinin cytoskeletal isoform) (F-actin cross-linking protein) (Non-muscle alpha-actinin-1)
drug.Protein;Q99623;PHB2;ENSG00000215021;Q99623;Prohibitin-2 (B-cell receptor-associated protein BAP37) (D-prohibitin) (Repressor of estrogen receptor activity)
drug.Protein;P31327;CPS1;ENSG00000021826;P31327;Carbamoyl-phosphate synthase [ammonia], mitochondrial (EC 6.3.4.16) (Carbamoyl-phosphate synthetase I) (CPSase I)
drug.Protein;P28300;LOX;ENSG00000113083;P28300;"Protein-lysine 6-oxidase (EC 1.4.3.13) (Lysyl oxidase) [Cleaved into: Protein-lysine 6-oxidase, long form; Protein-lysine 6-oxidase, short form]"
drug.Protein;P49281;SLC11A2;ENSG00000110911;P49281;Natural resistance-associated macrophage protein 2 (NRAMP 2) (Divalent cation transporter 1) (Divalent metal transporter 1) (DMT-1) (Solute carrier family 11 member 2)
drug.Protein;O75173;ADAMTS4;ENSG00000158859;O75173;A disintegrin and metalloproteinase with thrombospondin motifs 4 (ADAM-TS 4) (ADAM-TS4) (ADAMTS-4) (EC 3.4.24.82) (ADMP-1) (Aggrecanase-1)
drug.Protein;Q8NEB9;PIK3C3;ENSG00000078142;Q8NEB9;Phosphatidylinositol 3-kinase catalytic subunit type 3 (PI3-kinase type 3) (PI3K type 3) (PtdIns-3-kinase type 3) (EC 2.7.1.137) (Phosphatidylinositol 3-kinase p100 subunit) (Phosphoinositide-3-kinase class 3) (hVps34)
drug.Protein;Q15661;TPSAB1;ENSG00000172236;Q15661;Tryptase alpha/beta-1 (Tryptase-1) (EC 3.4.21.59) (Tryptase I) (Tryptase alpha-1)
drug.Protein;P48552;NRIP1;ENSG00000180530;P48552;Nuclear receptor-interacting protein 1 (Nuclear factor RIP140) (Receptor-interacting protein 140)
drug.Protein;P53350;PLK1;ENSG00000166851;P53350;Serine/threonine-protein kinase PLK1 (EC 2.7.11.21) (Polo-like kinase 1) (PLK-1) (Serine/threonine-protein kinase 13) (STPK13)
drug.Protein;Q16651;PRSS8;ENSG00000052344;Q16651;"Prostasin (EC 3.4.21.-) (Channel-activating protease 1) (CAP1) (Serine protease 8) [Cleaved into: Prostasin light chain; Prostasin heavy chain]"
drug.Protein;P08217;CELA2A;ENSG00000142615;P08217;Chymotrypsin-like elastase family member 2A (EC 3.4.21.71) (Elastase-2A)
drug.Protein;P78536;ADAM17;ENSG00000151694;P78536;Disintegrin and metalloproteinase domain-containing protein 17 (ADAM 17) (EC 3.4.24.86) (Snake venom-like protease) (TNF-alpha convertase) (TNF-alpha-converting enzyme) (CD antigen CD156b)
drug.Protein;P23467;PTPRB;ENSG00000127329;P23467;Receptor-type tyrosine-protein phosphatase beta (Protein-tyrosine phosphatase beta) (R-PTP-beta) (EC 3.1.3.48) (Vascular endothelial protein tyrosine phosphatase) (VE-PTP)
drug.Protein;P13051;UNG;ENSG00000076248;P13051;Uracil-DNA glycosylase (UDG) (EC 3.2.2.27)
drug.Protein;P45984;MAPK9;ENSG00000050748;P45984;Mitogen-activated protein kinase 9 (MAP kinase 9) (MAPK 9) (EC 2.7.11.24) (JNK-55) (Stress-activated protein kinase 1a) (SAPK1a) (Stress-activated protein kinase JNK2) (c-Jun N-terminal kinase 2)
drug.Protein;Q99933;BAG1;ENSG00000107262;Q99933;BAG family molecular chaperone regulator 1 (BAG-1) (Bcl-2-associated athanogene 1)
drug.Protein;Q13133;NR1H3;ENSG00000025434;Q13133;Oxysterols receptor LXR-alpha (Liver X receptor alpha) (Nuclear receptor subfamily 1 group H member 3)
drug.Protein;Q07817;BCL2L1;ENSG00000171552;Q07817;Bcl-2-like protein 1 (Bcl2-L-1) (Apoptosis regulator Bcl-X)
drug.Protein;Q13554;CAMK2B;ENSG00000058404;Q13554;Calcium/calmodulin-dependent protein kinase type II subunit beta (CaM kinase II subunit beta) (CaMK-II subunit beta) (EC 2.7.11.17)
drug.Protein;P42892;ECE1;ENSG00000117298;P42892;Endothelin-converting enzyme 1 (ECE-1) (EC 3.4.24.71)
drug.Protein;P51955;NEK2;ENSG00000117650;P51955;Serine/threonine-protein kinase Nek2 (EC 2.7.11.1) (HSPK 21) (Never in mitosis A-related kinase 2) (NimA-related protein kinase 2) (NimA-like protein kinase 1)
drug.Protein;P53609;PGGT1B;ENSG00000164219;P53609;Geranylgeranyl transferase type-1 subunit beta (EC 2.5.1.59) (Geranylgeranyl transferase type I subunit beta) (GGTase-I-beta) (Type I protein geranyl-geranyltransferase subunit beta)
drug.Protein;Q9UGN5;PARP2;ENSG00000129484;Q9UGN5;Poly [ADP-ribose] polymerase 2 (PARP-2) (hPARP-2) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 2) (ARTD2) (DNA ADP-ribosyltransferase PARP2) (EC 2.4.2.-) (NAD(+) ADP-ribosyltransferase 2) (ADPRT-2) (Poly[ADP-ribose] synthase 2) (pADPRT-2) (Protein poly-ADP-ribosyltransferase PARP2) (EC 2.4.2.-)
drug.Protein;Q9NQS7;INCENP;ENSG00000149503;Q9NQS7;Inner centromere protein
drug.Protein;Q8IVS2;MCAT;ENSG00000100294;Q8IVS2;Malonyl-CoA-acyl carrier protein transacylase, mitochondrial (MCT) (EC 2.3.1.39) (Mitochondrial malonyl CoA:ACP acyltransferase) (Mitochondrial malonyltransferase) ([Acyl-carrier-protein] malonyltransferase)
drug.Protein;O75460;ERN1;ENSG00000178607;O75460;"Serine/threonine-protein kinase/endoribonuclease IRE1 (Endoplasmic reticulum-to-nucleus signaling 1) (Inositol-requiring protein 1) (hIRE1p) (Ire1-alpha) (IRE1a) [Includes: Serine/threonine-protein kinase (EC 2.7.11.1); Endoribonuclease (EC 3.1.26.-)]"
drug.Protein;Q15118;PDK1;ENSG00000152256;Q15118;[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial (EC 2.7.11.2) (Pyruvate dehydrogenase kinase isoform 1) (PDH kinase 1)
drug.Protein;Q59FW3;;;;
drug.Protein;Q9UBT6;POLK;ENSG00000122008;Q9UBT6;DNA polymerase kappa (EC 2.7.7.7) (DINB protein) (DINP)
drug.Protein;Q494W8;CHRFAM7A;ENSG00000166664;Q494W8;CHRNA7-FAM7A fusion protein (CHRNA7-DR1) (D-10)
drug.Protein;Q9HB40;SCPEP1;ENSG00000121064;Q9HB40;Retinoid-inducible serine carboxypeptidase (EC 3.4.16.-) (Serine carboxypeptidase 1)
drug.Protein;P19784;CSNK2A2;ENSG00000070770;P19784;Casein kinase II subunit alpha' (CK II alpha') (EC 2.7.11.1)
drug.Protein;O14818;PSMA7;ENSG00000101182;O14818;Proteasome subunit alpha type-7 (Proteasome subunit RC6-1) (Proteasome subunit XAPC7)
drug.Protein;Q13627;DYRK1A;ENSG00000157540;Q13627;Dual specificity tyrosine-phosphorylation-regulated kinase 1A (EC 2.7.12.1) (Dual specificity YAK1-related kinase) (HP86) (Protein kinase minibrain homolog) (MNBH) (hMNB)
drug.Protein;Q9H2G2;SLK;ENSG00000065613;Q9H2G2;STE20-like serine/threonine-protein kinase (STE20-like kinase) (hSLK) (EC 2.7.11.1) (CTCL tumor antigen se20-9) (STE20-related serine/threonine-protein kinase) (STE20-related kinase) (Serine/threonine-protein kinase 2)
drug.Protein;Q16566;CAMK4;ENSG00000152495;Q16566;Calcium/calmodulin-dependent protein kinase type IV (CaMK IV) (EC 2.7.11.17) (CaM kinase-GR)
drug.Protein;P49761;CLK3;ENSG00000179335;P49761;Dual specificity protein kinase CLK3 (EC 2.7.12.1) (CDC-like kinase 3)
drug.Protein;Q9Y6F1;PARP3;ENSG00000041880;Q9Y6F1;Protein mono-ADP-ribosyltransferase PARP3 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 3) (ARTD3) (DNA ADP-ribosyltransferase PARP3) (EC 2.4.2.-) (IRT1) (NAD(+) ADP-ribosyltransferase 3) (ADPRT-3) (Poly [ADP-ribose] polymerase 3) (PARP-3) (hPARP-3) (Poly[ADP-ribose] synthase 3) (pADPRT-3)
drug.Protein;Q9HCD5;NCOA5;ENSG00000124160;Q9HCD5;Nuclear receptor coactivator 5 (NCoA-5) (Coactivator independent of AF-2) (CIA)
drug.Protein;Q16644;MAPKAPK3;ENSG00000114738;Q16644;MAP kinase-activated protein kinase 3 (MAPK-activated protein kinase 3) (MAPKAP kinase 3) (MAPKAP-K3) (MAPKAPK-3) (MK-3) (EC 2.7.11.1) (Chromosome 3p kinase) (3pK)
drug.Protein;Q01581;HMGCS1;ENSG00000112972;Q01581;Hydroxymethylglutaryl-CoA synthase, cytoplasmic (HMG-CoA synthase) (EC 2.3.3.10) (3-hydroxy-3-methylglutaryl coenzyme A synthase)
drug.Protein;Q00536;CDK16;ENSG00000102225;Q00536;Cyclin-dependent kinase 16 (EC 2.7.11.22) (Cell division protein kinase 16) (PCTAIRE-motif protein kinase 1) (Serine/threonine-protein kinase PCTAIRE-1)
drug.Protein;P01116;KRAS;ENSG00000133703;P01116;GTPase KRas (EC 3.6.5.2) (K-Ras 2) (Ki-Ras) (c-K-ras) (c-Ki-ras) [Cleaved into: GTPase KRas, N-terminally processed]
drug.Protein;P31751;AKT2;ENSG00000105221;P31751;RAC-beta serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase Akt-2) (Protein kinase B beta) (PKB beta) (RAC-PK-beta)
drug.Protein;Q6P093;AADACL2;ENSG00000197953;Q6P093;Arylacetamide deacetylase-like 2 (EC 3.1.1.-)
drug.Protein;Q15102;PAFAH1B3;ENSG00000079462;Q15102;Platelet-activating factor acetylhydrolase IB subunit alpha1 (EC 3.1.1.47) (PAF acetylhydrolase 29 kDa subunit) (PAF-AH 29 kDa subunit) (PAF-AH subunit gamma) (PAFAH subunit gamma)
drug.Protein;Q13557;CAMK2D;ENSG00000145349;Q13557;Calcium/calmodulin-dependent protein kinase type II subunit delta (CaM kinase II subunit delta) (CaMK-II subunit delta) (EC 2.7.11.17)
drug.Protein;Q9P289;STK26;ENSG00000134602;Q9P289;Serine/threonine-protein kinase 26 (EC 2.7.11.1) (MST3 and SOK1-related kinase) (Mammalian STE20-like protein kinase 4) (MST-4) (STE20-like kinase MST4) (Serine/threonine-protein kinase MASK)
drug.Protein;P07737;PFN1;ENSG00000108518;P07737;Profilin-1 (Epididymis tissue protein Li 184a) (Profilin I)
drug.Protein;Q7Z3Y4;;;;
drug.Protein;Q9UHY7;ENOPH1;ENSG00000145293;Q9UHY7;Enolase-phosphatase E1 (EC 3.1.3.77) (2,3-diketo-5-methylthio-1-phosphopentane phosphatase) (MASA homolog)
drug.Protein;Q13946;PDE7A;ENSG00000205268;Q13946;High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A (EC 3.1.4.53) (HCP1) (TM22)
drug.Protein;O60658;PDE8A;ENSG00000073417;O60658;High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A (EC 3.1.4.53)
drug.Protein;Q15375;EPHA7;ENSG00000135333;Q15375;Ephrin type-A receptor 7 (EC 2.7.10.1) (EPH homology kinase 3) (EHK-3) (EPH-like kinase 11) (EK11) (hEK11)
drug.Protein;Q96NX5;CAMK1G;ENSG00000008118;Q96NX5;Calcium/calmodulin-dependent protein kinase type 1G (EC 2.7.11.17) (CaM kinase I gamma) (CaM kinase IG) (CaM-KI gamma) (CaMKI gamma) (CaMKIG) (CaMK-like CREB kinase III) (CLICK III)
drug.Protein;P49862;KLK7;ENSG00000169035;P49862;Kallikrein-7 (hK7) (EC 3.4.21.117) (Serine protease 6) (Stratum corneum chymotryptic enzyme) (hSCCE)
drug.Protein;Q969V6;MRTFA;ENSG00000196588;Q969V6;Myocardin-related transcription factor A (MRTF-A) (MKL/myocardin-like protein 1) (Megakaryoblastic leukemia 1 protein) (Megakaryocytic acute leukemia protein)
drug.Protein;Q8WWL2;SPIRE2;ENSG00000204991;Q8WWL2;Protein spire homolog 2 (Spir-2)
drug.Protein;Q59EB3;;;;
drug.Protein;O75116;ROCK2;ENSG00000134318;O75116;Rho-associated protein kinase 2 (EC 2.7.11.1) (Rho kinase 2) (Rho-associated, coiled-coil-containing protein kinase 2) (Rho-associated, coiled-coil-containing protein kinase II) (ROCK-II) (p164 ROCK-2)
drug.Protein;O75521;ECI2;ENSG00000198721;O75521;Enoyl-CoA delta isomerase 2 (EC 5.3.3.8) (DRS-1) (Delta(3),delta(2)-enoyl-CoA isomerase) (D3,D2-enoyl-CoA isomerase) (Diazepam-binding inhibitor-related protein 1) (DBI-related protein 1) (Dodecenoyl-CoA isomerase) (Hepatocellular carcinoma-associated antigen 88) (Peroxisomal 3,2-trans-enoyl-CoA isomerase) (pECI) (Renal carcinoma antigen NY-REN-1)
drug.Protein;P35243;RCVRN;ENSG00000109047;P35243;Recoverin (Cancer-associated retinopathy protein) (Protein CAR)
drug.Protein;P63098;PPP3R1;ENSG00000221823;P63098;Calcineurin subunit B type 1 (Protein phosphatase 2B regulatory subunit 1) (Protein phosphatase 3 regulatory subunit B alpha isoform 1)
drug.Protein;Q08209;PPP3CA;ENSG00000138814;Q08209;Protein phosphatase 3 catalytic subunit alpha (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calcineurin A alpha) (Calmodulin-dependent calcineurin A subunit alpha isoform) (CNA alpha) (Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform)
drug.Protein;P43080;GUCA1A;ENSG00000048545;P43080;Guanylyl cyclase-activating protein 1 (GCAP 1) (Guanylate cyclase activator 1A)
drug.Protein;O95445;APOM;ENSG00000204444;O95445;Apolipoprotein M (Apo-M) (ApoM) (Protein G3a)
drug.Protein;O15143;ARPC1B;ENSG00000130429;O15143;Actin-related protein 2/3 complex subunit 1B (Arp2/3 complex 41 kDa subunit) (p41-ARC)
drug.Protein;P61160;ACTR2;ENSG00000138071;P61160;Actin-related protein 2 (Actin-like protein 2)
drug.Protein;P61158;ACTR3;ENSG00000115091;P61158;Actin-related protein 3 (Actin-like protein 3)
drug.Protein;O15144;ARPC2;ENSG00000163466;O15144;Actin-related protein 2/3 complex subunit 2 (Arp2/3 complex 34 kDa subunit) (p34-ARC)
drug.Protein;O15145;ARPC3;ENSG00000111229;O15145;Actin-related protein 2/3 complex subunit 3 (Arp2/3 complex 21 kDa subunit) (p21-ARC)
drug.Protein;P59998;ARPC4;ENSG00000241553;P59998;Actin-related protein 2/3 complex subunit 4 (Arp2/3 complex 20 kDa subunit) (p20-ARC)
drug.Protein;O15511;ARPC5;ENSG00000162704;O15511;Actin-related protein 2/3 complex subunit 5 (Arp2/3 complex 16 kDa subunit) (p16-ARC)
drug.Protein;P23083;IGHV1-2;ENSG00000211934;P23083;Immunoglobulin heavy variable 1-2 (Ig heavy chain V-I region ND) (Ig heavy chain V-I region V35)
drug.Protein;P04211;IGLV7-43;ENSG00000211652;P04211;Immunoglobulin lambda variable 7-43 (Ig lambda chain V region 4A)
drug.Protein;Q9HCP0;CSNK1G1;ENSG00000169118;Q9HCP0;Casein kinase I isoform gamma-1 (CKI-gamma 1) (EC 2.7.11.1)
drug.Protein;Q12866;MERTK;ENSG00000153208;Q12866;Tyrosine-protein kinase Mer (EC 2.7.10.1) (Proto-oncogene c-Mer) (Receptor tyrosine kinase MerTK)
drug.Protein;Q96GR2;ACSBG1;ENSG00000103740;Q96GR2;Long-chain-fatty-acid--CoA ligase ACSBG1 (EC 6.2.1.3) (Acyl-CoA synthetase bubblegum family member 1) (hBG1) (hsBG) (hsBGM) (Lipidosin)
drug.Protein;O75865;TRAPPC6A;ENSG00000007255;O75865;Trafficking protein particle complex subunit 6A (TRAPP complex subunit 6A)
drug.Protein;Q86SZ2;TRAPPC6B;ENSG00000182400;Q86SZ2;Trafficking protein particle complex subunit 6B (TRAPP complex subunit 6B)
drug.Protein;Q8IUR0;TRAPPC5;ENSG00000181029;Q8IUR0;Trafficking protein particle complex subunit 5
drug.Protein;Q9Y296;TRAPPC4;ENSG00000196655;Q9Y296;Trafficking protein particle complex subunit 4 (Hematopoietic stem/progenitor cell protein 172) (Synbindin) (TRS23 homolog)
drug.Protein;Q9Y5R8;TRAPPC1;ENSG00000170043;Q9Y5R8;Trafficking protein particle complex subunit 1 (BET5 homolog) (Multiple myeloma protein 2) (MUM-2)
drug.Protein;Q460N3;PARP15;ENSG00000173200;Q460N3;Protein mono-ADP-ribosyltransferase PARP15 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 7) (ARTD7) (B-aggressive lymphoma protein 3) (Poly [ADP-ribose] polymerase 15) (PARP-15)
drug.Protein;P11684;SCGB1A1;ENSG00000149021;P11684;Uteroglobin (Clara cell phospholipid-binding protein) (CCPBP) (Clara cells 10 kDa secretory protein) (CC10) (Secretoglobin family 1A member 1) (Urinary protein 1) (UP-1) (UP1) (Urine protein 1)
drug.Protein;P14649;MYL6B;ENSG00000196465;P14649;Myosin light chain 6B (Myosin light chain 1 slow-twitch muscle A isoform) (MLC1sa) (Smooth muscle and nonmuscle myosin light chain alkali 6B)
drug.Protein;P19105;MYL12A;ENSG00000101608;P19105;Myosin regulatory light chain 12A (Epididymis secretory protein Li 24) (HEL-S-24) (MLC-2B) (Myosin RLC) (Myosin regulatory light chain 2, nonsarcomeric) (Myosin regulatory light chain MRLC3)
drug.Protein;P12883;MYH7;ENSG00000092054;P12883;Myosin-7 (Myosin heavy chain 7) (Myosin heavy chain slow isoform) (MyHC-slow) (Myosin heavy chain, cardiac muscle beta isoform) (MyHC-beta)
drug.Protein;P01768;IGHV3-30;ENSG00000270550;P01768;Immunoglobulin heavy variable 3-30 (Ig heavy chain V-III region BUR) (Ig heavy chain V-III region CAM) (Ig heavy chain V-III region GA) (Ig heavy chain V-III region NIE)
drug.Protein;Q8IU85;CAMK1D;ENSG00000183049;Q8IU85;Calcium/calmodulin-dependent protein kinase type 1D (EC 2.7.11.17) (CaM kinase I delta) (CaM kinase ID) (CaM-KI delta) (CaMKI delta) (CaMKID) (CaMKI-like protein kinase) (CKLiK)
drug.Protein;P35568;IRS1;ENSG00000169047;P35568;Insulin receptor substrate 1 (IRS-1)
drug.Protein;P25786;PSMA1;ENSG00000129084;P25786;Proteasome subunit alpha type-1 (30 kDa prosomal protein) (PROS-30) (Macropain subunit C2) (Multicatalytic endopeptidase complex subunit C2) (Proteasome component C2) (Proteasome nu chain)
drug.Protein;P25787;PSMA2;ENSG00000106588;P25787;Proteasome subunit alpha type-2 (Macropain subunit C3) (Multicatalytic endopeptidase complex subunit C3) (Proteasome component C3)
drug.Protein;P25788;PSMA3;ENSG00000100567;P25788;Proteasome subunit alpha type-3 (Macropain subunit C8) (Multicatalytic endopeptidase complex subunit C8) (Proteasome component C8)
drug.Protein;P25789;PSMA4;ENSG00000041357;P25789;Proteasome subunit alpha type-4 (Macropain subunit C9) (Multicatalytic endopeptidase complex subunit C9) (Proteasome component C9) (Proteasome subunit L)
drug.Protein;P28066;PSMA5;ENSG00000143106;P28066;Proteasome subunit alpha type-5 (Macropain zeta chain) (Multicatalytic endopeptidase complex zeta chain) (Proteasome zeta chain)
drug.Protein;P60900;PSMA6;ENSG00000100902;P60900;Proteasome subunit alpha type-6 (27 kDa prosomal protein) (PROS-27) (p27K) (Macropain iota chain) (Multicatalytic endopeptidase complex iota chain) (Proteasome iota chain)
drug.Protein;P49721;PSMB2;ENSG00000126067;P49721;Proteasome subunit beta type-2 (Macropain subunit C7-I) (Multicatalytic endopeptidase complex subunit C7-I) (Proteasome component C7-I)
drug.Protein;P49720;PSMB3;ENSG00000277791;P49720;Proteasome subunit beta type-3 (Proteasome chain 13) (Proteasome component C10-II) (Proteasome theta chain)
drug.Protein;P28070;PSMB4;ENSG00000159377;P28070;Proteasome subunit beta type-4 (26 kDa prosomal protein) (HsBPROS26) (PROS-26) (Macropain beta chain) (Multicatalytic endopeptidase complex beta chain) (Proteasome beta chain) (Proteasome chain 3) (HsN3)
drug.Protein;P28072;PSMB6;ENSG00000142507;P28072;Proteasome subunit beta type-6 (EC 3.4.25.1) (Macropain delta chain) (Multicatalytic endopeptidase complex delta chain) (Proteasome delta chain) (Proteasome subunit Y)
drug.Protein;Q99436;PSMB7;ENSG00000136930;Q99436;Proteasome subunit beta type-7 (EC 3.4.25.1) (Macropain chain Z) (Multicatalytic endopeptidase complex chain Z) (Proteasome subunit Z)
drug.Protein;Q6PYX1;;;;
drug.Protein;P01615;IGKV2D-28;ENSG00000242534;P01615;Immunoglobulin kappa variable 2D-28 (Ig kappa chain V-II region FR) (Ig kappa chain V-II region GM607) (Ig kappa chain V-II region MIL) (Ig kappa chain V-II region TEW)
drug.Protein;P55196;AFDN;ENSG00000130396;P55196;Afadin (ALL1-fused gene from chromosome 6 protein) (Protein AF-6) (Afadin adherens junction formation factor)
drug.Protein;Q9NWZ3;IRAK4;ENSG00000198001;Q9NWZ3;Interleukin-1 receptor-associated kinase 4 (IRAK-4) (EC 2.7.11.1) (Renal carcinoma antigen NY-REN-64)
drug.Protein;Q15119;PDK2;ENSG00000005882;Q15119;[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial (EC 2.7.11.2) (Pyruvate dehydrogenase kinase isoform 2) (PDH kinase 2) (PDKII)
drug.Protein;Q9UKY3;CES1P1;ENSG00000228695;Q9UKY3;Putative inactive carboxylesterase 4 (Inactive carboxylesterase 1 pseudogene 1) (Placental carboxylesterase 3) (PCE-3)
drug.Protein;Q92793;CREBBP;ENSG00000005339;Q92793;CREB-binding protein (Histone lysine acetyltransferase CREBBP) (EC 2.3.1.48) (Protein-lysine acetyltransferase CREBBP) (EC 2.3.1.-)
drug.Protein;Q9NPJ3;ACOT13;ENSG00000112304;Q9NPJ3;Acyl-coenzyme A thioesterase 13 (Acyl-CoA thioesterase 13) (EC 3.1.2.-) (Hotdog-fold thioesterase superfamily member 2) (Palmitoyl-CoA hydrolase) (EC 3.1.2.2) (Thioesterase superfamily member 2) (THEM2) [Cleaved into: Acyl-coenzyme A thioesterase 13, N-terminally processed]
drug.Protein;P80192;MAP3K9;ENSG00000006432;P80192;Mitogen-activated protein kinase kinase kinase 9 (EC 2.7.11.25) (Mixed lineage kinase 1)
drug.Protein;Q9HBL8;NMRAL1;ENSG00000153406;Q9HBL8;NmrA-like family domain-containing protein 1
drug.Protein;P01100;FOS;ENSG00000170345;P01100;Protein c-Fos (Cellular oncogene fos) (Fos proto-oncogene, AP-1 transcription factor subunit) (G0/G1 switch regulatory protein 7) (Proto-oncogene c-Fos) (Transcription factor AP-1 subunit c-Fos)
drug.Protein;O75330;HMMR;ENSG00000072571;O75330;Hyaluronan mediated motility receptor (Intracellular hyaluronic acid-binding protein) (Receptor for hyaluronan-mediated motility) (CD antigen CD168)
drug.Protein;P13611;VCAN;ENSG00000038427;P13611;Versican core protein (Chondroitin sulfate proteoglycan core protein 2) (Chondroitin sulfate proteoglycan 2) (Glial hyaluronate-binding protein) (GHAP) (Large fibroblast proteoglycan) (PG-M)
drug.Protein;Q07021;C1QBP;ENSG00000108561;Q07021;Complement component 1 Q subcomponent-binding protein, mitochondrial (ASF/SF2-associated protein p32) (Glycoprotein gC1qBP) (C1qBP) (Hyaluronan-binding protein 1) (Mitochondrial matrix protein p32) (gC1q-R protein) (p33) (SF2AP32)
drug.Protein;P10915;HAPLN1;ENSG00000145681;P10915;Hyaluronan and proteoglycan link protein 1 (Cartilage-linking protein 1) (Cartilage-link protein) (Proteoglycan link protein)
drug.Protein;Q96S86;HAPLN3;ENSG00000140511;Q96S86;Hyaluronan and proteoglycan link protein 3
drug.Protein;Q14520;HABP2;ENSG00000148702;Q14520;"Hyaluronan-binding protein 2 (EC 3.4.21.-) (Factor VII-activating protease) (Factor seven-activating protease) (FSAP) (Hepatocyte growth factor activator-like protein) (Plasma hyaluronan-binding protein) [Cleaved into: Hyaluronan-binding protein 2 50 kDa heavy chain; Hyaluronan-binding protein 2 50 kDa heavy chain alternate form; Hyaluronan-binding protein 2 27 kDa light chain; Hyaluronan-binding protein 2 27 kDa light chain alternate form]"
drug.Protein;Q6UX15;LAYN;ENSG00000204381;Q6UX15;Layilin
drug.Protein;Q8WWQ8;STAB2;ENSG00000136011;Q8WWQ8;Stabilin-2 (FAS1 EGF-like and X-link domain-containing adhesion molecule 2) (Fasciclin, EGF-like, laminin-type EGF-like and link domain-containing scavenger receptor 2) (FEEL-2) (Hyaluronan receptor for endocytosis) [Cleaved into: 190 kDa form stabilin-2 (190 kDa hyaluronan receptor for endocytosis)]
drug.Protein;Q9BZV3;IMPG2;ENSG00000081148;Q9BZV3;Interphotoreceptor matrix proteoglycan 2 (Interphotoreceptor matrix proteoglycan of 200 kDa) (IPM 200) (Sialoprotein associated with cones and rods proteoglycan) (Spacrcan)
drug.Protein;Q5JVS0;HABP4;ENSG00000130956;Q5JVS0;Intracellular hyaluronan-binding protein 4 (IHABP-4) (IHABP4) (Hyaluronan-binding protein 4) (Ki-1/57 intracellular antigen)
drug.Protein;Q9Y5Y7;LYVE1;ENSG00000133800;Q9Y5Y7;Lymphatic vessel endothelial hyaluronic acid receptor 1 (LYVE-1) (Cell surface retention sequence-binding protein 1) (CRSBP-1) (Extracellular link domain-containing protein 1) (Hyaluronic acid receptor)
drug.Protein;Q9UHC3;ASIC3;ENSG00000213199;Q9UHC3;Acid-sensing ion channel 3 (ASIC3) (hASIC3) (Amiloride-sensitive cation channel 3) (Neuronal amiloride-sensitive cation channel 3) (Testis sodium channel 1) (hTNaC1)
drug.Protein;Q9NSD5;SLC6A13;ENSG00000010379;Q9NSD5;Sodium- and chloride-dependent GABA transporter 2 (GAT-2) (Solute carrier family 6 member 13)
drug.Protein;P48066;SLC6A11;ENSG00000132164;P48066;Sodium- and chloride-dependent GABA transporter 3 (GAT-3) (Solute carrier family 6 member 11)
drug.Protein;P48065;SLC6A12;ENSG00000111181;P48065;Sodium- and chloride-dependent betaine transporter (BGT-1) (Na(+)/Cl(-) betaine/GABA transporter) (Solute carrier family 6 member 12)
drug.Protein;Q9H228;S1PR5;ENSG00000180739;Q9H228;Sphingosine 1-phosphate receptor 5 (S1P receptor 5) (S1P5) (Endothelial differentiation G-protein-coupled receptor 8) (Sphingosine 1-phosphate receptor Edg-8) (S1P receptor Edg-8)
drug.Protein;P21453;S1PR1;ENSG00000170989;P21453;Sphingosine 1-phosphate receptor 1 (S1P receptor 1) (S1P1) (Endothelial differentiation G-protein coupled receptor 1) (Sphingosine 1-phosphate receptor Edg-1) (S1P receptor Edg-1) (CD antigen CD363)
drug.Protein;O95977;S1PR4;ENSG00000125910;O95977;Sphingosine 1-phosphate receptor 4 (S1P receptor 4) (S1P4) (Endothelial differentiation G-protein coupled receptor 6) (Sphingosine 1-phosphate receptor Edg-6) (S1P receptor Edg-6)
drug.Protein;Q99500;S1PR3;ENSG00000213694;Q99500;Sphingosine 1-phosphate receptor 3 (S1P receptor 3) (S1P3) (Endothelial differentiation G-protein coupled receptor 3) (Sphingosine 1-phosphate receptor Edg-3) (S1P receptor Edg-3)
drug.Protein;Q9NYA1;SPHK1;ENSG00000176170;Q9NYA1;Sphingosine kinase 1 (SK 1) (SPK 1) (EC 2.7.1.91) (Acetyltransferase SPHK1) (EC 2.3.1.-)
drug.Protein;P49763;PGF;ENSG00000119630;P49763;Placenta growth factor (PlGF)
drug.Protein;P49765;VEGFB;ENSG00000173511;P49765;Vascular endothelial growth factor B (VEGF-B) (VEGF-related factor) (VRF)
drug.Protein;P08697;SERPINF2;ENSG00000167711;P08697;Alpha-2-antiplasmin (Alpha-2-AP) (Alpha-2-plasmin inhibitor) (Alpha-2-PI) (Serpin F2)
drug.Protein;P28062;PSMB8;ENSG00000204264;P28062;Proteasome subunit beta type-8 (EC 3.4.25.1) (Low molecular mass protein 7) (Macropain subunit C13) (Multicatalytic endopeptidase complex subunit C13) (Proteasome component C13) (Proteasome subunit beta-5i) (Really interesting new gene 10 protein)
drug.Protein;P28065;PSMB9;ENSG00000240065;P28065;Proteasome subunit beta type-9 (EC 3.4.25.1) (Low molecular mass protein 2) (Macropain chain 7) (Multicatalytic endopeptidase complex chain 7) (Proteasome chain 7) (Proteasome subunit beta-1i) (Really interesting new gene 12 protein)
drug.Protein;P40306;PSMB10;ENSG00000205220;P40306;Proteasome subunit beta type-10 (EC 3.4.25.1) (Low molecular mass protein 10) (Macropain subunit MECl-1) (Multicatalytic endopeptidase complex subunit MECl-1) (Proteasome MECl-1) (Proteasome subunit beta-2i)
drug.Protein;P25092;GUCY2C;ENSG00000070019;P25092;Guanylyl cyclase C (GC-C) (EC 4.6.1.2) (Heat-stable enterotoxin receptor) (STA receptor) (hSTAR) (Intestinal guanylate cyclase)
drug.Protein;Q16832;DDR2;ENSG00000162733;Q16832;Discoidin domain-containing receptor 2 (Discoidin domain receptor 2) (EC 2.7.10.1) (CD167 antigen-like family member B) (Discoidin domain-containing receptor tyrosine kinase 2) (Neurotrophic tyrosine kinase, receptor-related 3) (Receptor protein-tyrosine kinase TKT) (Tyrosine-protein kinase TYRO10) (CD antigen CD167b)
drug.Protein;Q14145;KEAP1;ENSG00000079999;Q14145;Kelch-like ECH-associated protein 1 (Cytosolic inhibitor of Nrf2) (INrf2) (Kelch-like protein 19)
drug.Protein;P57059;SIK1;ENSG00000142178;P57059;Serine/threonine-protein kinase SIK1 (EC 2.7.11.1) (Salt-inducible kinase 1) (SIK-1) (Serine/threonine-protein kinase SNF1-like kinase 1) (Serine/threonine-protein kinase SNF1LK)
drug.Protein;Q8NG66;NEK11;ENSG00000114670;Q8NG66;Serine/threonine-protein kinase Nek11 (EC 2.7.11.1) (Never in mitosis A-related kinase 11) (NimA-related protein kinase 11)
drug.Protein;P53667;LIMK1;ENSG00000106683;P53667;LIM domain kinase 1 (LIMK-1) (EC 2.7.11.1)
drug.Protein;Q15303;ERBB4;ENSG00000178568;Q15303;Receptor tyrosine-protein kinase erbB-4 (EC 2.7.10.1) (Proto-oncogene-like protein c-ErbB-4) (Tyrosine kinase-type cell surface receptor HER4) (p180erbB4) [Cleaved into: ERBB4 intracellular domain (4ICD) (E4ICD) (s80HER4)]
drug.Protein;Q96PD7;DGAT2;ENSG00000062282;Q96PD7;Diacylglycerol O-acyltransferase 2 (EC 2.3.1.20) (Acyl-CoA retinol O-fatty-acyltransferase) (ARAT) (Retinol O-fatty-acyltransferase) (EC 2.3.1.76) (Diglyceride acyltransferase 2)
drug.Protein;O15393;TMPRSS2;ENSG00000184012;O15393;"Transmembrane protease serine 2 (EC 3.4.21.-) (Serine protease 10) [Cleaved into: Transmembrane protease serine 2 non-catalytic chain; Transmembrane protease serine 2 catalytic chain]"
drug.Protein;Q92482;AQP3;ENSG00000165272;Q92482;Aquaporin-3 (AQP-3) (Aquaglyceroporin-3)
drug.Protein;Q16552;IL17A;ENSG00000112115;Q16552;Interleukin-17A (IL-17) (IL-17A) (Cytotoxic T-lymphocyte-associated antigen 8) (CTLA-8)
drug.Protein;O43613;HCRTR1;ENSG00000121764;O43613;Orexin/Hypocretin receptor type 1 (Hypocretin receptor type 1) (Orexin receptor type 1) (Ox-1-R) (Ox1-R) (Ox1R)
drug.Protein;O43614;HCRTR2;ENSG00000137252;O43614;Orexin receptor type 2 (Ox-2-R) (Ox2-R) (Ox2R) (Hypocretin receptor type 2)
drug.Protein;P47775;GPR12;ENSG00000132975;P47775;G-protein coupled receptor 12
drug.Protein;Q9Y5S1;TRPV2;ENSG00000187688;Q9Y5S1;Transient receptor potential cation channel subfamily V member 2 (TrpV2) (Osm-9-like TRP channel 2) (OTRPC2) (Vanilloid receptor-like protein 1) (VRL-1)
drug.Protein;Q9HBA0;TRPV4;ENSG00000111199;Q9HBA0;Transient receptor potential cation channel subfamily V member 4 (TrpV4) (Osm-9-like TRP channel 4) (OTRPC4) (Transient receptor potential protein 12) (TRP12) (Vanilloid receptor-like channel 2) (Vanilloid receptor-like protein 2) (VRL-2) (Vanilloid receptor-related osmotically-activated channel) (VR-OAC)
drug.Protein;F1T0I5;;;;
drug.Protein;Q02083;NAAA;ENSG00000138744;Q02083;"N-acylethanolamine-hydrolyzing acid amidase (EC 3.5.1.60) (Acid ceramidase-like protein) (Acylsphingosine deacylase NAAA) (EC 3.5.1.23) (N-acylsphingosine amidohydrolase-like) (ASAH-like protein) [Cleaved into: N-acylethanolamine-hydrolyzing acid amidase subunit alpha; N-acylethanolamine-hydrolyzing acid amidase subunit beta]"
drug.Protein;P42765;ACAA2;ENSG00000167315;P42765;3-ketoacyl-CoA thiolase, mitochondrial (EC 2.3.1.16) (Acetyl-CoA acetyltransferase) (EC 2.3.1.9) (Acetyl-CoA acyltransferase) (Acyl-CoA hydrolase, mitochondrial) (EC 3.1.2.-, EC 3.1.2.1, EC 3.1.2.2) (Beta-ketothiolase) (Mitochondrial 3-oxoacyl-CoA thiolase) (T1)
drug.Protein;Q8IWW8;ADHFE1;ENSG00000147576;Q8IWW8;Hydroxyacid-oxoacid transhydrogenase, mitochondrial (HOT) (EC 1.1.99.24) (Alcohol dehydrogenase iron-containing protein 1) (ADHFe1) (Fe-containing alcohol dehydrogenase)
drug.Protein;P31391;SSTR4;ENSG00000132671;P31391;Somatostatin receptor type 4 (SS-4-R) (SS4-R) (SS4R) (SST4)
drug.Protein;P49895;DIO1;ENSG00000211452;P49895;Type I iodothyronine deiodinase (EC 1.21.99.4) (5DI) (DIOI) (Type 1 DI) (Type-I 5'-deiodinase)
drug.Protein;Q92813;DIO2;ENSG00000211448;Q92813;Type II iodothyronine deiodinase (EC 1.21.99.4) (5DII) (DIOII) (Type 2 DI) (Type-II 5'-deiodinase)
drug.Protein;P55073;DIO3;ENSG00000197406;P55073;Thyroxine 5-deiodinase (EC 1.21.99.3) (5DIII) (DIOIII) (Type 3 DI) (Type III iodothyronine deiodinase)
drug.Protein;O00338;SULT1C2;ENSG00000198203;O00338;Sulfotransferase 1C2 (ST1C2) (EC 2.8.2.1) (Sulfotransferase 1C1) (SULT1C#1) (humSULTC2)
drug.Protein;Q99571;P2RX4;ENSG00000135124;Q99571;P2X purinoceptor 4 (P2X4) (ATP receptor) (Purinergic receptor)
drug.Protein;P62807;"H2BC4; H2BC6; H2BC7; H2BC8; H2BC10";ENSG00000180596;P62807;Histone H2B type 1-C/E/F/G/I (Histone H2B.1 A) (Histone H2B.a) (H2B/a) (Histone H2B.g) (H2B/g) (Histone H2B.h) (H2B/h) (Histone H2B.k) (H2B/k) (Histone H2B.l) (H2B/l)
drug.Protein;P10412;H1-4;ENSG00000168298;P10412;Histone H1.4 (Histone H1b) (Histone H1s-4)
drug.Protein;P63261;ACTG1;ENSG00000184009;P63261;Actin, cytoplasmic 2 (Gamma-actin) [Cleaved into: Actin, cytoplasmic 2, N-terminally processed]
drug.Protein;P10809;HSPD1;ENSG00000144381;P10809;60 kDa heat shock protein, mitochondrial (EC 5.6.1.7) (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) (HuCHA60) (Mitochondrial matrix protein P1) (P60 lymphocyte protein)
drug.Protein;P48723;HSPA13;ENSG00000155304;P48723;Heat shock 70 kDa protein 13 (Microsomal stress-70 protein ATPase core) (Stress-70 protein chaperone microsome-associated 60 kDa protein)
drug.Protein;P15880;RPS2;ENSG00000140988;P15880;40S ribosomal protein S2 (40S ribosomal protein S4) (Protein LLRep3) (Small ribosomal subunit protein uS5)
drug.Protein;Q07955;SRSF1;ENSG00000136450;Q07955;Serine/arginine-rich splicing factor 1 (Alternative-splicing factor 1) (ASF-1) (Splicing factor, arginine/serine-rich 1) (pre-mRNA-splicing factor SF2, P33 subunit)
drug.Protein;P22626;HNRNPA2B1;ENSG00000122566;P22626;Heterogeneous nuclear ribonucleoproteins A2/B1 (hnRNP A2/B1)
drug.Protein;P31943;HNRNPH1;ENSG00000169045;P31943;Heterogeneous nuclear ribonucleoprotein H (hnRNP H) [Cleaved into: Heterogeneous nuclear ribonucleoprotein H, N-terminally processed]
drug.Protein;P31942;HNRNPH3;ENSG00000096746;P31942;Heterogeneous nuclear ribonucleoprotein H3 (hnRNP H3) (Heterogeneous nuclear ribonucleoprotein 2H9) (hnRNP 2H9)
drug.Protein;P14866;HNRNPL;ENSG00000104824;P14866;Heterogeneous nuclear ribonucleoprotein L (hnRNP L)
drug.Protein;P23246;SFPQ;ENSG00000116560;P23246;Splicing factor, proline- and glutamine-rich (100 kDa DNA-pairing protein) (hPOMp100) (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)
drug.Protein;Q15428;SF3A2;ENSG00000104897;Q15428;Splicing factor 3A subunit 2 (SF3a66) (Spliceosome-associated protein 62) (SAP 62)
drug.Protein;P63244;RACK1;ENSG00000204628;P63244;Receptor of activated protein C kinase 1 (Cell proliferation-inducing gene 21 protein) (Guanine nucleotide-binding protein subunit beta-2-like 1) (Guanine nucleotide-binding protein subunit beta-like protein 12.3) (Human lung cancer oncogene 7 protein) (HLC-7) (Receptor for activated C kinase) (Small ribosomal subunit protein RACK1) [Cleaved into: Receptor of activated protein C kinase 1, N-terminally processed (Guanine nucleotide-binding protein subunit beta-2-like 1, N-terminally processed)]
drug.Protein;P29401;TKT;ENSG00000163931;P29401;Transketolase (TK) (EC 2.2.1.1)
drug.Protein;P31948;STIP1;ENSG00000168439;P31948;Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)
drug.Protein;Q96RE1;;;;
drug.Protein;P56537;EIF6;ENSG00000242372;P56537;Eukaryotic translation initiation factor 6 (eIF-6) (B(2)GCN homolog) (B4 integrin interactor) (CAB) (p27(BBP))
drug.Protein;P60842;EIF4A1;ENSG00000161960;P60842;Eukaryotic initiation factor 4A-I (eIF-4A-I) (eIF4A-I) (EC 3.6.4.13) (ATP-dependent RNA helicase eIF4A-1)
drug.Protein;P31946;YWHAB;ENSG00000166913;P31946;14-3-3 protein beta/alpha (Protein 1054) (Protein kinase C inhibitor protein 1) (KCIP-1) [Cleaved into: 14-3-3 protein beta/alpha, N-terminally processed]
drug.Protein;P51858;HDGF;ENSG00000143321;P51858;Hepatoma-derived growth factor (HDGF) (High mobility group protein 1-like 2) (HMG-1L2)
drug.Protein;O00299;CLIC1;ENSG00000213719;O00299;Chloride intracellular channel protein 1 (Chloride channel ABP) (Nuclear chloride ion channel 27) (NCC27) (Regulatory nuclear chloride ion channel protein) (hRNCC)
drug.Protein;Q06323;PSME1;ENSG00000092010;Q06323;Proteasome activator complex subunit 1 (11S regulator complex subunit alpha) (REG-alpha) (Activator of multicatalytic protease subunit 1) (Interferon gamma up-regulated I-5111 protein) (IGUP I-5111) (Proteasome activator 28 subunit alpha) (PA28a) (PA28alpha)
drug.Protein;P30086;PEBP1;ENSG00000089220;P30086;Phosphatidylethanolamine-binding protein 1 (PEBP-1) (HCNPpp) (Neuropolypeptide h3) (Prostatic-binding protein) (Raf kinase inhibitor protein) (RKIP) [Cleaved into: Hippocampal cholinergic neurostimulating peptide (HCNP)]
drug.Protein;P18669;PGAM1;ENSG00000171314;P18669;Phosphoglycerate mutase 1 (EC 5.4.2.11) (EC 5.4.2.4) (BPG-dependent PGAM 1) (Phosphoglycerate mutase isozyme B) (PGAM-B)
drug.Protein;P43487;RANBP1;ENSG00000099901;P43487;Ran-specific GTPase-activating protein (Ran-binding protein 1) (RanBP1)
drug.Protein;O75880;SCO1;ENSG00000133028;O75880;Protein SCO1 homolog, mitochondrial
drug.Protein;F7VJQ1;PRNP;ENSG00000171867;F7VJQ1;Alternative prion protein (AltPrP)
drug.Protein;P42858;HTT;ENSG00000197386;P42858;Huntingtin (Huntington disease protein) (HD protein) [Cleaved into: Huntingtin, myristoylated N-terminal fragment]
drug.Protein;Q6MZM0;HEPHL1;ENSG00000181333;Q6MZM0;Ferroxidase HEPHL1 (EC 1.16.3.1) (Hephaestin-like protein 1)
drug.Protein;Q99497;PARK7;ENSG00000116288;Q99497;Parkinson disease protein 7 (Maillard deglycase) (Oncogene DJ1) (Parkinsonism-associated deglycase) (Protein DJ-1) (DJ-1) (Protein/nucleic acid deglycase DJ-1) (EC 3.1.2.-, EC 3.5.1.-, EC 3.5.1.124)
drug.Protein;P10997;IAPP;ENSG00000121351;P10997;Islet amyloid polypeptide (Amylin) (Diabetes-associated peptide) (DAP) (Insulinoma amyloid peptide)
drug.Protein;Q9UHF0;TAC3;ENSG00000166863;Q9UHF0;Tachykinin-3 (ZNEUROK1) [Cleaved into: Neurokinin-B (NKB) (Neuromedin-K)]
drug.Protein;P43652;AFM;ENSG00000079557;P43652;Afamin (Alpha-albumin) (Alpha-Alb)
drug.Protein;P02655;APOC2;ENSG00000234906;P02655;Apolipoprotein C-II (Apo-CII) (ApoC-II) (Apolipoprotein C2) [Cleaved into: Proapolipoprotein C-II (ProapoC-II)]
drug.Protein;P02656;APOC3;ENSG00000110245;P02656;Apolipoprotein C-III (Apo-CIII) (ApoC-III) (Apolipoprotein C3)
drug.Protein;P02748;C9;ENSG00000113600;P02748;"Complement component C9 [Cleaved into: Complement component C9a; Complement component C9b]"
drug.Protein;P45973;CBX5;ENSG00000094916;P45973;Chromobox protein homolog 5 (Antigen p25) (Heterochromatin protein 1 homolog alpha) (HP1 alpha)
drug.Protein;P01861;IGHG4;ENSG00000211892;P01861;Immunoglobulin heavy constant gamma 4 (Ig gamma-4 chain C region)
drug.Protein;P15814;IGLL1;ENSG00000128322;P15814;Immunoglobulin lambda-like polypeptide 1 (CD179 antigen-like family member B) (Ig lambda-5) (Immunoglobulin omega polypeptide) (Immunoglobulin-related protein 14.1) (CD antigen CD179b)
drug.Protein;P02750;LRG1;ENSG00000171236;P02750;Leucine-rich alpha-2-glycoprotein (LRG)
drug.Protein;P51884;LUM;ENSG00000139329;P51884;Lumican (Keratan sulfate proteoglycan lumican) (KSPG lumican)
drug.Protein;P36955;SERPINF1;ENSG00000132386;P36955;Pigment epithelium-derived factor (PEDF) (Cell proliferation-inducing gene 35 protein) (EPC-1) (Serpin F1)
drug.Protein;Q14061;COX17;ENSG00000138495;Q14061;Cytochrome c oxidase copper chaperone
drug.Protein;Q9BQS7;HEPH;ENSG00000089472;Q9BQS7;Hephaestin (EC 1.-.-.-)
drug.Protein;P03950;ANG;ENSG00000214274;P03950;Angiogenin (EC 3.1.27.-) (Ribonuclease 5) (RNase 5)
drug.Protein;P04080;CSTB;ENSG00000160213;P04080;Cystatin-B (CPI-B) (Liver thiol proteinase inhibitor) (Stefin-B)
drug.Protein;Q9Y5S8;NOX1;ENSG00000007952;Q9Y5S8;NADPH oxidase 1 (NOX-1) (EC 1.-.-.-) (Mitogenic oxidase 1) (MOX-1) (NADH/NADPH mitogenic oxidase subunit P65-MOX) (NOH-1)
drug.Protein;Q9BQT8;SLC25A21;ENSG00000183032;Q9BQT8;Mitochondrial 2-oxodicarboxylate carrier (ODC) (Mitochondrial 2-oxoadipate carrier) (Solute carrier family 25 member 21)
drug.Protein;Q86YT5;SLC13A5;ENSG00000141485;Q86YT5;Solute carrier family 13 member 5 (Na(+)/citrate cotransporter) (NaCT) (Sodium-coupled citrate transporter) (Sodium-dependent citrate transporter)
drug.Protein;P53007;SLC25A1;ENSG00000100075;P53007;Tricarboxylate transport protein, mitochondrial (Citrate transport protein) (CTP) (Solute carrier family 25 member 1) (Tricarboxylate carrier protein)
drug.Protein;P22897;MRC1;ENSG00000260314;P22897;Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206)
drug.Protein;P39905;GDNF;ENSG00000168621;P39905;Glial cell line-derived neurotrophic factor (hGDNF) (Astrocyte-derived trophic factor) (ATF)
drug.Protein;P08236;GUSB;ENSG00000169919;P08236;Beta-glucuronidase (EC 3.2.1.31) (Beta-G1)
drug.Protein;P34059;GALNS;ENSG00000141012;P34059;N-acetylgalactosamine-6-sulfatase (EC 3.1.6.4) (Chondroitinsulfatase) (Chondroitinase) (Galactose-6-sulfate sulfatase) (GalN6S) (N-acetylgalactosamine-6-sulfate sulfatase) (GalNAc6S sulfatase)
drug.Protein;P22304;IDS;ENSG00000010404;P22304;"Iduronate 2-sulfatase (EC 3.1.6.13) (Alpha-L-iduronate sulfate sulfatase) (Idursulfase) [Cleaved into: Iduronate 2-sulfatase 42 kDa chain; Iduronate 2-sulfatase 14 kDa chain]"
drug.Protein;P35475;IDUA;ENSG00000127415;P35475;Alpha-L-iduronidase (EC 3.2.1.76)
drug.Protein;P15848;ARSB;ENSG00000113273;P15848;Arylsulfatase B (ASB) (EC 3.1.6.12) (N-acetylgalactosamine-4-sulfatase) (G4S)
drug.Protein;Q8NBP7;PCSK9;ENSG00000169174;Q8NBP7;Proprotein convertase subtilisin/kexin type 9 (EC 3.4.21.-) (Neural apoptosis-regulated convertase 1) (NARC-1) (Proprotein convertase 9) (PC9) (Subtilisin/kexin-like protease PC9)
drug.Protein;Q9UBD6;RHCG;ENSG00000140519;Q9UBD6;Ammonium transporter Rh type C (Rh glycoprotein kidney) (Rhesus blood group family type C glycoprotein) (Rh family type C glycoprotein) (Rh type C glycoprotein) (Tumor-related protein DRC2)
drug.Protein;Q9GZR5;ELOVL4;ENSG00000118402;Q9GZR5;Elongation of very long chain fatty acids protein 4 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL4) (ELOVL fatty acid elongase 4) (ELOVL FA elongase 4) (Very long chain 3-ketoacyl-CoA synthase 4) (Very long chain 3-oxoacyl-CoA synthase 4)
drug.Protein;P28907;CD38;ENSG00000004468;P28907;ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 (EC 3.2.2.6) (2'-phospho-ADP-ribosyl cyclase) (2'-phospho-ADP-ribosyl cyclase/2'-phospho-cyclic-ADP-ribose transferase) (EC 2.4.99.20) (2'-phospho-cyclic-ADP-ribose transferase) (ADP-ribosyl cyclase 1) (ADPRC 1) (Cyclic ADP-ribose hydrolase 1) (cADPr hydrolase 1) (T10) (CD antigen CD38)
drug.Protein;P34981;TRHR;ENSG00000174417;P34981;Thyrotropin-releasing hormone receptor (TRH-R) (Thyroliberin receptor)
drug.Protein;Q8WUM9;SLC20A1;ENSG00000144136;Q8WUM9;Sodium-dependent phosphate transporter 1 (Gibbon ape leukemia virus receptor 1) (GLVR-1) (Leukemia virus receptor 1 homolog) (Phosphate transporter 1) (PiT-1) (Solute carrier family 20 member 1)
drug.Protein;Q08357;SLC20A2;ENSG00000168575;Q08357;Sodium-dependent phosphate transporter 2 (Gibbon ape leukemia virus receptor 2) (GLVR-2) (Phosphate transporter 2) (PiT-2) (Pit2) (hPit2) (Solute carrier family 20 member 2)
drug.Protein;Q06495;SLC34A1;ENSG00000131183;Q06495;Sodium-dependent phosphate transport protein 2A (Sodium-phosphate transport protein 2A) (Na(+)-dependent phosphate cotransporter 2A) (NaPi-3) (Sodium/phosphate cotransporter 2A) (Na(+)/Pi cotransporter 2A) (NaPi-2a) (Solute carrier family 34 member 1)
drug.Protein;O95436;SLC34A2;ENSG00000157765;O95436;Sodium-dependent phosphate transport protein 2B (Sodium-phosphate transport protein 2B) (Na(+)-dependent phosphate cotransporter 2B) (NaPi3b) (Sodium/phosphate cotransporter 2B) (Na(+)/Pi cotransporter 2B) (NaPi-2b) (Solute carrier family 34 member 2)
drug.Protein;Q8N130;SLC34A3;ENSG00000198569;Q8N130;Sodium-dependent phosphate transport protein 2C (Sodium-phosphate transport protein 2C) (Na(+)-dependent phosphate cotransporter 2C) (Sodium/inorganic phosphate cotransporter IIC) (Sodium/phosphate cotransporter 2C) (Na(+)/Pi cotransporter 2C) (NaPi-2c) (Solute carrier family 34 member 3)
drug.Protein;P17050;NAGA;ENSG00000198951;P17050;Alpha-N-acetylgalactosaminidase (EC 3.2.1.49) (Alpha-galactosidase B)
drug.Protein;O14520;AQP7;ENSG00000165269;O14520;Aquaporin-7 (AQP-7) (Aquaglyceroporin-7) (Aquaporin adipose) (AQPap) (Aquaporin-7-like)
drug.Protein;O43315;AQP9;ENSG00000103569;O43315;Aquaporin-9 (AQP-9) (Aquaglyceroporin-9) (Small solute channel 1)
drug.Protein;P05026;ATP1B1;ENSG00000143153;P05026;Sodium/potassium-transporting ATPase subunit beta-1 (Sodium/potassium-dependent ATPase subunit beta-1)
drug.Protein;P14415;ATP1B2;ENSG00000129244;P14415;Sodium/potassium-transporting ATPase subunit beta-2 (Adhesion molecule in glia) (AMOG) (Sodium/potassium-dependent ATPase subunit beta-2)
drug.Protein;P54709;ATP1B3;ENSG00000069849;P54709;Sodium/potassium-transporting ATPase subunit beta-3 (Sodium/potassium-dependent ATPase subunit beta-3) (ATPB-3) (CD antigen CD298)
drug.Protein;Q13733;ATP1A4;ENSG00000132681;Q13733;Sodium/potassium-transporting ATPase subunit alpha-4 (Na(+)/K(+) ATPase alpha-4 subunit) (EC 7.2.2.13) (Sodium pump subunit alpha-4)
drug.Protein;Q9BX84;TRPM6;ENSG00000119121;Q9BX84;Transient receptor potential cation channel subfamily M member 6 (EC 2.7.11.1) (Channel kinase 2) (Melastatin-related TRP cation channel 6)
drug.Protein;Q96GZ6;SLC41A3;ENSG00000114544;Q96GZ6;Solute carrier family 41 member 3
drug.Protein;Q9H8M5;CNNM2;ENSG00000148842;Q9H8M5;Metal transporter CNNM2 (Ancient conserved domain-containing protein 2) (Cyclin-M2)
drug.Protein;P47872;SCTR;ENSG00000080293;P47872;Secretin receptor (SCT-R)
drug.Protein;Q9UEW3;MARCO;ENSG00000019169;Q9UEW3;Macrophage receptor MARCO (Macrophage receptor with collagenous structure) (Scavenger receptor class A member 2)
drug.Protein;P37173;TGFBR2;ENSG00000163513;P37173;TGF-beta receptor type-2 (TGFR-2) (EC 2.7.11.30) (TGF-beta type II receptor) (Transforming growth factor-beta receptor type II) (TGF-beta receptor type II) (TbetaR-II)
drug.Protein;Q9BUP3;HTATIP2;ENSG00000109854;Q9BUP3;Oxidoreductase HTATIP2 (EC 1.1.1.-) (30 kDa HIV-1 TAT-interacting protein) (HIV-1 TAT-interactive protein 2)
drug.Protein;Q99828;CIB1;ENSG00000185043;Q99828;Calcium and integrin-binding protein 1 (CIB) (Calcium- and integrin-binding protein) (CIBP) (Calmyrin) (DNA-PKcs-interacting protein) (Kinase-interacting protein) (KIP) (SNK-interacting protein 2-28) (SIP2-28)
drug.Protein;P30626;SRI;ENSG00000075142;P30626;Sorcin (22 kDa protein) (CP-22) (CP22) (V19)
drug.Protein;Q99653;CHP1;ENSG00000187446;Q99653;Calcineurin B homologous protein 1 (Calcineurin B-like protein) (Calcium-binding protein CHP) (Calcium-binding protein p22) (EF-hand calcium-binding domain-containing protein p22)
drug.Protein;P09486;SPARC;ENSG00000113140;P09486;SPARC (Basement-membrane protein 40) (BM-40) (Osteonectin) (ON) (Secreted protein acidic and rich in cysteine)
drug.Protein;P35556;FBN2;ENSG00000138829;P35556;Fibrillin-2 [Cleaved into: Placensin]
drug.Protein;O14958;CASQ2;ENSG00000118729;O14958;Calsequestrin-2 (Calsequestrin, cardiac muscle isoform)
drug.Protein;Q15493;RGN;ENSG00000130988;Q15493;Regucalcin (RC) (Gluconolactonase) (GNL) (EC 3.1.1.17) (Senescence marker protein 30) (SMP-30)
drug.Protein;Q9UBV8;PEF1;ENSG00000162517;Q9UBV8;Peflin (PEF protein with a long N-terminal hydrophobic domain) (Penta-EF hand domain-containing protein 1)
drug.Protein;P06703;S100A6;ENSG00000197956;P06703;Protein S100-A6 (Calcyclin) (Growth factor-inducible protein 2A9) (MLN 4) (Prolactin receptor-associated protein) (PRA) (S100 calcium-binding protein A6)
drug.Protein;P13693;TPT1;ENSG00000133112;P13693;Translationally-controlled tumor protein (TCTP) (Fortilin) (Histamine-releasing factor) (HRF) (p23)
drug.Protein;O75838;CIB2;ENSG00000136425;O75838;Calcium and integrin-binding family member 2 (Kinase-interacting protein 2) (KIP 2)
drug.Protein;P31415;CASQ1;ENSG00000143318;P31415;Calsequestrin-1 (Calmitine) (Calsequestrin, skeletal muscle isoform)
drug.Protein;Q02818;NUCB1;ENSG00000104805;Q02818;Nucleobindin-1 (CALNUC)
drug.Protein;P80303;NUCB2;ENSG00000070081;P80303;Nucleobindin-2 (DNA-binding protein NEFA) (Epididymis secretory protein Li 109) (Gastric cancer antigen Zg4) (Prepronesfatin) [Cleaved into: Nesfatin-1]
drug.Protein;Q75N90;FBN3;ENSG00000142449;Q75N90;Fibrillin-3 [Cleaved into: Fibrillin-3 C-terminal peptide]
drug.Protein;P28676;GCA;ENSG00000115271;P28676;Grancalcin
drug.Protein;Q9ULU8;CADPS;ENSG00000163618;Q9ULU8;Calcium-dependent secretion activator 1 (Calcium-dependent activator protein for secretion 1) (CAPS-1)
drug.Protein;P0DP24;CALM2;ENSG00000143933;P0DP24;Calmodulin-2
drug.Protein;P0DP25;CALM3;ENSG00000160014;P0DP25;Calmodulin-3
drug.Protein;Q96FQ6;S100A16;ENSG00000188643;Q96FQ6;Protein S100-A16 (Aging-associated gene 13 protein) (Protein S100-F) (S100 calcium-binding protein A16)
drug.Protein;P22676;CALB2;ENSG00000172137;P22676;Calretinin (CR) (29 kDa calbindin)
drug.Protein;Q13938;CAPS;ENSG00000105519;Q13938;Calcyphosin (Calcyphosine)
drug.Protein;Q86UW7;CADPS2;ENSG00000081803;Q86UW7;Calcium-dependent secretion activator 2 (Calcium-dependent activator protein for secretion 2) (CAPS-2)
drug.Protein;Q96L12;CALR3;ENSG00000269058;Q96L12;Calreticulin-3 (Calreticulin-2) (Calsperin)
drug.Protein;Q9ULB1;NRXN1;ENSG00000179915;Q9ULB1;Neurexin-1 (Neurexin I-alpha) (Neurexin-1-alpha)
drug.Protein;P62166;NCS1;ENSG00000107130;P62166;Neuronal calcium sensor 1 (NCS-1) (Frequenin homolog) (Frequenin-like protein) (Frequenin-like ubiquitous protein)
drug.Protein;P05937;CALB1;ENSG00000104327;P05937;Calbindin (Calbindin D28) (D-28K) (Vitamin D-dependent calcium-binding protein, avian-type)
drug.Protein;Q9H1D0;TRPV6;ENSG00000165125;Q9H1D0;Transient receptor potential cation channel subfamily V member 6 (TrpV6) (CaT-like) (CaT-L) (Calcium transport protein 1) (CaT1) (Epithelial calcium channel 2) (ECaC2)
drug.Protein;Q9NQA5;TRPV5;ENSG00000127412;Q9NQA5;Transient receptor potential cation channel subfamily V member 5 (TrpV5) (Calcium transport protein 2) (CaT2) (Epithelial calcium channel 1) (ECaC) (ECaC1) (Osm-9-like TRP channel 3) (OTRPC3)
drug.Protein;Q9P0L9;PKD2L1;ENSG00000107593;Q9P0L9;Polycystic kidney disease 2-like 1 protein (Polycystin-2 homolog) (Polycystin-2L1) (Polycystin-L) (Polycystin-L1)
drug.Protein;Q15413;RYR3;ENSG00000198838;Q15413;Ryanodine receptor 3 (RYR-3) (RyR3) (Brain ryanodine receptor-calcium release channel) (Brain-type ryanodine receptor) (Type 3 ryanodine receptor)
drug.Protein;Q7Z443;PKD1L3;ENSG00000277481;Q7Z443;Polycystic kidney disease protein 1-like 3 (PC1-like 3 protein) (Polycystin-1L3)
drug.Protein;Q8NEC5;CATSPER1;ENSG00000175294;Q8NEC5;Cation channel sperm-associated protein 1 (CatSper1) (hCatSper)
drug.Protein;Q96RI0;F2RL3;ENSG00000127533;Q96RI0;Proteinase-activated receptor 4 (PAR-4) (Coagulation factor II receptor-like 3) (Thrombin receptor-like 3)
drug.Protein;P02679;FGG;ENSG00000171557;P02679;Fibrinogen gamma chain
drug.Protein;Q9NZQ7;CD274;ENSG00000120217;Q9NZQ7;Programmed cell death 1 ligand 1 (PD-L1) (PDCD1 ligand 1) (Programmed death ligand 1) (hPD-L1) (B7 homolog 1) (B7-H1) (CD antigen CD274)
drug.Protein;P20333;TNFRSF1B;ENSG00000028137;P20333;"Tumor necrosis factor receptor superfamily member 1B (Tumor necrosis factor receptor 2) (TNF-R2) (Tumor necrosis factor receptor type II) (TNF-RII) (TNFR-II) (p75) (p80 TNF-alpha receptor) (CD antigen CD120b) (Etanercept) [Cleaved into: Tumor necrosis factor receptor superfamily member 1b, membrane form; Tumor necrosis factor-binding protein 2 (TBP-2) (TBPII)]"
drug.Protein;Q9H222;ABCG5;ENSG00000138075;Q9H222;ATP-binding cassette sub-family G member 5 (EC 7.6.2.-) (Sterolin-1)
drug.Protein;Q9H221;ABCG8;ENSG00000143921;Q9H221;ATP-binding cassette sub-family G member 8 (EC 7.6.2.-) (Sterolin-2)
drug.Protein;O75964;ATP5MG;ENSG00000167283;O75964;ATP synthase subunit g, mitochondrial (ATPase subunit g) (ATP synthase membrane subunit g)
drug.Protein;P48047;ATP5PO;ENSG00000241837;P48047;ATP synthase subunit O, mitochondrial (ATP synthase peripheral stalk subunit OSCP) (Oligomycin sensitivity conferral protein) (OSCP)
drug.Protein;P21291;CSRP1;ENSG00000159176;P21291;Cysteine and glycine-rich protein 1 (Cysteine-rich protein 1) (CRP) (CRP1) (Epididymis luminal protein 141) (HEL-141)
drug.Protein;Q16555;DPYSL2;ENSG00000092964;Q16555;Dihydropyrimidinase-related protein 2 (DRP-2) (Collapsin response mediator protein 2) (CRMP-2) (N2A3) (Unc-33-like phosphoprotein 2) (ULIP-2)
drug.Protein;P21333;FLNA;ENSG00000196924;P21333;Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin)
drug.Protein;Q9C0B1;FTO;ENSG00000140718;Q9C0B1;Alpha-ketoglutarate-dependent dioxygenase FTO (Fat mass and obesity-associated protein) (U6 small nuclear RNA (2'-O-methyladenosine-N(6)-)-demethylase FTO) (EC 1.14.11.-) (U6 small nuclear RNA N(6)-methyladenosine-demethylase FTO) (EC 1.14.11.-) (mRNA (2'-O-methyladenosine-N(6)-)-demethylase FTO) (m6A(m)-demethylase FTO) (EC 1.14.11.-) (mRNA N(6)-methyladenosine demethylase FTO) (EC 1.14.11.53) (tRNA N1-methyl adenine demethylase FTO) (EC 1.14.11.-)
drug.Protein;Q14103;HNRNPD;ENSG00000138668;Q14103;Heterogeneous nuclear ribonucleoprotein D0 (hnRNP D0) (AU-rich element RNA-binding protein 1)
drug.Protein;P61978;HNRNPK;ENSG00000165119;P61978;Heterogeneous nuclear ribonucleoprotein K (hnRNP K) (Transformation up-regulated nuclear protein) (TUNP)
drug.Protein;Q5SSJ5;HP1BP3;ENSG00000127483;Q5SSJ5;Heterochromatin protein 1-binding protein 3 (Protein HP1-BP74)
drug.Protein;P46940;IQGAP1;ENSG00000140575;P46940;Ras GTPase-activating-like protein IQGAP1 (p195)
drug.Protein;P55786;NPEPPS;ENSG00000141279;P55786;Puromycin-sensitive aminopeptidase (PSA) (EC 3.4.11.14) (Cytosol alanyl aminopeptidase) (AAP-S)
drug.Protein;P27635;RPL10;ENSG00000147403;P27635;60S ribosomal protein L10 (Laminin receptor homolog) (Large ribosomal subunit protein uL16) (Protein QM) (Ribosomal protein L10) (Tumor suppressor QM)
drug.Protein;P50914;RPL14;ENSG00000188846;P50914;60S ribosomal protein L14 (CAG-ISL 7) (Large ribosomal subunit protein eL14)
drug.Protein;Q07020;RPL18;ENSG00000063177;Q07020;60S ribosomal protein L18 (Large ribosomal subunit protein eL18)
drug.Protein;P42766;RPL35;ENSG00000136942;P42766;60S ribosomal protein L35 (Large ribosomal subunit protein uL29)
drug.Protein;P36578;RPL4;ENSG00000174444;P36578;60S ribosomal protein L4 (60S ribosomal protein L1) (Large ribosomal subunit protein uL4)
drug.Protein;P62277;RPS13;ENSG00000110700;P62277;40S ribosomal protein S13 (Small ribosomal subunit protein uS15)
drug.Protein;P08708;RPS17;ENSG00000182774;P08708;40S ribosomal protein S17 (Small ribosomal subunit protein eS17)
drug.Protein;P62269;RPS18;ENSG00000231500;P62269;40S ribosomal protein S18 (Ke-3) (Ke3) (Small ribosomal subunit protein uS13)
drug.Protein;P39019;RPS19;ENSG00000105372;P39019;40S ribosomal protein S19 (Small ribosomal subunit protein eS19)
drug.Protein;P62857;RPS28;ENSG00000233927;P62857;40S ribosomal protein S28 (Small ribosomal subunit protein eS28)
drug.Protein;P46782;RPS5;ENSG00000083845;P46782;40S ribosomal protein S5 (Small ribosomal subunit protein uS7) [Cleaved into: 40S ribosomal protein S5, N-terminally processed]
drug.Protein;P62753;RPS6;ENSG00000137154;P62753;40S ribosomal protein S6 (Phosphoprotein NP33) (Small ribosomal subunit protein eS6)
drug.Protein;P62241;RPS8;ENSG00000142937;P62241;40S ribosomal protein S8 (Small ribosomal subunit protein eS8)
drug.Protein;P46781;RPS9;ENSG00000170889;P46781;40S ribosomal protein S9 (Small ribosomal subunit protein uS4)
drug.Protein;Q15637;SF1;ENSG00000168066;Q15637;Splicing factor 1 (Mammalian branch point-binding protein) (BBP) (mBBP) (Transcription factor ZFM1) (Zinc finger gene in MEN1 locus) (Zinc finger protein 162)
drug.Protein;P62316;SNRPD2;ENSG00000125743;P62316;Small nuclear ribonucleoprotein Sm D2 (Sm-D2) (snRNP core protein D2)
drug.Protein;P37108;SRP14;ENSG00000140319;P37108;Signal recognition particle 14 kDa protein (SRP14) (18 kDa Alu RNA-binding protein)
drug.Protein;Q08170;SRSF4;ENSG00000116350;Q08170;Serine/arginine-rich splicing factor 4 (Pre-mRNA-splicing factor SRP75) (SRP001LB) (Splicing factor, arginine/serine-rich 4)
drug.Protein;Q01995;TAGLN;ENSG00000149591;Q01995;Transgelin (22 kDa actin-binding protein) (Protein WS3-10) (Smooth muscle protein 22-alpha) (SM22-alpha)
drug.Protein;P37802;TAGLN2;ENSG00000158710;P37802;Transgelin-2 (Epididymis tissue protein Li 7e) (SM22-alpha homolog)
drug.Protein;P09493;TPM1;ENSG00000140416;P09493;Tropomyosin alpha-1 chain (Alpha-tropomyosin) (Tropomyosin-1)
drug.Protein;P08670;VIM;ENSG00000026025;P08670;Vimentin
drug.Protein;Q15942;ZYX;ENSG00000159840;Q15942;Zyxin (Zyxin-2)
drug.Protein;P35579;MYH9;ENSG00000100345;P35579;Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA)
drug.Protein;P17844;DDX5;ENSG00000108654;P17844;Probable ATP-dependent RNA helicase DDX5 (EC 3.6.4.13) (DEAD box protein 5) (RNA helicase p68)
drug.Protein;Q13838;DDX39B;ENSG00000198563;Q13838;Spliceosome RNA helicase DDX39B (EC 3.6.4.13) (56 kDa U2AF65-associated protein) (ATP-dependent RNA helicase p47) (DEAD box protein UAP56) (HLA-B-associated transcript 1 protein)
drug.Protein;P06748;NPM1;ENSG00000181163;P06748;Nucleophosmin (NPM) (Nucleolar phosphoprotein B23) (Nucleolar protein NO38) (Numatrin)
drug.Protein;Q13873;BMPR2;ENSG00000204217;Q13873;Bone morphogenetic protein receptor type-2 (BMP type-2 receptor) (BMPR-2) (EC 2.7.11.30) (Bone morphogenetic protein receptor type II) (BMP type II receptor) (BMPR-II)
drug.Protein;P36894;BMPR1A;ENSG00000107779;P36894;Bone morphogenetic protein receptor type-1A (BMP type-1A receptor) (BMPR-1A) (EC 2.7.11.30) (Activin receptor-like kinase 3) (ALK-3) (Serine/threonine-protein kinase receptor R5) (SKR5) (CD antigen CD292)
drug.Protein;P21860;ERBB3;ENSG00000065361;P21860;Receptor tyrosine-protein kinase erbB-3 (EC 2.7.10.1) (Proto-oncogene-like protein c-ErbB-3) (Tyrosine kinase-type cell surface receptor HER3)
drug.Protein;P32245;MC4R;ENSG00000166603;P32245;Melanocortin receptor 4 (MC4-R)
drug.Protein;P41968;MC3R;ENSG00000124089;P41968;Melanocortin receptor 3 (MC3-R)
drug.Protein;P33032;MC5R;ENSG00000176136;P33032;Melanocortin receptor 5 (MC5-R) (MC-2)
drug.Protein;Q14790;CASP8;ENSG00000064012;Q14790;"Caspase-8 (CASP-8) (EC 3.4.22.61) (Apoptotic cysteine protease) (Apoptotic protease Mch-5) (CAP4) (FADD-homologous ICE/ced-3-like protease) (FADD-like ICE) (FLICE) (ICE-like apoptotic protease 5) (MORT1-associated ced-3 homolog) (MACH) [Cleaved into: Caspase-8 subunit p18; Caspase-8 subunit p10]"
drug.Protein;Q15139;PRKD1;ENSG00000184304;Q15139;Serine/threonine-protein kinase D1 (EC 2.7.11.13) (Protein kinase C mu type) (Protein kinase D) (nPKC-D1) (nPKC-mu)
drug.Protein;P48764;SLC9A3;ENSG00000066230;P48764;Sodium/hydrogen exchanger 3 (Na(+)/H(+) exchanger 3) (NHE-3) (Solute carrier family 9 member 3)
drug.Protein;P01854;IGHE;ENSG00000211891;P01854;Immunoglobulin heavy constant epsilon (Ig epsilon chain C region) (Ig epsilon chain C region ND)
drug.Protein;Q9BQB4;SOST;ENSG00000167941;Q9BQB4;Sclerostin
drug.Protein;Q4VB53;;;;
drug.Protein;P53396;ACLY;ENSG00000131473;P53396;ATP-citrate synthase (EC 2.3.3.8) (ATP-citrate (pro-S-)-lyase) (ACL) (Citrate cleavage enzyme)
drug.Protein;O14975;SLC27A2;ENSG00000140284;O14975;Long-chain fatty acid transport protein 2 (Arachidonate--CoA ligase) (EC 6.2.1.15) (Fatty acid transport protein 2) (FATP-2) (Fatty-acid-coenzyme A ligase, very long-chain 1) (Long-chain-fatty-acid--CoA ligase) (EC 6.2.1.3) (Phytanate--CoA ligase) (EC 6.2.1.24) (Solute carrier family 27 member 2) (THCA-CoA ligase) (EC 6.2.1.7) (Very long-chain acyl-CoA synthetase) (VLACS) (VLCS) (EC 6.2.1.-) (Very long-chain-fatty-acid-CoA ligase)
drug.Protein;Q9H093;NUAK2;ENSG00000163545;Q9H093;NUAK family SNF1-like kinase 2 (EC 2.7.11.1) (Omphalocele kinase 2) (SNF1/AMP kinase-related kinase) (SNARK)
drug.Protein;O14980;XPO1;ENSG00000082898;O14980;Exportin-1 (Exp1) (Chromosome region maintenance 1 protein homolog)
drug.Protein;Q16288;NTRK3;ENSG00000140538;Q16288;NT-3 growth factor receptor (EC 2.7.10.1) (GP145-TrkC) (Trk-C) (Neurotrophic tyrosine kinase receptor type 3) (TrkC tyrosine kinase)
drug.Protein;P08922;ROS1;ENSG00000047936;P08922;Proto-oncogene tyrosine-protein kinase ROS (EC 2.7.10.1) (Proto-oncogene c-Ros) (Proto-oncogene c-Ros-1) (Receptor tyrosine kinase c-ros oncogene 1) (c-Ros receptor tyrosine kinase)
drug.Protein;Q9UK32;RPS6KA6;ENSG00000072133;Q9UK32;Ribosomal protein S6 kinase alpha-6 (S6K-alpha-6) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 6) (p90-RSK 6) (p90RSK6) (Ribosomal S6 kinase 4) (RSK-4) (pp90RSK4)
drug.Protein;Q8NI60;COQ8A;ENSG00000163050;Q8NI60;Atypical kinase COQ8A, mitochondrial (EC 2.7.-.-) (Chaperone activity of bc1 complex-like) (Chaperone-ABC1-like) (Coenzyme Q protein 8A) (aarF domain-containing protein kinase 3)
drug.Protein;Q8IY84;NIM1K;ENSG00000177453;Q8IY84;Serine/threonine-protein kinase NIM1 (EC 2.7.11.1) (NIM1 serine/threonine-protein kinase)
drug.Protein;Q9Y6E0;STK24;ENSG00000102572;Q9Y6E0;"Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)]"
drug.Protein;Q13188;STK3;ENSG00000104375;Q13188;"Serine/threonine-protein kinase 3 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 2) (MST-2) (STE20-like kinase MST2) (Serine/threonine-protein kinase Krs-1) [Cleaved into: Serine/threonine-protein kinase 3 36kDa subunit (MST2/N); Serine/threonine-protein kinase 3 20kDa subunit (MST2/C)]"
drug.Protein;P42680;TEC;ENSG00000135605;P42680;Tyrosine-protein kinase Tec (EC 2.7.10.2)
drug.Protein;Q9BYT3;STK33;ENSG00000130413;Q9BYT3;Serine/threonine-protein kinase 33 (EC 2.7.11.1)
drug.Protein;Q8TDR2;STK35;ENSG00000125834;Q8TDR2;Serine/threonine-protein kinase 35 (EC 2.7.11.1) (CLP-36-interacting kinase 1) (CLIK-1) (PDLIM1-interacting kinase 1) (Serine/threonine-protein kinase 35 L1)
drug.Protein;Q9NRP7;STK36;ENSG00000163482;Q9NRP7;Serine/threonine-protein kinase 36 (EC 2.7.11.1) (Fused homolog)
drug.Protein;Q15208;STK38;ENSG00000112079;Q15208;Serine/threonine-protein kinase 38 (EC 2.7.11.1) (NDR1 protein kinase) (Nuclear Dbf2-related kinase 1)
drug.Protein;Q9Y2H1;STK38L;ENSG00000211455;Q9Y2H1;Serine/threonine-protein kinase 38-like (EC 2.7.11.1) (NDR2 protein kinase) (Nuclear Dbf2-related kinase 2)
drug.Protein;Q9UEW8;STK39;ENSG00000198648;Q9UEW8;STE20/SPS1-related proline-alanine-rich protein kinase (Ste-20-related kinase) (EC 2.7.11.1) (DCHT) (Serine/threonine-protein kinase 39)
drug.Protein;Q7L7X3;TAOK1;ENSG00000160551;Q7L7X3;Serine/threonine-protein kinase TAO1 (EC 2.7.11.1) (Kinase from chicken homolog B) (hKFC-B) (MARK Kinase) (MARKK) (Prostate-derived sterile 20-like kinase 2) (PSK-2) (PSK2) (Prostate-derived STE20-like kinase 2) (Thousand and one amino acid protein kinase 1) (TAOK1) (hTAOK1)
drug.Protein;Q9H2K8;TAOK3;ENSG00000135090;Q9H2K8;Serine/threonine-protein kinase TAO3 (EC 2.7.11.1) (Cutaneous T-cell lymphoma-associated antigen HD-CL-09) (CTCL-associated antigen HD-CL-09) (Dendritic cell-derived protein kinase) (JNK/SAPK-inhibitory kinase) (Jun kinase-inhibitory kinase) (Kinase from chicken homolog A) (hKFC-A) (Thousand and one amino acid protein 3)
drug.Protein;Q9UHD2;TBK1;ENSG00000183735;Q9UHD2;Serine/threonine-protein kinase TBK1 (EC 2.7.11.1) (NF-kappa-B-activating kinase) (T2K) (TANK-binding kinase 1)
drug.Protein;Q15569;TESK1;ENSG00000107140;Q15569;Dual specificity testis-specific protein kinase 1 (EC 2.7.12.1) (Testicular protein kinase 1)
drug.Protein;P35590;TIE1;ENSG00000066056;P35590;Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1)
drug.Protein;Q9UKI8;TLK1;ENSG00000198586;Q9UKI8;Serine/threonine-protein kinase tousled-like 1 (EC 2.7.11.1) (PKU-beta) (Tousled-like kinase 1)
drug.Protein;Q86UE8;TLK2;ENSG00000146872;Q86UE8;Serine/threonine-protein kinase tousled-like 2 (EC 2.7.11.1) (HsHPK) (PKU-alpha) (Tousled-like kinase 2)
drug.Protein;Q9UKE5;TNIK;ENSG00000154310;Q9UKE5;TRAF2 and NCK-interacting protein kinase (EC 2.7.11.1)
drug.Protein;Q13470;TNK1;ENSG00000174292;Q13470;Non-receptor tyrosine-protein kinase TNK1 (EC 2.7.10.2) (CD38 negative kinase 1)
drug.Protein;Q59H18;TNNI3K;ENSG00000116783;Q59H18;Serine/threonine-protein kinase TNNI3K (EC 2.7.11.1) (Cardiac ankyrin repeat kinase) (Cardiac troponin I-interacting kinase) (TNNI3-interacting kinase)
drug.Protein;Q9BXA7;TSSK1B;ENSG00000212122;Q9BXA7;Testis-specific serine/threonine-protein kinase 1 (TSK-1) (TSK1) (TSSK-1) (Testis-specific kinase 1) (EC 2.7.11.1) (Serine/threonine-protein kinase 22A)
drug.Protein;P42681;TXK;ENSG00000074966;P42681;Tyrosine-protein kinase TXK (EC 2.7.10.2) (Protein-tyrosine kinase 4) (Resting lymphocyte kinase)
drug.Protein;Q06418;TYRO3;ENSG00000092445;Q06418;Tyrosine-protein kinase receptor TYRO3 (EC 2.7.10.1) (Tyrosine-protein kinase BYK) (Tyrosine-protein kinase DTK) (Tyrosine-protein kinase RSE) (Tyrosine-protein kinase SKY) (Tyrosine-protein kinase TIF)
drug.Protein;O75385;ULK1;ENSG00000177169;O75385;Serine/threonine-protein kinase ULK1 (EC 2.7.11.1) (Autophagy-related protein 1 homolog) (ATG1) (hATG1) (Unc-51-like kinase 1)
drug.Protein;Q8IYT8;ULK2;ENSG00000083290;Q8IYT8;Serine/threonine-protein kinase ULK2 (EC 2.7.11.1) (Unc-51-like kinase 2)
drug.Protein;Q6PHR2;ULK3;ENSG00000140474;Q6PHR2;Serine/threonine-protein kinase ULK3 (EC 2.7.11.1) (Unc-51-like kinase 3)
drug.Protein;Q56UN5;MAP3K19;ENSG00000176601;Q56UN5;Mitogen-activated protein kinase kinase kinase 19 (EC 2.7.11.1) (Regulated in COPD, protein kinase) (SPS1/STE20-related protein kinase YSK4)
drug.Protein;Q2M2I8;AAK1;ENSG00000115977;Q2M2I8;AP2-associated protein kinase 1 (EC 2.7.11.1) (Adaptor-associated kinase 1)
drug.Protein;Q96D53;COQ8B;ENSG00000123815;Q96D53;Atypical kinase COQ8B, mitochondrial (EC 2.7.-.-) (AarF domain-containing protein kinase 4) (Coenzyme Q protein 8B)
drug.Protein;Q8NFD2;ANKK1;ENSG00000170209;Q8NFD2;Ankyrin repeat and protein kinase domain-containing protein 1 (EC 2.7.11.1) (Protein kinase PKK2) (Sugen kinase 288) (SgK288) (X-kinase)
drug.Protein;P30530;AXL;ENSG00000167601;P30530;Tyrosine-protein kinase receptor UFO (EC 2.7.10.1) (AXL oncogene)
drug.Protein;P51451;BLK;ENSG00000136573;P51451;Tyrosine-protein kinase Blk (EC 2.7.10.2) (B lymphocyte kinase) (p55-Blk)
drug.Protein;Q9NSY1;BMP2K;ENSG00000138756;Q9NSY1;BMP-2-inducible protein kinase (BIKe) (EC 2.7.11.1)
drug.Protein;O00238;BMPR1B;ENSG00000138696;O00238;Bone morphogenetic protein receptor type-1B (BMP type-1B receptor) (BMPR-1B) (EC 2.7.11.30) (CD antigen CDw293)
drug.Protein;P51813;BMX;ENSG00000102010;P51813;Cytoplasmic tyrosine-protein kinase BMX (EC 2.7.10.2) (Bone marrow tyrosine kinase gene in chromosome X protein) (Epithelial and endothelial tyrosine kinase) (ETK) (NTK38)
drug.Protein;Q14012;CAMK1;ENSG00000134072;Q14012;Calcium/calmodulin-dependent protein kinase type 1 (EC 2.7.11.17) (CaM kinase I) (CaM-KI) (CaM kinase I alpha) (CaMKI-alpha)
drug.Protein;Q8N5S9;CAMKK1;ENSG00000004660;Q8N5S9;Calcium/calmodulin-dependent protein kinase kinase 1 (CaM-KK 1) (CaM-kinase kinase 1) (CaMKK 1) (EC 2.7.11.17) (CaM-kinase IV kinase) (Calcium/calmodulin-dependent protein kinase kinase alpha) (CaM-KK alpha) (CaM-kinase kinase alpha) (CaMKK alpha)
drug.Protein;Q96RR4;CAMKK2;ENSG00000110931;Q96RR4;Calcium/calmodulin-dependent protein kinase kinase 2 (CaM-KK 2) (CaM-kinase kinase 2) (CaMKK 2) (EC 2.7.11.17) (Calcium/calmodulin-dependent protein kinase kinase beta) (CaM-KK beta) (CaM-kinase kinase beta) (CaMKK beta)
drug.Protein;P07498;CSN3;ENSG00000171209;P07498;Kappa-casein
drug.Protein;Q6DT37;CDC42BPG;ENSG00000171219;Q6DT37;Serine/threonine-protein kinase MRCK gamma (EC 2.7.11.1) (CDC42-binding protein kinase gamma) (DMPK-like gamma) (Myotonic dystrophy kinase-related CDC42-binding kinase gamma) (MRCK gamma) (MRCKG) (Myotonic dystrophy protein kinase-like gamma) (Myotonic dystrophy protein kinase-like alpha)
drug.Protein;Q00532;CDKL1;ENSG00000100490;Q00532;Cyclin-dependent kinase-like 1 (EC 2.7.11.22) (Protein kinase p42 KKIALRE) (Serine/threonine-protein kinase KKIALRE)
drug.Protein;Q92772;CDKL2;ENSG00000138769;Q92772;Cyclin-dependent kinase-like 2 (EC 2.7.11.22) (Protein kinase p56 KKIAMRE) (Serine/threonine-protein kinase KKIAMRE)
drug.Protein;O14578;CIT;ENSG00000122966;O14578;Citron Rho-interacting kinase (CRIK) (EC 2.7.11.1) (Serine/threonine-protein kinase 21)
drug.Protein;P49760;CLK2;ENSG00000176444;P49760;Dual specificity protein kinase CLK2 (EC 2.7.12.1) (CDC-like kinase 2)
drug.Protein;Q9HAZ1;CLK4;ENSG00000113240;Q9HAZ1;Dual specificity protein kinase CLK4 (EC 2.7.12.1) (CDC-like kinase 4)
drug.Protein;P48729;CSNK1A1;ENSG00000113712;P48729;Casein kinase I isoform alpha (CKI-alpha) (EC 2.7.11.1) (CK1)
drug.Protein;Q9UIK4;DAPK2;ENSG00000035664;Q9UIK4;Death-associated protein kinase 2 (DAP kinase 2) (EC 2.7.11.1) (DAP-kinase-related protein 1) (DRP-1)
drug.Protein;O15075;DCLK1;ENSG00000133083;O15075;Serine/threonine-protein kinase DCLK1 (EC 2.7.11.1) (Doublecortin domain-containing protein 3A) (Doublecortin-like and CAM kinase-like 1) (Doublecortin-like kinase 1)
drug.Protein;Q8N568;DCLK2;ENSG00000170390;Q8N568;Serine/threonine-protein kinase DCLK2 (EC 2.7.11.1) (CaMK-like CREB regulatory kinase 2) (CL2) (CLICK-II) (CLICK2) (Doublecortin domain-containing protein 3B) (Doublecortin-like and CAM kinase-like 2) (Doublecortin-like kinase 2)
drug.Protein;Q9C098;DCLK3;ENSG00000163673;Q9C098;Serine/threonine-protein kinase DCLK3 (EC 2.7.11.1) (Doublecortin domain-containing protein 3C) (Doublecortin-like and CAM kinase-like 3) (Doublecortin-like kinase 3)
drug.Protein;Q9Y463;DYRK1B;ENSG00000105204;Q9Y463;Dual specificity tyrosine-phosphorylation-regulated kinase 1B (EC 2.7.12.1) (Minibrain-related kinase) (Mirk protein kinase)
drug.Protein;Q9BQI3;EIF2AK1;ENSG00000086232;Q9BQI3;Eukaryotic translation initiation factor 2-alpha kinase 1 (EC 2.7.11.1) (Heme-controlled repressor) (HCR) (Heme-regulated eukaryotic initiation factor eIF-2-alpha kinase) (Heme-regulated inhibitor) (hHRI) (Hemin-sensitive initiation factor 2-alpha kinase)
drug.Protein;Q9P2K8;EIF2AK4;ENSG00000128829;Q9P2K8;eIF-2-alpha kinase GCN2 (EC 2.7.11.1) (Eukaryotic translation initiation factor 2-alpha kinase 4) (GCN2-like protein)
drug.Protein;P21709;EPHA1;ENSG00000146904;P21709;Ephrin type-A receptor 1 (hEpha1) (EC 2.7.10.1) (EPH tyrosine kinase) (EPH tyrosine kinase 1) (Erythropoietin-producing hepatoma receptor) (Tyrosine-protein kinase receptor EPH)
drug.Protein;P29320;EPHA3;ENSG00000044524;P29320;Ephrin type-A receptor 3 (EC 2.7.10.1) (EPH-like kinase 4) (EK4) (hEK4) (HEK) (Human embryo kinase) (Tyrosine-protein kinase TYRO4) (Tyrosine-protein kinase receptor ETK1) (Eph-like tyrosine kinase 1)
drug.Protein;P54764;EPHA4;ENSG00000116106;P54764;Ephrin type-A receptor 4 (EC 2.7.10.1) (EPH-like kinase 8) (EK8) (hEK8) (Tyrosine-protein kinase TYRO1) (Tyrosine-protein kinase receptor SEK)
drug.Protein;Q9UF33;EPHA6;ENSG00000080224;Q9UF33;Ephrin type-A receptor 6 (EC 2.7.10.1) (EPH homology kinase 2) (EHK-2) (EPH-like kinase 12) (EK12)
drug.Protein;P29322;EPHA8;ENSG00000070886;P29322;Ephrin type-A receptor 8 (EC 2.7.10.1) (EPH- and ELK-related kinase) (EPH-like kinase 3) (EK3) (hEK3) (Tyrosine-protein kinase receptor EEK)
drug.Protein;P54762;EPHB1;ENSG00000154928;P54762;Ephrin type-B receptor 1 (EC 2.7.10.1) (ELK) (EPH tyrosine kinase 2) (EPH-like kinase 6) (EK6) (hEK6) (Neuronally-expressed EPH-related tyrosine kinase) (NET) (Tyrosine-protein kinase receptor EPH-2)
drug.Protein;O15197;EPHB6;ENSG00000106123;O15197;Ephrin type-B receptor 6 (HEP) (Tyrosine-protein kinase-defective receptor EPH-6)
drug.Protein;P16591;FER;ENSG00000151422;P16591;Tyrosine-protein kinase Fer (EC 2.7.10.2) (Feline encephalitis virus-related kinase FER) (Fujinami poultry sarcoma/Feline sarcoma-related protein Fer) (Proto-oncogene c-Fer) (Tyrosine kinase 3) (p94-Fer)
drug.Protein;P07332;FES;ENSG00000182511;P07332;Tyrosine-protein kinase Fes/Fps (EC 2.7.10.2) (Feline sarcoma/Fujinami avian sarcoma oncogene homolog) (Proto-oncogene c-Fes) (Proto-oncogene c-Fps) (p93c-fes)
drug.Protein;O14976;GAK;ENSG00000178950;O14976;Cyclin-G-associated kinase (EC 2.7.11.1)
drug.Protein;P49840;GSK3A;ENSG00000105723;P49840;Glycogen synthase kinase-3 alpha (GSK-3 alpha) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3A) (EC 2.7.11.1)
drug.Protein;Q9H2X6;HIPK2;ENSG00000064393;Q9H2X6;Homeodomain-interacting protein kinase 2 (hHIPk2) (EC 2.7.11.1)
drug.Protein;Q9H422;HIPK3;ENSG00000110422;Q9H422;Homeodomain-interacting protein kinase 3 (EC 2.7.11.1) (Androgen receptor-interacting nuclear protein kinase) (ANPK) (Fas-interacting serine/threonine-protein kinase) (FIST) (Homolog of protein kinase YAK1)
drug.Protein;Q9UPZ9;CILK1;ENSG00000112144;Q9UPZ9;Serine/threonine-protein kinase ICK (EC 2.7.11.1) (Ciliogenesis associated kinase 1) (Intestinal cell kinase) (hICK) (Laryngeal cancer kinase 2) (LCK2) (MAK-related kinase) (MRK)
drug.Protein;Q14164;IKBKE;ENSG00000263528;Q14164;Inhibitor of nuclear factor kappa-B kinase subunit epsilon (I-kappa-B kinase epsilon) (IKK-E) (IKK-epsilon) (IkBKE) (EC 2.7.11.10) (Inducible I kappa-B kinase) (IKK-i)
drug.Protein;P14616;INSRR;ENSG00000027644;P14616;"Insulin receptor-related protein (IRR) (EC 2.7.10.1) (IR-related receptor) [Cleaved into: Insulin receptor-related protein alpha chain; Insulin receptor-related protein beta chain]"
drug.Protein;P51617;IRAK1;ENSG00000184216;P51617;Interleukin-1 receptor-associated kinase 1 (IRAK-1) (EC 2.7.11.1)
drug.Protein;Q9Y616;IRAK3;ENSG00000090376;Q9Y616;Interleukin-1 receptor-associated kinase 3 (IRAK-3) (IL-1 receptor-associated kinase M) (IRAK-M) (Inactive IL-1 receptor-associated kinase 3)
drug.Protein;Q9Y2K2;SIK3;ENSG00000160584;Q9Y2K2;Serine/threonine-protein kinase SIK3 (EC 2.7.11.1) (Salt-inducible kinase 3) (SIK-3) (Serine/threonine-protein kinase QSK)
drug.Protein;O95835;LATS1;ENSG00000131023;O95835;Serine/threonine-protein kinase LATS1 (EC 2.7.11.1) (Large tumor suppressor homolog 1) (WARTS protein kinase) (h-warts)
drug.Protein;P53671;LIMK2;ENSG00000182541;P53671;LIM domain kinase 2 (LIMK-2) (EC 2.7.11.1)
drug.Protein;Q5S007;LRRK2;ENSG00000188906;Q5S007;Leucine-rich repeat serine/threonine-protein kinase 2 (EC 2.7.11.1) (EC 3.6.5.-) (Dardarin)
drug.Protein;P29376;LTK;ENSG00000062524;P29376;Leukocyte tyrosine kinase receptor (EC 2.7.10.1) (Protein tyrosine kinase 1)
drug.Protein;P46734;MAP2K3;ENSG00000034152;P46734;Dual specificity mitogen-activated protein kinase kinase 3 (MAP kinase kinase 3) (MAPKK 3) (EC 2.7.12.2) (MAPK/ERK kinase 3) (MEK 3) (Stress-activated protein kinase kinase 2) (SAPK kinase 2) (SAPKK-2) (SAPKK2)
drug.Protein;Q13163;MAP2K5;ENSG00000137764;Q13163;Dual specificity mitogen-activated protein kinase kinase 5 (MAP kinase kinase 5) (MAPKK 5) (EC 2.7.12.2) (MAPK/ERK kinase 5) (MEK 5)
drug.Protein;P52564;MAP2K6;ENSG00000108984;P52564;Dual specificity mitogen-activated protein kinase kinase 6 (MAP kinase kinase 6) (MAPKK 6) (EC 2.7.12.2) (MAPK/ERK kinase 6) (MEK 6) (Stress-activated protein kinase kinase 3) (SAPK kinase 3) (SAPKK-3) (SAPKK3)
drug.Protein;Q02779;MAP3K10;ENSG00000130758;Q02779;Mitogen-activated protein kinase kinase kinase 10 (EC 2.7.11.25) (Mixed lineage kinase 2) (Protein kinase MST)
drug.Protein;Q16584;MAP3K11;ENSG00000173327;Q16584;Mitogen-activated protein kinase kinase kinase 11 (EC 2.7.11.25) (Mixed lineage kinase 3) (Src-homology 3 domain-containing proline-rich kinase)
drug.Protein;Q12852;MAP3K12;ENSG00000139625;Q12852;Mitogen-activated protein kinase kinase kinase 12 (EC 2.7.11.25) (Dual leucine zipper bearing kinase) (DLK) (Leucine-zipper protein kinase) (ZPK) (MAPK-upstream kinase) (MUK) (Mixed lineage kinase)
drug.Protein;O43283;MAP3K13;ENSG00000073803;O43283;Mitogen-activated protein kinase kinase kinase 13 (EC 2.7.11.25) (Leucine zipper-bearing kinase) (Mixed lineage kinase) (MLK)
drug.Protein;Q6ZN16;MAP3K15;ENSG00000180815;Q6ZN16;Mitogen-activated protein kinase kinase kinase 15 (EC 2.7.11.25) (Apoptosis signal-regulating kinase 3) (MAPK/ERK kinase kinase 15) (MEK kinase 15) (MEKK 15)
drug.Protein;Q99759;MAP3K3;ENSG00000198909;Q99759;Mitogen-activated protein kinase kinase kinase 3 (EC 2.7.11.25) (MAPK/ERK kinase kinase 3) (MEK kinase 3) (MEKK 3)
drug.Protein;Q9Y6R4;MAP3K4;ENSG00000085511;Q9Y6R4;Mitogen-activated protein kinase kinase kinase 4 (EC 2.7.11.25) (MAP three kinase 1) (MAPK/ERK kinase kinase 4) (MEK kinase 4) (MEKK 4)
drug.Protein;O95382;MAP3K6;ENSG00000142733;O95382;Mitogen-activated protein kinase kinase kinase 6 (EC 2.7.11.25) (Apoptosis signal-regulating kinase 2)
drug.Protein;Q92918;MAP4K1;ENSG00000104814;Q92918;Mitogen-activated protein kinase kinase kinase kinase 1 (EC 2.7.11.1) (Hematopoietic progenitor kinase) (MAPK/ERK kinase kinase kinase 1) (MEK kinase kinase 1) (MEKKK 1)
drug.Protein;Q12851;MAP4K2;ENSG00000168067;Q12851;Mitogen-activated protein kinase kinase kinase kinase 2 (EC 2.7.11.1) (B lymphocyte serine/threonine-protein kinase) (Germinal center kinase) (GC kinase) (MAPK/ERK kinase kinase kinase 2) (MEK kinase kinase 2) (MEKKK 2) (Rab8-interacting protein)
drug.Protein;Q8IVH8;MAP4K3;ENSG00000011566;Q8IVH8;Mitogen-activated protein kinase kinase kinase kinase 3 (EC 2.7.11.1) (Germinal center kinase-related protein kinase) (GLK) (MAPK/ERK kinase kinase kinase 3) (MEK kinase kinase 3) (MEKKK 3)
drug.Protein;O95819;MAP4K4;ENSG00000071054;O95819;Mitogen-activated protein kinase kinase kinase kinase 4 (EC 2.7.11.1) (HPK/GCK-like kinase HGK) (MAPK/ERK kinase kinase kinase 4) (MEK kinase kinase 4) (MEKKK 4) (Nck-interacting kinase)
drug.Protein;Q9Y4K4;MAP4K5;ENSG00000012983;Q9Y4K4;Mitogen-activated protein kinase kinase kinase kinase 5 (EC 2.7.11.1) (Kinase homologous to SPS1/STE20) (KHS) (MAPK/ERK kinase kinase kinase 5) (MEK kinase kinase 5) (MEKKK 5)
drug.Protein;Q8TD08;MAPK15;ENSG00000181085;Q8TD08;Mitogen-activated protein kinase 15 (MAP kinase 15) (MAPK 15) (EC 2.7.11.24) (Extracellular signal-regulated kinase 7) (ERK-7) (Extracellular signal-regulated kinase 8) (ERK-8)
drug.Protein;P31152;MAPK4;ENSG00000141639;P31152;Mitogen-activated protein kinase 4 (MAP kinase 4) (MAPK 4) (EC 2.7.11.24) (Extracellular signal-regulated kinase 4) (ERK-4) (MAP kinase isoform p63) (p63-MAPK)
drug.Protein;Q13164;MAPK7;ENSG00000166484;Q13164;Mitogen-activated protein kinase 7 (MAP kinase 7) (MAPK 7) (EC 2.7.11.24) (Big MAP kinase 1) (BMK-1) (Extracellular signal-regulated kinase 5) (ERK-5)
drug.Protein;Q8IW41;MAPKAPK5;ENSG00000089022;Q8IW41;MAP kinase-activated protein kinase 5 (MAPK-activated protein kinase 5) (MAPKAP kinase 5) (MAPKAP-K5) (MAPKAPK-5) (MK-5) (MK5) (EC 2.7.11.1) (p38-regulated/activated protein kinase) (PRAK)
drug.Protein;Q9P0L2;MARK1;ENSG00000116141;Q9P0L2;Serine/threonine-protein kinase MARK1 (EC 2.7.11.1) (EC 2.7.11.26) (MAP/microtubule affinity-regulating kinase 1) (PAR1 homolog c) (Par-1c) (Par1c)
drug.Protein;Q7KZI7;MARK2;ENSG00000072518;Q7KZI7;Serine/threonine-protein kinase MARK2 (EC 2.7.11.1) (EC 2.7.11.26) (ELKL motif kinase 1) (EMK-1) (MAP/microtubule affinity-regulating kinase 2) (PAR1 homolog) (PAR1 homolog b) (Par-1b) (Par1b)
drug.Protein;P27448;MARK3;ENSG00000075413;P27448;MAP/microtubule affinity-regulating kinase 3 (EC 2.7.11.1) (C-TAK1) (cTAK1) (Cdc25C-associated protein kinase 1) (ELKL motif kinase 2) (EMK-2) (Protein kinase STK10) (Ser/Thr protein kinase PAR-1) (Par-1a) (Serine/threonine-protein kinase p78)
drug.Protein;Q96L34;MARK4;ENSG00000007047;Q96L34;MAP/microtubule affinity-regulating kinase 4 (EC 2.7.11.1) (MAP/microtubule affinity-regulating kinase-like 1)
drug.Protein;Q7Z460;CLASP1;ENSG00000074054;Q7Z460;CLIP-associating protein 1 (Cytoplasmic linker-associated protein 1) (Multiple asters homolog 1) (Protein Orbit homolog 1) (hOrbit1)
drug.Protein;Q9Y2H9;MAST1;ENSG00000105613;Q9Y2H9;Microtubule-associated serine/threonine-protein kinase 1 (EC 2.7.11.1) (Syntrophin-associated serine/threonine-protein kinase)
drug.Protein;P42679;MATK;ENSG00000007264;P42679;Megakaryocyte-associated tyrosine-protein kinase (EC 2.7.10.2) (CSK homologous kinase) (CHK) (Hematopoietic consensus tyrosine-lacking kinase) (Protein kinase HYL) (Tyrosine-protein kinase CTK)
drug.Protein;Q14680;MELK;ENSG00000165304;Q14680;Maternal embryonic leucine zipper kinase (hMELK) (EC 2.7.11.1) (Protein kinase Eg3) (pEg3 kinase) (Protein kinase PK38) (hPK38) (Tyrosine-protein kinase MELK) (EC 2.7.10.2)
drug.Protein;Q8N4C8;MINK1;ENSG00000141503;Q8N4C8;Misshapen-like kinase 1 (EC 2.7.11.1) (GCK family kinase MiNK) (MAPK/ERK kinase kinase kinase 6) (MEK kinase kinase 6) (MEKKK 6) (Misshapen/NIK-related kinase) (Mitogen-activated protein kinase kinase kinase kinase 6)
drug.Protein;Q9BUB5;MKNK1;ENSG00000079277;Q9BUB5;MAP kinase-interacting serine/threonine-protein kinase 1 (EC 2.7.11.1) (MAP kinase signal-integrating kinase 1) (MAPK signal-integrating kinase 1) (Mnk1)
drug.Protein;Q9HBH9;MKNK2;ENSG00000099875;Q9HBH9;MAP kinase-interacting serine/threonine-protein kinase 2 (EC 2.7.11.1) (MAP kinase signal-integrating kinase 2) (MAPK signal-integrating kinase 2) (Mnk2)
drug.Protein;Q04912;MST1R;ENSG00000164078;Q04912;"Macrophage-stimulating protein receptor (MSP receptor) (EC 2.7.10.1) (CDw136) (Protein-tyrosine kinase 8) (p185-Ron) (CD antigen CD136) [Cleaved into: Macrophage-stimulating protein receptor alpha chain; Macrophage-stimulating protein receptor beta chain]"
drug.Protein;O15146;MUSK;ENSG00000030304;O15146;Muscle, skeletal receptor tyrosine-protein kinase (EC 2.7.10.1) (Muscle-specific tyrosine-protein kinase receptor) (MuSK) (Muscle-specific kinase receptor)
drug.Protein;Q15746;MYLK;ENSG00000065534;Q15746;Myosin light chain kinase, smooth muscle (MLCK) (smMLCK) (EC 2.7.11.18) (Kinase-related protein) (KRP) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form]
drug.Protein;Q32MK0;MYLK3;ENSG00000140795;Q32MK0;Myosin light chain kinase 3 (EC 2.7.11.18) (Cardiac-MyBP-C-associated Ca/CaM kinase) (Cardiac-MLCK)
drug.Protein;Q86YV6;MYLK4;ENSG00000145949;Q86YV6;Myosin light chain kinase family member 4 (EC 2.7.11.1) (Sugen kinase 85) (SgK085)
drug.Protein;Q8NEV4;MYO3A;ENSG00000095777;Q8NEV4;Myosin-IIIa (EC 2.7.11.1)
drug.Protein;Q96PY6;NEK1;ENSG00000137601;Q96PY6;Serine/threonine-protein kinase Nek1 (EC 2.7.11.1) (Never in mitosis A-related kinase 1) (NimA-related protein kinase 1) (Renal carcinoma antigen NY-REN-55)
drug.Protein;P51956;NEK3;ENSG00000136098;P51956;Serine/threonine-protein kinase Nek3 (EC 2.7.11.1) (HSPK 36) (Never in mitosis A-related kinase 3) (NimA-related protein kinase 3)
drug.Protein;P51957;NEK4;ENSG00000114904;P51957;Serine/threonine-protein kinase Nek4 (EC 2.7.11.1) (Never in mitosis A-related kinase 4) (NimA-related protein kinase 4) (Serine/threonine-protein kinase 2) (Serine/threonine-protein kinase NRK2)
drug.Protein;Q6P3R8;NEK5;ENSG00000197168;Q6P3R8;Serine/threonine-protein kinase Nek5 (EC 2.7.11.1) (Never in mitosis A-related kinase 5) (NimA-related protein kinase 5)
drug.Protein;Q8TD19;NEK9;ENSG00000119638;Q8TD19;Serine/threonine-protein kinase Nek9 (EC 2.7.11.1) (Nercc1 kinase) (Never in mitosis A-related kinase 9) (NimA-related protein kinase 9) (NimA-related kinase 8) (Nek8)
drug.Protein;O60285;NUAK1;ENSG00000074590;O60285;NUAK family SNF1-like kinase 1 (EC 2.7.11.1) (AMPK-related protein kinase 5) (ARK5) (Omphalocele kinase 1)
drug.Protein;O95747;OXSR1;ENSG00000172939;O95747;Serine/threonine-protein kinase OSR1 (EC 2.7.11.1) (Oxidative stress-responsive 1 protein)
drug.Protein;Q13153;PAK1;ENSG00000149269;Q13153;Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK)
drug.Protein;Q13177;PAK2;ENSG00000180370;Q13177;"Serine/threonine-protein kinase PAK 2 (EC 2.7.11.1) (Gamma-PAK) (PAK65) (S6/H4 kinase) (p21-activated kinase 2) (PAK-2) (p58) [Cleaved into: PAK-2p27 (p27); PAK-2p34 (p34) (C-t-PAK2)]"
drug.Protein;O75914;PAK3;ENSG00000077264;O75914;Serine/threonine-protein kinase PAK 3 (EC 2.7.11.1) (Beta-PAK) (Oligophrenin-3) (p21-activated kinase 3) (PAK-3)
drug.Protein;O96013;PAK4;ENSG00000130669;O96013;Serine/threonine-protein kinase PAK 4 (EC 2.7.11.1) (p21-activated kinase 4) (PAK-4)
drug.Protein;Q9NQU5;PAK6;ENSG00000137843;Q9NQU5;Serine/threonine-protein kinase PAK 6 (EC 2.7.11.1) (PAK-5) (p21-activated kinase 6) (PAK-6)
drug.Protein;Q9P286;PAK5;ENSG00000101349;Q9P286;Serine/threonine-protein kinase PAK 5 (EC 2.7.11.1) (p21-activated kinase 5) (PAK-5) (p21-activated kinase 7) (PAK-7)
drug.Protein;Q00537;CDK17;ENSG00000059758;Q00537;Cyclin-dependent kinase 17 (EC 2.7.11.22) (Cell division protein kinase 17) (PCTAIRE-motif protein kinase 2) (Serine/threonine-protein kinase PCTAIRE-2)
drug.Protein;Q16816;PHKG1;ENSG00000164776;Q16816;Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform (PHK-gamma-M) (EC 2.7.11.19) (Phosphorylase kinase subunit gamma-1) (Serine/threonine-protein kinase PHKG1) (EC 2.7.11.1, EC 2.7.11.26)
drug.Protein;Q9UBF8;PI4KB;ENSG00000143393;Q9UBF8;Phosphatidylinositol 4-kinase beta (PI4K-beta) (PI4Kbeta) (PtdIns 4-kinase beta) (EC 2.7.1.67) (NPIK) (PI4K92) (PI4KIII)
drug.Protein;O00750;PIK3C2B;ENSG00000133056;O00750;Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta (PI3K-C2-beta) (PtdIns-3-kinase C2 subunit beta) (EC 2.7.1.137) (EC 2.7.1.154) (C2-PI3K) (Phosphoinositide 3-kinase-C2-beta)
drug.Protein;O75747;PIK3C2G;ENSG00000139144;O75747;Phosphatidylinositol 3-kinase C2 domain-containing subunit gamma (PI3K-C2-gamma) (PtdIns-3-kinase C2 subunit gamma) (EC 2.7.1.137) (EC 2.7.1.154) (Phosphoinositide 3-kinase-C2-gamma)
drug.Protein;Q86V86;PIM3;ENSG00000198355;Q86V86;Serine/threonine-protein kinase pim-3 (EC 2.7.11.1)
drug.Protein;P78356;PIP4K2B;ENSG00000276293;P78356;Phosphatidylinositol 5-phosphate 4-kinase type-2 beta (EC 2.7.1.149) (1-phosphatidylinositol 5-phosphate 4-kinase 2-beta) (Diphosphoinositide kinase 2-beta) (Phosphatidylinositol 5-phosphate 4-kinase type II beta) (PI(5)P 4-kinase type II beta) (PIP4KII-beta) (PtdIns(5)P-4-kinase isoform 2-beta)
drug.Protein;Q8TBX8;PIP4K2C;ENSG00000166908;Q8TBX8;Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma (EC 2.7.1.149) (Phosphatidylinositol 5-phosphate 4-kinase type II gamma) (PI(5)P 4-kinase type II gamma) (PIP4KII-gamma)
drug.Protein;Q99640;PKMYT1;ENSG00000127564;Q99640;Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase (EC 2.7.11.1) (Myt1 kinase)
drug.Protein;Q16512;PKN1;ENSG00000123143;Q16512;Serine/threonine-protein kinase N1 (EC 2.7.11.13) (Protease-activated kinase 1) (PAK-1) (Protein kinase C-like 1) (Protein kinase C-like PKN) (Protein kinase PKN-alpha) (Protein-kinase C-related kinase 1) (Serine-threonine protein kinase N)
drug.Protein;Q16513;PKN2;ENSG00000065243;Q16513;Serine/threonine-protein kinase N2 (EC 2.7.11.13) (PKN gamma) (Protein kinase C-like 2) (Protein-kinase C-related kinase 2)
drug.Protein;Q9NYY3;PLK2;ENSG00000145632;Q9NYY3;Serine/threonine-protein kinase PLK2 (EC 2.7.11.21) (Polo-like kinase 2) (PLK-2) (hPlk2) (Serine/threonine-protein kinase SNK) (hSNK) (Serum-inducible kinase)
drug.Protein;Q9H4B4;PLK3;ENSG00000173846;Q9H4B4;Serine/threonine-protein kinase PLK3 (EC 2.7.11.21) (Cytokine-inducible serine/threonine-protein kinase) (FGF-inducible kinase) (Polo-like kinase 3) (PLK-3) (Proliferation-related kinase)
drug.Protein;O00444;PLK4;ENSG00000142731;O00444;Serine/threonine-protein kinase PLK4 (EC 2.7.11.21) (Polo-like kinase 4) (PLK-4) (Serine/threonine-protein kinase 18) (Serine/threonine-protein kinase Sak)
drug.Protein;P05129;PRKCG;ENSG00000126583;P05129;Protein kinase C gamma type (PKC-gamma) (EC 2.7.11.13)
drug.Protein;Q13237;PRKG2;ENSG00000138669;Q13237;cGMP-dependent protein kinase 2 (cGK 2) (cGK2) (EC 2.7.11.12) (cGMP-dependent protein kinase II) (cGKII)
drug.Protein;Q13523;PRPF4B;ENSG00000112739;Q13523;Serine/threonine-protein kinase PRP4 homolog (EC 2.7.11.1) (PRP4 kinase) (PRP4 pre-mRNA-processing factor 4 homolog)
drug.Protein;Q9BRS2;RIOK1;ENSG00000124784;Q9BRS2;Serine/threonine-protein kinase RIO1 (EC 2.7.11.1) (EC 3.6.3.-) (RIO kinase 1)
drug.Protein;Q9BVS4;RIOK2;ENSG00000058729;Q9BVS4;Serine/threonine-protein kinase RIO2 (EC 2.7.11.1) (RIO kinase 2)
drug.Protein;O14730;RIOK3;ENSG00000101782;O14730;Serine/threonine-protein kinase RIO3 (EC 2.7.11.1) (RIO kinase 3) (sudD homolog)
drug.Protein;Q13546;RIPK1;ENSG00000137275;Q13546;Receptor-interacting serine/threonine-protein kinase 1 (EC 2.7.11.1) (Cell death protein RIP) (Receptor-interacting protein 1) (RIP-1)
drug.Protein;O43353;RIPK2;ENSG00000104312;O43353;Receptor-interacting serine/threonine-protein kinase 2 (EC 2.7.11.1) (CARD-containing interleukin-1 beta-converting enzyme-associated kinase) (CARD-containing IL-1 beta ICE-kinase) (RIP-like-interacting CLARP kinase) (Receptor-interacting protein 2) (RIP-2) (Tyrosine-protein kinase RIPK2) (EC 2.7.10.2)
drug.Protein;P57078;RIPK4;ENSG00000183421;P57078;Receptor-interacting serine/threonine-protein kinase 4 (EC 2.7.11.1) (Ankyrin repeat domain-containing protein 3) (PKC-delta-interacting protein kinase)
drug.Protein;Q52WX2;SBK1;ENSG00000188322;Q52WX2;Serine/threonine-protein kinase SBK1 (EC 2.7.11.1) (SH3-binding kinase 1)
drug.Protein;P0C264;SBK3;ENSG00000231274;P0C264;Uncharacterized serine/threonine-protein kinase SBK3 (EC 2.7.11.1) (SH3-binding domain kinase family member 3) (Sugen kinase 110)
drug.Protein;Q96BR1;SGK3;ENSG00000104205;Q96BR1;Serine/threonine-protein kinase Sgk3 (EC 2.7.11.1) (Cytokine-independent survival kinase) (Serum/glucocorticoid-regulated kinase 3) (Serum/glucocorticoid-regulated kinase-like)
drug.Protein;Q9H0K1;SIK2;ENSG00000170145;Q9H0K1;Serine/threonine-protein kinase SIK2 (EC 2.7.11.1) (Qin-induced kinase) (Salt-inducible kinase 2) (SIK-2) (Serine/threonine-protein kinase SNF1-like kinase 2)
drug.Protein;Q9NRH2;SNRK;ENSG00000163788;Q9NRH2;SNF-related serine/threonine-protein kinase (EC 2.7.11.1) (SNF1-related kinase)
drug.Protein;Q9H3Y6;SRMS;ENSG00000125508;Q9H3Y6;Tyrosine-protein kinase Srms (EC 2.7.10.2)
drug.Protein;O94804;STK10;ENSG00000072786;O94804;Serine/threonine-protein kinase 10 (EC 2.7.11.1) (Lymphocyte-oriented kinase)
drug.Protein;O75716;STK16;ENSG00000115661;O75716;Serine/threonine-protein kinase 16 (EC 2.7.11.1) (Myristoylated and palmitoylated serine/threonine-protein kinase) (MPSK) (Protein kinase PKL12) (TGF-beta-stimulated factor 1) (TSF-1) (Tyrosine-protein kinase STK16) (EC 2.7.10.2) (hPSK)
drug.Protein;Q9UEE5;STK17A;ENSG00000164543;Q9UEE5;Serine/threonine-protein kinase 17A (EC 2.7.11.1) (DAP kinase-related apoptosis-inducing protein kinase 1)
drug.Protein;Q8WU08;STK32A;ENSG00000169302;Q8WU08;Serine/threonine-protein kinase 32A (EC 2.7.11.1) (Yet another novel kinase 1)
drug.Protein;Q08477;CYP4F3;ENSG00000186529;Q08477;Cytochrome P450 4F3 (EC 1.14.14.1) (20-hydroxyeicosatetraenoic acid synthase) (20-HETE synthase) (CYPIVF3) (Cytochrome P450-LTB-omega) (Docosahexaenoic acid omega-hydroxylase CYP4F3) (EC 1.14.14.79) (Leukotriene-B(4) 20-monooxygenase 2) (Leukotriene-B(4) omega-hydroxylase 2) (EC 1.14.14.94)
drug.Protein;Q01344;IL5RA;ENSG00000091181;Q01344;Interleukin-5 receptor subunit alpha (IL-5 receptor subunit alpha) (IL-5R subunit alpha) (IL-5R-alpha) (IL-5RA) (CDw125) (CD antigen CD125)
drug.Protein;Q07011;TNFRSF9;ENSG00000049249;Q07011;Tumor necrosis factor receptor superfamily member 9 (4-1BB ligand receptor) (CDw137) (T-cell antigen 4-1BB homolog) (T-cell antigen ILA) (CD antigen CD137)
drug.Protein;P27037;ACVR2A;ENSG00000121989;P27037;Activin receptor type-2A (EC 2.7.11.30) (Activin receptor type IIA) (ACTR-IIA) (ACTRIIA)
drug.Protein;Q92847;GHSR;ENSG00000121853;Q92847;Growth hormone secretagogue receptor type 1 (GHS-R) (GH-releasing peptide receptor) (GHRP) (Ghrelin receptor)
drug.Protein;P10092;CALCB;ENSG00000175868;P10092;Calcitonin gene-related peptide 2 (Beta-type CGRP) (Beta-CGRP) (Calcitonin gene-related peptide II) (CGRP-II)
drug.Protein;P40259;CD79B;ENSG00000007312;P40259;B-cell antigen receptor complex-associated protein beta chain (B-cell-specific glycoprotein B29) (Ig-beta) (Immunoglobulin-associated B29 protein) (CD antigen CD79b)
drug.Protein;Q9P2E9;RRBP1;ENSG00000125844;Q9P2E9;Ribosome-binding protein 1 (180 kDa ribosome receptor homolog) (RRp) (ES/130-related protein) (Ribosome receptor protein)
drug.Protein;Q9Y221;NIP7;ENSG00000132603;Q9Y221;60S ribosome subunit biogenesis protein NIP7 homolog (KD93) (Nucleolar pre-rRNA processing protein NIP7)
drug.Protein;Q92843;BCL2L2;ENSG00000129473;Q92843;Bcl-2-like protein 2 (Bcl2-L-2) (Apoptosis regulator Bcl-W)
drug.Protein;Q92934;BAD;ENSG00000002330;Q92934;Bcl2-associated agonist of cell death (BAD) (Bcl-2-binding component 6) (Bcl-2-like protein 8) (Bcl2-L-8) (Bcl-xL/Bcl-2-associated death promoter) (Bcl2 antagonist of cell death)
drug.Protein;P51679;CCR4;ENSG00000183813;P51679;C-C chemokine receptor type 4 (C-C CKR-4) (CC-CKR-4) (CCR-4) (CCR4) (K5-5) (CD antigen CD194)
drug.Protein;P01350;GAST;ENSG00000184502;P01350;"Gastrin [Cleaved into: Gastrin-71 (Gastrin component I); Gastrin-52 (G52); Big gastrin (Gastrin component II) (Gastrin-34) (G34); Gastrin (Gastrin component III) (Gastrin-17) (G17); Gastrin-14 (G14); Gastrin-6 (G6)]"
drug.Protein;Q6QNK2;ADGRD1;ENSG00000111452;Q6QNK2;Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133) (G-protein coupled receptor PGR25)
drug.Protein;Q8N4T0;CPA6;ENSG00000165078;Q8N4T0;Carboxypeptidase A6 (EC 3.4.17.-)
drug.Protein;P62736;ACTA2;ENSG00000107796;P62736;Actin, aortic smooth muscle (Alpha-actin-2) (Cell growth-inhibiting gene 46 protein) [Cleaved into: Actin, aortic smooth muscle, intermediate form]
drug.Protein;P56385;ATP5ME;ENSG00000169020;P56385;ATP synthase subunit e, mitochondrial (ATPase subunit e) (ATP synthase membrane subunit e) [Cleaved into: ATP synthase subunit e, mitochondrial, N-terminally processed]
drug.Protein;O43169;CYB5B;ENSG00000103018;O43169;Cytochrome b5 type B (Cytochrome b5 outer mitochondrial membrane isoform)
drug.Protein;Q9NR28;DIABLO;ENSG00000184047;Q9NR28;Diablo IAP-binding mitochondrial protein (Diablo homolog, mitochondrial) (Direct IAP-binding protein with low pI) (Second mitochondria-derived activator of caspase) (Smac)
drug.Protein;Q8TF61;FBXO41;ENSG00000163013;Q8TF61;F-box only protein 41
drug.Protein;P52597;HNRNPF;ENSG00000169813;P52597;Heterogeneous nuclear ribonucleoprotein F (hnRNP F) (Nucleolin-like protein mcs94-1) [Cleaved into: Heterogeneous nuclear ribonucleoprotein F, N-terminally processed]
drug.Protein;P34932;HSPA4;ENSG00000170606;P34932;Heat shock 70 kDa protein 4 (HSP70RY) (Heat shock 70-related protein APG-2)
drug.Protein;P61604;HSPE1;ENSG00000115541;P61604;10 kDa heat shock protein, mitochondrial (Hsp10) (10 kDa chaperonin) (Chaperonin 10) (CPN10) (Early-pregnancy factor) (EPF)
drug.Protein;Q92598;HSPH1;ENSG00000120694;Q92598;Heat shock protein 105 kDa (Antigen NY-CO-25) (Heat shock 110 kDa protein)
drug.Protein;Q9Y266;NUDC;ENSG00000090273;Q9Y266;Nuclear migration protein nudC (Nuclear distribution protein C homolog)
drug.Protein;Q13219;PAPPA;ENSG00000182752;Q13219;Pappalysin-1 (EC 3.4.24.79) (Insulin-like growth factor-dependent IGF-binding protein 4 protease) (IGF-dependent IGFBP-4 protease) (IGFBP-4ase) (Pregnancy-associated plasma protein A) (PAPP-A)
drug.Protein;P17980;PSMC3;ENSG00000165916;P17980;26S proteasome regulatory subunit 6A (26S proteasome AAA-ATPase subunit RPT5) (Proteasome 26S subunit ATPase 3) (Proteasome subunit P50) (Tat-binding protein 1) (TBP-1)
drug.Protein;P60903;S100A10;ENSG00000197747;P60903;Protein S100-A10 (Calpactin I light chain) (Calpactin-1 light chain) (Cellular ligand of annexin II) (S100 calcium-binding protein A10) (p10 protein) (p11)
drug.Protein;Q12874;SF3A3;ENSG00000183431;Q12874;Splicing factor 3A subunit 3 (SF3a60) (Spliceosome-associated protein 61) (SAP 61)
drug.Protein;Q969G3;SMARCE1;ENSG00000073584;Q969G3;SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1 (BRG1-associated factor 57) (BAF57)
drug.Protein;O43399;TPD52L2;ENSG00000101150;O43399;Tumor protein D54 (hD54) (Tumor protein D52-like 2)
drug.Protein;P06753;TPM3;ENSG00000143549;P06753;Tropomyosin alpha-3 chain (Gamma-tropomyosin) (Tropomyosin-3) (Tropomyosin-5) (hTM5)
drug.Protein;P67936;TPM4;ENSG00000167460;P67936;Tropomyosin alpha-4 chain (TM30p1) (Tropomyosin-4)
drug.Protein;P10599;TXN;ENSG00000136810;P10599;Thioredoxin (Trx) (ATL-derived factor) (ADF) (Surface-associated sulphydryl protein) (SASP) (allergen Hom s Trx)
drug.Protein;P09936;UCHL1;ENSG00000154277;P09936;Ubiquitin carboxyl-terminal hydrolase isozyme L1 (UCH-L1) (EC 3.4.19.12) (Neuron cytoplasmic protein 9.5) (PGP 9.5) (PGP9.5) (Ubiquitin thioesterase L1)
drug.Protein;P54578;USP14;ENSG00000101557;P54578;Ubiquitin carboxyl-terminal hydrolase 14 (EC 3.4.19.12) (Deubiquitinating enzyme 14) (Ubiquitin thioesterase 14) (Ubiquitin-specific-processing protease 14)
drug.Protein;Q04917;YWHAH;ENSG00000128245;Q04917;14-3-3 protein eta (Protein AS1)
drug.Protein;P27348;YWHAQ;ENSG00000134308;P27348;14-3-3 protein theta (14-3-3 protein T-cell) (14-3-3 protein tau) (Protein HS1)
drug.Protein;P63104;YWHAZ;ENSG00000164924;P63104;14-3-3 protein zeta/delta (Protein kinase C inhibitor protein 1) (KCIP-1)
drug.Protein;Q9NRA0;SPHK2;ENSG00000063176;Q9NRA0;Sphingosine kinase 2 (SK 2) (SPK 2) (EC 2.7.1.91)
drug.Protein;P01563;IFNA2;ENSG00000188379;P01563;Interferon alpha-2 (IFN-alpha-2) (Interferon alpha-A) (LeIF A)
drug.Protein;Q13421;MSLN;ENSG00000102854;Q13421;"Mesothelin (CAK1 antigen) (Pre-pro-megakaryocyte-potentiating factor) [Cleaved into: Megakaryocyte-potentiating factor (MPF); Mesothelin, cleaved form]"
drug.Protein;Q76LX8;ADAMTS13;ENSG00000160323;Q76LX8;A disintegrin and metalloproteinase with thrombospondin motifs 13 (ADAM-TS 13) (ADAM-TS13) (ADAMTS-13) (EC 3.4.24.87) (von Willebrand factor-cleaving protease) (vWF-CP) (vWF-cleaving protease)
drug.Protein;Q15910;EZH2;ENSG00000106462;Q15910;Histone-lysine N-methyltransferase EZH2 (EC 2.1.1.356) (ENX-1) (Enhancer of zeste homolog 2) (Lysine N-methyltransferase 6)
drug.Protein;Q92800;EZH1;ENSG00000108799;Q92800;Histone-lysine N-methyltransferase EZH1 (EC 2.1.1.356) (ENX-2) (Enhancer of zeste homolog 1)
drug.Protein;P09758;TACSTD2;ENSG00000184292;P09758;Tumor-associated calcium signal transducer 2 (Cell surface glycoprotein Trop-2) (Membrane component chromosome 1 surface marker 1) (Pancreatic carcinoma marker protein GA733-1)
drug.Protein;Q96NY8;NECTIN4;ENSG00000143217;Q96NY8;Nectin-4 (Ig superfamily receptor LNIR) (Nectin cell adhesion molecule 4) (Poliovirus receptor-related protein 4) [Cleaved into: Processed poliovirus receptor-related protein 4]
drug.Protein;B4DP61;;;;
drug.Protein;P53794;SLC5A3;ENSG00000198743;P53794;Sodium/myo-inositol cotransporter (Na(+)/myo-inositol cotransporter) (Sodium/myo-inositol transporter 1) (SMIT1) (Solute carrier family 5 member 3)
drug.Protein;P81172;HAMP;ENSG00000105697;P81172;"Hepcidin (Liver-expressed antimicrobial peptide 1) (LEAP-1) (Putative liver tumor regressor) (PLTR) [Cleaved into: Hepcidin-25 (Hepc25); Hepcidin-20 (Hepc20)]"
drug.Protein;Q53TN4;CYBRD1;ENSG00000071967;Q53TN4;Plasma membrane ascorbate-dependent reductase CYBRD1 (EC 7.2.1.3) (Cytochrome b reductase 1) (Duodenal cytochrome b) (Ferric-chelate reductase 3)
drug.Protein;Q9NP59;SLC40A1;ENSG00000138449;Q9NP59;Solute carrier family 40 member 1 (Ferroportin-1) (Iron-regulated transporter 1)
drug.Protein;Q969S8;HDAC10;ENSG00000100429;Q969S8;Polyamine deacetylase HDAC10 (EC 3.5.1.48) (EC 3.5.1.62) (Histone deacetylase 10) (HD10)
drug.Protein;Q9HC29;NOD2;ENSG00000167207;Q9HC29;Nucleotide-binding oligomerization domain-containing protein 2 (Caspase recruitment domain-containing protein 15) (Inflammatory bowel disease protein 1)
drug.Protein;P06307;CCK;ENSG00000187094;P06307;"Cholecystokinin (CCK) [Cleaved into: Cholecystokinin-58 (CCK58); Cholecystokinin-58 desnonopeptide ((1-49)-CCK58); Cholecystokinin-39 (CCK39); Cholecystokinin-33 (CCK33); Cholecystokinin-25 (CCK25); Cholecystokinin-18 (CCK18); Cholecystokinin-12 (CCK12); Cholecystokinin-8 (CCK8); Cholecystokinin-7 (CCK7); Cholecystokinin-5 (CCK5)]"
drug.Protein;Q16518;RPE65;ENSG00000116745;Q16518;Retinoid isomerohydrolase (EC 3.1.1.64) (All-trans-retinyl-palmitate hydrolase) (Lutein isomerase) (Meso-zeaxanthin isomerase) (EC 5.3.3.22) (Retinal pigment epithelium-specific 65 kDa protein) (Retinol isomerase)
drug.Protein;Q14081;;;;
drug.Protein;Q6IQ20;NAPEPLD;ENSG00000161048;Q6IQ20;N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D (N-acyl phosphatidylethanolamine phospholipase D) (NAPE-PLD) (NAPE-hydrolyzing phospholipase D) (EC 3.1.4.54)
drug.Protein;Q7Z4T2;;;;
drug.Protein;P20393;NR1D1;ENSG00000126368;P20393;Nuclear receptor subfamily 1 group D member 1 (Rev-erbA-alpha) (V-erbA-related protein 1) (EAR-1)
drug.Protein;Q14995;NR1D2;ENSG00000174738;Q14995;Nuclear receptor subfamily 1 group D member 2 (Orphan nuclear hormone receptor BD73) (Rev-erb alpha-related receptor) (RVR) (Rev-erb-beta) (V-erbA-related protein 1-related) (EAR-1R)
drug.Protein;O75533;SF3B1;ENSG00000115524;O75533;Splicing factor 3B subunit 1 (Pre-mRNA-splicing factor SF3b 155 kDa subunit) (SF3b155) (Spliceosome-associated protein 155) (SAP 155)
drug.Protein;F5GY58;;;;
drug.Protein;Q9Y5I7;CLDN16;ENSG00000113946;Q9Y5I7;Claudin-16 (Paracellin-1) (PCLN-1)
drug.Protein;Q8IVJ1;SLC41A1;ENSG00000133065;Q8IVJ1;Solute carrier family 41 member 1
drug.Protein;Q9HD23;MRS2;ENSG00000124532;Q9HD23;Magnesium transporter MRS2 homolog, mitochondrial (MRS2-like protein)
drug.Protein;P00738;HP;ENSG00000257017;P00738;"Haptoglobin (Zonulin) [Cleaved into: Haptoglobin alpha chain; Haptoglobin beta chain]"
drug.Protein;P04114;APOB;ENSG00000084674;P04114;Apolipoprotein B-100 (Apo B-100) [Cleaved into: Apolipoprotein B-48 (Apo B-48)]
drug.Protein;P04196;HRG;ENSG00000113905;P04196;Histidine-rich glycoprotein (Histidine-proline-rich glycoprotein) (HPRG)
drug.Protein;P41238;APOBEC1;ENSG00000111701;P41238;C->U-editing enzyme APOBEC-1 (EC 3.5.4.36) (Apolipoprotein B mRNA-editing enzyme 1) (HEPR) (mRNA(cytosine(6666)) deaminase 1)
drug.Protein;Q02383;SEMG2;ENSG00000124157;Q02383;Semenogelin-2 (Semenogelin II) (SGII)
drug.Protein;Q9Y6M5;SLC30A1;ENSG00000170385;Q9Y6M5;Zinc transporter 1 (ZnT-1) (Solute carrier family 30 member 1)
drug.Protein;Q9BRI3;SLC30A2;ENSG00000158014;Q9BRI3;Zinc transporter 2 (ZnT-2) (Solute carrier family 30 member 2)
drug.Protein;Q99726;SLC30A3;ENSG00000115194;Q99726;Zinc transporter 3 (ZnT-3) (Solute carrier family 30 member 3)
drug.Protein;O14863;SLC30A4;ENSG00000104154;O14863;Zinc transporter 4 (ZnT-4) (Solute carrier family 30 member 4)
drug.Protein;Q6NXT4;SLC30A6;ENSG00000152683;Q6NXT4;Zinc transporter 6 (ZnT-6) (Solute carrier family 30 member 6)
drug.Protein;Q8TAD4;SLC30A5;ENSG00000145740;Q8TAD4;Zinc transporter 5 (ZnT-5) (Solute carrier family 30 member 5) (ZnT-like transporter 1) (hZTL1)
drug.Protein;Q8NEW0;SLC30A7;ENSG00000162695;Q8NEW0;Zinc transporter 7 (ZnT-7) (Solute carrier family 30 member 7) (Znt-like transporter 2)
drug.Protein;Q8IWU4;SLC30A8;ENSG00000164756;Q8IWU4;Zinc transporter 8 (ZnT-8) (Solute carrier family 30 member 8)
drug.Protein;Q6PML9;SLC30A9;ENSG00000014824;Q6PML9;Zinc transporter 9 (ZnT-9) (Human embryonic lung protein) (HuEL) (Solute carrier family 30 member 9)
drug.Protein;Q6XR72;SLC30A10;ENSG00000196660;Q6XR72;Zinc transporter 10 (ZnT-10) (Manganese transporter SLC30A10) (Solute carrier family 30 member 10)
drug.Protein;Q9NY26;SLC39A1;ENSG00000143570;Q9NY26;Zinc transporter ZIP1 (Solute carrier family 39 member 1) (Zinc-iron-regulated transporter-like) (Zrt- and Irt-like protein 1) (ZIP-1) (hZIP1)
drug.Protein;Q9NP94;SLC39A2;ENSG00000165794;Q9NP94;Zinc transporter ZIP2 (6A1) (Eti-1) (Solute carrier family 39 member 2) (Zrt- and Irt-like protein 2) (ZIP-2) (hZIP2)
drug.Protein;Q9BRY0;SLC39A3;ENSG00000141873;Q9BRY0;Zinc transporter ZIP3 (Solute carrier family 39 member 3) (Zrt- and Irt-like protein 3) (ZIP-3)
drug.Protein;Q6P5W5;SLC39A4;ENSG00000147804;Q6P5W5;Zinc transporter ZIP4 (Solute carrier family 39 member 4) (Zrt- and Irt-like protein 4) (ZIP-4)
drug.Protein;Q6ZMH5;SLC39A5;ENSG00000139540;Q6ZMH5;Zinc transporter ZIP5 (Solute carrier family 39 member 5) (Zrt- and Irt-like protein 5) (ZIP-5)
drug.Protein;Q13433;SLC39A6;ENSG00000141424;Q13433;Zinc transporter ZIP6 (Estrogen-regulated protein LIV-1) (Solute carrier family 39 member 6) (Zrt- and Irt-like protein 6) (ZIP-6)
drug.Protein;Q92504;SLC39A7;ENSG00000112473;Q92504;Zinc transporter SLC39A7 (Histidine-rich membrane protein Ke4) (Really interesting new gene 5 protein) (Solute carrier family 39 member 7) (Zrt-, Irt-like protein 7) (ZIP7)
drug.Protein;Q9C0K1;SLC39A8;ENSG00000138821;Q9C0K1;Metal cation symporter ZIP8 (BCG-induced integral membrane protein in monocyte clone 103 protein) (LIV-1 subfamily of ZIP zinc transporter 6) (LZT-Hs6) (Solute carrier family 39 member 8) (Zrt- and Irt-like protein 8) (ZIP-8)
drug.Protein;Q9NUM3;SLC39A9;ENSG00000029364;Q9NUM3;Zinc transporter ZIP9 (Solute carrier family 39 member 9) (Zrt- and Irt-like protein 9) (ZIP-9)
drug.Protein;Q9ULF5;SLC39A10;ENSG00000196950;Q9ULF5;Zinc transporter ZIP10 (Solute carrier family 39 member 10) (Zrt- and Irt-like protein 10) (ZIP-10)
drug.Protein;Q8N1S5;SLC39A11;ENSG00000133195;Q8N1S5;Zinc transporter ZIP11 (Solute carrier family 39 member 11) (Zrt- and Irt-like protein 11) (ZIP-11)
drug.Protein;Q504Y0;SLC39A12;ENSG00000148482;Q504Y0;Zinc transporter ZIP12 (LIV-1 subfamily of ZIP zinc transporter 8) (LZT-Hs8) (Solute carrier family 39 member 12) (Zrt- and Irt-like protein 12) (ZIP-12)
drug.Protein;Q96H72;SLC39A13;ENSG00000165915;Q96H72;Zinc transporter ZIP13 (LIV-1 subfamily of ZIP zinc transporter 9) (LZT-Hs9) (Solute carrier family 39 member 13) (Zrt- and Irt-like protein 13) (ZIP-13)
drug.Protein;Q15043;SLC39A14;ENSG00000104635;Q15043;Metal cation symporter ZIP14 (LIV-1 subfamily of ZIP zinc transporter 4) (LZT-Hs4) (Solute carrier family 39 member 14) (Zrt- and Irt-like protein 14) (ZIP-14)
drug.Protein;O75897;SULT1C4;ENSG00000198075;O75897;Sulfotransferase 1C4 (ST1C4) (EC 2.8.2.1) (Sulfotransferase 1C2) (SULT1C#2)
drug.Protein;P36404;ARL2;ENSG00000213465;P36404;ADP-ribosylation factor-like protein 2
drug.Protein;Q13535;ATR;ENSG00000175054;Q13535;Serine/threonine-protein kinase ATR (EC 2.7.11.1) (Ataxia telangiectasia and Rad3-related protein) (FRAP-related protein 1)
drug.Protein;P21730;C5AR1;ENSG00000197405;P21730;C5a anaphylatoxin chemotactic receptor 1 (C5a anaphylatoxin chemotactic receptor) (C5a-R) (C5aR) (CD antigen CD88)
drug.Protein;Q969D9;TSLP;ENSG00000145777;Q969D9;Thymic stromal lymphopoietin
drug.Protein;P32970;CD70;ENSG00000125726;P32970;CD70 antigen (CD27 ligand) (CD27-L) (Tumor necrosis factor ligand superfamily member 7) (CD antigen CD70)
drug.Protein;P51686;CCR9;ENSG00000173585;P51686;C-C chemokine receptor type 9 (C-C CKR-9) (CC-CKR-9) (CCR-9) (G-protein coupled receptor 28) (GPR-9-6) (CD antigen CDw199)
drug.Protein;P55899;FCGRT;ENSG00000104870;P55899;IgG receptor FcRn large subunit p51 (FcRn) (IgG Fc fragment receptor transporter alpha chain) (Neonatal Fc receptor)
drug.Protein;O15123;ANGPT2;ENSG00000091879;O15123;Angiopoietin-2 (ANG-2)
drug.Protein;Q9Y5C1;ANGPTL3;ENSG00000132855;Q9Y5C1;"Angiopoietin-related protein 3 (Angiopoietin-5) (ANG-5) (Angiopoietin-like protein 3) [Cleaved into: ANGPTL3(17-221); ANGPTL3(17-224)]"
drug.Protein;Q02153;GUCY1B1;ENSG00000061918;Q02153;Guanylate cyclase soluble subunit beta-1 (GCS-beta-1) (EC 4.6.1.2) (Guanylate cyclase soluble subunit beta-3) (GCS-beta-3) (Soluble guanylate cyclase small subunit)
drug.Protein;Q99814;EPAS1;ENSG00000116016;Q99814;Endothelial PAS domain-containing protein 1 (EPAS-1) (Basic-helix-loop-helix-PAS protein MOP2) (Class E basic helix-loop-helix protein 73) (bHLHe73) (HIF-1-alpha-like factor) (HLF) (Hypoxia-inducible factor 2-alpha) (HIF-2-alpha) (HIF2-alpha) (Member of PAS protein 2) (PAS domain-containing protein 2)
drug.Protein;Q8IXJ6;SIRT2;ENSG00000068903;Q8IXJ6;NAD-dependent protein deacetylase sirtuin-2 (EC 2.3.1.286) (NAD-dependent protein defatty-acylase sirtuin-2) (EC 2.3.1.-) (Regulatory protein SIR2 homolog 2) (SIR2-like protein 2)
drug.Protein;P35232;PHB1;ENSG00000167085;P35232;Prohibitin 1
drug.Protein;P11532;DMD;ENSG00000198947;P11532;Dystrophin
drug.Protein;Q5ZPR3;CD276;ENSG00000103855;Q5ZPR3;CD276 antigen (4Ig-B7-H3) (B7 homolog 3) (B7-H3) (Costimulatory molecule) (CD antigen CD276)
drug.Protein;Q02223;TNFRSF17;ENSG00000048462;Q02223;Tumor necrosis factor receptor superfamily member 17 (B-cell maturation protein) (CD antigen CD269)
drug.Protein;P09923;ALPI;ENSG00000163295;P09923;Intestinal-type alkaline phosphatase (IAP) (Intestinal alkaline phosphatase) (EC 3.1.3.1)
drug.Protein;P22760;AADAC;ENSG00000114771;P22760;Arylacetamide deacetylase (EC 3.1.1.3)
drug.Protein;P08476;INHBA;ENSG00000122641;P08476;Inhibin beta A chain (Activin beta-A chain) (Erythroid differentiation protein) (EDF)
drug.Protein;O60341;KDM1A;ENSG00000004487;O60341;Lysine-specific histone demethylase 1A (EC 1.14.99.66) (BRAF35-HDAC complex protein BHC110) (Flavin-containing amine oxidase domain-containing protein 2) ([histone H3]-dimethyl-L-lysine(4) FAD-dependent demethylase 1A)
drug.Protein;O60462;NRP2;ENSG00000118257;O60462;Neuropilin-2 (Vascular endothelial cell growth factor 165 receptor 2)
drug.Protein;O96007;MOCS2;ENSG00000164172;O96007;Molybdopterin synthase catalytic subunit (EC 2.8.1.12) (MOCO1-B) (Molybdenum cofactor synthesis protein 2 large subunit) (Molybdenum cofactor synthesis protein 2B) (MOCS2B) (Molybdopterin-synthase large subunit) (MPT synthase large subunit)
drug.Protein;Q504U8;;;;
drug.Protein;Q14242;SELPLG;ENSG00000110876;Q14242;P-selectin glycoprotein ligand 1 (PSGL-1) (Selectin P ligand) (CD antigen CD162)
drug.Protein;Q92952;KCNN1;ENSG00000105642;Q92952;Small conductance calcium-activated potassium channel protein 1 (SK1) (SKCa 1) (SKCa1) (KCa2.1)
drug.Protein;Q9H2S1;KCNN2;ENSG00000080709;Q9H2S1;Small conductance calcium-activated potassium channel protein 2 (SK2) (SKCa 2) (SKCa2) (KCa2.2)
drug.Protein;Q9UGI6;KCNN3;ENSG00000143603;Q9UGI6;Small conductance calcium-activated potassium channel protein 3 (SK3) (SKCa 3) (SKCa3) (KCa2.3)
